Disease trait	EFO term	EFO URI	Parent term	Parent URI
Clubfoot	familial clubfoot with or without associated lower limb anomalies	http://www.orpha.net/ORDO/Orphanet_199315	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Alcohol dependence or heroin dependence or methamphetamine dependence	metamphetamine dependence	http://www.ebi.ac.uk/efo/EFO_0004701	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Methamphetamine dependence	metamphetamine dependence	http://www.ebi.ac.uk/efo/EFO_0004701	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hypothyroidism	hypothyroidism	http://www.ebi.ac.uk/efo/EFO_0004705	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Age at menopause	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aging traits	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone geometry and menarche (age at onset)	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menarche and menopause (age at onset)	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menopause (age at onset)	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (hip) and age at menarche	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (spine) and age at menarche	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early age at menarche	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Late age at menarche	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lean body mass and age at menarche (combined)	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menarche (age at onset)	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menarche and menopause (age at onset)	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at smoking initiation in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Airway responsiveness in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma or chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass index (change over time) in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic bronchitis and chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic bronchitis in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic mucus hypersecretion in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease (moderate to severe)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease (severe)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease or stroke (pleiotropy)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic obstructive pulmonary disease-related biomarkers	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cotinine levels in smokers with chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Current cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lifetime average cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post bronchodilator FEV1 in COPD	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post bronchodilator FEV1/FVC ratio in COPD	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pulmonary artery enlargement and chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pulmonary artery enlargement in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to long-term oxygen therapy in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Smoking cessation in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Frontal lobe volume	frontal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010144	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Occipital lobe volume	occipital lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010145	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parietal lobe volume	parietal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010146	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Temporal lobe volume	temporal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010147	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pepsinogen-I levels	pepsinogen-I measurement	http://www.ebi.ac.uk/efo/EFO_0010148	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pepsinogen I/II ratio	pepsinogen I/II ratio	http://www.ebi.ac.uk/efo/EFO_0010149	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nodular sclerosis Hodgkin lymphoma	nodular sclerosis Hodgkin lymphoma	http://www.ebi.ac.uk/efo/EFO_0004708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Infantile hypertrophic pyloric stenosis	infantile hypertrophic pyloric stenosis	http://www.ebi.ac.uk/efo/EFO_0004707	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Opioid overdose severity score	opioid overdose severity measurement	http://www.ebi.ac.uk/efo/EFO_0010140	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
proportion of same-sex sexual behaviour among non-heterosexuals	same-sex sexual behavior	http://www.ebi.ac.uk/efo/EFO_0010142	Biological process	http://purl.obolibrary.org/obo/GO_0008150
same-sex sexual behaviour	same-sex sexual behavior	http://www.ebi.ac.uk/efo/EFO_0010142	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Chronic mountain sickness	chronic mountain sickness	http://www.ebi.ac.uk/efo/EFO_0010143	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lung function (FEV1/FVC)	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator FEV1/FVC ratio	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator FEV1/FVC ratio in COPD	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator FEV1/FVC ratio in smoking	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator lung function in asthma (FEV1/FVC)	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre bronchodilator FEV1/FVC ratio	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre bronchodilator FEV1/FVC ratio in never-smokers	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (smoking interaction)	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function decline	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Podoconiosis	podoconiosis	http://www.ebi.ac.uk/efo/EFO_0004712	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pelvic organ prolapse	pelvic organ prolapse	http://www.ebi.ac.uk/efo/EFO_0004710	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pelvic organ prolapse (moderate/severe)	pelvic organ prolapse	http://www.ebi.ac.uk/efo/EFO_0004710	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Brain infarct	mri defined brain infarct	http://www.ebi.ac.uk/efo/EFO_0004715	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Small subcortical brain infarct	mri defined brain infarct	http://www.ebi.ac.uk/efo/EFO_0004715	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Subclinical brain infarct	mri defined brain infarct	http://www.ebi.ac.uk/efo/EFO_0004715	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Oral cancers (chewing tobacco related)	mouth neoplasm	http://www.ebi.ac.uk/efo/EFO_0003868	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cerivastatin-induced rhabdomyolysis	rhabdomyolysis	http://www.ebi.ac.uk/efo/EFO_0003867	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sexual dysfunction (SSRI/SNRI-related)	sexual dysfunction	http://www.ebi.ac.uk/efo/EFO_0004714	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sexual dysfunction (female)	sexual dysfunction	http://www.ebi.ac.uk/efo/EFO_0004714	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombosis	abnormal thrombosis	http://purl.obolibrary.org/obo/HP_0001977	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Menstruation quality of life impact (joint pain)	arthralgia	http://purl.obolibrary.org/obo/HP_0002829	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Moyamoya disease	Moyamoya disease	http://www.orpha.net/ORDO/Orphanet_2573	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myopic maculopathy	myopic maculopathy severity measurement	http://www.ebi.ac.uk/efo/EFO_0009177	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in neurofilament light levels	neurofilament light chain measurement	http://www.ebi.ac.uk/efo/EFO_0009178	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma neurofilament light levels	neurofilament light chain measurement	http://www.ebi.ac.uk/efo/EFO_0009178	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	response to synacthen	http://www.ebi.ac.uk/efo/EFO_0009175	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	response to synacthen	http://www.ebi.ac.uk/efo/EFO_0009175	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sucrose liking	sucrose liking measurement	http://www.ebi.ac.uk/efo/EFO_0010157	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	adrenal suppression measurement	http://www.ebi.ac.uk/efo/EFO_0009176	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	adrenal suppression measurement	http://www.ebi.ac.uk/efo/EFO_0009176	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intake of sweets	sugar consumption	http://www.ebi.ac.uk/efo/EFO_0010158	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intake of total sugars	sugar consumption	http://www.ebi.ac.uk/efo/EFO_0010158	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pemphigus vulgaris	pemphigus vulgaris	http://www.ebi.ac.uk/efo/EFO_0004719	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+)	vascular dementia	http://www.ebi.ac.uk/efo/EFO_0004718	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)	vascular dementia	http://www.ebi.ac.uk/efo/EFO_0004718	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Vascular dementia	vascular dementia	http://www.ebi.ac.uk/efo/EFO_0004718	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cerebrospinal fluid sTREM-2 levels	soluble triggering receptor expressed on myeloid cells 2 measurement	http://www.ebi.ac.uk/efo/EFO_0010151	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phenylephrine infusion rate during anesthesia	response to phenylephrine	http://www.ebi.ac.uk/efo/EFO_0010152	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Serum platinum levels after completion of cisplatin chemotherapy	platinum measurement	http://www.ebi.ac.uk/efo/EFO_0010154	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteoarthritis	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (hand, severe)	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (hip)	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (hospital diagnosed)	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (self-reported)	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (with total hip replacement)	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis or femoral neck bone mineral density	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis or lumbar spine bone mineral density	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiac hypertrophy	cardiac hypertrophy	http://www.ebi.ac.uk/efo/EFO_0002503	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cutaneous lupus erythematosus	cutaneous lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0003834	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Glioblastoma	central nervous system cancer	http://www.ebi.ac.uk/efo/EFO_0000326	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glioma	central nervous system cancer	http://www.ebi.ac.uk/efo/EFO_0000326	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glioma (high-grade)	central nervous system cancer	http://www.ebi.ac.uk/efo/EFO_0000326	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-glioblastoma glioma	central nervous system cancer	http://www.ebi.ac.uk/efo/EFO_0000326	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	fever	http://purl.obolibrary.org/obo/HP_0001945	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Menstruation quality of life impact (fever)	fever	http://purl.obolibrary.org/obo/HP_0001945	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced fever in inflammatory bowel disease	fever	http://purl.obolibrary.org/obo/HP_0001945	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Carboplatin disposition in epthelial ovarian cancer	malignant epithelial tumor of ovary	http://www.orpha.net/ORDO/Orphanet_398934	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Epithelial ovarian cancer	malignant epithelial tumor of ovary	http://www.orpha.net/ORDO/Orphanet_398934	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Paclitaxel disposition in epithelial ovarian cancer	malignant epithelial tumor of ovary	http://www.orpha.net/ORDO/Orphanet_398934	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Vogt-Koyanagi-Harada syndrome	Vogt-Koyanagi-Harada disease	http://www.orpha.net/ORDO/Orphanet_3437	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	SPARC-like protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008289	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	small nuclear ribonucleoprotein F measurement	http://www.ebi.ac.uk/efo/EFO_0008288	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	tenascin measurement	http://www.ebi.ac.uk/efo/EFO_0008296	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	T-lymphocyte surface antigen Ly-9 measurement	http://www.ebi.ac.uk/efo/EFO_0008295	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Atorvastatin-induced myopathy	response to atorvastatin	http://www.ebi.ac.uk/efo/EFO_0010124	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	thioredoxin domain-containing protein 12 measurement	http://www.ebi.ac.uk/efo/EFO_0008298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	teratocarcinoma-derived growth factor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008297	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre-treatment viral load in HIV-1 infection	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre-treatment viral load in hepatitis C virus genotype 3	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking behaviour (age at first cigarette)	time to first cigarette measurement	http://www.ebi.ac.uk/efo/EFO_0010126	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Time to smoke first cigarette in the morning	time to first cigarette measurement	http://www.ebi.ac.uk/efo/EFO_0010126	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Stem cell growth factor beta levels	stem Cell Growth Factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008292	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgA x IgG x IgM)	serum immunoglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0010127	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Stem cell factor levels	stem Cell Factor measurement	http://www.ebi.ac.uk/efo/EFO_0008291	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	superoxide dismutase [Mn], mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008294	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgA x IgG)	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgA x IgG/IgM)	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgA/IgG)	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgA/IgM)	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Composite immunoglobulin trait (IgG/IgM)	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breakfast cereal skipping frequency	breakfast skipping measurement	http://www.ebi.ac.uk/efo/EFO_0010129	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breakfast skipping	breakfast skipping measurement	http://www.ebi.ac.uk/efo/EFO_0010129	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Stromal-cell-derived factor 1 alpha levels	stromal cell-derived factor 1 alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008293	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	spondin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008290	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Retinopathy in non-diabetics	retinopathy	http://www.ebi.ac.uk/efo/EFO_0003839	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Multiple traits (pleiotropy)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson disease and lewy body pathology	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (age at diagnosis)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (age of onset)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (coffee consumption interaction)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (familial)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (familial, age at onset)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (motor and cognition)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (non-familial, age at onset)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease (pesticide exposure interaction)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinson's disease in GBA mutation carriers (age at onset)	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinsonism in frontotemporal lobe dementia	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Fasting glucose change	fasting blood glucose change measurement	http://www.ebi.ac.uk/efo/EFO_0010120	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting glucose change (long-term)	fasting blood glucose change measurement	http://www.ebi.ac.uk/efo/EFO_0010120	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting glucose change (short-term)	fasting blood glucose change measurement	http://www.ebi.ac.uk/efo/EFO_0010120	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute post-radiotherapy pain in breast cancer	pain	http://www.ebi.ac.uk/efo/EFO_0003843	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Arthritic-like pain in Charcot-Marie-Tooth type 1A	pain	http://www.ebi.ac.uk/efo/EFO_0003843	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Pain	pain	http://www.ebi.ac.uk/efo/EFO_0003843	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Pre-treatment pain in head and neck squamous cell carcinoma	pain	http://www.ebi.ac.uk/efo/EFO_0003843	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Aggressive prostate cancer	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Erectile dysfunction and prostate cancer treatment	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (Gleason score)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (SNP x SNP interaction)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (advanced vs non-advanced)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (advanced)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (early onset)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer (survival)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer aggressiveness	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer aggressiveness (high vs low)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer aggressiveness (high vs low/intermediate)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer mortality	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in cancer (late toxicity)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in prostate cancer (overall toxicity)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in prostate cancer (toxicity)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Urinary symptoms in response to radiotherapy in prostate cancer	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy	http://www.orpha.net/ORDO/Orphanet_136	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Influenza (severity)	influenza infection	http://www.ebi.ac.uk/efo/EFO_0001669	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Chronic myeloid leukemia	chronic myelogenous leukemia	http://www.ebi.ac.uk/efo/EFO_0000339	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Kidney stones	kidney stone	http://www.ebi.ac.uk/efo/EFO_0003845	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	thrombospondin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008299	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brugada syndrome	Brugada syndrome	http://www.orpha.net/ORDO/Orphanet_130	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diabetic maculopathy in type 2 diabetes	diabetic maculopathy	http://www.ebi.ac.uk/efo/EFO_0010133	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic maculopathy with decreased visual acuity in type 2 diabetes	diabetic maculopathy	http://www.ebi.ac.uk/efo/EFO_0010133	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Anemia in mycophenolic acid treated kidney transplant patients (time to event)	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Tacrolimus trough concentration in kidney transplant patients	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Urine specific gravity measurement	urine specific gravity measurement	http://www.ebi.ac.uk/efo/EFO_0010135	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Low urine pH	urinary pH measurement	http://www.ebi.ac.uk/efo/EFO_0010136	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urine pH measurement	urinary pH measurement	http://www.ebi.ac.uk/efo/EFO_0010136	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Signs of urinary tract infection (nitrites and leukocyte esterase)	leukocyte esterase measurement	http://www.ebi.ac.uk/efo/EFO_0010137	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Signs of urinary tract infection (nitrites and leukocyte esterase)	nitrite measurement	http://www.ebi.ac.uk/efo/EFO_0010138	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fish intake frequency	fish consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010139	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mental health study participation (completed survey)	health study participation	http://www.ebi.ac.uk/efo/EFO_0010130	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Mental health study participation (provided email address)	health study participation	http://www.ebi.ac.uk/efo/EFO_0010130	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Walking difficulty in Charcot-Marie-Tooth disease 1A	decreased walking ability	http://www.ebi.ac.uk/efo/EFO_0010131	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	decreased fine motor function	http://www.ebi.ac.uk/efo/EFO_0010132	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	decreased fine motor function	http://www.ebi.ac.uk/efo/EFO_0010132	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Breslow thickness in cutaneous melanoma	cutaneous melanoma	http://www.ebi.ac.uk/efo/EFO_0000389	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cutaneous malignant melanoma	cutaneous melanoma	http://www.ebi.ac.uk/efo/EFO_0000389	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nevus count or cutaneous melanoma	cutaneous melanoma	http://www.ebi.ac.uk/efo/EFO_0000389	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lipoprotein (a) - cholesterol levels	lipoprotein A measurement	http://www.ebi.ac.uk/efo/EFO_0006925	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein (a) levels	lipoprotein A measurement	http://www.ebi.ac.uk/efo/EFO_0006925	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	lipoprotein A measurement	http://www.ebi.ac.uk/efo/EFO_0006925	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	lipoprotein A measurement	http://www.ebi.ac.uk/efo/EFO_0006925	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein phospholipase A2 activity in cardiovascular disease	lipoprotein-associated phospholipase a(2) measurement	http://www.ebi.ac.uk/efo/EFO_0004746	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	lipoprotein-associated phospholipase a(2) measurement	http://www.ebi.ac.uk/efo/EFO_0004746	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein-associated phospholipase A2 activity and mass	lipoprotein-associated phospholipase a(2) measurement	http://www.ebi.ac.uk/efo/EFO_0004746	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	lipoprotein-associated phospholipase a(2) measurement	http://www.ebi.ac.uk/efo/EFO_0004746	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Acute anterior uveitis in ankylosing spondylitis	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ankylosing spondylitis	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ankylosing spondylitis (SNP x SNP interaction)	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple traits (pleiotropy)	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
N-terminal pro B-type natriuretic peptide levels	nt-probnp measurement	http://www.ebi.ac.uk/efo/EFO_0004745	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Natriuretic peptide levels	nt-probnp measurement	http://www.ebi.ac.uk/efo/EFO_0004745	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	matrix metalloproteinase measurement	http://www.ebi.ac.uk/efo/EFO_0004744	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Matrix metalloproteinase levels	matrix metalloproteinase measurement	http://www.ebi.ac.uk/efo/EFO_0004744	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Oral cancers (chewing tobacco related)	matrix metalloproteinase measurement	http://www.ebi.ac.uk/efo/EFO_0004744	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiac muscle measurement	left ventricular hypertrophy	http://www.ebi.ac.uk/efo/EFO_0003896	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Facial morphology	facial morphology	http://www.ebi.ac.uk/efo/EFO_0004743	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Motion sickness	motion sickness	http://www.ebi.ac.uk/efo/EFO_0006928	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Gestational age at birth (child effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth (maternal effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in labor-initiated deliveries (child effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in labor-initiated deliveries (maternal effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-term birth	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spontaneous preterm birth (preterm birth)	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heart rate in heart failure with reduced ejection fraction	Reduced ejection fraction	http://purl.obolibrary.org/obo/HP_0012664	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Inflammatory biomarkers	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monocyte chemoattractant protein-1 levels	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Select biomarker traits	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spontaneous preterm birth (preterm delivery)	delivery measurement	http://www.ebi.ac.uk/efo/EFO_0006922	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma thyroid-stimulating hormone levels	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Quantitative traits	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum thyroid-stimulating hormone levels	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid hormone levels	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid stimulating hormone levels	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of children	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of children (6+ vs. 0 or 1)	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of live births	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of live births in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of miscarriages	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of miscarriages in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of pregnancies	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of stillbirths	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of stillbirths in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of live births	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of live births in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of miscarriages	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of miscarriages in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of stillbirths	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proportion of stillbirths in continuous marriage	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hematological and biochemical traits	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin A	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (small molecules and protein measures)	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (fetal genetic effect)	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (maternal genetic effect)	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-albumin protein levels	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein biomarker	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer (household air pollution interaction)	household air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0006924	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Addiction	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol or illicit drug dependence	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cannabis use (initiation)	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Drug abuse	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Substance dependence	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Substance dependence phenotypes	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Substance use disorder	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
B-type natriuretic peptide levels	BNP measurement	http://www.ebi.ac.uk/efo/EFO_0006920	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Beta-trace protein levels	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function and chronic kidney disease	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function-related traits (BUN)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function-related traits (eGRFcrea)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function-related traits (sCR)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function-related traits (urea)	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acne (severe teenage)	acne	http://www.ebi.ac.uk/efo/EFO_0003894	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Acne (severe)	acne	http://www.ebi.ac.uk/efo/EFO_0003894	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Menstruation quality of life impact (acne)	acne	http://www.ebi.ac.uk/efo/EFO_0003894	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood urea nitrogen levels	blood urea nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0004741	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	blood urea nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0004741	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal function-related traits (BUN)	blood urea nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0004741	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urea levels	blood urea nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0004741	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airflow obstruction	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<70%) in ever smokers	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<70%) in never smokers	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (maximal voluntary ventilation)	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator lung function in asthma (FEV1)	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator lung function in asthma (FEV1/FVC)	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (smoking interaction)	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function in asthmatics	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Anti-adalimumab antibody production in response to treatment in Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease (indolent vs progressive)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease (need for surgery)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease (time to first abdominal surgery)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease (time to progression)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease (time to surgery)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease and celiac disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease and psoriasis	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease and sarcoidosis (combined)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease-related phenotypes	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Inflammatory bowel disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Infliximab-induced mucosal healing in Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Paneth cell defects in Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Pediatric autoimmune diseases	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Poor prognosis in Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced early leukopenia in Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Ulcerative colitis or Crohn's disease	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Craniofacial microsomia	Hemifacial microsomia	http://www.orpha.net/ORDO/Orphanet_141136	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cytomegalovirus antibody response	response to virus	http://purl.obolibrary.org/obo/GO_0009615	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HIV-1 viral setpoint	response to virus	http://purl.obolibrary.org/obo/GO_0009615	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Immunoglobulin G index levels in multiple sclerosis	IgG index	http://www.ebi.ac.uk/efo/EFO_0006929	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Open-angle glaucoma and optic disc area	optic disc area measurement	http://www.ebi.ac.uk/efo/EFO_0006937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic disc area	optic disc area measurement	http://www.ebi.ac.uk/efo/EFO_0006937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dermatomyositis	dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0000398	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Dermatomyositis or juvenile dermatomyositis	dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0000398	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Inflammatory biomarkers	interleukin 1 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0004754	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Interleukin-1-receptor antagonist levels	interleukin 1 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0004754	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin 1 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0004754	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Open-angle glaucoma and vertical cup-disc ratio	cup-to-disc ratio measurement	http://www.ebi.ac.uk/efo/EFO_0006939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic nerve measurement (cup-to-disc ratio)	cup-to-disc ratio measurement	http://www.ebi.ac.uk/efo/EFO_0006939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vertical cup-disc ratio	cup-to-disc ratio measurement	http://www.ebi.ac.uk/efo/EFO_0006939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	putamen volume	http://www.ebi.ac.uk/efo/EFO_0006932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen volume	putamen volume	http://www.ebi.ac.uk/efo/EFO_0006932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen volume in trauma-exposed individuals	putamen volume	http://www.ebi.ac.uk/efo/EFO_0006932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcortical brain region volumes	putamen volume	http://www.ebi.ac.uk/efo/EFO_0006932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	pallidum volume	http://www.ebi.ac.uk/efo/EFO_0006933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pallidum volume in trauma-exposed individuals	pallidum volume	http://www.ebi.ac.uk/efo/EFO_0006933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amygdala volume in trauma-exposed individuals	amygdala volume	http://www.ebi.ac.uk/efo/EFO_0006934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	amygdala volume	http://www.ebi.ac.uk/efo/EFO_0006934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	thalamus volume	http://www.ebi.ac.uk/efo/EFO_0006935	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thalamus volume in trauma-exposed individuals	thalamus volume	http://www.ebi.ac.uk/efo/EFO_0006935	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Severe aortic features in Marfan syndrome	Marfan syndrome	http://www.orpha.net/ORDO/Orphanet_558	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety disorder or brain volume (pleiotropy)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cortical brain region measurements (area, volume and thickness)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-traumatic stress disorder or brain volume (pleiotropy)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcortical brain region volumes	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total ventricular volume	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total ventricular volume (Alzheimer's disease interaction)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tourette syndrome or brain region volumes (pleiotropy)	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	nucleus accumbens volume	http://www.ebi.ac.uk/efo/EFO_0006931	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nucleus accumbens volume in trauma-exposed individuals	nucleus accumbens volume	http://www.ebi.ac.uk/efo/EFO_0006931	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-12p70 levels	interleukin 12 measurement	http://www.ebi.ac.uk/efo/EFO_0004753	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	interleukin 12 measurement	http://www.ebi.ac.uk/efo/EFO_0004753	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma parathyroid hormone levels	parathyroid hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004752	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	parathyroid hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004752	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum parathyroid hormone levels	parathyroid hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004752	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	CCL4 measurement	http://www.ebi.ac.uk/efo/EFO_0004751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	CCL4 measurement	http://www.ebi.ac.uk/efo/EFO_0004751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	CCL4 measurement	http://www.ebi.ac.uk/efo/EFO_0004751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-10 levels	interleukin 10 measurement	http://www.ebi.ac.uk/efo/EFO_0004750	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin 10 measurement	http://www.ebi.ac.uk/efo/EFO_0004750	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin 10 measurement	http://www.ebi.ac.uk/efo/EFO_0004750	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Orofacial clefts	oral cleft	http://purl.obolibrary.org/obo/HP_0000202	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Aortic stiffness	carotid-femoral pulse wave velocity	http://www.ebi.ac.uk/efo/EFO_0004724	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cystic fibrosis severity	cystic fibrosis	http://www.orpha.net/ORDO/Orphanet_586	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cystic fibrosis-related diabetes	cystic fibrosis	http://www.orpha.net/ORDO/Orphanet_586	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lung disease severity in cystic fibrosis	cystic fibrosis	http://www.orpha.net/ORDO/Orphanet_586	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Endothelial growth factor levels	hepatocyte growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0006903	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hepatocyte growth factor levels	hepatocyte growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0006903	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Neuroendocrine tumor	neuroendocrine neoplasm	http://www.ebi.ac.uk/efo/EFO_1001901	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Coronary artery calcification	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coronary artery calcification (smoking interaction)	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Metabolite levels	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Severe coronary artery calcification	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Liver injury in anti-retroviral drug treated HIV	response to efavirenz	http://www.ebi.ac.uk/efo/EFO_0006904	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	response to efavirenz	http://www.ebi.ac.uk/efo/EFO_0006904	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	response to efavirenz	http://www.ebi.ac.uk/efo/EFO_0006904	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006905	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006906	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006906	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006906	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amyloid A serum levels	serum amyloid a protein measurement	http://www.ebi.ac.uk/efo/EFO_0004728	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Endothelial growth factor levels	endothelial growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0006900	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Endothelial growth factor levels	angiopoietin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0006901	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Endothelial growth factor levels	angiopoietin-2 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0006902	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Malate levels	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolic traits	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite risk score for predicting weight gain	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Niacinamide levels	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Uridine levels	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary metabolites	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Xanthine levels	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plantar fascial disorders	Plantar Fasciitis	http://www.ebi.ac.uk/efo/EFO_1001909	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Behavioral disturbance or psychiatric symptoms and prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Behavioral disturbance or psychiatric symptoms in prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mood disorder and prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mood disorder in prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Prion diseases	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychotic symptoms and prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychotic symptoms in prion disease	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal fluid beta-site APP cleaving enzyme levels	beta-secretase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0009179	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intracranial aneurysm	brain aneurysm	http://www.ebi.ac.uk/efo/EFO_0003870	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	brain aneurysm	http://www.ebi.ac.uk/efo/EFO_0003870	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Pneumoconiosis in silica exposure	pneumoconiosis	http://www.orpha.net/ORDO/Orphanet_182098	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Hyperthyroidism	hyperthyroidism	http://www.ebi.ac.uk/efo/EFO_0009189	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Hematology traits	platelet larger cell ratio	http://www.ebi.ac.uk/efo/EFO_0009186	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Heart rate increase in response to exercise	heart rate response to exercise	http://www.ebi.ac.uk/efo/EFO_0009184	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to exercise	heart rate response to exercise	http://www.ebi.ac.uk/efo/EFO_0009184	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise (10 sec)	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise (20 sec)	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise (30 sec)	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise (40 sec)	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to recovery post exercise (50 sec)	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Anhedonia	psychotic symptom measurement	http://www.ebi.ac.uk/efo/EFO_0009182	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive disorganisation	psychotic symptom measurement	http://www.ebi.ac.uk/efo/EFO_0009182	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Paranoia and hallucinations	psychotic symptom measurement	http://www.ebi.ac.uk/efo/EFO_0009182	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parent-rated negative symptoms	psychotic symptom measurement	http://www.ebi.ac.uk/efo/EFO_0009182	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive empathy	empathy measurement	http://www.ebi.ac.uk/efo/EFO_0009183	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Empathy quotient	empathy measurement	http://www.ebi.ac.uk/efo/EFO_0009183	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rosacea symptom severity	rosacea severity measurement	http://www.ebi.ac.uk/efo/EFO_0009180	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Growth differentiation factor-15 levels	growth differentiation factor 15 measurement	http://www.ebi.ac.uk/efo/EFO_0009181	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Growth differentiation factor-15 levels (conditioned on rs888663)	growth differentiation factor 15 measurement	http://www.ebi.ac.uk/efo/EFO_0009181	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Folate pathway vitamin levels	vitamin measurement	http://www.ebi.ac.uk/efo/EFO_0004729	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aggressiveness in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asthma and attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder (combined symptoms)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder (inattention symptoms)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder (sex interaction)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder (time to onset)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder and conduct disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder and obsessive compulsive disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder motor coordination	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or cannabis use	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention function in attention deficit hyperactive disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder or attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Emotional lability in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Executive function in ADHD	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Persistent attention-deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric diseases (pleiotropy) (HIPO component 1)	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder without cannabis use disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Sex difference in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alanine aminotransferase levels	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alanine aminotransferase levels in excessive alcohol consumption	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alanine aminotransferase levels in low alcohol consumption	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alanine aminotransferase levels in non-alcoholic fatty liver disease	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alanine transaminase levels	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Hematological and biochemical traits	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver disease biomarker	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels (alanine transaminase)	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Metabolite levels	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Non-alcoholic fatty liver disease histology (other)	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Obesity-related traits	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Response to Pazopanib in cancer (hepatotoxicity)	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Select biomarker traits	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Birth weight or coronary artery disease (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease and HDL cholesterol levels (multivariate analysis)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease and LDL cholesterol levels (multivariate analysis)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease and total cholesterol levels (multivariate analysis)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease and triglyceride levels (multivariate analysis)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease and/or body mass index (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease in diabetes	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease in type 1 diabetes	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease severity measurement	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine or coronary artery disease	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Severe depressive disorders in coronary artery disease	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Type 2 diabetes or coronary artery disease (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Type 2 diabetes or obesity or coronary artery disease (pleiotropy)	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0000378	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Anti-citrullinated peptide antibody	anti-cyclic citrullinated peptide antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004733	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-cyclic Citrullinated Peptide Antibody	anti-cyclic citrullinated peptide antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004733	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to Dalcetrapib treatment in acute coronary syndrome	response to dalcetrapib	http://www.ebi.ac.uk/efo/EFO_0006916	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Apolipoprotein Levels	lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (lipoprotein measures)	lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain lesion load	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic lymphocytic leukemia or multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Diffuse large B-cell lymphoma or multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Drug-induced liver injury in interferon-beta-treated multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Follicular lymphoma or multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Immunoglobulin G index levels in multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Marginal zone lymphoma or multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis (OCB status)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis (age of onset)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis (severity)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and C-reactive protein levels (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and HDL levels (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and LDL levels (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and body mass index (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and systolic blood pressure (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and triglyceride levels (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and type 2 diabetes (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis or amyotrophic lateral sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple sclerosis--Brain Glutamate Levels	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple traits (pleiotropy)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Normalized brain volume	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Oligoclonal band status in multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Relapse in multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to interferon beta in multiple sclerosis	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Early spontaneous preterm birth	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Moderate-to-late spontaneous preterm birth	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spontaneous preterm birth (maternal effect)	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spontaneous preterm birth (preterm birth)	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spontaneous preterm birth (preterm delivery)	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spontaneous preterm birth with premature rupture of membranes	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spontaneous preterm birth without premature rupture of membranes	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Circulating cell-free DNA	circulating cell free dna measurement	http://www.ebi.ac.uk/efo/EFO_0004739	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotenoid and tocopherol levels	tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0004738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotenoid and tocopherol levels	carotenoid measurement	http://www.ebi.ac.uk/efo/EFO_0004737	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aspartate aminotransferase levels	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Aspartate aminotransferase levels in excessive alcohol consumption	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Aspartate aminotransferase levels in low alcohol consumption	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Aspartate aminotransferase levels in non-alcoholic fatty liver disease	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Cardiovascular disease risk factors	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Hematological and biochemical traits	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels (aspartate transaminase)	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Obesity-related traits	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Protein quantitative trait loci	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Brain cytoarchitecture	prefrontal cortex cytoarchtiectural measurement	http://www.ebi.ac.uk/efo/EFO_0006913	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Common traits (Other)	functional laterality	http://www.ebi.ac.uk/efo/EFO_0003889	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to bleomycin (chromatid breaks)	response to antibiotic	http://purl.obolibrary.org/obo/GO_0046677	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Central corneal thickness	eye measurement	http://www.ebi.ac.uk/efo/EFO_0004731	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iris characteristics	eye measurement	http://www.ebi.ac.uk/efo/EFO_0004731	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Retinal arteriolar caliber	eye measurement	http://www.ebi.ac.uk/efo/EFO_0004731	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Retinal vascular caliber	eye measurement	http://www.ebi.ac.uk/efo/EFO_0004731	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease and diabetic kidney disease in diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease and diabetic kidney disease in type 2 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease and serum creatinine levels	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease in diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic kidney disease in type 2 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Dialysis-related mortality	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End stage renal disease in APOL1 risk genotype-negative individuals	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End stage renal disease in APOL1 risk genotype-positive individuals	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End stage renal disease x APOL1 genotype interaction	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End stage renal failure in renal transplantation (recipient effect)	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease (non-diabetic)	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease in Type 1 diabetics	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease in diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease in type 2 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
End-stage renal disease or diabetic nephropathy in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Fractional excretion of metabolites in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Glomerular filtration rate in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Gout in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Incident chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney disease (early and late stages) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney disease (early stage) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney disease (late stage) in type 1 diabetes	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kidney function decline traits	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Mild to moderate chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Proteinuria and chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Proteinuria in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Renal function and chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Serum metabolite concentrations in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Serum metabolite ratios in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Serum urate levels in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Urinary metabolite concentrations in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Urinary metabolite ratios in chronic kidney disease	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Dehydroepiandrosterone sulphate levels	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Testosterone levels	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid hormone levels	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone fracture in osteoporosis	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Obesity and osteoporosis	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoporosis	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoporosis or obesity (pleiotropy)	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoporosis-related phenotypes	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy (congestive heart failure) in breast cancer	congestive heart failure	http://www.ebi.ac.uk/efo/EFO_0000373	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lobar intracerebral hemorrhage	lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010177	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lobar intracerebral hemorrhage (MTAG)	lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010177	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Non-lobar intracerebral hemorrhage	non-lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010178	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Non-lobar intracerebral hemorrhage (MTAG)	non-lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010178	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Number of children	female fertility	http://www.ebi.ac.uk/efo/EFO_0006918	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Number of children (6+ vs. 0 or 1)	female fertility	http://www.ebi.ac.uk/efo/EFO_0006918	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Number of pregnancies	female fertility	http://www.ebi.ac.uk/efo/EFO_0006918	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coronary heart disease events during statin therapy	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Major coronary event in darapladib-treated cardiovascular disease (time to event)	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Major coronary event in placebo-treated cardiovascular disease (time to event)	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to Dalcetrapib treatment in acute coronary syndrome	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Obstructive sleep apnea (average oxygen saturation during sleep)	sleep apnea measurement	http://www.ebi.ac.uk/efo/EFO_0007817	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obstructive sleep apnea trait (apnea hypopnea index)	sleep apnea measurement	http://www.ebi.ac.uk/efo/EFO_0007817	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obstructive sleep apnea trait (average respiratory event duration)	sleep apnea measurement	http://www.ebi.ac.uk/efo/EFO_0007817	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Red blood cell traits	erythrocyte indices	http://www.ebi.ac.uk/efo/EFO_0004306	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	response to trametinib	http://www.ebi.ac.uk/efo/EFO_0007816	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood cell traits (multivariate analysis)	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological parameters	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemostatic factors and hematological phenotypes	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Other erythrocyte phenotypes	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell count	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Select biomarker traits	atrial natriuretic factor measurement	http://www.ebi.ac.uk/efo/EFO_0004789	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Advanced glycation end-product levels	advanced glycation end-product measurement	http://www.ebi.ac.uk/efo/EFO_0007819	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Erythrocyte sedimentation rate	blood sedimentation	http://www.ebi.ac.uk/efo/EFO_0004304	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Inflammatory biomarkers	blood sedimentation	http://www.ebi.ac.uk/efo/EFO_0004304	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	blood sedimentation	http://www.ebi.ac.uk/efo/EFO_0004304	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Endurance athleticism	athletic endurance measurement	http://www.ebi.ac.uk/efo/EFO_0007818	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
World class endurance athleticism	athletic endurance measurement	http://www.ebi.ac.uk/efo/EFO_0007818	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cotinine levels in current smokers	cotinine measurement	http://www.ebi.ac.uk/efo/EFO_0007813	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cotinine levels in smokers with chronic obstructive pulmonary disease	cotinine measurement	http://www.ebi.ac.uk/efo/EFO_0007813	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood cell traits (multivariate analysis)	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cardiometabolic and hematological traits	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological parameters	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Platelet count	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Platelet count and reactivity phenotypes	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)	Plasmodium falciparum antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007812	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	response to dabrafenib	http://www.ebi.ac.uk/efo/EFO_0007815	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood cell traits (multivariate analysis)	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
C-reactive protein and white blood cell count	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cardiometabolic and hematological traits	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological parameters	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Leukocyte count in ischemic stroke	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Low white blood cell count	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Low white blood cell count (conditioned on rs2814778)	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell types	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Axial length or spherical error (univariate decomposition analysis)	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical equivalent	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical equivalent (joint analysis main effects and education interaction)	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical equivalent or myopia (age of diagnosis)	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical error	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GIP levels in response to oral glucose tolerance test (120 minutes)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GIP levels in response to oral glucose tolerance test (fasting)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GLP-1 levels in response to oral glucose tolerance test (120 minutes)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GLP-1 levels in response to oral glucose tolerance test (fasting)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucagon levels in response to oral glucose tolerance test (120 minutes)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucagon levels in response to oral glucose tolerance test (fasting)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (multi-trait analysis)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (pregnancy)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (120 minutes)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (30 minutes)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (fasting)	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Two-hour glucose	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Two-hour glucose challenge	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Restricted and repetitive behaviours in autism spectrum disorder	behavior or behavioral disorder measurement	http://www.ebi.ac.uk/efo/EFO_0004782	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social and non-social autistic-like traits	behavior or behavioral disorder measurement	http://www.ebi.ac.uk/efo/EFO_0004782	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Temperament (bipolar disorder)	behavior or behavioral disorder measurement	http://www.ebi.ac.uk/efo/EFO_0004782	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)	Plasmodium falciparum antigen IgG3 measurement	http://www.ebi.ac.uk/efo/EFO_0007811	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)	Plasmodium falciparum antigen IgG3 measurement	http://www.ebi.ac.uk/efo/EFO_0007811	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG1 response to Plasmodium falciparum antigen (GLURP)	Plasmodium falciparum antigen IgG1 measurement	http://www.ebi.ac.uk/efo/EFO_0007810	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG1 response to Plasmodium falciparum antigen (MSP1)	Plasmodium falciparum antigen IgG1 measurement	http://www.ebi.ac.uk/efo/EFO_0007810	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits in newborns	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (anthropometric measures interaction)	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Height	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sexual dimorphism in anthropometric traits	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-hip ratio	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hemostatic factors and hematological phenotypes	blood viscosity	http://www.ebi.ac.uk/efo/EFO_0004301	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Neuranatomic and neurocognitive phenotypes	south texas assessment of neurocognition	http://www.ebi.ac.uk/efo/EFO_0004785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aging (time to death)	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lifespan	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longevity	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longevity (85 years and older)	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longevity (90 years and older)	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longevity (age >90th survival percentile)	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longevity (age >99th survival percentile)	longevity	http://www.ebi.ac.uk/efo/EFO_0004300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Autism and educational attainment (MTAG)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive ability (MTAG)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Educational attainment	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Educational attainment (MTAG)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Educational attainment (college completion)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Educational attainment (years of education)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical equivalent (joint analysis main effects and education interaction)	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	metastatic colorectal cancer	http://www.ebi.ac.uk/efo/EFO_1001480	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	metastatic colorectal cancer	http://www.ebi.ac.uk/efo/EFO_1001480	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	metastatic colorectal cancer	http://www.ebi.ac.uk/efo/EFO_1001480	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Anthracycline-induced cardiotoxicity in childhood cancer	cardiotoxicity	http://www.ebi.ac.uk/efo/EFO_1001482	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Nonobstructive coronary artery disease	non-obstructive coronary artery disease	http://www.ebi.ac.uk/efo/EFO_1001483	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Anti-gp210 seropositivity in primary biliary cholangitis	primary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001486	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Anti-sp100 seropositivity in primary biliary cholangitis	primary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001486	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Primary biliary cholangitis	primary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001486	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Primary biliary cirrhosis	primary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001486	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Common traits (Other)	Sneeze	http://purl.obolibrary.org/obo/HP_0025095	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Influenza A (H1N1) infection	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Mild influenza (H1N1) infection	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Severe influenza A (H1N1) infection	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Skin and soft tissue Staphylococcus aureus infection	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Daytime nap	daytime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007828	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Daytime sleep phenotypes	daytime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007828	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diurnal inactivity	daytime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007828	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Extraversion	extraversion	http://www.ebi.ac.uk/efo/EFO_0004317	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Night sleep phenotypes	nighttime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007827	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholelithiasis-related traits in sickle cell anemia	cholelithiasis	http://www.ebi.ac.uk/efo/EFO_0004799	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Gallstone disease	cholelithiasis	http://www.ebi.ac.uk/efo/EFO_0004799	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drinking behavior	drinking behavior	http://www.ebi.ac.uk/efo/EFO_0004315	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Asthma (bronchodilator response)	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bronchodilator response in asthma	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post bronchodilator FEV1	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post bronchodilator FEV1 in COPD	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post bronchodilator FEV1/FVC ratio	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post bronchodilator FEV1/FVC ratio in COPD	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post-bronchodilator lung function in asthma (FEV1)	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Post-bronchodilator lung function in asthma (FEV1/FVC)	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
FEV1	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (forced expiratory volume in 1 second)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (low FEV1 vs high FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (low FEV1 vs high FEV1) x smoking interaction	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (high FEV1 vs average FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (low FEV1 vs average FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (low FEV1 vs high FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (high FEV1 vs average FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (low FEV1 vs average FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (low FEV1 vs high FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator FEV1	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator FEV1 in COPD	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post bronchodilator percent predicted FEV1 in smoking	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator lung function in asthma (FEV1)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre bronchodilator FEV1	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (smoking interaction)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function decline	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function in asthmatics	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rate of change of FEV1 (time interaction)	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food addiction	eating behaviour	http://www.ebi.ac.uk/efo/EFO_0007829	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Menstruation quality of life impact (increased appetite)	eating behaviour	http://www.ebi.ac.uk/efo/EFO_0007829	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Hair shape	hair shape measurement	http://www.ebi.ac.uk/efo/EFO_0007824	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Scalp hair shape	hair shape measurement	http://www.ebi.ac.uk/efo/EFO_0007824	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Beard thickness	facial hair thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007823	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eyebrow thickness	facial hair thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007823	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monobrow thickness	facial hair thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007823	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thick vs thin eyebrows	facial hair thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007823	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
3-hydroxypropylmercapturic acid levels in smokers	smoking cessation	http://www.ebi.ac.uk/efo/EFO_0004319	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking cessation	smoking cessation	http://www.ebi.ac.uk/efo/EFO_0004319	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking cessation (MTAG)	smoking cessation	http://www.ebi.ac.uk/efo/EFO_0004319	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking cessation in chronic obstructive pulmonary disease	smoking cessation	http://www.ebi.ac.uk/efo/EFO_0004319	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aggressiveness in attention deficit hyperactivity disorder	aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007826	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
3-hydroxy-1-methylpropylmercapturic acid levels in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
3-hydroxypropylmercapturic acid levels in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Adult onset asthma (smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Adult onset asthma in ever-smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
BMI (adjusted for smoking behaviour)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
BMI (smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
BMI in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood pressure (smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Body mass index (joint analysis main effects and smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bone mineral density x blood lead interaction in current smokers (1df test)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bone mineral density x blood lead interaction in current smokers (2df test)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Depression in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Emphysema distribution in smoking	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Exhaled carbon monoxide levels	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
MGMT methylation in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Non-small cell lung cancer in heavy smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Post bronchodilator FEV1/FVC ratio in smoking	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Post bronchodilator percent predicted FEV1 in smoking	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
S-phenylmercapturic acid levels in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking behavior	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking interaction in lung adenocarcinoma (1df test)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking interaction in non-small cell lung cancer (1df test)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking interaction in squamous cell lung cancer (1df test)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking status (ever vs never smokers)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist circumference adjusted for BMI (adjusted for smoking behaviour)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist circumference adjusted for BMI (smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist circumference adjusted for BMI in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist-to-hip ratio adjusted for BMI (smoking interaction)	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Waist-to-hip ratio adjusted for BMI in smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
nicotine metabolite ratio in current smokers	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Balding	balding measurement	http://www.ebi.ac.uk/efo/EFO_0007825	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Balding type 1	balding measurement	http://www.ebi.ac.uk/efo/EFO_0007825	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hair morphology traits	balding measurement	http://www.ebi.ac.uk/efo/EFO_0007825	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Male-pattern baldness	balding measurement	http://www.ebi.ac.uk/efo/EFO_0007825	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to cognitive-behavioural therapy in anxiety and major depressive disorders	cognitive behavioural therapy	http://www.ebi.ac.uk/efo/EFO_0007820	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to cognitive-behavioural therapy in anxiety disorder	cognitive behavioural therapy	http://www.ebi.ac.uk/efo/EFO_0007820	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to cognitive-behavioural therapy in major depressive disorder	cognitive behavioural therapy	http://www.ebi.ac.uk/efo/EFO_0007820	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hemostatic factors and hematological phenotypes	plasminogen activator inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004792	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasminogen activator inhibitor type 1 levels (PAI-1)	plasminogen activator inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004792	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasminogen activator inhibitor-1 (PAI-1) levels	plasminogen activator inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004792	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hair color	hair colour measurement	http://www.ebi.ac.uk/efo/EFO_0007822	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hair greying	hair colour measurement	http://www.ebi.ac.uk/efo/EFO_0007822	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hair morphology traits	hair colour measurement	http://www.ebi.ac.uk/efo/EFO_0007822	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin, hair and eye pigmentation (multivariate analysis)	hair colour measurement	http://www.ebi.ac.uk/efo/EFO_0007822	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hemostatic factors and hematological phenotypes	tissue plasminogen activator measurement	http://www.ebi.ac.uk/efo/EFO_0004791	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Plasma plasminogen activator levels	tissue plasminogen activator measurement	http://www.ebi.ac.uk/efo/EFO_0004791	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hair morphology traits	hair morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007821	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Straight vs curly hair	hair morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007821	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Select biomarker traits	CD40 ligand measurement	http://www.ebi.ac.uk/efo/EFO_0004790	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Soluble CD40 ligand levels	CD40 ligand measurement	http://www.ebi.ac.uk/efo/EFO_0004790	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	maximal midexpiratory flow rate	http://www.ebi.ac.uk/efo/EFO_0004313	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FVC)	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (forced vital capacity)	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean forced vital capacity from 2 exams	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Atrioventricular conduction	heart function measurement	http://www.ebi.ac.uk/efo/EFO_0004311	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS duration	heart function measurement	http://www.ebi.ac.uk/efo/EFO_0004311	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Skin sensitivity to sun	skin sensitivity to sun	http://www.ebi.ac.uk/efo/EFO_0004795	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Activated partial thromboplastin time	partial thromboplastin time	http://www.ebi.ac.uk/efo/EFO_0004310	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Antipsychotic drug-induced QTc interval change in schizophrenia	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Antipsychotic drug-induced QTc interval prolongation	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Resistance to antipsychotic treatment in schizophrenia	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic therapy (extrapyramidal side effects)	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment in schizophrenia	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to aripiprazole in schizophrenia	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to lurasidone in schizophrenia	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Follicule stimulating hormone	follicle stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Follicule stimulating hormone levels in polycystic ovary syndrome	follicle stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	follicle stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Red wine liking	red wine liking measurement	http://www.ebi.ac.uk/efo/EFO_0006947	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue/subcutaneous adipose tissue ratio	visceral:subcutaneous adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0004767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	visceral:subcutaneous adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0004767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	visceral:subcutaneous adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0004767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White wine liking	white wine liking measurement	http://www.ebi.ac.uk/efo/EFO_0006948	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to antipsychotic treatment	response to perphenazine	http://purl.obolibrary.org/obo/GO_0097334	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to perphenazine in schizophrenia	response to perphenazine	http://purl.obolibrary.org/obo/GO_0097334	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Subcutaneous adipose tissue	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcutaneous adipose tissue (sex interaction)	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcutaneous adipose tissue adjusted for BMI	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subscapular skin fold thickness	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	response to olanzapine	http://purl.obolibrary.org/obo/GO_0097333	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to olanzapine	http://purl.obolibrary.org/obo/GO_0097333	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to olanzapine in schizophrenia	response to olanzapine	http://purl.obolibrary.org/obo/GO_0097333	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Predicted visceral adipose tissue	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue (sex interaction)	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue adjusted for BMI	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue adjusted for BMI (sex interaction)	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue attenuation (Hounslow unit scale)	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue/subcutaneous adipose tissue ratio	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral fat	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (parental or offspring effect)	blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006943	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure response to hydrochlorothiazide in hypertension	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to beta blocker use in hypertension (systolic blood pressure)	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure change trajectories	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure night-to-day ratio in hypertension	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure response to hydrochlorothiazide in hypertension	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure response to hydrochlorothiazide in hypertension	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure night-to-day ratio in hypertension	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure response to hydrochlorothiazide in hypertension	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to beta blocker use in hypertension (diastolic blood pressure)	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	anti-Mullerian hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004769	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Behavioral disinhibition	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Impulsivity	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Impulsivity (attentional)	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Impulsivity (motor)	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Impulsivity (non-planning)	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lack of perseverance	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lack of premeditation	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Negative urgency	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Positive urgency	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Risky sexual behaviors (alcohol dependence interaction)	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sensation seeking	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease biomarkers	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal T-tau levels	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid p-tau levels in mild cognitive impairment	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau levels	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau levels in mild cognitive impairment	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau levels in normal cognition	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma t-tau levels	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Open-angle glaucoma and optic cup area	optic cup area measurement	http://www.ebi.ac.uk/efo/EFO_0006940	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic cup area	optic cup area measurement	http://www.ebi.ac.uk/efo/EFO_0006940	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bipolar disorder lithium response (categorical) or schizophrenia	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bipolar disorder lithium response (continuous) or schizophrenia	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Objective response to lithium treatment	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Objective response to lithium treatment in bipolar disorder	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to lithium treatment in bipolar disorder	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Subjective response to lithium treatment	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Subjective response to lithium treatment in bipolar disorder	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Hand grip strength	grip strength measurement	http://www.ebi.ac.uk/efo/EFO_0006941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial pigmentation	facial pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0006942	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Methadone dose in opioid dependence	opioid dependence	http://www.ebi.ac.uk/efo/EFO_0005611	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Opioid dependence	opioid dependence	http://www.ebi.ac.uk/efo/EFO_0005611	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Body mass index and fat mass	adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total adipose tissue	adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total adipose tissue adjusted for BMI	adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease biomarkers	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal P-tau181p levels	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid p-tau levels	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid p-tau levels in normal cognition	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vascular endothelial growth factor levels	vascular endothelial growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0004762	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Biochemical measures	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cardiometabolic and hematological traits	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cardiovascular disease risk factors	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Fractional excretion of uric acid	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Glomerular load of uric acid	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hematological and biochemical traits	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hyperuricemia	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Metabolite levels	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Renal function-related traits (urea)	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to allopurinol in gout (change in serum uric acid levels)	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Serum uric acid levels	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Serum uric acid levels in response to allopurinol in gout	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Uric acid clearance	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Uric acid levels	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Uric acid levels (SNP x SNP interaction)	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Glaucoma (low intraocular pressure)	low tension glaucoma	http://www.ebi.ac.uk/efo/EFO_1001022	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Antipsychotic drug-induced QTc interval prolongation	response to risperidone	http://purl.obolibrary.org/obo/GO_0097336	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Early response to risperidone in schizophrenia	response to risperidone	http://purl.obolibrary.org/obo/GO_0097336	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to risperidone	http://purl.obolibrary.org/obo/GO_0097336	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to risperidone in schizophrenia	response to risperidone	http://purl.obolibrary.org/obo/GO_0097336	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Antipsychotic drug-induced QTc interval prolongation	response to quetiapine	http://purl.obolibrary.org/obo/GO_0097335	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to quetiapine	http://purl.obolibrary.org/obo/GO_0097335	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to quetiapine in schizophrenia	response to quetiapine	http://purl.obolibrary.org/obo/GO_0097335	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Clozapine-induced agranulocytosis	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Clozapine-induced cytotoxicity	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutrophil level response to clozapine in treatment-resistant schizophrenia	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma clozapine levels in treatment-resistant schizophrenia	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma norclozapine levels in treatment-resistant schizophrenia	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antipsychotic treatment	response to ziprasidone	http://purl.obolibrary.org/obo/GO_0097337	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to ziprazidone in schizophrenia	response to ziprasidone	http://purl.obolibrary.org/obo/GO_0097337	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood metabolite levels	mannose measurement	http://www.ebi.ac.uk/efo/EFO_0006958	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease-related phenotypes	perianal Crohn's disease	http://www.ebi.ac.uk/efo/EFO_0005627	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Environmental confusion in the home	chaos measure	http://www.ebi.ac.uk/efo/EFO_0004779	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to fenofibrate (total cholesterol levels)	total cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007806	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	total cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007806	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Gene methylation in lung tissue	gene methylation measurement	http://www.ebi.ac.uk/efo/EFO_0006959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
MGMT methylation in smokers	gene methylation measurement	http://www.ebi.ac.uk/efo/EFO_0006959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007805	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol x physical activity interaction (2df test)	HDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007805	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to fenofibrate (HDL cholesterol levels)	HDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007805	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to statins (HDL cholesterol change)	HDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007805	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Major depressive disorder (stressful life events interaction)	self rated health	http://www.ebi.ac.uk/efo/EFO_0004778	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Reporting of stressful life event	self rated health	http://www.ebi.ac.uk/efo/EFO_0004778	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	self rated health	http://www.ebi.ac.uk/efo/EFO_0004778	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Self-rated health	self rated health	http://www.ebi.ac.uk/efo/EFO_0004778	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Alcohol withdrawal symptoms	alcohol withdrawal	http://www.ebi.ac.uk/efo/EFO_0004777	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bortezomib-induced peripheral neuropathy in multiple myeloma	response to bortezomib	http://www.ebi.ac.uk/efo/EFO_0007808	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Alcohol and nicotine co-dependence	alcohol and nicotine codependence	http://www.ebi.ac.uk/efo/EFO_0004776	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Erythrocyte cadmium concentration	erythrocyte cadmium measurement	http://www.ebi.ac.uk/efo/EFO_0007807	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Erythrocyte cadmium concentration in never smokers	erythrocyte cadmium measurement	http://www.ebi.ac.uk/efo/EFO_0007807	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	response to triamcinolone acetonide	http://www.ebi.ac.uk/efo/EFO_0006954	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Obsessive-compulsive symptoms	obsessive-compulsive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007802	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	obsessive-compulsive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007802	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
ADAMTS13 activity	ADAMTS13 activity measurement	http://www.ebi.ac.uk/efo/EFO_0006955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease-related phenotypes	ileocolitis	http://www.ebi.ac.uk/efo/EFO_0005624	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Serum lycopene concentrations	lycopene measurement	http://www.ebi.ac.uk/efo/EFO_0007801	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	intraocular pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006956	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007804	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels	LDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007804	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to fenofibrate (LDL cholesterol levels)	LDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007804	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to statins (LDL cholesterol change)	LDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007804	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Blood metabolite levels	X12063 measurement	http://www.ebi.ac.uk/efo/EFO_0006957	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Discordance in emotional problems in monozygotic twins	emotional symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007803	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emotional dysregulation	emotional symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007803	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Occipital cortical area (total cortical area interaction)	visual cortical surface area measurement	http://www.ebi.ac.uk/efo/EFO_0004771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	response to vincristine	http://www.ebi.ac.uk/efo/EFO_0006950	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cisplatin-induced hearing loss in brain tumor patients	ototoxicity	http://www.ebi.ac.uk/efo/EFO_0006951	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cisplatin-induced ototoxicity	ototoxicity	http://www.ebi.ac.uk/efo/EFO_0006951	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ovarian reserve	ovarian reserve	http://www.ebi.ac.uk/efo/EFO_0004770	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body fat percentage	body fat percentage	http://www.ebi.ac.uk/efo/EFO_0007800	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	body fat percentage	http://www.ebi.ac.uk/efo/EFO_0007800	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Clozapine-induced cytotoxicity	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Paclitaxel-induced cytotoxicity	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to Homoharringtonine (cytotoxicity)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to carboplatin in ovarian cancer (MTT IC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to metformin (IC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paclitaxel in ovarian cancer (MTT IC50)	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triptolide cytotoxicity	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Familial lung adenocarcinoma	family history of lung cancer	http://www.ebi.ac.uk/efo/EFO_0006953	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Familial lung cancer	family history of lung cancer	http://www.ebi.ac.uk/efo/EFO_0006953	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Familial squamous cell lung carcinoma	family history of lung cancer	http://www.ebi.ac.uk/efo/EFO_0006953	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer and family history of lung cancer	family history of lung cancer	http://www.ebi.ac.uk/efo/EFO_0006953	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Hypertension (young onset)	early onset hypertension	http://www.ebi.ac.uk/efo/EFO_0004772	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Pulse pressure in young-onset hypertension	early onset hypertension	http://www.ebi.ac.uk/efo/EFO_0004772	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Late-onset myasthenia gravis	late-onset myasthenia gravis	http://www.ebi.ac.uk/efo/EFO_1001490	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Advanced age-related macular degeneration	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (CNV vs. GA)	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (geographic atrophy)	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Atrophic age-related macular degeneration	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Disease progression to geographic atrophy form in age-related macular degeneration	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Ischemic stroke (cardioembolic)	cardiac embolism	http://www.ebi.ac.uk/efo/EFO_1001493	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Psoriasis vulgaris	psoriasis vulgaris	http://www.ebi.ac.uk/efo/EFO_1001494	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ischemic stroke (small artery occlusion)	small artery occlusion	http://www.ebi.ac.uk/efo/EFO_1001495	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Limited cutaneous systemic scleroderma	limited scleroderma	http://www.ebi.ac.uk/efo/EFO_1001017	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Drug-induced liver injury	response to flupirtine	http://www.ebi.ac.uk/efo/EFO_0007809	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Age-related disease endophenotypes	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Age-related diseases, mortality and associated endophenotypes	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood cell traits (multivariate analysis)	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cardiometabolic and hematological traits	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematocrit	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological and biochemical traits	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood pressure (smoking interaction)	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cigarettes smoked per day (MTAG)	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Current cigarettes per day in chronic obstructive pulmonary disease	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia or cigarettes per day (pleiotropy)	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking behaviour (cigarettes smoked per day)	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial depth	facial depth measurement	http://www.ebi.ac.uk/efo/EFO_0007857	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal sclerosis	hippocampal sclerosis of aging	http://www.ebi.ac.uk/efo/EFO_0005678	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hippocampal sclerosis of aging	hippocampal sclerosis of aging	http://www.ebi.ac.uk/efo/EFO_0005678	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Barrett's esophagus x pack-years of smoking exposure interaction	pack-years measurement	http://www.ebi.ac.uk/efo/EFO_0006526	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	pack-years measurement	http://www.ebi.ac.uk/efo/EFO_0006526	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Esophageal adenocarcinoma x pack-years of smoking exposure interaction	pack-years measurement	http://www.ebi.ac.uk/efo/EFO_0006526	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking behaviour (cigarette pack-years)	pack-years measurement	http://www.ebi.ac.uk/efo/EFO_0006526	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 4, facial height related to vertical position of gnathion)	facial height measurement	http://www.ebi.ac.uk/efo/EFO_0007856	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 9, facial height related to vertical position of nasion)	facial height measurement	http://www.ebi.ac.uk/efo/EFO_0007856	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lower facial height	facial height measurement	http://www.ebi.ac.uk/efo/EFO_0007856	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
ACPA-negative rheumatoid arthritis (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
ACPA-positive rheumatoid arthritis (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adenocarcinoma in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related macular degeneration (smoking status interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<70%) in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<70%) in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Barrett's esophagus x smoking interaction	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cluster headache	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (environment interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coronary artery calcification (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cotinine levels in smokers with chronic obstructive pulmonary disease	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (cigarette smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emphysema annual change measurement in smokers (adjusted lung density)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emphysema annual change measurement in smokers (percent low attenuation area)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Esophageal adenocarcinoma x smoking interaction	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels in current smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels in non smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels in current smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels in non smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer (smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (low FEV1 vs high FEV1) x smoking interaction	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (high FEV1 vs average FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (low FEV1 vs average FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in heavy smokers (low FEV1 vs high FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (high FEV1 vs average FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (low FEV1 vs average FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function in never smokers (low FEV1 vs high FEV1)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pre bronchodilator FEV1/FVC ratio in never-smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Self-reported childhood asthma in adult smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking initiation (ever regular vs never regular)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking initiation (ever regular vs never regular) (MTAG)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status (current vs former)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status (ever vs never smokers)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status (heavy vs never)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (cigarette smoking interaction)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels in current smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels in ever smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels in never smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels in non smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary 1,3-butadiene metabolite levels in smokers	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depression in response to interferon-based therapy in chronic hepatitis C	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to interferon treatment in hepatitis C virus genotype 3	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Double-edged eyelids	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye length	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye morphology	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye morphology (partial least square model)	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye morphology (principal component model)	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 14, intercanthal width)	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 2, vertical position of orbits relative to midface)	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interorbital distance	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Upper eyelid morphology	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total mean fractional anisotropy measurement in first episode schizophrenia	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure (global fractional anisotropy)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or waist circumference (pleiotropy)	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiovascular risk factors	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiovascular risk factors (age interaction)	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Quantitative traits	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Sexual dimorphism in anthropometric traits	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference (sex interaction)	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference and related phenotypes	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Colorectal cancer (calcium intake interaction)	calcium intake measurement	http://www.ebi.ac.uk/efo/EFO_0006521	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Asymmetrical dimethylarginine levels	asymmetrical dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0006522	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Body fat distribution (arm fat ratio)	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body fat distribution (leg fat ratio)	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body fat distribution (trunk fat ratio)	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Fat distribution (HIV)	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Lean body mass and age at menarche (combined)	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Quantitative traits	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Serum vitamin D-binding protein levels	vitamin D-binding protein measurement	http://www.ebi.ac.uk/efo/EFO_0005675	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thiopurine S-methyltransferase activity	thiopurine methyltransferase activity measurement	http://www.ebi.ac.uk/efo/EFO_0007852	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	thiopurine methyltransferase activity measurement	http://www.ebi.ac.uk/efo/EFO_0007852	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related disease endophenotypes	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Age-related diseases, mortality and associated endophenotypes	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Anthropometric traits	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
BMI (adjusted for smoking behaviour)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
BMI (smoking interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
BMI in non-smokers	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
BMI in smokers	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
BMI x dairy intake interaction (1df interaction test)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Barrett's esophagus x BMI interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Biomedical quantitative traits	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Bipolar disorder (body mass index interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or body mass index (pleiotropy)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Blood pressure (anthropometric measures interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass in chronic obstructive pulmonary disease	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index  (smoking years interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (SNP x SNP interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (adult)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (age <50)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (age>50)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (alcohol intake interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (dietary energy interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (education interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (ever vs never smoking interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (joint analysis main effects and physical activity interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (joint analysis main effects and smoking interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (physical activity interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (recreational physical activity interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (sex interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index and cholesterol (psychopharmacological treatment)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index and fat mass	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index and waist-hip ratio (pleiotropy)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index in asthmatics	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index in non-asthmatics	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index in physically active individuals	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index in physically inactive individuals	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index variance	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index x age interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index x sex interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index x sex x age interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index x sex x age interaction (4df test)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Childhood body mass index	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Coronary artery disease and/or body mass index (pleiotropy)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Esophageal adenocarcinoma x BMI interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Fasting blood glucose (BMI interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Fasting blood insulin (BMI interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Homeostasis model assessment of insulin resistance x BMI interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hyperglycemia x BMI interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hyperinsulinemia x BMI interaction	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Multiple sclerosis and body mass index (pleiotropy)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Normal body mass index vs. thin	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Quantitative traits	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Urate levels (BMI interaction)	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Visceral adipose tissue adjusted for BMI	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune Hepatitis	http://www.ebi.ac.uk/efo/EFO_0005676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Autoimmune hepatitis type-1	Autoimmune Hepatitis	http://www.ebi.ac.uk/efo/EFO_0005676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Cranial base width	facial width measurement	http://www.ebi.ac.uk/efo/EFO_0007855	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 1, breadth of lateral portion of upper face)	facial width measurement	http://www.ebi.ac.uk/efo/EFO_0007855	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Symmetrical dimethylarginine levels	symmetrical dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0006523	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
L-arginine levels	L-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0006524	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	L-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0006524	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	L-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0006524	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	L-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0006524	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Puberty onset	puberty onset measurement	http://www.ebi.ac.uk/efo/EFO_0005677	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Puberty onset (breast development)	puberty onset measurement	http://www.ebi.ac.uk/efo/EFO_0005677	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Puberty onset (genital enlargement)	puberty onset measurement	http://www.ebi.ac.uk/efo/EFO_0005677	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
knee peak torque response	knee peak torque measurement	http://www.ebi.ac.uk/efo/EFO_0007854	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at smoking initiation in chronic obstructive pulmonary disease	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Age of smoking initiation	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Age of smoking initiation (MTAG)	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking behaviour (age at first cigarette)	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking initiation	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Smoking initiation (ever regular vs never regular)	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anger	aggressive behavior	http://www.ebi.ac.uk/efo/EFO_0003015	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cannabis-related aggression	aggressive behavior	http://www.ebi.ac.uk/efo/EFO_0003015	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Menstruation quality of life impact (aggressiveness)	aggressive behavior	http://www.ebi.ac.uk/efo/EFO_0003015	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Brain imaging	neuroimaging measurement	http://www.ebi.ac.uk/efo/EFO_0004346	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain imaging measurements	neuroimaging measurement	http://www.ebi.ac.uk/efo/EFO_0004346	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuranatomic and neurocognitive phenotypes	neuroimaging measurement	http://www.ebi.ac.uk/efo/EFO_0004346	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Voxel-wise structural brain imaging measurements	neuroimaging measurement	http://www.ebi.ac.uk/efo/EFO_0004346	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index  (smoking years interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (ever vs never smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid plaque burden (smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Current cigarettes per day in chronic obstructive pulmonary disease	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (cigarette smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lifetime average cigarettes per day in chronic obstructive pulmonary disease	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function (smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking quantity	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status (daily vs non-daily)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking status (heavy vs light)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (cigarette smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip circumference ratio (ever vs never smoking interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip circumference ratio (smoking years interaction)	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corneal curvature	corneal topography	http://www.ebi.ac.uk/efo/EFO_0004345	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corneal structure	corneal topography	http://www.ebi.ac.uk/efo/EFO_0004345	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein phospholipase A2 activity in cardiovascular disease	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in darapladib-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in placebo-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in placebo-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Odor events in darapladib-treated cardiovascular disease (time to event)	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Plasma cystastin c levels in acute coronary syndrome	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to Dalcetrapib treatment in acute coronary syndrome	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Anthropometric traits in newborns	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or HDL cholesterol levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or LDL cholesterol levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or body mass index (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or coronary artery disease (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or fasting glucose levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or fasting insulin levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or hemoglobin A1C levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or insulin secretion (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or insulin sensitivity index (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or myocardial infarction (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or total cholesterol levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or triglycerides levels (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or type 2 diabetes (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or waist circumference (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or waist-hip ratio (pleiotropy)	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Offspring birth weight	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hepatitis B (viral clearance)	seroconversion	http://www.ebi.ac.uk/efo/EFO_0007851	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Age spots	solar lentigines measurement	http://www.ebi.ac.uk/efo/EFO_0007850	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Anthropometric traits	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Biomedical quantitative traits	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birth weight or waist-hip ratio (pleiotropy)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index and waist-hip ratio (pleiotropy)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Metabolic syndrome	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Sexual dimorphism in anthropometric traits	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-hip ratio	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip circumference ratio (alcohol intake interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip circumference ratio (dietary energy interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip circumference ratio (ever vs never smoking interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip circumference ratio (recreational physical activity interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip circumference ratio (smoking years interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio (sex interaction)	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Chronic mucus hypersecretion	chronic mucus hypersecretion	http://www.ebi.ac.uk/efo/EFO_0005673	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Chronic mucus hypersecretion in chronic obstructive pulmonary disease	chronic mucus hypersecretion	http://www.ebi.ac.uk/efo/EFO_0005673	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Exhaled carbon monoxide levels	carbon monoxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0006520	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	carbon monoxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0006520	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Juvenile osteochondritis dissecans	Osteochondritis Dissecans	http://purl.obolibrary.org/obo/HP_0010886	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Event-related brain oscillations	event-related brain oscillation	http://www.ebi.ac.uk/efo/EFO_0004358	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
NHDL cholesterol	non-high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0005689	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	response to erlotinib	http://www.ebi.ac.uk/efo/EFO_0007868	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to dabigatran etexilate treatment	response to dabigatran etexilate	http://www.ebi.ac.uk/efo/EFO_0005205	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Multiple sclerosis (OCB status)	oligoclonal band measurement	http://www.ebi.ac.uk/efo/EFO_0005206	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Oligoclonal band status in multiple sclerosis	oligoclonal band measurement	http://www.ebi.ac.uk/efo/EFO_0005206	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	response to gefitinib	http://www.ebi.ac.uk/efo/EFO_0007867	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Congenital heart disease	congenital heart disease	http://www.ebi.ac.uk/efo/EFO_0005207	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Congenital heart disease (inherited effect)	congenital heart disease	http://www.ebi.ac.uk/efo/EFO_0005207	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Congenital heart disease (maternal effect)	congenital heart disease	http://www.ebi.ac.uk/efo/EFO_0005207	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiometabolic traits	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate change in renal transplantation (donor effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate change in renal transplantation (recipient effect)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate in diabetes	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate in non-diabetics	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate reduction (30%)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate (creatinine)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate (cystatin C)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in chronic kidney disease	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in diabetes	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in diabetics (creatinine)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in non diabetics (creatinine)	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in type 2 diabetes	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eudaimonic well-being	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hedonic well-being	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Life satisfaction	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Positive affect	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing (depressiveness)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing (health and vitality)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing (social role performance and self-confidence)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing index (total score)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing index 1 (lack of subjective wellbeing and health)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing index 12 (lack of enjoying daily life)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological wellbeing index 3 (fatigue and loss of appetite)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social science traits (pleiotropy) (HIPO component 1)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subjective well-being	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subjective well-being (MTAG)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Well-being spectrum (multivariate analysis)	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint destruction and growth retardation	height growth measurement	http://www.ebi.ac.uk/efo/EFO_0005201	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Pubertal anthropometrics	height growth measurement	http://www.ebi.ac.uk/efo/EFO_0005201	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Serum sulfate level	sulfate measurement	http://www.ebi.ac.uk/efo/EFO_0007864	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute kidney injury in critical illness	illness severity status	http://www.ebi.ac.uk/efo/EFO_0007863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases and mortality	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases, mortality and associated endophenotypes	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer specific mortality in breast cancer	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer specific mortality in estrogen receptor negative breast cancer	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer specific mortality in estrogen receptor positive breast cancer	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mortality	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mortality in heart failure	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mortality in sepsis	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diastolic blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to thiazide diuretic treatment (hypokalemia)	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Systolic blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiazide-induced adverse metabolic effects in hypertensive patients	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Receptive language ability	receptive language perception	http://www.ebi.ac.uk/efo/EFO_0005686	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anorexia nervosa	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Bipolar disorder and eating disorder	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Eating disorder in bipolar disorder	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Eating disorders	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Eating disorders (purging via substances)	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	resting heart rate	http://www.ebi.ac.uk/efo/EFO_0004351	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse rate	resting heart rate	http://www.ebi.ac.uk/efo/EFO_0004351	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Resting heart rate	resting heart rate	http://www.ebi.ac.uk/efo/EFO_0004351	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Fibromyalgia	fibromyalgia	http://www.ebi.ac.uk/efo/EFO_0005687	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Liver injury in anti-tuberculosis drug treatment	response to rifampicin	http://www.ebi.ac.uk/efo/EFO_0007866	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	response to rifampicin	http://www.ebi.ac.uk/efo/EFO_0007866	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bulimia nervosa	bulimia nervosa	http://www.ebi.ac.uk/efo/EFO_0005204	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Feeling lonely	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Loneliness	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Loneliness (MTAG)	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Loneliness (linear analysis)	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Loneliness (multivariate analysis)	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Reasoning	reasoning	http://www.ebi.ac.uk/efo/EFO_0004350	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to antipsychotic treatment in schizophrenia (reasoning)	reasoning	http://www.ebi.ac.uk/efo/EFO_0004350	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Verbal-numerical reasoning	reasoning	http://www.ebi.ac.uk/efo/EFO_0004350	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Attention deficit hyperactivity disorder symptom score	ADHD symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007860	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electroencephalogram traits	electroencephalogram measurement	http://www.ebi.ac.uk/efo/EFO_0004357	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fast beta electroencephalogram	electroencephalogram measurement	http://www.ebi.ac.uk/efo/EFO_0004357	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resting-state electroencephalogram vigilance	electroencephalogram measurement	http://www.ebi.ac.uk/efo/EFO_0004357	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infective endocarditis in Staphylococcus aureus infection	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Staphylococcus aureus infection	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Beta thalassemia/hemoglobin E disease	hemoglobin E disease	http://www.orpha.net/ORDO/Orphanet_2133	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Oxygen saturation of hemoglobin levels	oxygen saturation measurement	http://www.ebi.ac.uk/efo/EFO_0005682	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	oxygen saturation measurement	http://www.ebi.ac.uk/efo/EFO_0005682	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronotype	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Common traits (Other)	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Morning vs. evening chronotype	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Relative amplitude of rest-activity cycles	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sleep traits (multi-trait analysis)	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Presence of antiphospholipid antibodies	antiphospholipid antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005200	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Musical aptitude	musical aptitude	http://www.ebi.ac.uk/efo/EFO_0005690	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Plasma trimethylamine N-oxide levels	plasma trimethylamine N-oxide measurement	http://www.ebi.ac.uk/efo/EFO_0005691	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aging traits	exercise test	http://www.ebi.ac.uk/efo/EFO_0004328	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Exercise treadmill test traits	exercise test	http://www.ebi.ac.uk/efo/EFO_0004328	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Nicotine glucouronidation	nicotine glucuronidation measurement	http://www.ebi.ac.uk/efo/EFO_0006507	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to antithyroid drugs in Graves disease	response to anti-thyroid drug	http://www.ebi.ac.uk/efo/EFO_0007838	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anti-thyroid drug induced agranulocytosis	response to anti-thyroid drug	http://www.ebi.ac.uk/efo/EFO_0007838	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cotinine glucuronidation	cotinine glucuronidation measurement	http://www.ebi.ac.uk/efo/EFO_0006508	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrocardiographic conduction measures	electrocardiography	http://www.ebi.ac.uk/efo/EFO_0004327	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Electrocardiographic traits	electrocardiography	http://www.ebi.ac.uk/efo/EFO_0004327	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Global electrical heterogeneity phenotypes	electrocardiography	http://www.ebi.ac.uk/efo/EFO_0004327	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Biomedical quantitative traits	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Electrocardiographic traits	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate in heart failure with reduced ejection fraction	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to beta blockers	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to beta blockers (atenolol add-on therapy)	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate response to beta blockers (atenolol monotherapy)	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate variability traits	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Obesity-related traits	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse rate	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood pressure	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (age interaction)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (response to antihypertensive medication)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (cold pressor test)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium intervention)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (low sodium intervention)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure variability	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure x alcohol consumption interaction	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tonometry	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglycerides-Blood Pressure (TG-BP)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (desire to cut drinking)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (drinking despite problems)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (drinking more than intended)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (time spent drinking)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (tolerance)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (withdrawal)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence symptom count	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol misuse (trauma interaction)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol use disorder (dependence and problematic use scores)	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fast beta electroencephalogram	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Problematic alcohol use in trauma-exposed individuals	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mammographic density (dense area)	dense area measurement	http://www.ebi.ac.uk/efo/EFO_0006503	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Endophenotypes for schizophrenia in healthy individuals	endophenotype	http://www.ebi.ac.uk/efo/EFO_0006988	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Mammographic density (non-dense area)	non-dense area measurement	http://www.ebi.ac.uk/efo/EFO_0006504	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	response to protease inhibitor	http://www.ebi.ac.uk/efo/EFO_0005657	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	response to protease inhibitor	http://www.ebi.ac.uk/efo/EFO_0005657	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Chronic bronchitis and chronic obstructive pulmonary disease	chronic bronchitis	http://www.ebi.ac.uk/efo/EFO_0006505	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic bronchitis in chronic obstructive pulmonary disease	chronic bronchitis	http://www.ebi.ac.uk/efo/EFO_0006505	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Non-response to selective serotonin reuptake inhibitors and depression	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Remission after SSRI treatment in MDD or neuroticism	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Remission after SSRI treatment in MDD or openness	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Remission after SSRI treatment in major depression	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to SSRI (symptom improvement)	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to SSRI (symptom remission)	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to SSRI in MDD or conscientiouness	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to SSRI in MDD or openness	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to selective serotonin reuptake inhibitors and depression	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to selective serotonin reuptake inhibitors in depression	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to serotonin reuptake inhibitors in major depressive disorder	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	anti-citrullinated protein antibody seropositivity	http://www.ebi.ac.uk/efo/EFO_0007837	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alcohol consumption (drinkers vs non-drinkers)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alcohol consumption (drinks per week)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alcohol consumption (max-drinks)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alcohol consumption (transferrin glycosylation)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Behavioural disinhibition (generation interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure (alcohol consumption interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x alcohol consumption interaction (1df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x alcohol consumption interaction (2df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HDL cholesterol levels in current drinkers	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL cholesterol levels in current drinkers	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Mean arterial pressure (alcohol consumption interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Mean arterial pressure x alcohol consumption interaction (2df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Pulse pressure (alcohol consumption interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Pulse pressure x alcohol consumption interaction (2df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure (alcohol consumption interaction)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x alcohol consumption interaction (1df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x alcohol consumption interaction (2df test)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Triglyceride levels in current drinkers	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Coenzyme Q10 levels	coenzyme Q10 measurement	http://www.ebi.ac.uk/efo/EFO_0007836	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepatic lipid content in extreme obesity	hepatic lipid content measurement	http://www.ebi.ac.uk/efo/EFO_0006506	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma amyloid beta peptide concentrations (ABx-40)	plasma beta-amyloid 1-40 measurement	http://www.ebi.ac.uk/efo/EFO_0005659	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-accommodative esotropia	non-accommodative esotropia	http://purl.obolibrary.org/obo/HP_0031760	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicidal ideation	suicidal ideation	http://www.ebi.ac.uk/efo/EFO_0004320	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicidal ideation in depression or bipolar disorder	suicidal ideation	http://www.ebi.ac.uk/efo/EFO_0004320	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Food addiction	food addiction measurement	http://www.ebi.ac.uk/efo/EFO_0007830	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum metabolite concentrations in chronic kidney disease	serum metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005653	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum metabolite levels	serum metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005653	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum metabolite ratios in chronic kidney disease	serum metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005653	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone properties (heel)	velocity of sound measurement	http://www.ebi.ac.uk/efo/EFO_0005654	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid plaque burden	carotid plaque build	http://www.ebi.ac.uk/efo/EFO_0006501	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Carotid plaque burden (smoking interaction)	carotid plaque build	http://www.ebi.ac.uk/efo/EFO_0006501	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Percent mammographic density	mammographic density percentage	http://www.ebi.ac.uk/efo/EFO_0006502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to cytadine analogues (cytosine arabinoside)	response to cytosine arabinoside	http://www.ebi.ac.uk/efo/EFO_0005655	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anthropometric traits	body weights and measures	http://www.ebi.ac.uk/efo/EFO_0004324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits (multi-trait analysis)	body weights and measures	http://www.ebi.ac.uk/efo/EFO_0004324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive function	mental process	http://www.ebi.ac.uk/efo/EFO_0004323	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Affective disorder and suicide attempts	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in bipolar disorder	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in bipolar disorder or schizophrenia	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in depression or bipolar disorder	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in major depressive disorder	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in major depressive disorder or bipolar disorder	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide attempts in schizophrenia	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide in bipolar disorder	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide risk	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anthropometric traits	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Blood pressure (anthropometric measures interaction)	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Height	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Pericardial adipose tissue adjusted for height and weight	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Pubertal anthropometrics	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Quantitative traits	body height	http://www.ebi.ac.uk/efo/EFO_0004339	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Birdshot chorioretinopathy	Birdshot chorioretinopathy	http://www.orpha.net/ORDO/Orphanet_179	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	response to losartan	http://www.ebi.ac.uk/efo/EFO_0006518	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anthropometric traits	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Pericardial adipose tissue adjusted for height and weight	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Quantitative traits	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Weight	body weight	http://www.ebi.ac.uk/efo/EFO_0004338	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Brain activation in response to working memory task	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate activity during disappointment	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate activity during reward	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen activity during reward	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen actvity during disappointment	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Febrile seizures	MMR-related febrile seizures	http://www.ebi.ac.uk/efo/EFO_0006519	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Febrile seizures (MMR vaccine-related)	MMR-related febrile seizures	http://www.ebi.ac.uk/efo/EFO_0006519	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Bipolar disorder or intelligence (pleiotropy)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive ability	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive ability (MTAG)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive ability in schizophrenia	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive function	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Extremely high intelligence	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Full scale intelligence quotient (cesarean section interaction)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
General cognitive ability	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Intelligence	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Intelligence (MTAG)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Intelligence (childhood)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Performance intelligence quotient (cesarean section interaction)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Schizophrenia or intelligence (pleiotropy)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Verbal intelligence quotient (cesarean section interaction)	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury	http://purl.obolibrary.org/obo/HP_0001919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Acute kidney injury in critical illness	Acute kidney injury	http://purl.obolibrary.org/obo/HP_0001919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Acute kidney injury	http://purl.obolibrary.org/obo/HP_0001919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Acute kidney injury	http://purl.obolibrary.org/obo/HP_0001919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Speech perception in dyslexia	speech perception	http://www.ebi.ac.uk/efo/EFO_0004336	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alzheimer's disease progression score	Alzheimer's disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Alzheimer's disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to stavudine in HIV (lipoatrophy)	response to stavudine	http://www.ebi.ac.uk/efo/EFO_0006998	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Urinary albumin excretion rate in type 1 diabetes	urinary albumin excretion rate	http://www.ebi.ac.uk/efo/EFO_0005667	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aggressive prostate cancer	cancer aggressiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006999	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate cancer aggressiveness	cancer aggressiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006999	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anterior chamber depth	anterior chamber depth measurement	http://www.ebi.ac.uk/efo/EFO_0005668	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	angiotensin-converting enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0006515	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 15, philtrum width)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 17, height of vermillion upper lip)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 3, length of philtrum)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 6, height of vermillion lower lip)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Labial fissure length	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lip morphology	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lip thickness	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Philtrum width	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
lower facial morphology traits (ordinal measurement)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
lower facial morphology traits (quantitative measurement)	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Apolipoprotein A-IV levels	apolipoprotein A-IV measurement	http://www.ebi.ac.uk/efo/EFO_0007848	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Hematoma volume in lobar spontaneous intracerebral hemorrhage	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Intracerebral hemorrhage	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Intracerebral hemorrhage (MTAG)	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Intracranial haemorrhage in renal transplantation (donors)	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Superior frontal gyrus grey matter volume	superior frontal gyrus grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0006516	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cheek morphology (partial least square model)	cheekbone morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cheek morphology (principal component model)	cheekbone morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
middle facial morphology traits (ordinal measurement)	cheekbone morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interferon alpha levels in systemic lupus erythematosus	interferon alpha measurement	http://www.ebi.ac.uk/efo/EFO_0006517	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chin dimples	chin morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007842	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
lower facial morphology traits (ordinal measurement)	chin morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007842	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
lower facial morphology traits (quantitative measurement)	chin morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007842	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	response to gases and fumes exposure	http://www.ebi.ac.uk/efo/EFO_0006994	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Shingles	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Urinary uromodulin levels	urinary uromodulin measurement	http://www.ebi.ac.uk/efo/EFO_0005663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acylcarnitine levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amino acid levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood metabolite levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood metabolite ratios	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycerophospholipid levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hexose levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (lipid measures)	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (lipoprotein measures)	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (small molecules and protein measures)	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sphingolipid levels	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine consumption	coffee consumption	http://www.ebi.ac.uk/efo/EFO_0004330	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Coffee consumption	coffee consumption	http://www.ebi.ac.uk/efo/EFO_0004330	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Coffee consumption (cups per day)	coffee consumption	http://www.ebi.ac.uk/efo/EFO_0004330	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Parkinson's disease (coffee consumption interaction)	coffee consumption	http://www.ebi.ac.uk/efo/EFO_0004330	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diisocyanate-induced asthma	response to diisocyanate	http://www.ebi.ac.uk/efo/EFO_0006995	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Facial morphology (factor 16)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 18)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 19)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 20)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 22)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 23)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology traits (63 three-dimensional facial segments)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lower face length	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Side of face morphology (partial least square model)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Side of face morphology (principal component model)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
facial morphology traits (multivariate analysis)	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint destruction and growth retardation	Kashin-Beck disease	http://www.ebi.ac.uk/efo/EFO_0006511	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Kashin-Beck disease	Kashin-Beck disease	http://www.ebi.ac.uk/efo/EFO_0006511	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Palmar length-width ratio in Kashin-Beck disease	Kashin-Beck disease	http://www.ebi.ac.uk/efo/EFO_0006511	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Betaine levels in individuals undergoing cardiac evaluation	angiographic measurement	http://www.ebi.ac.uk/efo/EFO_0006512	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Coronary artery disease-related phenotypes	angiographic measurement	http://www.ebi.ac.uk/efo/EFO_0006512	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Brow ridge morphology (partial least square model)	forehead morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007844	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brow ridge morphology (principal component model)	forehead morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007844	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forehead morphology	forehead morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007844	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
upper facial morphology traits (ordinal measurement)	forehead morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007844	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to Homoharringtonine (cytotoxicity)	response to homoharringtonine	http://www.ebi.ac.uk/efo/EFO_0006996	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
White matter hyperintensities in ischemic stroke	white matter hyperintensity measurement	http://www.ebi.ac.uk/efo/EFO_0005665	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter hyperintensity burden	white matter hyperintensity measurement	http://www.ebi.ac.uk/efo/EFO_0005665	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter hyperintensity volume	white matter hyperintensity measurement	http://www.ebi.ac.uk/efo/EFO_0005665	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	white matter hyperintensity measurement	http://www.ebi.ac.uk/efo/EFO_0005665	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma anti-thyroid peroxidase levels	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid peroxidase antibody levels	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid peroxidase antibody positivity	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid peroxidase autoantibody levels in type 1 diabetes	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	response to cold medicine	http://www.ebi.ac.uk/efo/EFO_0006997	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	response to cold medicine	http://www.ebi.ac.uk/efo/EFO_0006997	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Facial morphology (factor 10, width of nasal floor)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 11, projection of the nose)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 21, depth of nasal alae)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 7, width of cartilaginous portion of nose)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nasal root breadth	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nasal root height	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose length	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose morphology	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose morphology (partial least square model)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose morphology (principal component model)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose size	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nose wing breadth	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nosetip height	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
middle facial morphology traits (ordinal measurement)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
middle facial morphology traits (quantitative measurement)	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	hereditary hemochromatosis type 1	http://www.ebi.ac.uk/efo/EFO_0006513	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Brain activation in response to working memory task	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Memory (short-term)	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to antipsychotic treatment in schizophrenia (working memory)	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Short-term memory (digit-span task)	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Working memory	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Plasma amyloid beta peptide concentrations (ABx-42)	plasma beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0005660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Episodic memory	episodic memory	http://www.ebi.ac.uk/efo/EFO_0004333	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	response to biological dust exposure	http://www.ebi.ac.uk/efo/EFO_0006992	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Parkinson's disease (pesticide exposure interaction)	pesticide exposure measurement	http://www.ebi.ac.uk/efo/EFO_0007840	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Preschool internalizing problems	Child Behaviour Checklist assessment	http://www.ebi.ac.uk/efo/EFO_0005661	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	response to mineral dust exposure	http://www.ebi.ac.uk/efo/EFO_0006993	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Multiple system atrophy	multiple system atrophy	http://www.ebi.ac.uk/efo/EFO_1001050	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Multiple system atrophy (pathologically confirmed)	multiple system atrophy	http://www.ebi.ac.uk/efo/EFO_1001050	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to haloperidol in psychosis	response to haloperidol	http://purl.obolibrary.org/obo/GO_1905119	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to haloperidol in schizophrenia	response to haloperidol	http://purl.obolibrary.org/obo/GO_1905119	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diverticular disease	diverticular disease	http://www.ebi.ac.uk/efo/EFO_0009959	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Obesity-related traits	CCL5 measurement	http://www.ebi.ac.uk/efo/EFO_0005117	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
RANTES levels	CCL5 measurement	http://www.ebi.ac.uk/efo/EFO_0005117	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Obesity-related traits	IGFBP-1 measurement	http://www.ebi.ac.uk/efo/EFO_0005118	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to Pazopanib in cancer (hepatotoxicity)	response to pazopanib	http://www.ebi.ac.uk/efo/EFO_0007779	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Obesity-related traits	antioxidant measurement	http://www.ebi.ac.uk/efo/EFO_0005119	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Atypical femoral fracture in phosphonate treatment	response to bisphosphonate	http://www.ebi.ac.uk/efo/EFO_0009958	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bisphosphonate-associated atypical femoral fracture	response to bisphosphonate	http://www.ebi.ac.uk/efo/EFO_0009958	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Peripheral arterial disease (traffic-related air pollution interaction)	peripheral arterial disease	http://www.ebi.ac.uk/efo/EFO_0004265	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Peripheral artery disease	peripheral arterial disease	http://www.ebi.ac.uk/efo/EFO_0004265	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Postoperative acute renal failure after cardiac surgery	post-operative acute kidney injury	http://www.ebi.ac.uk/efo/EFO_0009955	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Prothrombin fragments F1+2 levels in ischemic stroke	prothrombin fragments F1+2 measurement	http://www.ebi.ac.uk/efo/EFO_0007776	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	head circumference	http://www.ebi.ac.uk/efo/EFO_0005114	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Postoperative stroke after cardiac surgery	post-operative stroke	http://www.ebi.ac.uk/efo/EFO_0009956	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Thrombin-antithrombin complex levels in ischemic stroke	thrombin-antithrombin complex measurement	http://www.ebi.ac.uk/efo/EFO_0007775	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epilepsy	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Focal epilepsy	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Focal epilepsy (lesion negative)	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Focal epilepsy (with hippocampal sclerosis)	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Focal epilepsy (with lesion other than hippocampal sclerosis)	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Partial epilepsies	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obesity-related traits	metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0005115	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postoperative myocardial infarction after cardiac surgery	post-operative myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0009953	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Urinary albumin-to-creatinine ratio	urinary albumin to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007778	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary albumin-to-creatinine ratio in diabetes	urinary albumin to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007778	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary albumin-to-creatinine ratio in non-diabetics	urinary albumin to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007778	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Basal metabolic rate	base metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0007777	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fractional excretion of metabolites in chronic kidney disease	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary metabolite concentrations in chronic kidney disease	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary metabolite ratios in chronic kidney disease	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary metabolites	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary metabolites (H-NMR features)	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Panic disorder	panic disorder	http://www.ebi.ac.uk/efo/EFO_0004262	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Postoperative delirium after cardiac surgery	post-operative delirium	http://www.ebi.ac.uk/efo/EFO_0009954	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	response to camptothecin	http://purl.obolibrary.org/obo/GO_1901563	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Calcaneal bone ultrasound measurement (speed of sound)	calcaneal bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0007772	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Calcaneus stiffness index	calcaneal bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0007772	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Life threatening arrhythmia	cardiac arrhythmia	http://www.ebi.ac.uk/efo/EFO_0004269	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Postoperative acute renal failure after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Postoperative atrial fibrillation after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Postoperative complication after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Postoperative delirium after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Postoperative myocardial infarction after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Postoperative stroke after cardiac surgery	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Autoimmune hepatitis in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Cholangiocarcinoma in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Colectomy in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Colorectal carcinoma in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Gallbladder carcinoma in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatocellular carcinoma in primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver transplant-free survival in primary sclerosing cholangitis (time to event)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Primary sclerosing cholangitis	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Primary sclerosing cholangitis (small duct vs large duct)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Sclerosing cholangitis and ulcerative colitis (combined)	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Breast milk fatty acid composition (infant genotype effect)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Breast milk fatty acid composition (maternal genotype effect)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
C-reactive protein (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cardiometabolic traits	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cellular adhesion molecule (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Circulating odd-numbered chain saturated fatty acid levels (C15:0)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Circulating odd-numbered chain saturated fatty acid levels (C17:0)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Circulating odd-numbered chain saturated fatty acid levels (C19:0)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Circulating odd-numbered chain saturated fatty acid levels (C23:0)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Homeostasis model assessment of insulin resistance in less-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Homeostasis model assessment of insulin resistance in more-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperglycemia in less-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperglycemia in more-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperglycemia x saturated fatty acids interaction	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperinsulinemia in less-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperinsulinemia in more-fat diet	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hyperinsulinemia x saturated fatty acids interaction	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Interleukin-6 (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Obesity-related traits	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Oleic acid (18:1n-9) levels	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Osteoprotegerin (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
P-Selectin (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Palmitic acid (16:0) levels	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Palmitoleic acid (16:1n-7) levels	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Red blood cell fatty acid levels	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Stearic acid (18:0) levels	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	pathologic complete response measurement	http://www.ebi.ac.uk/efo/EFO_0007771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pathological complete response in breast cancer treated with or without bevacizumab	pathologic complete response measurement	http://www.ebi.ac.uk/efo/EFO_0007771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	pathologic complete response measurement	http://www.ebi.ac.uk/efo/EFO_0007771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postoperative atrial fibrillation after cardiac surgery	post-operative atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0009952	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Obesity-related traits	folic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum folate levels	folic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin B levels in ischemic stroke	folic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Primary biliary cholangitis	biliary liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_0004267	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Thrombomodulin levels in ischemic stroke	thrombomodulin measurement	http://www.ebi.ac.uk/efo/EFO_0007774	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cutaneous psoriasis	cutaneous psoriasis measurement	http://www.ebi.ac.uk/efo/EFO_0007773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psoriatic arthritis vs Cutaneous psoriasis	cutaneous psoriasis measurement	http://www.ebi.ac.uk/efo/EFO_0007773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth (child effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth (maternal effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in labor-initiated deliveries (child effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in labor-initiated deliveries (maternal effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-term birth	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Premature menopause in childhood cancer survivors	primary ovarian insufficiency	http://www.ebi.ac.uk/efo/EFO_0004266	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Premature ovarian failure	primary ovarian insufficiency	http://www.ebi.ac.uk/efo/EFO_0004266	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Alcohol misuse (trauma interaction)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (stressful life events interaction)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x dependent stressful life events interaction (1df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x dependent stressful life events interaction (2df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x independent stressful life events interaction (1df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x independent stressful life events interaction (2df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x stressful life events interaction (1df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x stressful life events interaction (2df test)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Major depressive disorder (stressful life events interaction)	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological resilience (outcome-based) in high deployment stress exposure	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Reporting of stressful life event	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic periodontitis (mean interproximal clinical attachment level)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Loose teeth	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Painful gums	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease related phenotype (PCT2)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease related phenotype (PCT3)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease related phenotype (PCT4)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease related phenotype (PCT5)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease related phenotype (PCT6)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontal disease-related phenotype (Socransky)	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Periodontitis or loose teeth	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anemia in mycophenolic acid treated kidney transplant patients (time to event)	anemia	http://www.ebi.ac.uk/efo/EFO_0004272	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iron deficiency	anemia	http://www.ebi.ac.uk/efo/EFO_0004272	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ribavirin-induced anemia	anemia	http://www.ebi.ac.uk/efo/EFO_0004272	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Restless legs syndrome	restless legs syndrome	http://www.ebi.ac.uk/efo/EFO_0004270	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Febrile seizures	febrile seizures	http://purl.obolibrary.org/obo/HP_0002373	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Febrile seizures (MMR vaccine-unrelated)	febrile seizures	http://purl.obolibrary.org/obo/HP_0002373	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Albumin-globulin ratio	albumin:globulin ratio measurement	http://www.ebi.ac.uk/efo/EFO_0005128	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hematology traits	albumin:globulin ratio measurement	http://www.ebi.ac.uk/efo/EFO_0005128	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hepatitis C induced liver cirrhosis	hepatitis C induced liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_0005129	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Metabolic traits	inflammatory response	http://purl.obolibrary.org/obo/GO_0006954	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Betaine levels in individuals undergoing cardiac evaluation	plasma betaine measurement	http://www.ebi.ac.uk/efo/EFO_0007787	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Stevens-Johnson syndrome	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Length of menstrual cycle	menstrual cycle measurement	http://www.ebi.ac.uk/efo/EFO_0007786	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)	response to stress	http://purl.obolibrary.org/obo/GO_0006950	Biological process	http://purl.obolibrary.org/obo/GO_0008150
White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	response to stress	http://purl.obolibrary.org/obo/GO_0006950	Biological process	http://purl.obolibrary.org/obo/GO_0008150
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)	response to stress	http://purl.obolibrary.org/obo/GO_0006950	Biological process	http://purl.obolibrary.org/obo/GO_0008150
White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	response to stress	http://purl.obolibrary.org/obo/GO_0006950	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anthropometric traits	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI (adjusted for smoking behaviour)	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI (physical activity interaction)	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI (smoking interaction)	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI in active individuals	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI in inactive individuals	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI in non-smokers	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for BMI in smokers	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist circumference adjusted for body mass index	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Bipolar II disorder	bipolar II disoder	http://www.ebi.ac.uk/efo/EFO_0009964	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Gout	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Gout in chronic kidney disease	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Gout vs. Hyperuricemia	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Renal overload gout	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Renal underexcretion gout	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Response to allopurinol in gout (change in serum uric acid levels)	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Serum uric acid levels in response to allopurinol in gout	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Urate levels	gout	http://www.ebi.ac.uk/efo/EFO_0004274	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Paraoxonase activity	arylesterase enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0005126	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Adolescent idiopathic scoliosis	scoliosis	http://www.ebi.ac.uk/efo/EFO_0004273	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Scoliosis	scoliosis	http://www.ebi.ac.uk/efo/EFO_0004273	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Scoliosis in Charcot-Marie-Tooth disease 1A	scoliosis	http://www.ebi.ac.uk/efo/EFO_0004273	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
PCA3 expression level	cancer biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005127	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tumor biomarkers	cancer biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005127	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizoaffective disorder-bipolar type	Schizoaffective disorder-bipolar type	http://www.ebi.ac.uk/efo/EFO_0009965	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Waist-to-hip ratio adjusted for BMI	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (additive genetic model)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (age <50)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (age >50)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (physical activity interaction)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (recessive genetic model)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI (smoking interaction)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI in active individuals	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI in inactive individuals	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI in non-smokers	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI in smokers	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI x age interaction	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI x sex interaction	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI x sex x age interaction	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Waist-to-hip ratio adjusted for body mass index	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Mosaic loss of chromosome Y	mosaic loss of chromosome Y measurement	http://www.ebi.ac.uk/efo/EFO_0007783	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Radioiodine-refractory disease in thyroid cancer	response to radioiodine	http://www.ebi.ac.uk/efo/EFO_0009962	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bipolar I disorder	bipolar I disorder	http://www.ebi.ac.uk/efo/EFO_0009963	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Low tan response	suntan	http://www.ebi.ac.uk/efo/EFO_0004279	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Skin pigmentation traits	suntan	http://www.ebi.ac.uk/efo/EFO_0004279	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Tanning	suntan	http://www.ebi.ac.uk/efo/EFO_0004279	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Atypical femoral fracture in phosphonate treatment	atypical femoral fracture	http://www.ebi.ac.uk/efo/EFO_0009960	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bisphosphonate-associated atypical femoral fracture	atypical femoral fracture	http://www.ebi.ac.uk/efo/EFO_0009960	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bone mineral density (Ward's triangle area)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (femoral neck)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (femoral neck) in inflammatory bowel disease	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone geometry	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone mineral density	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone mineral density or breast cancer (pleiotropy)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone mineral density or plasma lipids (pleiotropy)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip osteoarthritis or femoral neck bone mineral density	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Knee osteoarthritis or femoral neck bone mineral density	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteoarthritis or femoral neck bone mineral density	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral density (femoral neck)	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sudden cardiac arrest	sudden cardiac arrest	http://www.ebi.ac.uk/efo/EFO_0004278	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Homocysteine level response to multivitamin in cerebral infarction	brain infarction	http://www.ebi.ac.uk/efo/EFO_0004277	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Insulinogenic index	Insulinogenic index measurement	http://www.ebi.ac.uk/efo/EFO_0009961	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Moderate functional decline in sporadic amyotrophic lateral sclerosis	functional decline measurement	http://www.ebi.ac.uk/efo/EFO_0007784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rapid functional decline in sporadic amyotrophic lateral sclerosis	functional decline measurement	http://www.ebi.ac.uk/efo/EFO_0007784	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	Epstein Barr virus nuclear antigen 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007790	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein Barr virus nuclear antigen 1 IgG levels	Epstein Barr virus nuclear antigen 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007790	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Epstein Barr virus nuclear antigen 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007790	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007792	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Free thyroxine concentration	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid hormone levels	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroxine levels	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triiodothyronine levels and thyroxine levels	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	rheumatoid factor seropositivity measurement	http://www.ebi.ac.uk/efo/EFO_0007791	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatoid factor seropositivity in rheumatoid arthritis	rheumatoid factor seropositivity measurement	http://www.ebi.ac.uk/efo/EFO_0007791	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	thoracic aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004282	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Severe aortic features in Marfan syndrome	thoracic aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004282	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Thoracic aortic aneurysms and dissections	thoracic aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004282	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Alzheimer's disease (late onset)	late-onset Alzheimers disease	http://www.ebi.ac.uk/efo/EFO_1001870	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Late-onset Alzheimer's disease	late-onset Alzheimers disease	http://www.ebi.ac.uk/efo/EFO_1001870	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tardive dyskinesia	movement disorder	http://www.ebi.ac.uk/efo/EFO_0004280	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tardive dyskinesia in schizophrenia	movement disorder	http://www.ebi.ac.uk/efo/EFO_0004280	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Medication use (antimigraine preparations)	Antimigraine preparation use measurement	http://www.ebi.ac.uk/efo/EFO_0009939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Meningococcal disease	meningococcal infection	http://www.ebi.ac.uk/efo/EFO_0004249	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Male infertility	male infertility	http://www.ebi.ac.uk/efo/EFO_0004248	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Medication use (opioids)	Opioid use measurement	http://www.ebi.ac.uk/efo/EFO_0009937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Staphylococcus aureus nasal carriage (intermittent)	intermittent Staphylococcus aureus carrier status	http://www.ebi.ac.uk/efo/EFO_0007758	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (anilides)	Anilide use measurement	http://www.ebi.ac.uk/efo/EFO_0009938	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Staphylococcus aureus nasal carriage (persistent)	persistent Staphylococcus aureus carrier status	http://www.ebi.ac.uk/efo/EFO_0007757	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (anti-inflammatory and antirheumatic products, non-steroids)	Non-steroidal anti-inflammatory and antirheumatic product use measurement	http://www.ebi.ac.uk/efo/EFO_0009935	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (drugs affecting bone structure and mineralization)	Drugs affecting bone structure and mineralization use measurement	http://www.ebi.ac.uk/efo/EFO_0009936	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	alpha-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007759	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	response to immunochemotherapy	http://www.ebi.ac.uk/efo/EFO_0007754	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Ileal carcinoids	carcinoid tumor	http://www.ebi.ac.uk/efo/EFO_0004243	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Medication use (thyroid preparations)	Thyroid preparation use measurement	http://www.ebi.ac.uk/efo/EFO_0009933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pemphigus foliaceus	pemphigus foliaceus	http://www.ebi.ac.uk/efo/EFO_0008601	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Anorexia nervosa or obsessive-compulsive disorder	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Attention deficit hyperactivity disorder and obsessive compulsive disorder	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hoarding	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obsessive-compulsive disorder	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obsessive-compulsive disorder or autism spectrum disorder	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obsessive-compulsive disorder x sex interaction	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tourette's syndrome or obsessive-compulsive disorder	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Gut microbiome composition (summer and winter)	seasonal gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007753	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiome composition (summer)	seasonal gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007753	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiome composition (winter)	seasonal gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007753	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (immunosuppressants)	Immunosuppressant use measurement	http://www.ebi.ac.uk/efo/EFO_0009934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (agents acting on the renin-angiotensin system)	Agents acting on the renin-angiotensin system use measurement	http://www.ebi.ac.uk/efo/EFO_0009931	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Oral cavity and pharyngeal cancer	pharynx cancer	http://www.ebi.ac.uk/efo/EFO_0005577	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alcohol dependence or heroin dependence or methamphetamine dependence	heroin dependence	http://www.ebi.ac.uk/efo/EFO_0004240	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Heroin addiction	heroin dependence	http://www.ebi.ac.uk/efo/EFO_0004240	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Heroin dependence	heroin dependence	http://www.ebi.ac.uk/efo/EFO_0004240	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Atopic march	atopic march	http://www.ebi.ac.uk/efo/EFO_0007755	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Medication use (HMG CoA reductase inhibitors)	HMG CoA reductase inhibitor use measurement	http://www.ebi.ac.uk/efo/EFO_0009932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Affective disorder and suicide attempts	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressed affect	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major mood disorders	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mood disorder and prion disease	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mood disorder in prion disease	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to antidepressants and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to bupropion and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to citalopram or escitalopram and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to selective serotonin reuptake inhibitors and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to antidepressants and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to antidepressants in depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to bupropion and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to bupropion in depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to citalopram or escitalopram and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to citalopram or escitalopram in depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to selective serotonin reuptake inhibitors and depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to selective serotonin reuptake inhibitors in depression	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Coronary arterial lesions in patients with Kawasaki disease	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Coronary artery aneurysm in Kawasaki disease	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Inflammatory biomarkers in Kawasaki disease	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Kawasaki disease	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to intravenous immunoglobulin treatment in Kawasaki disease	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Medication use (calcium channel blockers)	Calcium channel blocker use measurement	http://www.ebi.ac.uk/efo/EFO_0009930	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interstitial lung disease	interstitial lung disease	http://www.ebi.ac.uk/efo/EFO_0004244	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Methotrexate-induced interstitial lung disease in rheumatoid arthritis	interstitial lung disease	http://www.ebi.ac.uk/efo/EFO_0004244	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cleft lip with or without cleft palate	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft palate	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft plate (environmental tobacco smoke interaction)	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with cleft palate	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with or without cleft palate	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Orofacial clefts (cleft lip vs. cleft lip and palate)	cleft palate	http://purl.obolibrary.org/obo/HP_0000175	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Glucocorticoid-induced osteonecrosis	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Glucocorticoid-induced osteonecrosis (age 10 years and older)	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Glucocorticoid-induced osteonecrosis (time dependent analysis)	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Glucocorticoid-induced osteonecrosis (time independent analysis)	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteonecrosis of the jaw	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Maternal chorioamnionitis	chorioamnionitis	http://www.ebi.ac.uk/efo/EFO_0009948	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Obesity-related traits	body composition measurement	http://www.ebi.ac.uk/efo/EFO_0005106	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Thoracic-to-hip circumference ratio	thoracic-to-hip circumference ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007769	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
KANNO antigen negativity	KANNO antigen measurement	http://www.ebi.ac.uk/efo/EFO_0009949	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to exercise (triglyceride level interaction)	response to exercise	http://www.ebi.ac.uk/efo/EFO_0007768	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Low density lipoprotein triglyceride levels	low density lipoprotein triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0009946	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Obesity-related traits	arm span	http://www.ebi.ac.uk/efo/EFO_0005108	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	nucleoside diphosphate kinase A measurement	http://www.ebi.ac.uk/efo/EFO_0009947	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	energy expenditure	http://www.ebi.ac.uk/efo/EFO_0005109	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Delta-6 desaturase activity	delta-6 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	delta-6 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Idiopathic membranous nephropathy	membranous glomerulonephritis	http://www.ebi.ac.uk/efo/EFO_0004254	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Membranous nephropathy	membranous glomerulonephritis	http://www.ebi.ac.uk/efo/EFO_0004254	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Medication use (antiglaucoma preparations and miotics)	Antiglaucoma preparations and miotics use measurement	http://www.ebi.ac.uk/efo/EFO_0009944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delta-5 desaturase activity	delta-5 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	delta-5 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nephrolithiasis	nephrolithiasis	http://www.ebi.ac.uk/efo/EFO_0004253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Psychological resilience (outcome-based)	psychological resilience measurement	http://www.ebi.ac.uk/efo/EFO_0009945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological resilience (outcome-based) in high deployment stress exposure	psychological resilience measurement	http://www.ebi.ac.uk/efo/EFO_0009945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological resilience (self-assessed)	psychological resilience measurement	http://www.ebi.ac.uk/efo/EFO_0009945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiovascular disease in hypertension (calcium channel blocker interaction)	response to calcium channel blocker	http://www.ebi.ac.uk/efo/EFO_0007767	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	response to calcium channel blocker	http://www.ebi.ac.uk/efo/EFO_0007767	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in hypertension (calcium channel blocker interaction)	response to calcium channel blocker	http://www.ebi.ac.uk/efo/EFO_0007767	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Medication use (glucocorticoids)	Glucocorticoid use measurement	http://www.ebi.ac.uk/efo/EFO_0009942	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nasopharyngeal carcinoma	nasopharyngeal neoplasm	http://www.ebi.ac.uk/efo/EFO_0004252	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nasopharyngeal carcinoma (SNP x SNP interaction)	nasopharyngeal neoplasm	http://www.ebi.ac.uk/efo/EFO_0004252	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Radiation-induced brain injury in nasopharyngeal carcinoma	nasopharyngeal neoplasm	http://www.ebi.ac.uk/efo/EFO_0004252	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cardiovascular disease in hypertension (beta blocker interaction)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Heart rate response to beta blockers	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Heart rate response to beta blockers (atenolol add-on therapy)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Heart rate response to beta blockers (atenolol monotherapy)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in hypertension (beta blocker interaction)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to beta blocker use in hypertension (diastolic blood pressure)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to beta blocker use in hypertension (systolic blood pressure)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Medication use (antihistamines for systemic use)	Antihistamine use measurement	http://www.ebi.ac.uk/efo/EFO_0009943	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Myeloproliferative neoplasms	myeloproliferative disorder	http://www.ebi.ac.uk/efo/EFO_0004251	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cardiometabolic traits	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Interleukin-6 (red blood cell fatty acid level interaction)	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Medication use (antidepressants)	Antidepressant use measurement	http://www.ebi.ac.uk/efo/EFO_0009940	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (adrenergics, inhalants)	Inhalant adrenergic use measurement	http://www.ebi.ac.uk/efo/EFO_0009941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuroticism	neurotic disorder	http://www.ebi.ac.uk/efo/EFO_0004257	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neuroticism (age interaction)	neurotic disorder	http://www.ebi.ac.uk/efo/EFO_0004257	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	eicosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007760	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Neuromyelitis optica	neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0004256	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	dihomo-gamma-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007763	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Childhood steroid-sensitive nephrotic syndrome	nephrotic syndrome	http://www.ebi.ac.uk/efo/EFO_0004255	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nephrotic syndrome (acquired)	nephrotic syndrome	http://www.ebi.ac.uk/efo/EFO_0004255	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	gamma-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007762	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	post-operative fentanyl consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007770	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Paget's disease	osteitis deformans	http://www.ebi.ac.uk/efo/EFO_0004261	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Testicular germ cell tumor	Testicular Germ Cell Tumor	http://www.ebi.ac.uk/efo/EFO_1000566	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Severe skin toxicity response to cetuximab in colorectal cancer	skin disease	http://www.ebi.ac.uk/efo/EFO_0000701	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced skin symptoms in inflammatory bowel disease	skin disease	http://www.ebi.ac.uk/efo/EFO_0000701	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Small cell lung carcinoma	small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000702	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Small-cell lung cancer (survival)	small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000702	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Sagittal craniosynostosis	isolated scaphocephaly	http://www.orpha.net/ORDO/Orphanet_35093	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Esophageal cancer (squamous cell)	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal squamous cell cancer (length of survival)	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple keratinocyte cancers	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Squamous cell carcinoma	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Familial squamous cell lung carcinoma	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Smoking interaction in squamous cell lung cancer (1df test)	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Squamous cell lung carcinoma	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Age-related diseases and mortality	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related diseases, mortality and associated endophenotypes	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Chronic obstructive pulmonary disease or stroke (pleiotropy)	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease or ischemic stroke	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ischemic stroke	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Stroke	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Stroke (ischemic)	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Stroke (pediatric)	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Thrombosis	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Vitamin B levels in ischemic stroke	stroke	http://www.ebi.ac.uk/efo/EFO_0000712	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	disturbance of skin sensation	http://www.ebi.ac.uk/efo/EFO_0009522	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Homocysteine level response to multivitamin in cerebral infarction	response to vitamin	http://purl.obolibrary.org/obo/GO_0033273	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to Vitamin E supplementation	response to vitamin	http://purl.obolibrary.org/obo/GO_0033273	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Drug-induced liver injury in interferon-beta-treated multiple sclerosis	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to interferon beta in multiple sclerosis	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to interferon beta therapy	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	response to antimetabolite	http://purl.obolibrary.org/obo/GO_0097329	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carboplatin disposition in epthelial ovarian cancer	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy (carboplatin)	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Systemic lupus erythematosus and Systemic sclerosis	systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0000717	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Systemic sclerosis	systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0000717	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0000717	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (survival time)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer (survival)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Esophageal squamous cell cancer (length of survival)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-small cell lung cancer (survival)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate cancer (survival)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate cancer mortality	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sepsis from pneumonia (survival)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in breast cancer (estrogen-receptor negative)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in breast cancer (estrogen-receptor positive)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colorectal cancer	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colorectal cancer (distant metastatic)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colorectal cancer (non-distant metastatic)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in endocrine treated breast cancer (estrogen-receptor positive)	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in head and neck cancer	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in sporadic amyotrophic lateral sclerosis	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Achilles tendinopathy	Tendinopathy	http://www.ebi.ac.uk/efo/EFO_1001434	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tendinopathy	Tendinopathy	http://www.ebi.ac.uk/efo/EFO_1001434	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thyroid nodules	thyroid nodule	http://www.ebi.ac.uk/efo/EFO_1001436	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Capecitabine sensitivity	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Chemotherapeutic susceptibility	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Methotrexate phramacokinetics (acute lymphoblastic leukemia)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pathological complete response in breast cancer treated with or without bevacizumab	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antineoplastic agents	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to tamoxifen in breast cancer	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to taxane treatment (docetaxel)	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to treatment for acute lymphoblastic leukemia	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Serum ceruloplasmin levels	serum ceruloplasmin measurement	http://www.ebi.ac.uk/efo/EFO_0005139	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Developmental language disorder (linguistic errors)	linguistic error measurement	http://www.ebi.ac.uk/efo/EFO_0007798	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ventricular fibrillation	ventricular fibrillation	http://www.ebi.ac.uk/efo/EFO_0004287	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cognitive performance (language ability)	language measurement	http://www.ebi.ac.uk/efo/EFO_0007797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (language ability) x major depressive disorder status interaction	language measurement	http://www.ebi.ac.uk/efo/EFO_0007797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Language performance in older adults (adjusted for episodic memory)	language measurement	http://www.ebi.ac.uk/efo/EFO_0007797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma factor V levels in venous thrombosis	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Plasma factor V levels in venous thrombosis (conditioned on rs6027)	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Thrombosis	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Venous thromboembolism	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Venous thromboembolism (SNP x SNP interaction)	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Venous thromboembolism adjusted for sickle cell variant rs77121243-T	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Albuminuria	albuminuria	http://www.ebi.ac.uk/efo/EFO_0004285	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Urinary albumin excretion	albuminuria	http://www.ebi.ac.uk/efo/EFO_0004285	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Urinary albumin excretion (no hypertensive medication)	albuminuria	http://www.ebi.ac.uk/efo/EFO_0004285	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Developmental language disorder (syntactic complexity)	syntactic complexity measurement	http://www.ebi.ac.uk/efo/EFO_0007799	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Oral cavity and pharyngeal cancer	upper aerodigestive tract neoplasm	http://www.ebi.ac.uk/efo/EFO_0004284	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Metabolite levels (HVA)	HVA measurement	http://www.ebi.ac.uk/efo/EFO_0005131	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA-5-HIAA Factor score)	HVA measurement	http://www.ebi.ac.uk/efo/EFO_0005131	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA/5-HIAA ratio)	HVA measurement	http://www.ebi.ac.uk/efo/EFO_0005131	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA/MHPG ratio)	HVA measurement	http://www.ebi.ac.uk/efo/EFO_0005131	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mucinous ovarian carcinoma	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nicotine metabolite ratio	nicotine metabolite ratio	http://www.ebi.ac.uk/efo/EFO_0007794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
nicotine metabolite ratio in current smokers	nicotine metabolite ratio	http://www.ebi.ac.uk/efo/EFO_0007794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (5-HIAA)	5-HIAA measurement	http://www.ebi.ac.uk/efo/EFO_0005132	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (5-HIAA/ MHPG Ratio)	5-HIAA measurement	http://www.ebi.ac.uk/efo/EFO_0005132	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA-5-HIAA Factor score)	5-HIAA measurement	http://www.ebi.ac.uk/efo/EFO_0005132	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA/5-HIAA ratio)	5-HIAA measurement	http://www.ebi.ac.uk/efo/EFO_0005132	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
circulating leptin levels adjusted for BMI	BMI-adjusted leptin measurement	http://www.ebi.ac.uk/efo/EFO_0007793	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (5-HIAA/ MHPG Ratio)	MHPG measurement	http://www.ebi.ac.uk/efo/EFO_0005133	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (HVA/MHPG ratio)	MHPG measurement	http://www.ebi.ac.uk/efo/EFO_0005133	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (MHPG)	MHPG measurement	http://www.ebi.ac.uk/efo/EFO_0005133	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental extreme longevity (95 years and older)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental lifespan	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (at least one long-lived parent)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (both parents in top 10%)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (combined parental age at death)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (combined parental attained age, Martingale residuals)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (father's age at death)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (father's attained age)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (mother's age at death)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parental longevity (mother's attained age)	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amino acid levels	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Branched-chain amino acid levels (Isoleucine)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Branched-chain amino acid levels (Leucine)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Branched-chain amino acid levels (Valine)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (small molecules and protein measures)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anxiety	anxiety disorder measurement	http://www.ebi.ac.uk/efo/EFO_0007795	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anxiety disorder (factor score)	anxiety disorder measurement	http://www.ebi.ac.uk/efo/EFO_0007795	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colon cancer	colonic neoplasm	http://www.ebi.ac.uk/efo/EFO_0004288	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in colon cancer	colonic neoplasm	http://www.ebi.ac.uk/efo/EFO_0004288	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Autoimmune traits	autoimmune disease	http://www.ebi.ac.uk/efo/EFO_0005140	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	autoimmune disease	http://www.ebi.ac.uk/efo/EFO_0005140	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Diverticulitis	diverticulitis	http://www.ebi.ac.uk/efo/EFO_1001460	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Echocardiographic traits	left atrial function	http://www.ebi.ac.uk/efo/EFO_0004294	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Common traits (Other)	braces	http://www.ebi.ac.uk/efo/EFO_0004291	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thyroid-associated orbitopathy in graves' disease	Graves ophthalmopathy	http://www.ebi.ac.uk/efo/EFO_1001466	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Knee pain	knee pain	http://purl.obolibrary.org/obo/HP_0030839	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cluster headache	Cluster headache	http://purl.obolibrary.org/obo/HP_0012199	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cardiac muscle measurement	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiac structure and function	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiovascular disease risk factors	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Echocardiographic traits	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Endothelial function traits	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinical laboratory measurements	clinical laboratory measurement	http://www.ebi.ac.uk/efo/EFO_0004297	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyroid function	thyroid function	http://www.ebi.ac.uk/efo/EFO_0004296	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thyroid stimulating hormone levels	thyroid function	http://www.ebi.ac.uk/efo/EFO_0004296	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Echocardiographic traits	left ventricular function	http://www.ebi.ac.uk/efo/EFO_0004295	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Left ventricular function change in anthracycline treatment	left ventricular function	http://www.ebi.ac.uk/efo/EFO_0004295	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Foot ulcer and neuropathy in diabetes	diabetic foot	http://www.ebi.ac.uk/efo/EFO_1001459	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Foot ulcer in diabetes and neuropathy	diabetic foot	http://www.ebi.ac.uk/efo/EFO_1001459	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	matrilysin measurement	http://www.ebi.ac.uk/efo/EFO_0008227	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	MAP kinase-activated protein kinase 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008226	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	melanoma-derived growth regulatory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008229	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	mediator of RNA polymerase II transcription subunit 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008228	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Beta-2 microglubulin plasma levels	beta-2 microglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0005197	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	mannan-binding lectin serine protease 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008223	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	macrophage scavenger receptor types I and II measurement	http://www.ebi.ac.uk/efo/EFO_0008222	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft rejection in renal transplantation (donor effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft rejection in renal transplantation (donor-recipient interaction)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft rejection in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
End stage renal failure in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate change in renal transplantation (donor effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate change in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Graft survival time in renal transplantation (donor effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Graft survival time in renal transplantation (donor-recipient interaction)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Graft survival time in renal transplantation (recipient effect)	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal transplant outcome	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tacrolimus trough concentration in kidney transplant patients	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	MAP kinase-activated protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008225	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	mannose-binding protein C measurement	http://www.ebi.ac.uk/efo/EFO_0008224	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mental composite score	mental development measurement	http://www.ebi.ac.uk/efo/EFO_0008230	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mental development (prenatal lead exposure interaction)	mental development measurement	http://www.ebi.ac.uk/efo/EFO_0008230	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	methionine aminopeptidase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008232	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	metalloproteinase inhibitor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008231	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	melanoma	http://www.ebi.ac.uk/efo/EFO_0000756	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Melanoma	melanoma	http://www.ebi.ac.uk/efo/EFO_0000756	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	myeloid cell surface antigen CD33 measurement	http://www.ebi.ac.uk/efo/EFO_0008238	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Motor composite score	motor development measurement	http://www.ebi.ac.uk/efo/EFO_0008237	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Motor development (prenatal lead exposure interaction)	motor development measurement	http://www.ebi.ac.uk/efo/EFO_0008237	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	N-acetyl-D-glucosamine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0008239	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	MHC class I polypeptide-related sequence B measurement	http://www.ebi.ac.uk/efo/EFO_0008234	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	MHC class I polypeptide-related sequence A measurement	http://www.ebi.ac.uk/efo/EFO_0008233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monokine induced by gamma interferon levels	monokine induced by gamma interferon measurement	http://www.ebi.ac.uk/efo/EFO_0008236	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	monokine induced by gamma interferon measurement	http://www.ebi.ac.uk/efo/EFO_0008236	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	monocyte chemotactic protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008235	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	NAD-dependent protein deacetylase sirtuin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008241	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	N-acylethanolamine-hydrolyzing acid amidase measurement	http://www.ebi.ac.uk/efo/EFO_0008240	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	natural cytotoxicity triggering receptor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008243	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	NADPH--cytochrome P450 reductase measurement	http://www.ebi.ac.uk/efo/EFO_0008242	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	leukocyte immunoglobulin-like receptor subfamily B member 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008209	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008208	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left atrial antero-posterior diameter	left ventricular structural measurement	http://www.ebi.ac.uk/efo/EFO_0008205	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricle diastolic internal dimension	left ventricular structural measurement	http://www.ebi.ac.uk/efo/EFO_0008205	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricle wall thickness	left ventricular structural measurement	http://www.ebi.ac.uk/efo/EFO_0008205	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricular mass	left ventricular structural measurement	http://www.ebi.ac.uk/efo/EFO_0008205	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Change in LVEF in response to paclitaxel in HER2+ breast cancer	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Deceleration time of the mitral E-wave	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Diastolic dysfunction with preserved ejection pressure	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart failure with preserved ejection fraction	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Isovolumetric relaxation time	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricular internal dimension in diastole	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Peak velocity of excursion of lateral mitral annulus in early diastolic phase	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Peak velocity of the mitral A-wave	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Peak velocity of the mitral E-wave	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood protein levels	leucine carboxyl methyltransferase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008207	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left  ventricle systolic dysfunction	left ventricular systolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008206	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricular fractional shortening	left ventricular systolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008206	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricular internal dimension in systole	left ventricular systolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008206	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood protein levels	kynureninase measurement	http://www.ebi.ac.uk/efo/EFO_0008201	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Kunitz-type protease inhibitor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008200	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	lactadherin measurement	http://www.ebi.ac.uk/efo/EFO_0008203	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	L-Selectin measurement	http://www.ebi.ac.uk/efo/EFO_0008202	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	low affinity immunoglobulin epsilon Fc receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008210	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma (corticosteroid response)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Asthma control x inhaled corticosteroid treatment interaction (1df)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Asthma control x inhaled corticosteroid treatment interaction (2df)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Asthma exacerbations in inhaled corticosteroid treatment	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bone mineral accretion in asthma (oral corticosteroid dose interaction)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cytokine and corticosteroid-stimulated IL-6 production	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Hyperemesis gravidarum	hyperemesis gravidarum	http://www.ebi.ac.uk/efo/EFO_1000971	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Childhood onset ulcerative colitis	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Inflammatory bowel disease	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple traits (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Sclerosing cholangitis and ulcerative colitis (combined)	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ulcerative colitis	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ulcerative colitis or Crohn's disease	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Uterine fibroids	uterine fibroid	http://www.ebi.ac.uk/efo/EFO_0000731	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Wilms tumor	nephroblastoma	http://www.orpha.net/ORDO/Orphanet_654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Macrophage inflammatory protein 1b levels	macrophage inflammatory protein 1b measurement	http://www.ebi.ac.uk/efo/EFO_0008219	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	lysozyme C measurement	http://www.ebi.ac.uk/efo/EFO_0008216	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	lysosomal protective protein measurement	http://www.ebi.ac.uk/efo/EFO_0008215	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Macrophage inflammatory protein 1a levels	macrophage inflammatory protein 1a measurement	http://www.ebi.ac.uk/efo/EFO_0008218	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Macrophage colony stimulating factor levels	macrophage colony stimulating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008217	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	low affinity immunoglobulin gamma Fc region receptor III-B measurement	http://www.ebi.ac.uk/efo/EFO_0008212	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	low affinity immunoglobulin gamma Fc region receptor II-a/b measurement	http://www.ebi.ac.uk/efo/EFO_0008211	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
C-peptide levels	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
C-peptide levels in type I diabetes	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting C-peptide levels in type I diabetes	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (pregnancy)	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Random C-peptide levels in type I diabetes	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Stimulated C-peptide levels in type I diabetes	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	lymphotactin measurement	http://www.ebi.ac.uk/efo/EFO_0008214	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	CCL11 measurement	http://www.ebi.ac.uk/efo/EFO_0005188	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Obesity-related traits	CCL11 measurement	http://www.ebi.ac.uk/efo/EFO_0005188	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Blood protein levels	low molecular weight phosphotyrosine protein phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0008213	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	respiratory quotient	http://www.ebi.ac.uk/efo/EFO_0005189	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG N-glycosylation phenotypes (multivariate analysis)	serum IgG glycosylation measurement	http://www.ebi.ac.uk/efo/EFO_0005193	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG glycosylation	serum IgG glycosylation measurement	http://www.ebi.ac.uk/efo/EFO_0005193	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG glycosylation patterns	serum IgG glycosylation measurement	http://www.ebi.ac.uk/efo/EFO_0005193	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease biomarkers	amyloid-beta measurement	http://www.ebi.ac.uk/efo/EFO_0005194	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cingulate cortical amyloid beta load	amyloid-beta measurement	http://www.ebi.ac.uk/efo/EFO_0005194	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	macrophage migration inhibitory factor measurement	http://www.ebi.ac.uk/efo/EFO_0008221	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Macrophage Migration Inhibitory Factor levels	macrophage migration inhibitory factor measurement	http://www.ebi.ac.uk/efo/EFO_0008221	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (sleepiness)	sleepiness	http://purl.obolibrary.org/obo/NCIT_C95746	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cholinesterase inhibitors in Alzheimer's disease	response to cholinesterase inhibitor	http://www.ebi.ac.uk/efo/EFO_0005195	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	macrophage metalloelastase measurement	http://www.ebi.ac.uk/efo/EFO_0008220	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Circulating vasoactive peptide levels	vasoactive peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005196	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Obesity-related traits	urinary nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0005190	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	waist height ratio	http://www.ebi.ac.uk/efo/EFO_0005191	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Blood cell traits (multivariate analysis)	red blood cell distribution width	http://www.ebi.ac.uk/efo/EFO_0005192	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	red blood cell distribution width	http://www.ebi.ac.uk/efo/EFO_0005192	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	red blood cell distribution width	http://www.ebi.ac.uk/efo/EFO_0005192	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red cell distribution width	red blood cell distribution width	http://www.ebi.ac.uk/efo/EFO_0005192	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Esophageal cancer	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal cancer  (alcohol interaction)	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal cancer (squamous cell)	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal cancer and gastric cancer	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal squamous cell cancer (length of survival)	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Immunoglobulin A vasculitis	Henoch-Schoenlein purpura	http://www.ebi.ac.uk/efo/EFO_1000965	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Idiopathic inflammatory myopathy	myositis	http://www.ebi.ac.uk/efo/EFO_0000783	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Myositis	myositis	http://www.ebi.ac.uk/efo/EFO_0000783	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	myositis	http://www.ebi.ac.uk/efo/EFO_0000783	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Acute post-radiotherapy pain in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Adverse response to chemotherapy (congestive heart failure) in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast Cancer in BRCA1 mutation carriers	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (early onset)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (estrogen-receptor negative)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (male)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (menopausal hormone therapy interaction)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (prognosis)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (survival)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer and/or colorectal cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in BRCA2 mutation carriers	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer specific mortality in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer-free interval (treatment with aromatase inhibitor)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Disease-free survival in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Estrogen receptor status in HER2 negative breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Estrogen receptor status in HER2 positive breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Estrogen receptor status in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Femoral neck bone mineral density or breast cancer (pleiotropy)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
HER2 status in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lumbar spine bone mineral density or breast cancer (pleiotropy)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuropathy in taxane-treated breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pathological complete response in breast cancer treated with or without bevacizumab	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Percent mammographic density	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Progression-free survival response to gemcitabine in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to radiotherapy in cancer (late toxicity)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in breast cancer (TP53 expression interaction)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in breast cancer (estrogen-receptor negative)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in breast cancer (estrogen-receptor positive)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in endocrine treated breast cancer (estrogen-receptor positive)	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Taxane-induced peripheral neuropathy in breast cancer	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
CD19-positive B-lymphocyte count	CD19-positive B-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010108	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
CD56-positive NK-lymphocyte cell count	CD56-positive NK-lymphocyte cell count	http://www.ebi.ac.uk/efo/EFO_0010109	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	polymeric immunoglobulin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008267	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009115	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking behaviour (cigarette pack-years)	tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009115	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling hurt	feeling emotionally hurt measurement	http://www.ebi.ac.uk/efo/EFO_0009599	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	plexin-C1 measurement	http://www.ebi.ac.uk/efo/EFO_0008266	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	vitamin supplement exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	properdin measurement	http://www.ebi.ac.uk/efo/EFO_0008269	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	alcohol exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009113	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling nervous	feeling nervous measurement	http://www.ebi.ac.uk/efo/EFO_0009597	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	programmed cell death 1 ligand 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling miserable	feeling miserable measurement	http://www.ebi.ac.uk/efo/EFO_0009598	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	retinoic acid receptor responder protein 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008274	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Multisite chronic pain	multisite chronic pain	http://www.ebi.ac.uk/efo/EFO_0010100	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	repulsive guidance molecule A measurement	http://www.ebi.ac.uk/efo/EFO_0008273	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Low susceptibility to hepatitis C infection	decreased susceptibility to hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0010101	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	scavenger receptor class F member 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008276	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	S-formylglutathione hydrolase measurement	http://www.ebi.ac.uk/efo/EFO_0008275	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mouth ulcers	oral ulcer	http://purl.obolibrary.org/obo/HP_0000155	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Peginterferon alfa-2a treatment response in chronic hepatitis B infection	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	proprotein convertase subtilisin/kexin type 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008270	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Health literacy	health literacy measurement	http://www.ebi.ac.uk/efo/EFO_0010104	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
CD4-positive T-lymphocyte count	CD4-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010105	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Excessive hairiness	Hirsutism	http://purl.obolibrary.org/obo/HP_0001007	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	proto-oncogene tyrosine-protein kinase receptor Ret measurement	http://www.ebi.ac.uk/efo/EFO_0008272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
CD3-positive T-lymphocyte count	CD3-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010106	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	protein jagged-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
CD8-positive T-lymphocyte count	CD8-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010107	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Childhood dental caries in permanent teeth	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Childhood dental caries in primary teeth	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Dental caries	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Early childhood caries	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Number of decayed and filled tooth surfaces per available tooth surface	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Number of decayed, missing and filled tooth surfaces	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Number of decayed, missing and filled tooth surfaces or use of dentures	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver disease severity in Alagille syndrome	Alagille syndrome	http://www.orpha.net/ORDO/Orphanet_52	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Migraine	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine - clinic-based	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine in bipolar disorder	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine in psychiatric disorder	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine or coronary artery disease	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine with aura	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Migraine without aura	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Paediatric migraine	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related diseases and mortality	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Age-related diseases, mortality and associated endophenotypes	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Body mass index (change over time) in cancer	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to Pazopanib in cancer (hepatotoxicity)	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to opioid analgesics in cancer (pain decrease)	cancer	http://www.ebi.ac.uk/efo/EFO_0000311	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Age-related diseases and mortality	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related diseases, mortality and associated endophenotypes	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease or ischemic stroke	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease or large artery stroke	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery disease-related phenotypes	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary heart disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary heart disease (SNP X SNP interaction)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary heart disease event reduction (statin therapy interaction)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary heart disease in familial hypercholesterolemia	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Incident coronary heart disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein phospholipase A2 activity in cardiovascular disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in darapladib-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Major coronary event in placebo-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in coronary artery disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in placebo-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Odor events in darapladib-treated cardiovascular disease (time to event)	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to clopidogrel therapy in coronary heart disease	coronary heart disease	http://www.ebi.ac.uk/efo/EFO_0001645	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiometabolic traits	omega-3 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0010119	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Blood protein levels	semaphorin-3A measurement	http://www.ebi.ac.uk/efo/EFO_0008278	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Secreted frizzled-related protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008277	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	semaphorin-3E measurement	http://www.ebi.ac.uk/efo/EFO_0008279	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	sialic acid-binding Ig-like lectin 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008285	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	acetoacetate measurement	http://www.ebi.ac.uk/efo/EFO_0010111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholesteryl ester transfer protein levels	cholesteryl ester transfer protein measurement	http://www.ebi.ac.uk/efo/EFO_0009133	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	sialic acid-binding Ig-like lectin 14 measurement	http://www.ebi.ac.uk/efo/EFO_0008284	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	acetate measurement	http://www.ebi.ac.uk/efo/EFO_0010112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma trimethyllysine levels	trimethyllysine measurement	http://www.ebi.ac.uk/efo/EFO_0009134	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	SLAM family member 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008287	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	3-hydroxybutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010113	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	response to polyunsaturated fatty acid supplementation	http://www.ebi.ac.uk/efo/EFO_0009131	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	response to polyunsaturated fatty acid supplementation	http://www.ebi.ac.uk/efo/EFO_0009131	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood protein levels	sialic acid-binding Ig-like lectin 9 measurement	http://www.ebi.ac.uk/efo/EFO_0008286	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	citrate measurement	http://www.ebi.ac.uk/efo/EFO_0010114	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholesterol efflux capacity	cholesterol efflux capacity measurement	http://www.ebi.ac.uk/efo/EFO_0009132	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol efflux capacity (ABCA-1 dependent assay)	cholesterol efflux capacity measurement	http://www.ebi.ac.uk/efo/EFO_0009132	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol efflux capacity (BHK stimulated assay)	cholesterol efflux capacity measurement	http://www.ebi.ac.uk/efo/EFO_0009132	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol efflux capacity (cAMP stimulated assay)	cholesterol efflux capacity measurement	http://www.ebi.ac.uk/efo/EFO_0009132	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Blood protein levels	serine/threonine-protein kinase 17B measurement	http://www.ebi.ac.uk/efo/EFO_0008281	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	serine protease 27 measurement	http://www.ebi.ac.uk/efo/EFO_0008280	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clostridium difficile infection in multiple myeloma	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	serum amyloid P-component measurement	http://www.ebi.ac.uk/efo/EFO_0008283	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	pyruvate measurement	http://www.ebi.ac.uk/efo/EFO_0010117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	serum amyloid A-1 protein measurement	http://www.ebi.ac.uk/efo/EFO_0008282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	sphingomyelin measurement	http://www.ebi.ac.uk/efo/EFO_0010118	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Sphingomyelin 24:0 levels	sphingomyelin measurement	http://www.ebi.ac.uk/efo/EFO_0010118	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Sphingomyelin levels	sphingomyelin measurement	http://www.ebi.ac.uk/efo/EFO_0010118	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Alcohol dependence	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol dependence (age at onset)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol dependence or heroin dependence or methamphetamine dependence	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol use disorder	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcoholism (12-month weekly alcohol consumption)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcoholism (alcohol dependence factor score)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcoholism (alcohol use disorder factor score)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcoholism (heaviness of drinking)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Behavioural disinhibition (generation interaction)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression and alcohol dependence	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Electroencephalographic traits in alcoholism	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depression and alcohol dependence	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Risky sexual behaviors (alcohol dependence interaction)	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Risky sexual behaviors in alcohol dependence	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cardiomyopathy in childhood cancer survivors	cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000318	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000318	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiovascular disease	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular disease in hypertension (ACE inhibitor interaction)	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular disease in hypertension (beta blocker interaction)	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular disease in hypertension (calcium channel blocker interaction)	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular disease in hypertension (diuretic interaction)	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular disease risk factors	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular event in rheumatoid arthritis	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular heart disease in diabetics	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular risk factors	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardiovascular risk factors (age interaction)	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Major CVD	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Vascular constriction	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thrombosis	pulmonary embolism	http://www.ebi.ac.uk/efo/EFO_0003827	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiometabolic traits	ketone body measurement	http://www.ebi.ac.uk/efo/EFO_0010110	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bilirubin levels in tenofovir-treated HIV infection	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Common carotid intima-media thickness in HIV infection	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Liver injury in anti-retroviral drug treated HIV	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (rash)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to dendritic cell-based immunotherapy in HIV infection	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tenofovir clearance in HIV infection	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Idiopathic pulmonary fibrosis	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
AIDS	aids	http://www.ebi.ac.uk/efo/EFO_0000765	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
AIDS progression	aids	http://www.ebi.ac.uk/efo/EFO_0000765	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	nidogen-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008249	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	neutrophil collagenase measurement	http://www.ebi.ac.uk/efo/EFO_0008248	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	neurexophilin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008244	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	neutral ceramidase measurement	http://www.ebi.ac.uk/efo/EFO_0008247	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	neurogenic locus notch homolog protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008246	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	OCIA domain-containing protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008252	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dimensional psychopathology (Social)	social domain measurement	http://www.ebi.ac.uk/efo/EFO_0009100	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuromyelitis optica (AQP4-IgG-positive)	AQP4-IgG-positive neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0009584	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Age at first birth	age at first birth measurement	http://www.ebi.ac.uk/efo/EFO_0009101	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at first birth in continuous marriage	age at first birth measurement	http://www.ebi.ac.uk/efo/EFO_0009101	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	non-receptor tyrosine-protein kinase TYK2 measurement	http://www.ebi.ac.uk/efo/EFO_0008251	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuromyelitis optica (AQP4-IgG-negative)	AQP4-IgG-negative neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0009585	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	P-Selectin measurement	http://www.ebi.ac.uk/efo/EFO_0008254	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
P-Selectin (red blood cell fatty acid level interaction)	P-Selectin measurement	http://www.ebi.ac.uk/efo/EFO_0008254	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	OX-2 membrane glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008253	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Population density of place of residence	place of residence measurement	http://www.ebi.ac.uk/efo/EFO_0009583	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Socioeconomic status of place of residence	place of residence measurement	http://www.ebi.ac.uk/efo/EFO_0009583	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Headache	Headache	http://purl.obolibrary.org/obo/HP_0002315	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Menstruation quality of life impact (headache)	Headache	http://purl.obolibrary.org/obo/HP_0002315	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	NKG2-D type II integral membrane protein measurement	http://www.ebi.ac.uk/efo/EFO_0008250	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein-Barr virus copy number in lymphoblastoid cell lines	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Epstein-Barr virus immune response (EBNA-1)	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Microalbuminuria	microalbuminuria	http://purl.obolibrary.org/obo/HP_0012594	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Type 2 diabetes nephropathy including microalbuminuria	microalbuminuria	http://purl.obolibrary.org/obo/HP_0012594	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Takayasu arteritis	Takayasu arteritis	http://www.ebi.ac.uk/efo/EFO_1001857	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Hepatitis	hepatitis	http://purl.obolibrary.org/obo/HP_0012115	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Change in HbA1c levels in response to metformin treatment in type 2 diabetes	response to metformin	http://purl.obolibrary.org/obo/GO_1901558	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Multiple traits (pleiotropy)	response to metformin	http://purl.obolibrary.org/obo/GO_1901558	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to metformin (IC50)	response to metformin	http://purl.obolibrary.org/obo/GO_1901558	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to metformin in type 2 diabetes (HbA1c reduction)	response to metformin	http://purl.obolibrary.org/obo/GO_1901558	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to metformin in type 2 diabetes (glycemic)	response to metformin	http://purl.obolibrary.org/obo/GO_1901558	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Ribavirin-induced anemia	response to ribavirin	http://purl.obolibrary.org/obo/GO_1901559	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to angiotensin II receptor blocker therapy	response to candesartan	http://purl.obolibrary.org/obo/GO_1901556	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	response to candesartan	http://purl.obolibrary.org/obo/GO_1901556	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	phospholipase A2, membrane associated measurement	http://www.ebi.ac.uk/efo/EFO_0008259	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	phospholipase A2, membrane associated measurement	http://www.ebi.ac.uk/efo/EFO_0008259	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Inflammatory biomarkers	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate (HDL cholesterol levels)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate (LDL cholesterol levels)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate (adiponectin levels)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate (total cholesterol levels)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fenofibrate (triglyceride levels)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride change in response to fenofibrate (parental genotype effect)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride change in response to fenofibrate treatment	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride levels in response to fenofibrate	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to acetaminophen (hepatotoxicity)	response to acetaminophen	http://purl.obolibrary.org/obo/GO_1901554	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in LVEF in response to paclitaxel in HER2+ breast cancer	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neuropathy in taxane-treated breast cancer	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Paclitaxel disposition in epithelial ovarian cancer	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Paclitaxel-induced cytotoxicity	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Paclitaxel-induced neuropathy	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paclitaxel in ovarian cancer (MTT IC50)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to taxane treatment (placlitaxel)	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Arthritic-like pain in Charcot-Marie-Tooth type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Balance difficulty in Charcot-Marie-Tooth disease type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Foot deformity in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hearing loss in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neuropathy in Charcot-Marie-Tooth disease type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Scoliosis in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Walking difficulty in Charcot-Marie-Tooth disease 1A	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	peptidyl-prolyl cis-trans isomerase D measurement	http://www.ebi.ac.uk/efo/EFO_0008256	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling fed-up	feeling "fed-up" measurement	http://www.ebi.ac.uk/efo/EFO_0009588	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gout vs. Hyperuricemia	hyperuricemia	http://www.ebi.ac.uk/efo/EFO_0009104	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Hyperuricemia	hyperuricemia	http://www.ebi.ac.uk/efo/EFO_0009104	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Malignant pleural mesothelioma	malignant pleural mesothelioma	http://www.ebi.ac.uk/efo/EFO_0000770	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Feeling worry	worry measurement	http://www.ebi.ac.uk/efo/EFO_0009589	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Worry	worry measurement	http://www.ebi.ac.uk/efo/EFO_0009589	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Worry too long after an embarrassing experience	worry measurement	http://www.ebi.ac.uk/efo/EFO_0009589	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Worry/vulnerability (special factor of neuroticism)	worry measurement	http://www.ebi.ac.uk/efo/EFO_0009589	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High altitude adaptation	high altitude adaptation	http://www.ebi.ac.uk/efo/EFO_0009105	Biological process	http://purl.obolibrary.org/obo/GO_0008150
QT interval (ambient particulate matter interaction)	particulate matter air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0008255	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	persulfide dioxygenase ETHE1, mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008258	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of children ever born	number of children ever born measurement	http://www.ebi.ac.uk/efo/EFO_0009102	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin hydration	skin hydration measurement	http://www.ebi.ac.uk/efo/EFO_0009586	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anhedonia in major depressive disorder	anhedonia measurement	http://www.ebi.ac.uk/efo/EFO_0009587	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (anhedonia) (binary trait)	anhedonia measurement	http://www.ebi.ac.uk/efo/EFO_0009587	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (anhedonia) (ordinal trait)	anhedonia measurement	http://www.ebi.ac.uk/efo/EFO_0009587	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	peptidyl-prolyl cis-trans isomerase E measurement	http://www.ebi.ac.uk/efo/EFO_0008257	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Theory of mind score in adolescence (Emotional Triangles Task)	theory of mind measurement	http://www.ebi.ac.uk/efo/EFO_0009103	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	platelet glycoprotein VI measurement	http://www.ebi.ac.uk/efo/EFO_0008263	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling guilty	guilt measurement	http://www.ebi.ac.uk/efo/EFO_0009595	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	platelet glycoprotein 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008262	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Feeling tense	feeling tense measurement	http://www.ebi.ac.uk/efo/EFO_0009596	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	platelet-derived growth factor receptor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008265	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Irritable mood	irritability measurement	http://www.ebi.ac.uk/efo/EFO_0009594	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Platelet-derived growth factor BB levels	platelet-derived growth factor BB measurement	http://www.ebi.ac.uk/efo/EFO_0008264	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory	verbal memory measurement	http://www.ebi.ac.uk/efo/EFO_0009591	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ability to confide in someone	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Regular attendance at a gym or sports club	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Regular attendance at a pub or social club	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Regular attendance at a religious group	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social isolation	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	plasma protease C1 inhibitor measurement	http://www.ebi.ac.uk/efo/EFO_0008261	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	plasma kallikrein measurement	http://www.ebi.ac.uk/efo/EFO_0008260	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visual memory	visual memory measurement	http://www.ebi.ac.uk/efo/EFO_0009590	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute myeloid leukemia	acute myeloid leukemia	http://www.ebi.ac.uk/efo/EFO_0000222	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Core binding factor acute myeloid leukemia	acute myeloid leukemia	http://www.ebi.ac.uk/efo/EFO_0000222	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Urolithiasis	urolithiasis	http://purl.obolibrary.org/obo/MONDO_0024647	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Conotruncal heart defects	Conotruncal heart malformations	http://www.orpha.net/ORDO/Orphanet_2445	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Conotruncal heart defects (inherited effects)	Conotruncal heart malformations	http://www.orpha.net/ORDO/Orphanet_2445	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Conotruncal heart defects (maternal effects)	Conotruncal heart malformations	http://www.orpha.net/ORDO/Orphanet_2445	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Acute lymphoblastic leukemia (B-cell precursor)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Acute lymphoblastic leukemia (adolescents and young adults)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Acute lymphoblastic leukemia (childhood)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Asparaginase hypersensitivity in acute lymphoblastic leukemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to treatment for acute lymphoblastic leukemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Interleukin-7 levels	interleukin 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008189	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	killer cell immunoglobulin-like receptor 2DL4 measurement	http://www.ebi.ac.uk/efo/EFO_0008197	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	kallistatin measurement	http://www.ebi.ac.uk/efo/EFO_0008196	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Kunitz-type protease inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008199	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	kininogen-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008198	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interstitial collagenase measurement	http://www.ebi.ac.uk/efo/EFO_0008193	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-9 levels	interleukin 9 measurement	http://www.ebi.ac.uk/efo/EFO_0008192	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	kallikrein-7 measurement	http://www.ebi.ac.uk/efo/EFO_0008195	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	kallikrein-12 measurement	http://www.ebi.ac.uk/efo/EFO_0008194	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-8 levels	interleukin 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008191	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008191	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 7 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008190	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Childhood absence epilepsy	Childhood absence epilepsy	http://www.orpha.net/ORDO/Orphanet_64280	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Epilepsy	generalised epilepsy	http://www.ebi.ac.uk/efo/EFO_0005917	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Generalized epilepsy	generalised epilepsy	http://www.ebi.ac.uk/efo/EFO_0005917	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Osteoprotegerin (red blood cell fatty acid level interaction)	osteoprotegerin measurement	http://www.ebi.ac.uk/efo/EFO_0005918	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Osteoprotegerin levels	osteoprotegerin measurement	http://www.ebi.ac.uk/efo/EFO_0005918	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Recombination measurement	recombination measurement	http://www.ebi.ac.uk/efo/EFO_0005919	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Binge eating behaviour and bipolar disorder	binge eating	http://www.ebi.ac.uk/efo/EFO_0005924	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Binge eating behaviour in bipolar disorder	binge eating	http://www.ebi.ac.uk/efo/EFO_0005924	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary function in asthmatics	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rate of change of FEV1 (time interaction)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to montelukast in asthma (change in FEV1)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to zileuton treatment in asthma (FEV1 change interaction)	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Esophageal squamous cell carcinoma	esophageal squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0005922	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	esophageal squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0005922	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alloimmunization response to red blood cell transfusion in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cholelithiasis-related traits in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
F-cell distribution in sickle cell anaemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Fetal hemoglobin levels in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hemoglobin A2 levels in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mean corpuscular hemoglobin concentration in sickle cell disease	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Red blood cell density in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Sickle cell anemia (haemolysis)	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Sickle cell anemia (severity)	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Systolic blood pressure in sickle cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Vaso-occlusive pain in sickle-cell anemia	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Radioiodine-refractory disease in thyroid cancer	thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0002892	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Thyroid cancer	thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0002892	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Thyroid cancer (Papillary, radiation-related)	thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0002892	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Corneal astigmatism	corneal astigmatism	http://www.ebi.ac.uk/efo/EFO_1002040	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough	http://purl.obolibrary.org/obo/HP_0012735	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Serum tamsulosin hydrochloride concentration	response to tamsulosin	http://purl.obolibrary.org/obo/GO_1901905	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Monoclonal gammopathy of undetermined significance	monoclonal gammopathy	http://www.ebi.ac.uk/efo/EFO_0000203	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Multiple myeloma and monoclonal gammopathy	monoclonal gammopathy	http://www.ebi.ac.uk/efo/EFO_0000203	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Ketonuria	ketonuria	http://purl.obolibrary.org/obo/HP_0002919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ketonuria (mild)	ketonuria	http://purl.obolibrary.org/obo/HP_0002919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ketonuria (moderate to severe)	ketonuria	http://purl.obolibrary.org/obo/HP_0002919	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Respiratory diseases	respiratory system disease	http://www.ebi.ac.uk/efo/EFO_0000684	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
ACPA-negative rheumatoid arthritis (smoking interaction)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
ACPA-positive rheumatoid arthritis (smoking interaction)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Cardiovascular event in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Carotid intima media thickness in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Carotid plaques in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Celiac disease and Rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic lymphocytic leukemia or rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Diffuse large B-cell lymphoma or rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Follicular lymphoma or rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ischemic heart disease in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Joint damage in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Marginal zone lymphoma or rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Methotrexate-induced interstitial lung disease in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to TNF-alpha inhibitors in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to anti-TNF therapy in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to methotrexate in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to tocilizumab in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid arthritis (ACPA-negative)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid arthritis (ACPA-positive)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Rheumatoid factor seropositivity in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Sero-negative rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Severe progression in rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic lupus erythematosus or rheumatoid arthritis	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	interleukin 1 receptor-like 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008168	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 1 Receptor accessory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008167	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 1 receptor-like 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008169	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal cell carcinoma	renal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000681	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Renal cell carcinoma x sex interaction	renal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000681	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	interleukin 17 receptor A measurement	http://www.ebi.ac.uk/efo/EFO_0008175	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-17 levels	interleukin 17 measurement	http://www.ebi.ac.uk/efo/EFO_0008174	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 17 receptor D measurement	http://www.ebi.ac.uk/efo/EFO_0008177	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 17 receptor B measurement	http://www.ebi.ac.uk/efo/EFO_0008176	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-13 levels	interleukin 13 measurement	http://www.ebi.ac.uk/efo/EFO_0008171	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 12 receptor subunit beta-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008170	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008173	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-16 levels	interleukin 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008173	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (maternal genetic effect)	interleukin 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008173	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pandemrix-induced narcolepsy	narcolepsy	http://purl.obolibrary.org/obo/MONDO_0021107	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	interleukin 15 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008172	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (nervousness)	nervousness	http://purl.obolibrary.org/obo/NCIT_C74532	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suffering from nerves	nervousness	http://purl.obolibrary.org/obo/NCIT_C74532	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Gastritis	gastritis	http://www.ebi.ac.uk/efo/EFO_0000217	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Sjögren's syndrome	Sjogren syndrome	http://www.ebi.ac.uk/efo/EFO_0000699	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	interleukin 18 receptor accessory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008179	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 18 receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008178	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anti-saccade error rate in psychotic disorders	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Antipsychotic drug-induced QTc interval change in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Antipsychotic drug-induced weight gain in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism and schizophrenia (MTAG)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder and schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder lithium response (categorical) or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder lithium response (continuous) or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cannabis use disorder vs schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive ability in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Dentate gyrus volume x schizophrenia interaction	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eye movement in schizophrenia (duration of fixations)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eye movement in schizophrenia (horizontal position gain)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eye movement in schizophrenia (integrated eye movement score)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eye movement in schizophrenia (scanpath length)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Gray matter volume (schizophrenia interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hippocampal volume in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Initial pursuit acceleration in psychotic disorders	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Left superior temporal gyrus thickness (schizophrenia interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Methamphetamine dependence	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Multiple traits (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric diseases (pleiotropy) (HIPO component 1)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder without cannabis use disorder	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pursuit maintenance gain in psychotic disorders	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Resistance to antipsychotic treatment in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to antipsychotic treatment in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to aripiprazole in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to haloperidol in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to lurasidone in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to olanzapine in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to paliperidone in schizophrenia (CGI-S score)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to paliperidone in schizophrenia (Multivariate)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to paliperidone in schizophrenia (PANSS score)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to paliperidone in schizophrenia (negative Marder score)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to paliperidone in schizophrenia (positive Marder score)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to perphenazine in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to quetiapine in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to risperidone in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ziprazidone in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (age at onset)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (age at onset) (sex interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (cytomegalovirus infection interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (inflammation and infection response interaction)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (negative symptoms)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia and type 2 diabetes	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or bipolar disorder	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or cigarettes per day (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or general cognitive function (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or intelligence (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or lung cancer (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or reaction time (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or verbal-numerical reasoning (pleiotropy)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia vs schizophrenia and type 2 diabetes	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia vs type 2 diabetes	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, schizoaffective disorder or bipolar disorder	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in bipolar disorder or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Total mean fractional anisotropy measurement in first episode schizophrenia	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Type 2 diabetes vs schizophrenia and type 2 diabetes	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
antipsychotic drug dosage in schizophrenia or schizoaffective disorder	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	interleukin 5 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008186	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008185	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-5 levels	interleukin 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008185	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 6 receptor subunit beta measurement	http://www.ebi.ac.uk/efo/EFO_0008188	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 6 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008187	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 25 measurement	http://www.ebi.ac.uk/efo/EFO_0008182	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 23 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008181	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-4 levels	interleukin 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008184	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008184	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 27 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008183	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin 19 measurement	http://www.ebi.ac.uk/efo/EFO_0008180	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sciatica	Sciatica	http://purl.obolibrary.org/obo/HP_0011868	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica	http://purl.obolibrary.org/obo/HP_0011868	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Alloimmunization response to red blood cell transfusion in sickle cell anemia	alloimmunization	http://www.ebi.ac.uk/efo/EFO_0006804	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Orofacial clefts	progranulin measurement	http://www.ebi.ac.uk/efo/EFO_0004625	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progranulin levels	progranulin measurement	http://www.ebi.ac.uk/efo/EFO_0004625	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psoriatic arthritis	psoriatic arthritis	http://www.ebi.ac.uk/efo/EFO_0003778	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Psoriatic arthritis vs Cutaneous psoriasis	psoriatic arthritis	http://www.ebi.ac.uk/efo/EFO_0003778	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Elevated serum prostate-specific antigen levels in healthy men	prostate specific antigen measurement	http://www.ebi.ac.uk/efo/EFO_0004624	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate-specific antigen levels	prostate specific antigen measurement	http://www.ebi.ac.uk/efo/EFO_0004624	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate-specific antigen levels (conditioned on lead SNPs)	prostate specific antigen measurement	http://www.ebi.ac.uk/efo/EFO_0004624	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum prostate-specific antigen levels	prostate specific antigen measurement	http://www.ebi.ac.uk/efo/EFO_0004624	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Long-term memory (delayed word recall task)	word list delayed recall measurement	http://www.ebi.ac.uk/efo/EFO_0006805	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal declarative memory	word list delayed recall measurement	http://www.ebi.ac.uk/efo/EFO_0006805	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute kidney injury in coronary artery bypass surgery (creatinine rise)	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Perioperative myocardial infarction in coronary artery bypass surgery	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Postoperative atrial fibrillation in coronary artery bypass grafting surgery	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombocytopenia in coronary artery bypass surgery	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Vein graft stenosis in coronary artery bypass grafting	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Aortic valve stenosis	aortic stenosis	http://www.ebi.ac.uk/efo/EFO_0000266	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Calcific aortic valve stenosis	aortic stenosis	http://www.ebi.ac.uk/efo/EFO_0000266	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Biochemical measures	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Chronic obstructive pulmonary disease-related biomarkers	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fibrinogen	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fibrinogen levels	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fibrinogen levels in ischemic stroke	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Protein quantitative trait loci	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Verbal declarative memory	paragraph delayed recall measurement	http://www.ebi.ac.uk/efo/EFO_0006806	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006807	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006807	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Red blood cell fatty acid levels	linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006807	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Metabolite levels	sphingolipid measurement	http://www.ebi.ac.uk/efo/EFO_0004622	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Sphingolipid levels	sphingolipid measurement	http://www.ebi.ac.uk/efo/EFO_0004622	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Blood protein levels	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
End-stage coagulation	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Low vWF levels	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
vWF and FVIII levels	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
vWF levels	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
vWF levels in ischaemic stroke and hyperhomocysteinaemia	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Vascular brain injury	vascular brain injury measurement	http://www.ebi.ac.uk/efo/EFO_0006800	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Dementia and core Alzheimer's disease neuropathologic changes	Alzheimer's disease neuropathologic change	http://www.ebi.ac.uk/efo/EFO_0006801	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Insulin-like growth factor 1 levels	insulin like growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0004628	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	insulin like growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0004628	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alloimmunization response to red blood cell transfusion in sickle cell anemia	response to red blood cell transfusion	http://www.ebi.ac.uk/efo/EFO_0006802	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood protein levels	IgF-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin-like growth factors	IgF-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	IgF-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Hashimoto thyroiditis	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Hashimoto thyroiditis versus Graves' disease	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	igfbp-3 measurement	http://www.ebi.ac.uk/efo/EFO_0004626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin-like growth factors	igfbp-3 measurement	http://www.ebi.ac.uk/efo/EFO_0004626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	igfbp-3 measurement	http://www.ebi.ac.uk/efo/EFO_0004626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diabetic retinopathy	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic retinopathy (all NPDR and PDR)	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic retinopathy (moderate NPDR and PDR)	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic retinopathy in type 2 diabetes	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Severe diabetic retinopathy in type 2 diabetes	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Sight-threatening diabetic retinopathy in type 2 diabetes	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Sex difference in attention deficit hyperactivity disorder	sexual dimorphism	http://www.ebi.ac.uk/efo/EFO_0005951	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sexual dimorphism in anthropometric traits	sexual dimorphism	http://www.ebi.ac.uk/efo/EFO_0005951	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Bicuspid aortic valve	bicuspid aortic valve	http://purl.obolibrary.org/obo/HP_0001647	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Bicuspid aortic valve without aortic dilation	bicuspid aortic valve	http://purl.obolibrary.org/obo/HP_0001647	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
4-pyridoxic acid levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
B6 vitamer levels (multivariate analysis)	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid pyridoxal phosphate levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Folate pathway vitamin levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma pyridoxal phosphate levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma pyridoxal phosphate to pyridoxal ratio	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma pyridoxic acid to pyridoxal phosphate ratio	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pyridoxal 5'-phosphate levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pyridoxal levels	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin B levels in ischemic stroke	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Folate pathway vitamin levels	vitamin B12 measurement	http://www.ebi.ac.uk/efo/EFO_0004620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	vitamin B12 measurement	http://www.ebi.ac.uk/efo/EFO_0004620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin B levels in ischemic stroke	vitamin B12 measurement	http://www.ebi.ac.uk/efo/EFO_0004620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin B12 levels	vitamin B12 measurement	http://www.ebi.ac.uk/efo/EFO_0004620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	progressive supranuclear palsy	http://www.orpha.net/ORDO/Orphanet_683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Progressive supranuclear palsy	progressive supranuclear palsy	http://www.orpha.net/ORDO/Orphanet_683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	progressive supranuclear palsy	http://www.orpha.net/ORDO/Orphanet_683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Corneal resistance factor	corneal resistance factor	http://www.ebi.ac.uk/efo/EFO_0010067	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	respiratory symptom change measurement	http://www.ebi.ac.uk/efo/EFO_0010068	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nontyphoidal Salmonella bacteraemia	non-typhoidal Salmonella bacteremia	http://www.ebi.ac.uk/efo/EFO_0009087	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sural nerve conduction velocity	nerve conduction velocity	http://www.ebi.ac.uk/efo/EFO_0010069	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infection persistence (>18 months) in genital human papillomavirus 16 infection	chronic human papillomavirus infection	http://www.ebi.ac.uk/efo/EFO_0010060	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to salmeterol	http://www.ebi.ac.uk/efo/EFO_0010062	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to salmeterol	http://www.ebi.ac.uk/efo/EFO_0010062	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	response to salmeterol	http://www.ebi.ac.uk/efo/EFO_0010062	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	arachidonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006808	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Red blood cell fatty acid levels	arachidonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006808	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Red blood cell fatty acid levels	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hematuria	Hematuria	http://purl.obolibrary.org/obo/HP_0000790	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hematuria (mild)	Hematuria	http://purl.obolibrary.org/obo/HP_0000790	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hematuria (moderate to severe)	Hematuria	http://purl.obolibrary.org/obo/HP_0000790	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Hematuria	http://purl.obolibrary.org/obo/HP_0000790	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to intravenous immunoglobulin treatment in Kawasaki disease	response to intravenous immunoglobulin therapy	http://www.ebi.ac.uk/efo/EFO_0010065	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Corneal hysteresis	corneal hysteresis	http://www.ebi.ac.uk/efo/EFO_0010066	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-obstructive azoospermia	azoospermia	http://www.ebi.ac.uk/efo/EFO_0000279	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	leptin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Soluble leptin receptor levels	leptin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heparin-induced thrombocytopenia	response to heparin	http://www.ebi.ac.uk/efo/EFO_0006816	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anticoagulant levels	coagulation factor measurement	http://www.ebi.ac.uk/efo/EFO_0004634	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coagulation factor levels	coagulation factor measurement	http://www.ebi.ac.uk/efo/EFO_0004634	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
End-stage coagulation	coagulation factor measurement	http://www.ebi.ac.uk/efo/EFO_0004634	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
vWF and FVIII levels	coagulation factor measurement	http://www.ebi.ac.uk/efo/EFO_0004634	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Yang-deficiency constitution	yang deficiency	http://www.ebi.ac.uk/efo/EFO_0006817	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anticoagulant levels	protein c measurement	http://www.ebi.ac.uk/efo/EFO_0004633	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemostatic factors and hematological phenotypes	protein c measurement	http://www.ebi.ac.uk/efo/EFO_0004633	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Protein C levels	protein c measurement	http://www.ebi.ac.uk/efo/EFO_0004633	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Crohn's disease-related phenotypes	stricture	http://www.ebi.ac.uk/efo/EFO_0006818	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Pancreatitis	pancreatitis	http://www.ebi.ac.uk/efo/EFO_0000278	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced pancreatitis in inflammatory bowel disease	pancreatitis	http://www.ebi.ac.uk/efo/EFO_0000278	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Red blood cell fatty acid levels	linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006811	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	autoimmune thyroid disease	http://www.ebi.ac.uk/efo/EFO_0006812	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Hashimoto thyroiditis versus Graves' disease	autoimmune thyroid disease	http://www.ebi.ac.uk/efo/EFO_0006812	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	autoimmune thyroid disease	http://www.ebi.ac.uk/efo/EFO_0006812	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Type 1 diabetes and autoimmune thyroid diseases	autoimmune thyroid disease	http://www.ebi.ac.uk/efo/EFO_0006812	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Metabolite levels	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels (plasma)	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in IDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in chylomicrons and largest VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in large HDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in large LDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in large VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in medium HDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in medium LDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in medium VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in small VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in very large HDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in very large VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in very small VLDL	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Aging	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aging (facial)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aging (time to death)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aging (time to event)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aging traits	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Differential aging (cerebellum)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Differential aging (frontal cortex)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Differential aging in older adults (cerebellum)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Differential aging in older adults (frontal cortex)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Differential aging in younger adults (frontal cortex)	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Epigenetic age acceleration in alcohol use disorder	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Extrinsic epigenetic age acceleration	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Intrinsic epigenetic age acceleration	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Residual cognition	aging	http://purl.obolibrary.org/obo/GO_0007568	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anticoagulant levels	protein S measurement	http://www.ebi.ac.uk/efo/EFO_0004637	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemostatic factors and hematological phenotypes	protein S measurement	http://www.ebi.ac.uk/efo/EFO_0004637	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Geographic atrophy lesion growth rate in age-related macular degeneration	geographic atrophy lesion growth	http://www.ebi.ac.uk/efo/EFO_0010080	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid atherosclerosis in HIV infection	carotid artery disease	http://www.ebi.ac.uk/efo/EFO_0003781	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Behcet's disease	Behcet's syndrome	http://www.ebi.ac.uk/efo/EFO_0003780	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adult asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Allergic disease (asthma, hay fever or eczema)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Allergic rhinitis in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (SNP x SNP interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (age of onset)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (bronchodilator response)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (childhood onset)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (corticosteroid response)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (moderate or severe)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (sex interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (time to onset)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (toluene diisocyanate-induced)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma and anxiety disorder	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma and attention deficit hyperactivity disorder	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma and hay fever	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma and major depressive disorder	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma onset (childhood vs adult)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma or allergic disease (pleiotropy)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma or atopy (farm exposure interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma or chronic obstructive pulmonary disease	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Body mass index in asthmatics	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bone mineral accretion in asthma (oral corticosteroid dose interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bronchial hyperresponsiveness in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bronchodilator response in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Clinical remission in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Complete remission in asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Diisocyanate-induced asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
IgE levels in asthmatics	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
IgE levels in asthmatics (D.f. specific)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
IgE levels in asthmatics (D.p. specific)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post-bronchodilator lung function in asthma (FEV1)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post-bronchodilator lung function in asthma (FEV1/FVC)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pulmonary function in asthmatics	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to mepolizumab in severe asthma	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to montelukast in asthma (change in FEV1)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to zileuton treatment in asthma (FEV1 change interaction)	asthma	http://www.ebi.ac.uk/efo/EFO_0000270	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
C-reactive protein (red blood cell fatty acid level interaction)	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cellular adhesion molecule (red blood cell fatty acid level interaction)	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Oleic acid (18:1n-9) levels	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Red blood cell fatty acid levels	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Age-related diseases and mortality	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related diseases, mortality and associated endophenotypes	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Atrial fibrillation	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Atrial fibrillation (SNPxSNP interaction)	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Atrial fibrillation/atrial flutter	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Early onset atrial fibrillation	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Incident atrial fibrillation	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Postoperative atrial fibrillation in coronary artery bypass grafting surgery	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Prevalent atrial fibrillation	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to rate control therapy in atrial fibrillation	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Allergic disease (asthma, hay fever or eczema)	allergy	http://www.ebi.ac.uk/efo/EFO_0003785	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Allergy	allergy	http://www.ebi.ac.uk/efo/EFO_0003785	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Asthma or allergic disease (pleiotropy)	allergy	http://www.ebi.ac.uk/efo/EFO_0003785	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Self-reported allergy	allergy	http://www.ebi.ac.uk/efo/EFO_0003785	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Nevus count	nevus count	http://www.ebi.ac.uk/efo/EFO_0004632	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nevus count or cutaneous melanoma	nevus count	http://www.ebi.ac.uk/efo/EFO_0004632	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Select biomarker traits	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum 25-Hydroxyvitamin D levels	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin D levels	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin D levels (dietary vitamin D intake interaction)	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-melanoma skin cancer	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Perceived skin darkness	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Skin colour saturation	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Skin pigmentation	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Skin pigmentation traits	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
End-stage coagulation	factor VIII measurement	http://www.ebi.ac.uk/efo/EFO_0004630	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Factor VIII levels	factor VIII measurement	http://www.ebi.ac.uk/efo/EFO_0004630	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
vWF and FVIII levels	factor VIII measurement	http://www.ebi.ac.uk/efo/EFO_0004630	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Atopic dermatitis	atopic eczema	http://www.ebi.ac.uk/efo/EFO_0000274	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Atopic march	atopic eczema	http://www.ebi.ac.uk/efo/EFO_0000274	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Inflammatory skin disease	atopic eczema	http://www.ebi.ac.uk/efo/EFO_0000274	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Dentures	dentures	http://www.ebi.ac.uk/efo/EFO_0010078	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Number of decayed, missing and filled tooth surfaces or use of dentures	dentures	http://www.ebi.ac.uk/efo/EFO_0010078	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Corneal endothelial cell density	corneal endothelial cell measurement	http://www.ebi.ac.uk/efo/EFO_0010079	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corneal endothelial cell shape (percentage of hexagonally shaped cells)	corneal endothelial cell measurement	http://www.ebi.ac.uk/efo/EFO_0010079	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corneal endothelial cell size variation coefficient	corneal endothelial cell measurement	http://www.ebi.ac.uk/efo/EFO_0010079	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dimensional psychopathology (Cognitive)	cognitive domain measurement	http://www.ebi.ac.uk/efo/EFO_0009098	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dimensional psychopathology (Arousal)	arousal domain measurement	http://www.ebi.ac.uk/efo/EFO_0009099	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dimensional psychopathology (Negative)	negative domain measurement	http://www.ebi.ac.uk/efo/EFO_0009096	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dimensional psychopathology (Positive)	positive domain measurement	http://www.ebi.ac.uk/efo/EFO_0009097	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Idiopathic dilated cardiomyopathy	idiopathic dilated cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0009094	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Breast milk fatty acid composition (infant genotype effect)	breast milk measurement	http://www.ebi.ac.uk/efo/EFO_0009092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast milk fatty acid composition (maternal genotype effect)	breast milk measurement	http://www.ebi.ac.uk/efo/EFO_0009092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sural nerve amplitude potential	nerve conduction amplitude	http://www.ebi.ac.uk/efo/EFO_0010070	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiac troponin-I levels	cardiac troponin I measurement	http://www.ebi.ac.uk/efo/EFO_0010071	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Choroidal melanoma	choroidal melanoma	http://www.ebi.ac.uk/efo/EFO_0009093	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Vision loss in proton beam irradiation treatment of choroidal melanoma	choroidal melanoma	http://www.ebi.ac.uk/efo/EFO_0009093	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Toothache	toothache	http://www.ebi.ac.uk/efo/EFO_0010072	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Number of natural teeth	number of teeth measurement	http://www.ebi.ac.uk/efo/EFO_0010073	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease-related phenotypes	mild disease course	http://www.ebi.ac.uk/efo/EFO_0006819	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Trochanter size	trochanter size	http://www.ebi.ac.uk/efo/EFO_0010074	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Intertrochanteric region size	intertrochanteric region size	http://www.ebi.ac.uk/efo/EFO_0010075	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Femoral neck size	femoral neck size	http://www.ebi.ac.uk/efo/EFO_0010076	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Response to belimumab (SLE response index) in systemic lupus erythematosus	response to belimumab	http://www.ebi.ac.uk/efo/EFO_0010077	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Autism and educational attainment (MTAG)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism and major depressive disorder (MTAG)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism and schizophrenia (MTAG)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder or schizophrenia	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder-related traits	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorders (language delay)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Maternal genotype effects in autism spectrum disorder families	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obsessive-compulsive disorder or autism spectrum disorder	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric diseases (pleiotropy) (HIPO component 1)	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder without cannabis use disorder	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Restricted and repetitive behaviours in autism spectrum disorder	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Colorectal cancer (environment interaction)	overweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005935	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Overweight status	overweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005935	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Urate levels in overweight individuals	overweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005935	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Underweight status	underweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005936	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Urate levels in lean individuals	underweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005936	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Antipsychotic drug-induced weight gain (time interaction)	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (age interaction)	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time)	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in cancer	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in chronic obstructive pulmonary disease	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in gastrointestinal cancer	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in lung cancer	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Congenital left-sided heart lesions	congenital left-sided heart lesions	http://www.ebi.ac.uk/efo/EFO_0005938	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Congenital left-sided heart lesions (maternal effect)	congenital left-sided heart lesions	http://www.ebi.ac.uk/efo/EFO_0005938	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Left ventricular obstructive tract defect (inherited effect)	congenital left-sided heart lesions	http://www.ebi.ac.uk/efo/EFO_0005938	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Left ventricular obstructive tract defect (maternal effect)	congenital left-sided heart lesions	http://www.ebi.ac.uk/efo/EFO_0005938	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Duodenal ulcer	duodenal ulcer	http://www.ebi.ac.uk/efo/EFO_0004607	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Gallbladder cancer	gallbladder neoplasm	http://www.ebi.ac.uk/efo/EFO_0004606	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Gallbladder carcinoma in primary sclerosing cholangitis	gallbladder neoplasm	http://www.ebi.ac.uk/efo/EFO_0004606	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Autism	autism	http://www.ebi.ac.uk/efo/EFO_0003758	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder-related traits	autism	http://www.ebi.ac.uk/efo/EFO_0003758	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer disease and age of onset	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (SNP x SNP interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (age of onset)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (cognitive decline)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (late onset)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (neuritic plaque pathology)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (survival time)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease biomarkers	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease in APOE e4+ carriers	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease in APOE e4- carriers	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease in hypertension	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease in hypertension-negative individuals	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or HDL levels (pleiotropy)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or fasting glucose levels (pleiotropy)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or fasting insulin levels (pleiotropy)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or small vessel stroke	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease with language domain impairment	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease with memory domain impairment	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease with multiple cognitive domain impairments	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease with no specific cognitive domain impairment	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease with visuospatial domain impairment	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer’s disease (clinical subgroup AD+)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer’s disease (clinical subgroup AD++)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer’s disease (clinical subgroup AD+++)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Brain structure (temporal lobe volume)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal fluid clusterin levels in APOEe4- carriers	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Entorhinal cortical thickness (Alzheimer's disease interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Entorhinal cortical volume (Alzheimer's disease interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hippocampal volume (Alzheimer's disease interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hippocampal volume in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Logical memory (delayed recall) in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Logical memory (immediate recall) in Alzheimer's disease dementia	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Posterior cortical atrophy and Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychosis and Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychosis in Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cholinesterase inhibitors in Alzheimer's disease	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Total ventricular volume (Alzheimer's disease interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Whole-brain volume (Alzheimer's disease interaction)	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asperger disorder	asperger syndrome	http://www.ebi.ac.uk/efo/EFO_0003757	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asperger syndrome	asperger syndrome	http://www.ebi.ac.uk/efo/EFO_0003757	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Morphine dose requirement in tonsillectomy and adenoidectomy surgery	response to morphine	http://purl.obolibrary.org/obo/GO_0043278	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Common variable immunodeficiency	common variable immunodeficiency	http://www.orpha.net/ORDO/Orphanet_1572	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	common variable immunodeficiency	http://www.orpha.net/ORDO/Orphanet_1572	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Asthma control	asthma symptoms measurement	http://www.ebi.ac.uk/efo/EFO_0010049	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma control x inhaled corticosteroid treatment interaction (1df)	asthma symptoms measurement	http://www.ebi.ac.uk/efo/EFO_0010049	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma control x inhaled corticosteroid treatment interaction (2df)	asthma symptoms measurement	http://www.ebi.ac.uk/efo/EFO_0010049	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neutrophil level response to clozapine in treatment-resistant schizophrenia	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma clozapine levels in treatment-resistant schizophrenia	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma norclozapine levels in treatment-resistant schizophrenia	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia (treatment resistant)	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cystic fibrosis (meconium ileus)	cystic fibrosis associated meconium ileum	http://www.ebi.ac.uk/efo/EFO_0004608	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Meconium ileus in cystic fibrosis	cystic fibrosis associated meconium ileum	http://www.ebi.ac.uk/efo/EFO_0004608	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Breast milk fatty acid composition (maternal genotype effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Congenital left-sided heart lesions (maternal effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Conotruncal heart defects	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Egg allergy (maternal genetic effects)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Egg allergy (parent-of-origin effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food allergy (maternal genetic effects)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food allergy (parent-of-origin effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational age at birth (maternal effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Milk allergy (maternal genetic effects)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Milk allergy (parent-of-origin effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (maternal genetic effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Offspring birth weight	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peanut allergy (maternal genetic effects)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peanut allergy (parent-of-origin effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Preterm birth (maternal effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spontaneous preterm birth (maternal effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride change in response to fenofibrate (parental genotype effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels (parental genotype effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Apolipoprotein A1 levels	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic traits	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lp (a) levels	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Protein quantitative trait loci	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Ratio of apolipoprotein A1 to apolipoprotein B	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Bone mineral density (femoral neck) in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Bone mineral density (lumbar spine) in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Erythema nodosum in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Inflammatory bowel disease (early onset)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Pyoderma gangrenosum in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced alopecia in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced digestive symptoms in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced fever in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced infection in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced leukopenia in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced liver dysfunction in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced myelosuppression in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced pancreatitis in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced severe alopecia in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced severe leukopenia in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced skin symptoms in inflammatory bowel disease	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Age-related disease endophenotypes	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Age-related diseases, mortality and associated endophenotypes	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Alzheimer's disease or HDL levels (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Biochemical measures	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Birth weight or HDL cholesterol levels (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic and hematological traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular disease risk factors	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular risk factors	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular risk factors (age interaction)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol and Triglycerides	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in medium HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in very large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Coronary artery disease and HDL cholesterol levels (multivariate analysis)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in medium HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in very large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL Cholesterol - Triglycerides (HDLC-TG)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL Cholesterol in HIV-infection	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol (SNP x SNP interaction)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol and triglyceride levels	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol and triglyceride levels (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels in current drinkers	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels in current smokers	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels in ever smokers	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels in never smokers	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels in non smokers	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
HDL cholesterol x physical activity interaction (1df test)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Hematological and biochemical traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
High density lipoprotein cholesterol levels	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Large HDL particle concentration	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 1)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 2)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Low HDL-cholesterol levels	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Low high density lipoprotein cholesterol levels	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Medium HDL particle concentration	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Metabolic syndrome	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Multiple sclerosis and HDL levels (pleiotropy)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Obesity-related traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in medium HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in very large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Quantitative traits	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to fenofibrate (HDL cholesterol levels)	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Small HDL particle concentration	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in medium HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in very large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Triglyceride levels in small HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Triglyceride levels in very large HDL	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Very large HDL particle concentration	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Waist circumference and related phenotypes	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Biochemical measures	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Birth weight or LDL cholesterol levels (pleiotropy)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic traits	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular disease risk factors	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular risk factors	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiovascular risk factors (age interaction)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in large LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in medium LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cognitive impairment and LDL levels (pleiotropy)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Coronary artery disease and LDL cholesterol levels (multivariate analysis)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in large LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL (oxidized)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels in current drinkers	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels in current smokers	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels in ever smokers	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels in never smokers	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels in non smokers	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol subfractions	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol x physical activity interaction (1df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol x physical activity interaction (2df test)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Large LDL particle concentration	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid levels in hepatitis C treatment	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 1)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 2)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Low density lipoprotein cholesterol levels	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Medium LDL particle concentration	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Metabolite levels	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Multiple sclerosis and LDL levels (pleiotropy)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Obesity-related traits	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in large LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in medium LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Quantitative traits	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to statin therapy (LDL cholesterol subfractions)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Response to statins (LDL cholesterol change)	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Small LDL particle concentration	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in large LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in medium LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels in small LDL	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Anti-gp210 seropositivity in primary biliary cholangitis	antinuclear antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005949	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-sp100 seropositivity in primary biliary cholangitis	antinuclear antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005949	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antinuclear antibody levels	antinuclear antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005949	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Circulating phylloquinone levels	vitamin K measurement	http://www.ebi.ac.uk/efo/EFO_0004618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Select biomarker traits	vitamin K measurement	http://www.ebi.ac.uk/efo/EFO_0004618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	chemotherapy-induced hypertension	http://www.ebi.ac.uk/efo/EFO_0005942	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	chemotherapy-induced hypertension	http://www.ebi.ac.uk/efo/EFO_0005942	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adverse response to chemotherapy (congestive heart failure) in breast cancer	response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005943	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005943	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005943	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic kidney disease	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cystatin C	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate (cystatin C)	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma cystastin c levels in acute coronary syndrome	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Knee osteoarthritis	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Knee osteoarthritis or femoral neck bone mineral density	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Knee osteoarthritis or lumbar spine bone mineral density	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee (hospital diagnosed)	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee (with total joint replacement)	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the knee (hospital diagnosed)	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the knee (with total joint replacement)	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Apolipoprotein B levels	apolipoprotein B measurement	http://www.ebi.ac.uk/efo/EFO_0004615	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Blood protein levels	apolipoprotein B measurement	http://www.ebi.ac.uk/efo/EFO_0004615	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic traits	apolipoprotein B measurement	http://www.ebi.ac.uk/efo/EFO_0004615	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Ratio of apolipoprotein A1 to apolipoprotein B	apolipoprotein B measurement	http://www.ebi.ac.uk/efo/EFO_0004615	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Nicotine dependence	nicotine dependence	http://www.ebi.ac.uk/efo/EFO_0003768	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (age of onset and psychotic symptoms)	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychosis and Alzheimer's disease	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychosis in Alzheimer's disease	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychotic experience	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychotic experience (distressing)	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychotic experience (multiple occurrences)	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychotic symptoms and prion disease	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Psychotic symptoms in prion disease	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Mammographic density	mammographic density measurement	http://www.ebi.ac.uk/efo/EFO_0005941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mammographic density (dense area)	mammographic density measurement	http://www.ebi.ac.uk/efo/EFO_0005941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mammographic density (non-dense area)	mammographic density measurement	http://www.ebi.ac.uk/efo/EFO_0005941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Percent mammographic density	mammographic density measurement	http://www.ebi.ac.uk/efo/EFO_0005941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tetralogy of Fallot	tetralogy of fallot	http://purl.obolibrary.org/obo/HP_0001636	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Acute lung injury	acute lung injury	http://www.ebi.ac.uk/efo/EFO_0004610	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis (age of onset)	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis or frontotemporal dementia	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Multiple sclerosis or amyotrophic lateral sclerosis	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Vitamin D insufficiency	vitamin D deficiency	http://www.ebi.ac.uk/efo/EFO_0003762	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anhedonia in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asthma and major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism and major depressive disorder (MTAG)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder or major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or bipolar disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or major depressive disorder (recurrent)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or major depressive disorder (self-reported)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or schizophrenia	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive performance (language ability) x major depressive disorder status interaction	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive performance (processing speed) in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive performance (processing speed) x major depressive disorder status interaction	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cognitive performance (processing speed) x major depressive disorder type interaction	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressed affect	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression (broad)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression (quantitative trait)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression in smokers	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressive symptom measurement or major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressive symptoms	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Duloxetine response in major depressive disorder (% change in symptom score)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Duloxetine response in major depressive disorder (remitter/non-remitter status)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Duloxetine response in major depressive disorder (responder/non-responder status)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depression and alcohol dependence	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (ICD-10 coded)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (broad)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (exposed to adversity)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (probable)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (stressful life events interaction)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Major depressive disorder (unexposed to adversity)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Menstruation quality of life impact (depression)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to antidepressants and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to bupropion and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to citalopram or escitalopram and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-response to selective serotonin reuptake inhibitors and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Placebo response in major depressive disorder (% change in symptom score)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Placebo response in major depressive disorder (remitter/non-remitter status)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Placebo response in major depressive disorder (responder/non-responder status)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma kynurenine levels in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Plasma kynurenine to tryptophan ratio in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric diseases (pleiotropy) (HIPO component 1)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder without cannabis use disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Recurrent major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Remission after SSRI treatment in MDD or neuroticism	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Remission after SSRI treatment in MDD or openness	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Remission after SSRI treatment in major depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Remission after antidepressant treatment in major depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to SSRI in MDD or conscientiouness	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to SSRI in MDD or openness	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to antidepressants and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to antidepressants in depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to bupropion and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to bupropion in depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to citalopram or escitalopram and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to citalopram or escitalopram in depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cognitive-behavioural therapy in anxiety and major depressive disorders	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cognitive-behavioural therapy in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketamine in bipolar disorder or major depression (antidepressant effects)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketamine in bipolar disorder or major depression (dissociation effects)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to selective serotonin reuptake inhibitors and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to selective serotonin reuptake inhibitors in depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to serotonin reuptake inhibitors in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, bipolar disorder and depression (combined)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Seasonality and depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Seasonality in depression	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Severe depressive disorders in coronary artery disease	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Stress sensitivity (neuroticism score x major depressive disorder status interaction)	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicidal ideation in depression or bipolar disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in depression or bipolar disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder or bipolar disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide ideation score in major depressive disorder	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Liver iron content	liver iron measurement	http://www.ebi.ac.uk/efo/EFO_0010056	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Soluble VCAM-1 levels	vascular cell adhesion molecule-1 measurement	http://www.ebi.ac.uk/efo/EFO_0010057	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral microbleed progression	cerebral microbleeds	http://www.ebi.ac.uk/efo/EFO_0010059	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cerebral microbleeds	cerebral microbleeds	http://www.ebi.ac.uk/efo/EFO_0010059	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Mitral valve prolapse	Mitral valve prolapse	http://purl.obolibrary.org/obo/HP_0001634	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Thyroglobulin plasma levels	thyroglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0010050	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Factor VII	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Factor VII activity	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Factor VII activity or levels	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Factor VII levels	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	response to tacrolimus	http://www.ebi.ac.uk/efo/EFO_0010052	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	response to cyclosporine	http://www.ebi.ac.uk/efo/EFO_0010053	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anemia in mycophenolic acid treated kidney transplant patients (time to event)	response to mycophenolic acid	http://www.ebi.ac.uk/efo/EFO_0010054	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	response to mycophenolic acid	http://www.ebi.ac.uk/efo/EFO_0010054	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	response to calcineurin inhibitor	http://www.ebi.ac.uk/efo/EFO_0010055	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Estrogen receptor status in HER2 negative breast cancer	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrogen receptor status in HER2 positive breast cancer	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HER2 status in breast cancer	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Liver disease biomarker	liver disease biomarker	http://www.ebi.ac.uk/efo/EFO_0006845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	diabetes mellitus biomarker	http://www.ebi.ac.uk/efo/EFO_0006842	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrogen receptor status in HER2 negative breast cancer	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrogen receptor status in HER2 positive breast cancer	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrogen receptor status in breast cancer	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral amyloid deposition (PET imaging)	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral amyloid deposition positivity (PET imaging)	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive impairment (brain beta-amyloid deposition interaction)	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cortical amyloid beta load	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuropathic pain in head and neck cancer	head and neck malignant neoplasia	http://www.ebi.ac.uk/efo/EFO_0006859	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in head and neck cancer	head and neck malignant neoplasia	http://www.ebi.ac.uk/efo/EFO_0006859	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Parasitemia in Tripanosoma cruzi seropositivity	parasitemia measurement	http://www.ebi.ac.uk/efo/EFO_0005528	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Manic episodes in bipolar disorder	manic or hypomanic episode	http://www.ebi.ac.uk/efo/EFO_0007706	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cerebrospinal fluid p-Tau181p:AB1-42 ratio	p-tau:beta-amyloid 1-42 ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007709	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau:AB1-42 ratio	t-tau:beta-amyloid 1-42 ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007708	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coronary artery disease or large artery stroke	large artery stroke	http://www.ebi.ac.uk/efo/EFO_0005524	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ischemic stroke (large artery atherosclerosis)	large artery stroke	http://www.ebi.ac.uk/efo/EFO_0005524	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Large artery stroke	large artery stroke	http://www.ebi.ac.uk/efo/EFO_0005524	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Multiple traits (pleiotropy)	large artery stroke	http://www.ebi.ac.uk/efo/EFO_0005524	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Bone mineral density (hip)	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (hip) and age at menarche	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (total hip)	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip bone mineral density and alcohol drinking	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Low bone mineral density (hip)	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral density (hip)	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive and manic episodes in bipolar disorder	manic episode measurement	http://www.ebi.ac.uk/efo/EFO_0007705	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Initial alcohol sensitivity	response to alcohol	http://www.ebi.ac.uk/efo/EFO_0005526	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Number of alcoholic drinks required to feel an effect (first five times drinking)	response to alcohol	http://www.ebi.ac.uk/efo/EFO_0005526	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Number of alcoholic drinks required to feel an effect (long-term average)	response to alcohol	http://www.ebi.ac.uk/efo/EFO_0005526	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to alcohol consumption (flushing response)	response to alcohol	http://www.ebi.ac.uk/efo/EFO_0005526	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Depressive and manic episodes in bipolar disorder	depressive episode measurement	http://www.ebi.ac.uk/efo/EFO_0007704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive episodes in bipolar disorder	depressive episode measurement	http://www.ebi.ac.uk/efo/EFO_0007704	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ejection fraction	ejection fraction measurement	http://www.ebi.ac.uk/efo/EFO_0005527	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Ejection fraction in Tripanosoma cruzi seropositivity	ejection fraction measurement	http://www.ebi.ac.uk/efo/EFO_0005527	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Alzheimer's disease biomarkers	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Annualised percent change of cerebrospinal fluid AB1-42 levels	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal AB1-42 levels in mild cognitive impairment	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal AB1-42 levels in normal cognition	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid AB1-42 levels	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (lumbar spine) in inflammatory bowel disease	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (spine)	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (spine) and age at menarche	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip osteoarthritis or lumbar spine bone mineral density	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Knee osteoarthritis or lumbar spine bone mineral density	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Low bone mineral density (spine)	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lumbar spine bone mineral density	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lumbar spine bone mineral density or breast cancer (pleiotropy)	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteoarthritis or lumbar spine bone mineral density	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral density (spine)	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spine bone mineral density and alcohol drinking	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exploratory eye movement dysfunction in schizophrenia (responsive search score)	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Liver injury in anti-tuberculosis drug treatment	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tuberculosis	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tuberculosis (SNP x SNP interaction)	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bronchopulmonary dysplasia	bronchopulmonary dysplasia	http://www.orpha.net/ORDO/Orphanet_70589	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Bronchopulmonary dysplasia in preterm infants	bronchopulmonary dysplasia	http://www.orpha.net/ORDO/Orphanet_70589	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lipoprotein diameter	bronchopulmonary dysplasia	http://www.orpha.net/ORDO/Orphanet_70589	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Platinum-induced hepatotoxicity in non-small cell lung cancer	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Platinum-induced myelosuppression in non-small cell lung cancer	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to carboplatin in ovarian cancer (MTT IC50)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based agents	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy in head and neck cancers	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy in non-small-cell lung cancer	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy in small cell and non-small cell lung cancers	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy in small-cell lung cancer	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Trans fatty acid levels	trans/trans-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006826	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Hepatitis B vaccine response	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted IFN-alpha)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted IL-10)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted IL-12p40)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted IL-1beta)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted IL-2)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune reponse to smallpox (secreted TNF-alpha)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune response to anthrax vaccine	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune response to measles vaccine (measles-induced IFN gamma)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune response to measles vaccine (measles-specific neutralising antibody titre)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune response to measles-mumps-rubella vaccine	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Immune response to smallpox vaccine (IL-6)	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Meningococcal C IgG concentrations post childhood immunization	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Meningococcal C functional antibody titers post childhood immunization	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pandemrix-induced narcolepsy	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to hepatitis B vaccine	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Rubella-specific interferon-gamma secretion	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Rubella-specific interleukin-6 secretion	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tetanus toxoid IgG concentrations post childhood immunization	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Vaccine-related adverse events	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma renin activity levels	plasma renin activity measurement	http://www.ebi.ac.uk/efo/EFO_0006828	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Anti-saccade error rate in psychotic disorders	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Binge eating behaviour and bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Binge eating behaviour in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar I disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (Negative mood delusions)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (age of onset and psychotic symptoms)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (body mass index interaction)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (early onset)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (inflammation and infection response interaction)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder (mania)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder and eating disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder and schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder lithium response (categorical) or schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder lithium response (continuous) or schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder or attention deficit hyperactivity disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder or intelligence (pleiotropy)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder or major depressive disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bipolar disorder with mood-incongruent psychosis	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Broad depression or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressive and manic episodes in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depressive episodes in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eating disorder in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hypersomnia during a major depressive episode in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Initial pursuit acceleration in psychotic disorders	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Manic episodes in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Migraine in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Migraine in psychiatric disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Objective response to lithium treatment	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Objective response to lithium treatment in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Personality traits in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric diseases (pleiotropy) (HIPO component 1)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder without cannabis use disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pursuit maintenance gain in psychotic disorders	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketamine in bipolar disorder or major depression (antidepressant effects)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketamine in bipolar disorder or major depression (dissociation effects)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to lithium treatment in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, bipolar disorder and depression (combined)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, schizoaffective disorder or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Seasonality and depression	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Seasonality in depression	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Subjective response to lithium treatment	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Subjective response to lithium treatment in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicidal ideation in depression or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in bipolar disorder or schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in depression or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder or bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide in bipolar disorder	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Temperament (bipolar disorder)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
White matter integrity (bipolar disorder risk interaction)	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Early cardiac repolarization	TPE interval measurement	http://www.ebi.ac.uk/efo/EFO_0004644	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Glomerular filtration rate change in heart transplantation	GFR change measurement	http://www.ebi.ac.uk/efo/EFO_0006829	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Kidney function decline traits	GFR change measurement	http://www.ebi.ac.uk/efo/EFO_0006829	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Trans fatty acid levels	trans-16:1n-7 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006822	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Trans fatty acid levels	total trans-18:1 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006823	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Sweet beverage consumption	sweet beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010090	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Trans fatty acid levels	cis/trans-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006824	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Tea consumption	tea consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010091	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Trans fatty acid levels	trans/cis-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006825	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Barrett's esophagus	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Barrett's esophagus x BMI interaction	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Barrett's esophagus x pack-years of smoking exposure interaction	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Barrett's esophagus x smoking interaction	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Multiple traits (pleiotropy)	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Crohn's disease-related phenotypes	complicated disease course	http://www.ebi.ac.uk/efo/EFO_0006820	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Trans fatty acid levels	trans fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006821	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Male-pattern baldness	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced alopecia in inflammatory bowel disease	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced severe alopecia in inflammatory bowel disease	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cortisol secretion	cortisol secretion measurement	http://www.ebi.ac.uk/efo/EFO_0004642	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	cortisol secretion measurement	http://www.ebi.ac.uk/efo/EFO_0004642	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Benign prostatic hyperplasia	benign prostatic hyperplasia	http://www.ebi.ac.uk/efo/EFO_0000284	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Benign prostatic hyperplasia and lower urinary tract symptoms	benign prostatic hyperplasia	http://www.ebi.ac.uk/efo/EFO_0000284	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	benign prostatic hyperplasia	http://www.ebi.ac.uk/efo/EFO_0000284	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Benign prostatic hyperplasia and/or lower urinary tract symptoms	benign prostatic hyperplasia	http://www.ebi.ac.uk/efo/EFO_0000284	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
White matter integrity	white matter integrity	http://www.ebi.ac.uk/efo/EFO_0004641	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter integrity (bipolar disorder risk interaction)	white matter integrity	http://www.ebi.ac.uk/efo/EFO_0004641	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter integrity (fractional anisotropy)	white matter integrity	http://www.ebi.ac.uk/efo/EFO_0004641	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter integrity (mean diffusivity)	white matter integrity	http://www.ebi.ac.uk/efo/EFO_0004641	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	haptoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004640	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Haptoglobin levels	haptoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004640	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Plasma haptoglobin levels in type 2 diabetes	haptoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004640	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Urinary haptoglobin levels in type 2 diabetes	haptoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004640	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Bitter beverage consumption	bitter beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010089	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer (HER2 positive)	HER2 positive breast carcinoma	http://www.ebi.ac.uk/efo/EFO_1000294	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Dentate gyrus volume	dentate gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010083	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dentate gyrus volume x schizophrenia interaction	dentate gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010083	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Meningococcal C IgG concentrations post childhood immunization	anti-meningococcal C IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010084	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tetanus toxoid IgG concentrations post childhood immunization	anti-tetanus toxoid IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010085	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	anti-Haemophilus influenzae type b polyribosylribitol phosphate IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010086	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Meningococcal C functional antibody titers post childhood immunization	anti-meningococcal C serum bactericidal antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010087	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	glucose effectiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006833	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sepsis from pneumonia (survival)	septic shock	http://www.ebi.ac.uk/efo/EFO_0006834	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Pyoderma gangrenosum in inflammatory bowel disease	pyoderma gangrenosum	http://www.ebi.ac.uk/efo/EFO_0006835	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Kidney function decline traits	rapid kidney function decline	http://www.ebi.ac.uk/efo/EFO_0006836	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Glucose homeostasis traits	insulin metabolic clearance rate measurement	http://www.ebi.ac.uk/efo/EFO_0006830	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute insulin response	acute insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0006831	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute insulin response (insulin secretion adjusted)	acute insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0006831	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute insulin response (insulin secretion and BMI adjusted)	acute insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0006831	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	acute insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0006831	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bladder cancer	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Bladder cancer (smoking interaction)	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer EORTC risk category	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer age at diagnosis	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer tumour size	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Urinary bladder cancer	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glucose homeostasis traits	disposition index measurement	http://www.ebi.ac.uk/efo/EFO_0006832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin disposition index	disposition index measurement	http://www.ebi.ac.uk/efo/EFO_0006832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin disposition index (BMI adjusted)	disposition index measurement	http://www.ebi.ac.uk/efo/EFO_0006832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-adalimumab antibody production in response to treatment in Crohn's disease	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Infliximab-induced mucosal healing in Crohn's disease	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF antagonist treatment	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to TNF-alpha inhibitors in rheumatoid arthritis	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-TNF alpha therapy in inflammatory bowel disease	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-TNF therapy in rheumatoid arthritis	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Idiopathic intracranial hypertension	pseudotumor cerebri	http://www.ebi.ac.uk/efo/EFO_1001132	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Bitter alcoholic beverage consumption	bitter alcoholic beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bitter non-alcoholic beverage consumption	bitter non-alcoholic beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010093	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Grapefruit juice consumption	grapefruit juice consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010094	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pure non-grapefruit juice consumption	non-grapefruit juice consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010095	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Artificially sweetened beverage consumption	artificially sweetened beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010096	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sugar-sweetened beverage consumption	sugar sweetened beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010097	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anxiety and stress-related disorders	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (excluding adjustment disorder)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (including obsessive-compulsive disorder)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (propensity-score-matching design)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Stress-related disorders	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Chronic widespread pain	chronic widespread pain	http://www.ebi.ac.uk/efo/EFO_0010099	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Dupuytren's disease	dupuytren contracture	http://www.ebi.ac.uk/efo/EFO_0004229	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Carbamazepine-induced liver injury	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced cholestatic/mixed liver injury	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced hepatocellular liver injury	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (amoxicillin)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (amoxicillin-clavulanate)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (anti-tuberculosis drugs)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (diclofenac)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (flucloxacillin)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (fluoroquinolones)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (isoxazolyl penicillins)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (nitrofurantoin)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (statins)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury (terbinafine)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Drug-induced liver injury in interferon-beta-treated multiple sclerosis	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Lapatinib-induced hepatotoxicity	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver injury in anti-retroviral drug treated HIV	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver injury in anti-tuberculosis drug treatment	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Lumiracoxib-related liver injury	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Platinum-induced hepatotoxicity in non-small cell lung cancer	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Left superior temporal gyrus thickness (schizophrenia interaction)	left superior temporal gyrus thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007739	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dengue shock syndrome	dengue hemorrhagic fever	http://www.ebi.ac.uk/efo/EFO_0004227	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Creutzfeldt-Jakob disease	creutzfeldt jacob disease	http://www.ebi.ac.uk/efo/EFO_0004226	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Creutzfeldt-Jakob disease (variant)	creutzfeldt jacob disease	http://www.ebi.ac.uk/efo/EFO_0004226	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cingulate cortical amyloid beta load	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Decline in glucose metabolism in posterior cingulate cortex	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adiponectin levels (BMI-adjusted)	BMI-adjusted adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0007737	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	BMI-adjusted adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0007737	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic hepatitis C infection	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Depression in response to interferon-based therapy in chronic hepatitis C	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
IFN-related cytopenia	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Lipid levels in hepatitis C treatment	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to hepatitis C treatment	chronic hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0004220	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Amyotrophic lateral sclerosis or frontotemporal dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Behavioural changes in frontotemporal lobe dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontotemporal dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontotemporal dementia (age at onset)	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontotemporal dementia with GRN mutation	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontotemporal dementia with GRN mutation (age at onset)	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Language impairment in frontotemporal lobe dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Memory dysfunction in frontotemporal lobe dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parkinsonism in frontotemporal lobe dementia	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Coronary spasm	coronary vasospasm	http://www.ebi.ac.uk/efo/EFO_0004225	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary restenosis	coronary restenosis	http://www.ebi.ac.uk/efo/EFO_0004224	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age at suicide	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Deliberate self-harm	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Predicted suicide risk	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicidality	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicidality (suicidal ideation/attempts)	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicide attempt severity	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicide in bipolar disorder	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electroencephalogram traits	alpha peak frequency measurement	http://www.ebi.ac.uk/efo/EFO_0006883	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatic heart disease	rheumatic heart disease	http://www.ebi.ac.uk/efo/EFO_1001161	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adult onset asthma (smoking interaction)	adult onset asthma	http://www.ebi.ac.uk/efo/EFO_1002011	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adult onset asthma in ever-smokers	adult onset asthma	http://www.ebi.ac.uk/efo/EFO_1002011	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adult onset asthma in non-smokers	adult onset asthma	http://www.ebi.ac.uk/efo/EFO_1002011	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (adult onset)	adult onset asthma	http://www.ebi.ac.uk/efo/EFO_1002011	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Survival in TP53 positive breast cancer	TP53 positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1002010	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	alcoholic pancreatitis	http://www.ebi.ac.uk/efo/EFO_1002013	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Alcoholic chronic pancreatitis	alcoholic pancreatitis	http://www.ebi.ac.uk/efo/EFO_1002013	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic alcoholic pancreatitis or alcohol-related cirrhosis	alcoholic pancreatitis	http://www.ebi.ac.uk/efo/EFO_1002013	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Anterior cruciate ligament rupture	ligament rupture	http://www.ebi.ac.uk/efo/EFO_1002012	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Differentiated thyroid cancer	differentiated thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_1002017	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	oligoarticular juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_1002019	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Corticobasal degeneration	corticobasal degeneration	http://www.orpha.net/ORDO/Orphanet_278	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	corticobasal degeneration	http://www.orpha.net/ORDO/Orphanet_278	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Chronic hepatitis B infection	chronic hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004239	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	chronic hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004239	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver disease in chronic hepatitis B virus infection	chronic hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004239	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Peginterferon alfa-2a treatment response in chronic hepatitis B infection	chronic hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004239	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Cisplatin-induced hearing loss in brain tumor patients	hearing loss	http://www.ebi.ac.uk/efo/EFO_0004238	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hearing impairment	hearing loss	http://www.ebi.ac.uk/efo/EFO_0004238	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hearing loss in Charcot-Marie-Tooth disease 1A	hearing loss	http://www.ebi.ac.uk/efo/EFO_0004238	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Medication use (diuretics)	Diuretic use measurement	http://www.ebi.ac.uk/efo/EFO_0009928	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to antithyroid drugs in Graves disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Graves' disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Hashimoto thyroiditis versus Graves' disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Thionamide-induced agranulocytosis in Graves' disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Thyroid-associated orbitopathy in graves' disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Thyrotoxic hypokalemic periodic paralysis and Graves disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Thyrotoxic hypokalemic periodic paralysis in Graves disease	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Medication use (beta blocking agents)	Beta blocking agent use measurement	http://www.ebi.ac.uk/efo/EFO_0009929	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (vasodilators used in cardiac diseases)	Vasodilators used in cardiac diseases use measurement	http://www.ebi.ac.uk/efo/EFO_0009926	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	PCSK9 protein measurement	http://www.ebi.ac.uk/efo/EFO_0006899	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to simvastatin treatment (PCSK9 protein level change)	PCSK9 protein measurement	http://www.ebi.ac.uk/efo/EFO_0006899	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postburn hypertrophic scarring severity	postburn hypertrophic scarring severity measurement	http://www.ebi.ac.uk/efo/EFO_0007747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postburn scar height	postburn hypertrophic scarring severity measurement	http://www.ebi.ac.uk/efo/EFO_0007747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postburn scar pliability	postburn hypertrophic scarring severity measurement	http://www.ebi.ac.uk/efo/EFO_0007747	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (antihypertensives)	Antihypertensive use measurement	http://www.ebi.ac.uk/efo/EFO_0009927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter lesion progression	white matter lesion progression measurement	http://www.ebi.ac.uk/efo/EFO_0007746	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter lesion progression (adjusted for white matter lesion burden at baseline)	white matter lesion progression measurement	http://www.ebi.ac.uk/efo/EFO_0007746	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (drugs used in diabetes)	Drugs used in diabetes use measurement	http://www.ebi.ac.uk/efo/EFO_0009924	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (antithrombotic agents)	Antithrombotic agent use measurement	http://www.ebi.ac.uk/efo/EFO_0009925	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eosinophilic esophagitis	eosinophilic esophagitis	http://www.ebi.ac.uk/efo/EFO_0004232	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Eosinophilic esophagitis (pediatric)	eosinophilic esophagitis	http://www.ebi.ac.uk/efo/EFO_0004232	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Influenza A (H1N1) severity	influenza A severity measurement	http://www.ebi.ac.uk/efo/EFO_0007743	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	glucose homeostasis measurement	http://www.ebi.ac.uk/efo/EFO_0006896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left ventricular QRS voltage	QRS amplitude	http://www.ebi.ac.uk/efo/EFO_0007742	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (12-leadsum)	QRS amplitude	http://www.ebi.ac.uk/efo/EFO_0007742	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (Cornell)	QRS amplitude	http://www.ebi.ac.uk/efo/EFO_0007742	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (Sokolow-Lyon)	QRS amplitude	http://www.ebi.ac.uk/efo/EFO_0007742	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	http://www.ebi.ac.uk/efo/EFO_0009923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway responsiveness in chronic obstructive pulmonary disease	airway responsiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006897	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal or endometrial cancer	endometrial neoplasm	http://www.ebi.ac.uk/efo/EFO_0004230	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Endometrial cancer	endometrial neoplasm	http://www.ebi.ac.uk/efo/EFO_0004230	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Plasma lactate levels	lactate measurement	http://www.ebi.ac.uk/efo/EFO_0007745	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to thiazide diuretic treatment (hypokalemia)	hypokalemia	http://purl.obolibrary.org/obo/HP_0002900	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Airway wall thickness	airway wall thickness measurement	http://www.ebi.ac.uk/efo/EFO_0006898	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung disease severity in cystic fibrosis	lung disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0007744	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerulosclerosis	focal segmental glomerulosclerosis	http://www.ebi.ac.uk/efo/EFO_0004236	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Meningioma	meningioma	http://www.orpha.net/ORDO/Orphanet_2495	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Dementia and core Alzheimer's disease neuropathologic changes	dementia	http://purl.obolibrary.org/obo/HP_0000726	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Exfoliation glaucoma or exfoliation syndrome	exfoliation syndrome	http://www.ebi.ac.uk/efo/EFO_0004235	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Exfoliation syndrome	exfoliation syndrome	http://www.ebi.ac.uk/efo/EFO_0004235	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Glaucoma (exfoliation)	exfoliation syndrome	http://www.ebi.ac.uk/efo/EFO_0004235	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pseudoexfoliation syndrome	exfoliation syndrome	http://www.ebi.ac.uk/efo/EFO_0004235	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Erectile dysfunction	erectile dysfunction	http://www.ebi.ac.uk/efo/EFO_0004234	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Erectile dysfunction and prostate cancer treatment	erectile dysfunction	http://www.ebi.ac.uk/efo/EFO_0004234	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Erectile dysfunction in type 1 diabetes	erectile dysfunction	http://www.ebi.ac.uk/efo/EFO_0004234	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Left ventricular QRS voltage	R wave amplitude	http://www.ebi.ac.uk/efo/EFO_0007741	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Epirubicin-induced leukopenia	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced early leukopenia in Crohn's disease	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced leukopenia in inflammatory bowel disease	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced severe leukopenia in inflammatory bowel disease	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Left ventricular QRS voltage	S wave amplitude	http://www.ebi.ac.uk/efo/EFO_0007740	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Oral cavity and pharyngeal cancer	oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0005570	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Oral cavity cancer	oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0005570	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Takotsubo syndrome	Takotsubo cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_1002000	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
High-altitude pulmonary edema	high altitude pulmonary edema	http://www.ebi.ac.uk/efo/EFO_1002002	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Carbamazepine-induced reaction with eosinophilia and systemic symptoms	drug hypersensitivity syndrome	http://www.ebi.ac.uk/efo/EFO_1002004	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	drug hypersensitivity syndrome	http://www.ebi.ac.uk/efo/EFO_1002004	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Nevirapine-induced hypersensitivity in HIV	hypersensitivity reaction disease	http://www.ebi.ac.uk/efo/EFO_1002003	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Resistance to antihypertensive treatment in hypertension	treatment-resistant hypertension	http://www.ebi.ac.uk/efo/EFO_1002006	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Resistant hypertension	treatment-resistant hypertension	http://www.ebi.ac.uk/efo/EFO_1002006	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	lumbar disc herniation	http://www.ebi.ac.uk/efo/EFO_1002005	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Macular telangiectasia type 2	macular telangiectasia type 2	http://www.ebi.ac.uk/efo/EFO_1002009	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Carotid artery stiffness	carotid artery stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0007718	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Myopia (pathological)	pathological myopia	http://www.ebi.ac.uk/efo/EFO_0004207	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Myopia (severe)	pathological myopia	http://www.ebi.ac.uk/efo/EFO_0004207	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Carotid artery external diameter	carotid artery external diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007719	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrodermal activity	electrodermal activity measurement	http://www.ebi.ac.uk/efo/EFO_0006866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrodermal activity	skin conductance level	http://www.ebi.ac.uk/efo/EFO_0006867	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exhaled nitric oxide levels	nitric oxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0005536	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exhaled nitric oxide output	nitric oxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0005536	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fractional exhaled nitric oxide (childhood)	nitric oxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0005536	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fractional exhaled nitric oxide levels	nitric oxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0005536	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Electrodermal activity	skin conductance response amplitude	http://www.ebi.ac.uk/efo/EFO_0006868	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hypospadias	hypospadias	http://www.ebi.ac.uk/efo/EFO_0004209	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Electrodermal activity	skin conductance response frequency	http://www.ebi.ac.uk/efo/EFO_0006869	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thrombin generation potential phenotypes	thrombin generation potential measurement	http://www.ebi.ac.uk/efo/EFO_0005538	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitiligo	vitiligo	http://www.ebi.ac.uk/efo/EFO_0004208	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vitiligo (early onset)	vitiligo	http://www.ebi.ac.uk/efo/EFO_0004208	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vitiligo (late onset)	vitiligo	http://www.ebi.ac.uk/efo/EFO_0004208	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vitiligo (non-segmental)	vitiligo	http://www.ebi.ac.uk/efo/EFO_0004208	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	cognitive decline measurement	http://www.ebi.ac.uk/efo/EFO_0007710	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive decline rate in late mild cognitive impairment	cognitive decline measurement	http://www.ebi.ac.uk/efo/EFO_0007710	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Language performance in older adults (adjusted for episodic memory)	cognitive decline measurement	http://www.ebi.ac.uk/efo/EFO_0007710	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rate of cognitive decline in mild cognitive impairment (time interaction)	cognitive decline measurement	http://www.ebi.ac.uk/efo/EFO_0007710	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	urticaria	http://www.ebi.ac.uk/efo/EFO_0005531	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Advanced age-related macular degeneration	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (CNV vs. GA)	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (choroidal neovascularisation)	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Disease progression to choroidal neovascularization form in age-related macular degeneration	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Exudative age-related macular degeneration	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Laterality in neovascular age-related macular degeneration	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neovascular age-related macular degeneration	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ranibizumab in age-related macular degeneration (exudative)	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	angioedema	http://www.ebi.ac.uk/efo/EFO_0005532	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Angioedema in response to angiotensin-converting enzyme inhibitor	angioedema	http://www.ebi.ac.uk/efo/EFO_0005532	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Electrocardiographic traits	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval (ambient particulate matter interaction)	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval (drug interaction)	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval (sulfonylurea treatment interaction)	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QT interval in Tripanosoma cruzi seropositivity	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	response to non-steroidal anti-inflammatory	http://www.ebi.ac.uk/efo/EFO_0005533	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	response to non-steroidal anti-inflammatory	http://www.ebi.ac.uk/efo/EFO_0005533	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Non-steroidal anti-inflammatory drug-induced enteropathy	response to non-steroidal anti-inflammatory	http://www.ebi.ac.uk/efo/EFO_0005533	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Breastfeeding duration	breastfeeding duration	http://www.ebi.ac.uk/efo/EFO_0006864	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delayed encephalopathy in acute carbon monoxide poisoning	delayed encephalopathy after acute carbon monoxide poisoning	http://www.ebi.ac.uk/efo/EFO_0005534	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Urgency urinary incontinence	urgency urinary incontinence	http://www.ebi.ac.uk/efo/EFO_0006865	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hip geometry	hip geometry	http://www.ebi.ac.uk/efo/EFO_0004685	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hip shape (DXA scan)	hip geometry	http://www.ebi.ac.uk/efo/EFO_0004685	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Antibody status in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ejection fraction in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
PR interval in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parasitemia in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
QRS duration in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
QT interval in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic obstructive pulmonary disease-related biomarkers	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Obesity-related traits	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Select biomarker traits	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Tumor necrosis factor alpha levels	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Mixed cellularity Hodgkin lymphoma	Hodgkins lymphoma, mixed cellularity	http://www.ebi.ac.uk/efo/EFO_1002031	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Acute post-radiotherapy pain in breast cancer	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Adverse response to radiation therapy	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Erectile dysfunction and prostate cancer treatment	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Obesity in adult survivors of childhood cancer exposed to cranial radiation	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Radiation response	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Radiation-induced brain injury in nasopharyngeal carcinoma	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to radiotherapy in cancer (late toxicity)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to radiotherapy in prostate cancer (overall toxicity)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to radiotherapy in prostate cancer (toxicity)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Urinary symptoms in response to radiotherapy in prostate cancer	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Vision loss in proton beam irradiation treatment of choroidal melanoma	response to radiation	http://purl.obolibrary.org/obo/GO_0009314	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Behavioral disturbance or psychiatric symptoms and prion disease	behavioral abnormality	http://purl.obolibrary.org/obo/HP_0000708	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Behavioral disturbance or psychiatric symptoms in prion disease	behavioral abnormality	http://purl.obolibrary.org/obo/HP_0000708	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Attention deficit hyperactivity disorder and conduct disorder	conduct disorder	http://www.ebi.ac.uk/efo/EFO_0004216	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Conduct disorder	conduct disorder	http://www.ebi.ac.uk/efo/EFO_0004216	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Conduct disorder (maternal expressed emotions interaction)	conduct disorder	http://www.ebi.ac.uk/efo/EFO_0004216	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Conduct disorder (symptom count)	conduct disorder	http://www.ebi.ac.uk/efo/EFO_0004216	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anorexia nervosa	anorexia nervosa	http://www.ebi.ac.uk/efo/EFO_0004215	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)	anorexia nervosa	http://www.ebi.ac.uk/efo/EFO_0004215	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Anorexia nervosa or obsessive-compulsive disorder	anorexia nervosa	http://www.ebi.ac.uk/efo/EFO_0004215	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Psychiatric disorder	anorexia nervosa	http://www.ebi.ac.uk/efo/EFO_0004215	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Gambling	gambling behaviour	http://www.ebi.ac.uk/efo/EFO_0004699	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Carotid artery circumferential wall stress	carotid artery circumferential wall stress measurement	http://www.ebi.ac.uk/efo/EFO_0007724	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ambidextrousness	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness (Left-handed vs. non-left-handed)	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness (Right-handed vs. non-right-handed)	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness (left-handed vs. right-handed)	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness (non-right-handed vs right-handed)	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Handedness in dyslexia	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Relative hand skill	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Relative hand skill in reading disability	handedness	http://www.ebi.ac.uk/efo/EFO_0009902	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	factor XI measurement	http://www.ebi.ac.uk/efo/EFO_0004694	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Factor XI	factor XI measurement	http://www.ebi.ac.uk/efo/EFO_0004694	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Carotid artery central pulse pressure	carotid artery central pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0007721	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electroencephalogram traits	theta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gallstone disease	gallstones	http://www.ebi.ac.uk/efo/EFO_0004210	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Anti-saccade error rate in psychotic disorders	antisaccade response measurement	http://www.ebi.ac.uk/efo/EFO_0006874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-saccade response	antisaccade response measurement	http://www.ebi.ac.uk/efo/EFO_0006874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery internal diameter	carotid artery internal diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007720	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glioblastoma	glioma	http://www.ebi.ac.uk/efo/EFO_0005543	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glioma	glioma	http://www.ebi.ac.uk/efo/EFO_0005543	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glioma (pediatric/youth onset)	glioma	http://www.ebi.ac.uk/efo/EFO_0005543	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-glioblastoma glioma	glioma	http://www.ebi.ac.uk/efo/EFO_0005543	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Acoustic startle blink response	acoustic startle blink response measurement	http://www.ebi.ac.uk/efo/EFO_0006875	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery mean blood pressure	carotid artery mean blood pressure measurement	http://www.ebi.ac.uk/efo/EFO_0007723	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery wall cross sectional area	carotid artery wall cross sectional area measurement	http://www.ebi.ac.uk/efo/EFO_0007722	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Seasonality	seasonality measurement	http://www.ebi.ac.uk/efo/EFO_0006876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Seasonality and depression	seasonality measurement	http://www.ebi.ac.uk/efo/EFO_0006876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Seasonality in depression	seasonality measurement	http://www.ebi.ac.uk/efo/EFO_0006876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Abdominal aortic aneurysm	abdominal aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004214	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	abdominal aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004214	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Insomnia	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Insomnia complaints	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Insomnia complaints (continuous)	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Insomnia complaints (dichotomous)	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Insomnia complaints (sex interaction)	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Electroencephalogram traits	alpha wave measurement	http://www.ebi.ac.uk/efo/EFO_0006870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estradiol levels	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estradiol plasma levels (breast cancer)	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Otosclerosis	otosclerosis	http://www.ebi.ac.uk/efo/EFO_0004213	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Electroencephalogram traits	beta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006871	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone-binding globulin levels	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone-binding globulin levels in polycystic ovary syndrome	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Keloid	keloid	http://www.ebi.ac.uk/efo/EFO_0004212	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Electroencephalogram traits	delta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hypertriglyceridemia	hypertriglyceridemia	http://www.ebi.ac.uk/efo/EFO_0004211	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Intraocular pressure	intraocular pressure measurement	http://www.ebi.ac.uk/efo/EFO_0004695	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intraocular pressure (Goldman correlated)	intraocular pressure measurement	http://www.ebi.ac.uk/efo/EFO_0004695	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intraocular pressure (corneal compensated)	intraocular pressure measurement	http://www.ebi.ac.uk/efo/EFO_0004695	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Open-angle glaucoma and intra-ocular pressure	intraocular pressure measurement	http://www.ebi.ac.uk/efo/EFO_0004695	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	polyarticular juvenile idiopathic arthritis, rheumatoid factor negative	http://www.ebi.ac.uk/efo/EFO_1002020	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ankle injury	ankle injury	http://www.ebi.ac.uk/efo/EFO_1002021	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Chronic rhinosinusitis with nasal polyps	chronic rhinosinusitis with nasal polyps	http://www.ebi.ac.uk/efo/EFO_1002029	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Foot ulcer and neuropathy in diabetes	neuropathy	http://www.ebi.ac.uk/efo/EFO_0004149	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Foot ulcer in diabetes and neuropathy	neuropathy	http://www.ebi.ac.uk/efo/EFO_0004149	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neuropathy in Charcot-Marie-Tooth disease type 1A	neuropathy	http://www.ebi.ac.uk/efo/EFO_0004149	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Paclitaxel-induced neuropathy	neuropathy	http://www.ebi.ac.uk/efo/EFO_0004149	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease (APOE e4 interaction)	APOE carrier status	http://www.ebi.ac.uk/efo/EFO_0007659	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	APOE carrier status	http://www.ebi.ac.uk/efo/EFO_0007659	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid clusterin levels in APOEe4+ carriers	APOE carrier status	http://www.ebi.ac.uk/efo/EFO_0007659	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anti-depressant treatment in major depressive disorder	response to sertraline	http://www.ebi.ac.uk/efo/EFO_0006327	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Breast Cancer in BRCA1 mutation carriers	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ovarian cancer in BRCA1 mutation carriers	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ovarian cancer in BRCA2 mutation carriers	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes in high risk HLA genotype individuals (time to event)	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anti-depressant treatment in major depressive disorder	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Non-response to citalopram or escitalopram and depression	response to citalopram	http://www.ebi.ac.uk/efo/EFO_0006329	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-depressant treatment in major depressive disorder	response to citalopram	http://www.ebi.ac.uk/efo/EFO_0006329	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to citalopram or escitalopram and depression	response to citalopram	http://www.ebi.ac.uk/efo/EFO_0006329	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to citalopram or escitalopram in depression	response to citalopram	http://www.ebi.ac.uk/efo/EFO_0006329	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-depressant treatment in major depressive disorder	antidepressant-induced visual impairment	http://www.ebi.ac.uk/efo/EFO_0006323	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Carpal tunnel syndrome	carpal tunnel syndrome	http://www.ebi.ac.uk/efo/EFO_0004143	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Ideal cardiovascular health (clinical and behavioural)	clinical and behavioural ideal cardiovascular health	http://www.ebi.ac.uk/efo/EFO_0007654	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cerebrospinal fluid clusterin levels	cerebrospinal fluid clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007657	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cerebrospinal fluid clusterin levels in APOEe4+ carriers	cerebrospinal fluid clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007657	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cerebrospinal fluid clusterin levels in APOEe4- carriers	cerebrospinal fluid clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007657	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Non-response to bupropion and depression	response to bupropion	http://www.ebi.ac.uk/efo/EFO_0006326	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-depressant treatment in major depressive disorder	response to bupropion	http://www.ebi.ac.uk/efo/EFO_0006326	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to bupropion and depression	response to bupropion	http://www.ebi.ac.uk/efo/EFO_0006326	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to bupropion in depression	response to bupropion	http://www.ebi.ac.uk/efo/EFO_0006326	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma clusterin levels	plasma clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007656	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
S-phenylmercapturic acid levels in smokers	urinary S-phenylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007651	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (fetal genetic effect)	soluble interleukin-2 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0007650	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	soluble interleukin-2 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0007650	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Soluble interleukin-2 receptor subunit alpha	soluble interleukin-2 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0007650	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anti-depressant treatment in major depressive disorder	antidepressant-induced side effect	http://www.ebi.ac.uk/efo/EFO_0006320	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ideal cardiovascular health (clinical)	clinical ideal cardiovascular health	http://www.ebi.ac.uk/efo/EFO_0007653	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to anti-depressant treatment in major depressive disorder	antidepressant-induced dizziness	http://www.ebi.ac.uk/efo/EFO_0006321	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Atorvastatin-induced myopathy	myopathy	http://www.ebi.ac.uk/efo/EFO_0004145	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Simvastatin-induced myopathy	myopathy	http://www.ebi.ac.uk/efo/EFO_0004145	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Statin-induced myopathy	myopathy	http://www.ebi.ac.uk/efo/EFO_0004145	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Statin-induced myopathy (severe)	myopathy	http://www.ebi.ac.uk/efo/EFO_0004145	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to anti-depressant treatment in major depressive disorder	antidepressant-induced sexual dysfunction	http://www.ebi.ac.uk/efo/EFO_0006322	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
diarrhoeal disease at age 1	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
diarrhoeal disease at age 1 with doctor diagnosis	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
diarrhoeal disease at age 2	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
diarrhoeal disease at age 2 with doctor diagnosis	diarrhea	http://purl.obolibrary.org/obo/HP_0002014	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Dysphagia	dysphagia	http://purl.obolibrary.org/obo/HP_0002015	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
General factor of neuroticism	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurociticism	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuroticism	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuroticism (MTAG)	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Remission after SSRI treatment in MDD or neuroticism	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social science traits (pleiotropy) (HIPO component 1)	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Stress sensitivity (neuroticism score x major depressive disorder status interaction)	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mortality in sepsis	sepsis	http://purl.obolibrary.org/obo/HP_0100806	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sepsis from pneumonia (survival)	sepsis	http://purl.obolibrary.org/obo/HP_0100806	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
High-grade serous ovarian cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Low-grade serous and serous borderline ovarian cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Low-grade serous ovarian cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Serous borderline ovarian cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Serous invasive ovarian cancer	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pit-and-Fissure caries	pit and fissure surface dental caries	http://www.ebi.ac.uk/efo/EFO_0006338	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Antitragus size	antitragus size	http://www.ebi.ac.uk/efo/EFO_0007669	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Smooth-surface caries	smooth surface dental caries	http://www.ebi.ac.uk/efo/EFO_0006339	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Fuchs's corneal dystrophy	Fuchs endothelial corneal dystrophy	http://www.orpha.net/ORDO/Orphanet_98974	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Iron status biomarkers	total iron binding capacity	http://www.ebi.ac.uk/efo/EFO_0006334	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (total iron binding capacity)	total iron binding capacity	http://www.ebi.ac.uk/efo/EFO_0006334	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lobe size	lobe size	http://www.ebi.ac.uk/efo/EFO_0007666	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Age-related disease endophenotypes	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases, mortality and associated endophenotypes	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Biomedical quantitative traits	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (anthropometric measures interaction)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (cold pressor test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium intervention)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (low sodium intervention)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure traits (multi-trait analysis)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Multiple sclerosis and systolic blood pressure (pleiotropy)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Quantitative traits	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (alcohol consumption interaction)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (cigarette smoking interaction)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (dietary potassium intake interaction)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (long-term average)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure in sickle cell anemia	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x alcohol consumption interaction (1df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x alcohol consumption interaction (2df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity interaction (1df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity interaction (2df)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x sodium interaction (1df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x sodium interaction (2df test)	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ear protrusion	ear protrusion	http://www.ebi.ac.uk/efo/EFO_0007665	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Age-related disease endophenotypes	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases, mortality and associated endophenotypes	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Biomedical quantitative traits	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (age interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (anthropometric measures interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (smoking interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (cold pressor test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium intervention)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (low sodium intervention)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure traits (multi-trait analysis)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DIastolic blood pressure x physical activity interaction (2df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (alcohol consumption interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (cigarette smoking interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (dietary potassium intake interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (long-term average)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x alcohol consumption interaction (1df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x alcohol consumption interaction (2df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity interaction (1df)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x sodium interaction (1df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x sodium interaction (2df test)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure (alcohol consumption interaction)	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolic syndrome	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Quantitative traits	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tragus size	tragus size	http://www.ebi.ac.uk/efo/EFO_0007668	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lobe attachment	lobe attachment	http://www.ebi.ac.uk/efo/EFO_0007667	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lobe attachment (rater scored)	lobe attachment	http://www.ebi.ac.uk/efo/EFO_0007667	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lobe attachment (rater-scored or self-reported)	lobe attachment	http://www.ebi.ac.uk/efo/EFO_0007667	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to allopurinol in gout (change in serum uric acid levels)	response to allopurinol	http://www.ebi.ac.uk/efo/EFO_0006337	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Serum uric acid levels in response to allopurinol in gout	response to allopurinol	http://www.ebi.ac.uk/efo/EFO_0006337	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-depressant treatment in major depressive disorder	response to buspirone	http://www.ebi.ac.uk/efo/EFO_0006330	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triptolide cytotoxicity	response to triptolide	http://www.ebi.ac.uk/efo/EFO_0007662	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood and toenail selenium levels	selenium measurement	http://www.ebi.ac.uk/efo/EFO_0006331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Toenail selenium levels	selenium measurement	http://www.ebi.ac.uk/efo/EFO_0006331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epilepsy and lamotrigine-induced maculopapular eruptions	response to lamotrigine	http://www.ebi.ac.uk/efo/EFO_0007661	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Lamotrigine-induced maculopapular exanthema	response to lamotrigine	http://www.ebi.ac.uk/efo/EFO_0007661	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Obesity-related traits	leptin measurement	http://www.ebi.ac.uk/efo/EFO_0005000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	leptin measurement	http://www.ebi.ac.uk/efo/EFO_0005000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
circulating leptin levels	leptin measurement	http://www.ebi.ac.uk/efo/EFO_0005000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ear morphology	outer ear morphology trait	http://www.ebi.ac.uk/efo/EFO_0007664	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Triptolide cytotoxicity	outer ear morphology trait	http://www.ebi.ac.uk/efo/EFO_0007664	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	serum iron measurement	http://www.ebi.ac.uk/efo/EFO_0006332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers	serum iron measurement	http://www.ebi.ac.uk/efo/EFO_0006332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (iron levels)	serum iron measurement	http://www.ebi.ac.uk/efo/EFO_0006332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aggressiveness in attention deficit hyperactivity disorder	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Childhood and early adolescence aggressive behavior	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early childhood aggressive behavior	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Middle childhood and early adolescence aggressive behavior	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triptolide cytotoxicity	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers	transferrin saturation measurement	http://www.ebi.ac.uk/efo/EFO_0006333	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (transferrin saturation)	transferrin saturation measurement	http://www.ebi.ac.uk/efo/EFO_0006333	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	lysine measurement	http://www.ebi.ac.uk/efo/EFO_0005002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	lysine measurement	http://www.ebi.ac.uk/efo/EFO_0005002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	lysine measurement	http://www.ebi.ac.uk/efo/EFO_0005002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Folding of antihelix	folding of antihelix	http://www.ebi.ac.uk/efo/EFO_0007671	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood pressure	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (age interaction)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (cold pressor test)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium intervention)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (low sodium intervention)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure (alcohol consumption interaction)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure (dietary potassium intake interaction)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure (long-term average)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x alcohol consumption interaction (2df test)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x sodium interaction (1df test)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x sodium interaction (2df test)	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Helix rolling	helix rolling	http://www.ebi.ac.uk/efo/EFO_0007670	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Developmental language disorder	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Developmental language disorder (linguistic errors)	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Developmental language disorder (syntactic complexity)	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability or specific language impairment (pleiotropy)	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Endometrial cancer	endometrial carcinoma	http://www.ebi.ac.uk/efo/EFO_1001512	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Endometrial cancer (Non-endometrioid histology)	endometrial carcinoma	http://www.ebi.ac.uk/efo/EFO_1001512	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Endometrial cancer (endometrioid histology)	endometrial carcinoma	http://www.ebi.ac.uk/efo/EFO_1001512	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Endometriosis or endometrial cancer (pleiotropy)	endometrial carcinoma	http://www.ebi.ac.uk/efo/EFO_1001512	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Complex regional pain syndrome	complex regional pain syndrome	http://www.ebi.ac.uk/efo/EFO_1001998	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Endometrial endometrioid carcinoma	endometrial endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001514	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	ovarian endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001515	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	ovarian endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001515	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Endometrioid ovarian cancer	ovarian endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001515	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	systemic juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_1001999	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic juvenile idiopathic arthritis	systemic juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_1001999	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	plasma plasminogen measurement	http://www.ebi.ac.uk/efo/EFO_0006309	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma plasminogen levels	plasma plasminogen measurement	http://www.ebi.ac.uk/efo/EFO_0006309	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (change over time) in gastrointestinal cancer	digestive system carcinoma	http://www.ebi.ac.uk/efo/EFO_1000218	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	digestive system carcinoma	http://www.ebi.ac.uk/efo/EFO_1000218	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Enteric fever	typhoid fever	http://www.ebi.ac.uk/efo/EFO_0006789	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Attention function	attention function measurement	http://www.ebi.ac.uk/efo/EFO_0007636	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention function in attention deficit hyperactive disorder	attention function measurement	http://www.ebi.ac.uk/efo/EFO_0007636	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ultraviolet-induced skin pigmentation (minimal erythema dose)	minimal erythema dose	http://www.ebi.ac.uk/efo/EFO_0007639	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type	http://www.ebi.ac.uk/efo/EFO_0007638	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antithyroid drug-induced agranulocytosis	response to thioamide	http://www.ebi.ac.uk/efo/EFO_0007633	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thionamide-induced agranulocytosis in Graves' disease	response to thioamide	http://www.ebi.ac.uk/efo/EFO_0007633	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Infant length	infant body height	http://www.ebi.ac.uk/efo/EFO_0006785	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	concentration dose ratio	http://www.ebi.ac.uk/efo/EFO_0007635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	concentration dose ratio	http://www.ebi.ac.uk/efo/EFO_0007635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	concentration dose ratio	http://www.ebi.ac.uk/efo/EFO_0007635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	concentration dose ratio	http://www.ebi.ac.uk/efo/EFO_0007635	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anxiety and stress-related disorders	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (excluding adjustment disorder)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (including obsessive-compulsive disorder)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (propensity-score-matching design)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety disorder	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety disorder or brain volume (pleiotropy)	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety disorders	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asthma and anxiety disorder	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cognitive-behavioural therapy in anxiety and major depressive disorders	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to cognitive-behavioural therapy in anxiety disorder	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hypersomnia during a major depressive episode in bipolar disorder	major depressive episode	http://www.ebi.ac.uk/efo/EFO_0007634	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Coffee consumption	coffee consumption measurement	http://www.ebi.ac.uk/efo/EFO_0006781	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coffee consumption	cups of coffee per day measurement	http://www.ebi.ac.uk/efo/EFO_0006782	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coffee consumption (cups per day)	cups of coffee per day measurement	http://www.ebi.ac.uk/efo/EFO_0006782	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hexose levels	hexose measurement	http://www.ebi.ac.uk/efo/EFO_0007631	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip circumference (psychosocial stress interaction)	psychosocial stress measurement	http://www.ebi.ac.uk/efo/EFO_0006783	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Perceived stress	psychosocial stress measurement	http://www.ebi.ac.uk/efo/EFO_0006783	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Birth length	body height at birth	http://www.ebi.ac.uk/efo/EFO_0006784	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	glycerophospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0007630	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Glycerophospholipid levels	glycerophospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0007630	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cerebral amyloid angiopathy	cerebral amyloid angiopathy	http://www.ebi.ac.uk/efo/EFO_0006790	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	cerebral amyloid angiopathy	http://www.ebi.ac.uk/efo/EFO_0006790	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	cerebral amyloid angiopathy	http://www.ebi.ac.uk/efo/EFO_0006790	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	cerebral amyloid angiopathy	http://www.ebi.ac.uk/efo/EFO_0006790	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Vascular brain injury	vascular brain injury	http://www.ebi.ac.uk/efo/EFO_0006791	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Expressive vocabulary in infants	infant expressive language ability	http://www.ebi.ac.uk/efo/EFO_0006316	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Vancomycin trough in vancomycin therapy	vancomycin trough measurement	http://www.ebi.ac.uk/efo/EFO_0007648	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak creatinine levels in vancomycin therapy	response to vancomycin	http://www.ebi.ac.uk/efo/EFO_0007647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Renal elimination rate in vancomycin therapy	response to vancomycin	http://www.ebi.ac.uk/efo/EFO_0007647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Vancomycin trough in vancomycin therapy	response to vancomycin	http://www.ebi.ac.uk/efo/EFO_0007647	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced alopecia in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced digestive symptoms in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced early leukopenia in Crohn's disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced fever in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced infection in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced leukopenia in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced liver dysfunction in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced myelosuppression in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced pancreatitis in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced severe alopecia in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced severe leukopenia in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thiopurine-induced skin symptoms in inflammatory bowel disease	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
HIV-1 viral setpoint	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Setpoint viral load in HIV-1 infection	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal elimination rate in vancomycin therapy	renal elimination rate measurement	http://www.ebi.ac.uk/efo/EFO_0007649	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mitochondrial DNA copy number	mitochondrial DNA measurement	http://www.ebi.ac.uk/efo/EFO_0006312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mitochondrial DNA copy number (white blood cells)	mitochondrial DNA measurement	http://www.ebi.ac.uk/efo/EFO_0006312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mitochondrial DNA levels	mitochondrial DNA measurement	http://www.ebi.ac.uk/efo/EFO_0006312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Very long-chain saturated fatty acid levels (fatty acid 20:0)	very long-chain saturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006796	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Very long-chain saturated fatty acid levels (fatty acid 22:0)	very long-chain saturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006796	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Very long-chain saturated fatty acid levels (fatty acid 24:0)	very long-chain saturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006796	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Neuritic plaques or neurofibrillary tangles (pleiotropy)	neurofibrillary tangles measurement	http://www.ebi.ac.uk/efo/EFO_0006797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	neurofibrillary tangles measurement	http://www.ebi.ac.uk/efo/EFO_0006797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurofibrillary tangles	neurofibrillary tangles measurement	http://www.ebi.ac.uk/efo/EFO_0006797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	neurofibrillary tangles measurement	http://www.ebi.ac.uk/efo/EFO_0006797	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	chemotherapy-induced oral mucositis	http://www.ebi.ac.uk/efo/EFO_0006313	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Longitudinal change in brain amyloid plaque burden	amyloid plaque accumulation rate	http://www.ebi.ac.uk/efo/EFO_0007646	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuritic plaque	neuritic plaque measurement	http://www.ebi.ac.uk/efo/EFO_0006798	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	neuritic plaque measurement	http://www.ebi.ac.uk/efo/EFO_0006798	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuritic plaques or neurofibrillary tangles (pleiotropy)	neuritic plaque measurement	http://www.ebi.ac.uk/efo/EFO_0006798	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	neuritic plaque measurement	http://www.ebi.ac.uk/efo/EFO_0006798	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	response to high-dose melphalan	http://www.ebi.ac.uk/efo/EFO_0006314	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Alcohol use disorder (consumption score)	longitudinal alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007645	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Longitudinal alcohol consumption	longitudinal alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007645	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lewy body disease	Lewy body dementia measurement	http://www.ebi.ac.uk/efo/EFO_0006799	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	thiopurine immunosuppressant-induced pancreatitis	http://www.ebi.ac.uk/efo/EFO_0006315	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Dementia with Lewy bodies	Lewy body dementia	http://www.ebi.ac.uk/efo/EFO_0006792	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lewy body disease	Lewy body dementia	http://www.ebi.ac.uk/efo/EFO_0006792	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	left inferior lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0006793	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal P-tau181p levels	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal T-tau levels	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid AB1-42 levels	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid biomarker levels	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid α-synuclein levels	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum VEGFR2 concentration	serum VEGFR2 concentration measurement	http://www.ebi.ac.uk/efo/EFO_0006795	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement (duration of fixations)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement (horizontal position gain)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement (integrated eye movement score)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement (scanpath length)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement in schizophrenia (duration of fixations)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement in schizophrenia (horizontal position gain)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement in schizophrenia (integrated eye movement score)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye movement in schizophrenia (scanpath length)	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Platelet function and related traits	platelet measurement	http://www.ebi.ac.uk/efo/EFO_0005036	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Aortic root size	aortic root size	http://www.ebi.ac.uk/efo/EFO_0005037	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Parkinson's disease in GBA mutation carriers (age at onset)	GBA carrier status	http://www.ebi.ac.uk/efo/EFO_0007698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Common traits (Other)	hair morphology	http://www.ebi.ac.uk/efo/EFO_0005038	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hair morphology	hair morphology	http://www.ebi.ac.uk/efo/EFO_0005038	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Straight vs curly hair	hair morphology	http://www.ebi.ac.uk/efo/EFO_0005038	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hippocampal atrophy	hippocampal atrophy	http://www.ebi.ac.uk/efo/EFO_0005039	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Opioid requirements during laparoscopic-assisted colectomy	response to opioid	http://www.ebi.ac.uk/efo/EFO_0008541	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to opioid analgesics in cancer (pain decrease)	response to opioid	http://www.ebi.ac.uk/efo/EFO_0008541	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tramadol metabolism (O-desmethyltramadol to tramadol ratio)	response to opioid	http://www.ebi.ac.uk/efo/EFO_0008541	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Opioid requirements during laparoscopic-assisted colectomy	analgesia requirement measurement	http://www.ebi.ac.uk/efo/EFO_0008544	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain structure	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain structure (hippocampal volume)	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume (Alzheimer's disease interaction)	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in Alzheimer's disease dementia	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in mild cognitive impairment	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in normal cognition	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in schizophrenia	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in trauma-exposed individuals	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcortical brain region volumes	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total hippocampal volume	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum C3d:C3 ratio (systemic complement activation)	c3d:C3 ratio	http://www.ebi.ac.uk/efo/EFO_0008543	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Male-pattern baldness	androgenetic alopecia	http://www.ebi.ac.uk/efo/EFO_0004191	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nonischemic cardiomyopathy	nonischemic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0009881	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Glaucoma (high intraocular pressure)	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Glaucoma (primary open-angle)	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Open-angle glaucoma and intra-ocular pressure	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Open-angle glaucoma and optic cup area	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Open-angle glaucoma and optic disc area	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Open-angle glaucoma and vertical cup-disc ratio	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Urinary potassium to creatinine ratio	urinary potassium to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0009882	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgA nephropathy	IgA glomerulonephritis	http://www.ebi.ac.uk/efo/EFO_0004194	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Basal cell carcinoma	basal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0004193	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple keratinocyte cancers	basal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0004193	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alopecia areata	alopecia areata	http://www.ebi.ac.uk/efo/EFO_0004192	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Vaginal discharge (itching)	abnormal vaginal discharge itching	http://www.ebi.ac.uk/efo/EFO_0009409	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Vaginal discharge (smell)	abnormal vaginal discharge smell	http://www.ebi.ac.uk/efo/EFO_0009408	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Clinical laboratory measurements	erythrocyte measurement	http://www.ebi.ac.uk/efo/EFO_0005047	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	erythrocyte measurement	http://www.ebi.ac.uk/efo/EFO_0005047	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	erythrocyte measurement	http://www.ebi.ac.uk/efo/EFO_0005047	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Parasubiculum volume	parasubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009405	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parasubiculum volume (corrected for total hippocampal volume)	parasubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009405	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute-on-chronic liver failure in hepatitis B	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic hepatitis B infection	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Familial hepatitis B virus-related hepatocellular carcinoma	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis B	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis B (viral clearance)	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis B virus-related hepatocellular carcinoma	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatocellular carcinoma in hepatitis B infection	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Susceptibility to persistent hepatitis B virus infection	hepatitis B infection	http://www.ebi.ac.uk/efo/EFO_0004197	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Dentate gyrus granule cell layer volume	granule cell layer dentate gyrus volume	http://www.ebi.ac.uk/efo/EFO_0009403	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	granule cell layer dentate gyrus volume	http://www.ebi.ac.uk/efo/EFO_0009403	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal fissure volume	hippocampal fissure volume	http://www.ebi.ac.uk/efo/EFO_0009404	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal fissure volume (corrected for total hippocampal volume)	hippocampal fissure volume	http://www.ebi.ac.uk/efo/EFO_0009404	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiac Troponin-T levels	cardiac troponin T measurement	http://www.ebi.ac.uk/efo/EFO_0005043	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Frailty index	frailty measurement	http://www.ebi.ac.uk/efo/EFO_0009885	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HATA volume	hippocampal amigdala transition area volume	http://www.ebi.ac.uk/efo/EFO_0009401	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HATA volume (corrected for total hippocampal volume)	hippocampal amigdala transition area volume	http://www.ebi.ac.uk/efo/EFO_0009401	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fimbria volume	hippocampus fimbria volume	http://www.ebi.ac.uk/efo/EFO_0009402	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fimbria volume (corrected for total hippocampal volume)	hippocampus fimbria volume	http://www.ebi.ac.uk/efo/EFO_0009402	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Leishmaniasis (visceral)	visceral Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005045	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Multiple traits (pleiotropy)	visceral Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005045	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Urinary sodium to creatinine ratio	urinary sodium to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0009883	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Presubiculum volume	presubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009400	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Presubiculum volume (corrected for total hippocampal volume)	presubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009400	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary sodium to potassium ratio	urinary sodium to potassium ratio	http://www.ebi.ac.uk/efo/EFO_0009884	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial attractiveness (female raters)	facial attractiveness measurement	http://www.ebi.ac.uk/efo/EFO_0009892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial attractiveness (male raters)	facial attractiveness measurement	http://www.ebi.ac.uk/efo/EFO_0009892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acenocoumarol maintenance dosage	response to anticoagulant	http://purl.obolibrary.org/obo/GO_0061476	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Warfarin maintenance dose	response to anticoagulant	http://purl.obolibrary.org/obo/GO_0061476	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Warfarin maintenance dose (adjusted for clinical factors)	response to anticoagulant	http://purl.obolibrary.org/obo/GO_0061476	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Warfarin-associated bleeding	response to anticoagulant	http://purl.obolibrary.org/obo/GO_0061476	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	response to oxcarbazepine	http://www.ebi.ac.uk/efo/EFO_0009893	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Oxcarbazepine-induced hyponatremia in epilepsy	response to oxcarbazepine	http://www.ebi.ac.uk/efo/EFO_0009893	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	response to oxcarbazepine	http://www.ebi.ac.uk/efo/EFO_0009893	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to aromatase inhibitors	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Breast cancer-free interval (treatment with aromatase inhibitor)	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Trunk fat mass adjusted for trunk lean mass	lean mass-adjusted fat body mass	http://www.ebi.ac.uk/efo/EFO_0009890	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	carbamazepine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009891	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid atherosclerosis in HIV infection	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Subclinical atherosclerosis traits (other)	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to clopidogrel therapy	response to platelet aggregation inhibitor	http://purl.obolibrary.org/obo/GO_0061478	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced hypersensitivity in HIV	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced hypersensitivity in HIV (rash)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Nevirapine-induced rash	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to temozolomide	response to temozolomide	http://purl.obolibrary.org/obo/GO_1990054	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Brooding (response to stress)	brooding stress response	http://www.ebi.ac.uk/efo/EFO_0009858	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Plasma kynurenine levels in major depressive disorder	kynurenine measurement	http://www.ebi.ac.uk/efo/EFO_0008529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Reflection (response to stress)	reflective stress response	http://www.ebi.ac.uk/efo/EFO_0009859	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007677	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phenytoin-induced maculopapular exanthema	response to phenytoin	http://www.ebi.ac.uk/efo/EFO_0006345	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Phenytoin-induced severe cutaneous adverse reactions	response to phenytoin	http://www.ebi.ac.uk/efo/EFO_0006345	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced serious cutaneous adverse reaction	severe cutaneous adverse reaction	http://www.ebi.ac.uk/efo/EFO_0006346	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Phenytoin-induced severe cutaneous adverse reactions	severe cutaneous adverse reaction	http://www.ebi.ac.uk/efo/EFO_0006346	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Severe cutaneous adverse drug reactions	severe cutaneous adverse reaction	http://www.ebi.ac.uk/efo/EFO_0006346	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to zileuton treatment in asthma (FEV1 change interaction)	response to zileuton	http://www.ebi.ac.uk/efo/EFO_0007676	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Rumination (response to stress)	ruminative stress response	http://www.ebi.ac.uk/efo/EFO_0009857	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	oppositional defiant disorder measurement	http://www.ebi.ac.uk/efo/EFO_0007679	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary artery enlargement and chronic obstructive pulmonary disease	pulmonary artery enlargement	http://www.ebi.ac.uk/efo/EFO_0006347	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Pulmonary artery enlargement in chronic obstructive pulmonary disease	pulmonary artery enlargement	http://www.ebi.ac.uk/efo/EFO_0006347	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Treatment resistant depression	treatment resistant depression	http://www.ebi.ac.uk/efo/EFO_0009854	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Frontal fibrosing alopecia	frontal fibrosing alopecia	http://www.ebi.ac.uk/efo/EFO_0009855	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
LDL peak particle diameter (total fat intake interaction)	total fat intake measurement	http://www.ebi.ac.uk/efo/EFO_0007678	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	transferrin measurement	http://www.ebi.ac.uk/efo/EFO_0006341	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers	transferrin measurement	http://www.ebi.ac.uk/efo/EFO_0006341	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (transferrin levels)	transferrin measurement	http://www.ebi.ac.uk/efo/EFO_0006341	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Superior crus of antihelix expression	superior crus of antihelix expression	http://www.ebi.ac.uk/efo/EFO_0007673	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Aggressive periodontitis	aggressive periodontitis	http://www.ebi.ac.uk/efo/EFO_0006342	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Aggressive periodontitis (sex interaction)	aggressive periodontitis	http://www.ebi.ac.uk/efo/EFO_0006342	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Common traits (Other)	Attached earlobe	http://purl.obolibrary.org/obo/HP_0009907	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Crus helix expression	crus helix expression	http://www.ebi.ac.uk/efo/EFO_0007672	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Metastasis at diagnosis in osteosarcoma	metastasis measurement	http://www.ebi.ac.uk/efo/EFO_0007675	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	metastasis measurement	http://www.ebi.ac.uk/efo/EFO_0007675	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colorectal cancer (distant metastatic)	metastasis measurement	http://www.ebi.ac.uk/efo/EFO_0007675	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colorectal cancer (non-distant metastatic)	metastasis measurement	http://www.ebi.ac.uk/efo/EFO_0007675	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Darwin's tubercle	Darwin's tubercule	http://www.ebi.ac.uk/efo/EFO_0007674	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Medication adherence in chronic diseases	medication adherence behavior	http://www.ebi.ac.uk/efo/EFO_0006344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Four meter walk test score	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gait rhythm	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gait speed in old age	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gait variability	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tandem gait	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (total)	chromosomal aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009860	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (total) in genotoxic compound exposure	chromosomal aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009860	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (total)	chromosomal aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009860	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (total) in genotoxic compound exposure	chromosomal aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009860	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	response to cetuximab	http://www.ebi.ac.uk/efo/EFO_0007682	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	response to cetuximab	http://www.ebi.ac.uk/efo/EFO_0007682	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Severe skin toxicity response to cetuximab in colorectal cancer	response to cetuximab	http://www.ebi.ac.uk/efo/EFO_0007682	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Postprandial triglyceride response to high fat diet meal	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Response to exercise (triglyceride level interaction)	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Response to fenofibrate (triglyceride levels)	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride change in response to fenofibrate (parental genotype effect)	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride change in response to fenofibrate treatment	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
HIV-1 susceptibility	susceptibility to viral and mycobacterial infections	http://www.orpha.net/ORDO/Orphanet_391311	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Susceptibility to persistent hepatitis B virus infection	susceptibility to viral and mycobacterial infections	http://www.orpha.net/ORDO/Orphanet_391311	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vitamin D levels (dietary vitamin D intake interaction)	vitamin D dietary intake measurement	http://www.ebi.ac.uk/efo/EFO_0008539	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Helping behaviour (self reported)	helping behavior measurement	http://www.ebi.ac.uk/efo/EFO_0008538	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post traumatic stress disorder symptom count in trauma-exposed individuals	post-traumatic stress disorder symptom measurement	http://www.ebi.ac.uk/efo/EFO_0008535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-traumatic stress disorder (re-experiencing symptoms)	post-traumatic stress disorder symptom measurement	http://www.ebi.ac.uk/efo/EFO_0008535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-traumatic stress disorder symptoms in trauma-exposed soldiers	post-traumatic stress disorder symptom measurement	http://www.ebi.ac.uk/efo/EFO_0008535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
CSF tryptophan concentration in tuberculous meningitis	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolic coherence (transcriptomic)	transcriptome measurement	http://www.ebi.ac.uk/efo/EFO_0009865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systemic sclerosis (anti-topoisomerase-positive)	anti-topoisomerase-I-antibody-positive systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0008537	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Systemic sclerosis (anti-centromere-positive)	anti-centromere-antibody-positive systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0008536	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anxiety/tension (special factor of neuroticism)	anxiety measurement	http://www.ebi.ac.uk/efo/EFO_0009863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GLP-1-stimulated insulin secretion	GLP-1-stimulated insulin response	http://www.ebi.ac.uk/efo/EFO_0008531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Laryngeal squamous cell carcinoma	laryngeal squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0006352	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Postprandial triglyceride response to high fat diet meal	response to high fat food intake	http://www.ebi.ac.uk/efo/EFO_0007684	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Metabolic coherence (transcriptomic)	metabolic network measurement	http://www.ebi.ac.uk/efo/EFO_0009864	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma kynurenine to tryptophan ratio in major depressive disorder	kynurenine:tryptophan ratio	http://www.ebi.ac.uk/efo/EFO_0008530	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	response to CAPOX-B	http://www.ebi.ac.uk/efo/EFO_0007683	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	response to CAPOX-B	http://www.ebi.ac.uk/efo/EFO_0007683	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Chromosomal aberration frequency (chromosome type)	chromosome-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009861	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	chromosome-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009861	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromosome type)	chromosome-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009861	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	chromosome-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009861	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (chromatid type)	chromatid-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009862	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	chromatid-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009862	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromatid type)	chromatid-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009862	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	chromatid-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009862	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinically amyopathic dermatomyositis	clinically amyopathic dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0008532	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Trichloroethylene-induced hypersensitivity syndrome	trichloroethylene-induced hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0007685	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Presence of epithelioid cells in uveal melanoma	Epithelioid Cell Uveal Melanoma	http://www.ebi.ac.uk/efo/EFO_1000244	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma with epithelioid cells	Epithelioid Cell Uveal Melanoma	http://www.ebi.ac.uk/efo/EFO_1000244	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma (11q deletion)	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma (1p deletion)	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma (MYCN amplification)	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neuroblastoma (high-risk)	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Sporadic neuroblastoma	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple traits (pleiotropy)	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pneumococcal bacteremia	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pathological gambling	pathological gambling	http://www.ebi.ac.uk/efo/EFO_1001926	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cutaneous squamous cell carcinoma	cutaneous squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_1001927	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	Dickkopf-related protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008109	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cutaneous nevi	nevus	http://www.ebi.ac.uk/efo/EFO_0000625	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Small intestine neuroendocrine tumor	small intestine neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_1001928	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Selective IgA deficiency	selective IgA deficiency disease	http://www.ebi.ac.uk/efo/EFO_1001929	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	cystatin-SN measurement	http://www.ebi.ac.uk/efo/EFO_0008106	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of pregnancies	number of pregnancies measurement	http://www.ebi.ac.uk/efo/EFO_0009438	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of pregnancies in continuous marriage	number of pregnancies measurement	http://www.ebi.ac.uk/efo/EFO_0009438	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cystatin-SA measurement	http://www.ebi.ac.uk/efo/EFO_0008105	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholesterol ester levels in large LDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in large VLDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in medium HDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in medium LDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in medium VLDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol ester levels in very large HDL	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesteryl ester levels	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Esterified cholesterol levels	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Number of twin births	multiple births measurement	http://www.ebi.ac.uk/efo/EFO_0009439	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of twin births in continuous marriage	multiple births measurement	http://www.ebi.ac.uk/efo/EFO_0009439	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	dermatopontin measurement	http://www.ebi.ac.uk/efo/EFO_0008108	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child survival (Number of children surviving at 5 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child survival (Proportion of children surviving at 5 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child survival in continuous marriage (Number of children surviving at 5 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child survival in continuous marriage (Proportion of children surviving at 5 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant survival (Number of children surviving at 1 year)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant survival (Proportion of children surviving at 1 year)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant survival in continuous marriage (Number of children surviving at 1 year)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant survival in continuous marriage (Proportion of children surviving at 1 year)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile survival (Number of children surviving at 15 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile survival (Proportion of children surviving at 15 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile survival in continuous marriage (Number of children surviving at 15 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile survival in continuous marriage (Proportion of children surviving at 15 years)	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	death-associated protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008107	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child death (Number of children surviving at 1 year but died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child death (Proportion of children surviving at 1 year but died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child death in continuous marriage (Number of children surviving at 1 year but died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Child death in continuous marriage (Proportion of children surviving at 1 year but died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant and Child death (Number of children died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant and Child death (Proportion of children died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant and Child death in continuous marriage (Number of children died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant and Child death in continuous marriage (Proportion of children died <5 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant death (Number of children died <1 year)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant death (Proportion of children died <1 year)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant death in continuous marriage (Number of children died <1 year)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant death in continuous marriage (Proportion of children died <1 year)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant, child and juvenile death (number of children died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant, child and juvenile death (proportion of children died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant, child and juvenile death in continuous marriage (number of children died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile death (Number of children surviving at 5 years but died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile death (Proportion of children surviving at 5 years but died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile death in continuous marriage (Number of children surviving at 5 years but died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile death in continuous marriage (Proportion of children surviving at 5 years but died <15 years)	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	copine-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008102	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	contactin-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008101	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	arthritis disease activity score measurement	http://www.ebi.ac.uk/efo/EFO_0009435	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cystatin-F measurement	http://www.ebi.ac.uk/efo/EFO_0008104	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cystatin-D measurement	http://www.ebi.ac.uk/efo/EFO_0008103	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epilepsy (generalized, with tonic-clonic seizures alone)	epilepsy with generalized tonic-clonic seizures	http://www.ebi.ac.uk/efo/EFO_0007262	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Mean diameter of LDL particles	low density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008593	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma	Waldenstrom macroglobulinemia	http://www.ebi.ac.uk/efo/EFO_0009441	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Mean diameter of HDL particles	high density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008592	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Body mass index (dietary energy interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (diet interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting insulin (dietary factor interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of beta-cell function (dietary factor interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance (dietary factor interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prudent dietary pattern	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip circumference ratio (dietary energy interaction)	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Western dietary pattern	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in IDL	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
IDL particle concentration	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in IDL	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Triglyceride levels in IDL	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Age at last pregnancy	age at last pregnancy measurement	http://www.ebi.ac.uk/efo/EFO_0009440	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at last pregnancy in continuous marriage	age at last pregnancy measurement	http://www.ebi.ac.uk/efo/EFO_0009440	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Dickkopf-related protein 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008110	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean diameter of VLDL particles	very low density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008594	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Chronic obstructive pulmonary disease-related biomarkers	CC16 measurement	http://www.ebi.ac.uk/efo/EFO_0005080	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic obstructive pulmonary disease-related biomarkers	surfactant protein D measurement	http://www.ebi.ac.uk/efo/EFO_0005081	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Free cholesterol levels	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in IDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in large HDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in large LDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in large VLDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in medium VLDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in small VLDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Free cholesterol levels in very large HDL	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Blood protein levels	elafin measurement	http://www.ebi.ac.uk/efo/EFO_0008117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	EGF-like module-containing mucin-like hormone receptor-like 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008116	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	endoplasmic reticulum aminopeptidase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008119	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	endoglin measurement	http://www.ebi.ac.uk/efo/EFO_0008118	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	dual specificity mitogen-activated protein kinase kinase 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008113	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	dual specificity mitogen-activated protein kinase kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008112	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chylomicron and largest VLDL particle concentration	chylomicron measurement	http://www.ebi.ac.uk/efo/EFO_0008596	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Phospholipid levels in chylomicrons and largest VLDL	chylomicron measurement	http://www.ebi.ac.uk/efo/EFO_0008596	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Triglyceride levels in chylomicrons and largest VLDL	chylomicron measurement	http://www.ebi.ac.uk/efo/EFO_0008596	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Testicular cancer	testicular carcinoma	http://www.ebi.ac.uk/efo/EFO_0005088	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Testicular germ cell cancer	testicular carcinoma	http://www.ebi.ac.uk/efo/EFO_0005088	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Testicular germ cell tumor	testicular carcinoma	http://www.ebi.ac.uk/efo/EFO_0005088	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Tinnitus in cisplatin-treated testicular cancer	testicular carcinoma	http://www.ebi.ac.uk/efo/EFO_0005088	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
BRCA1/2-negative high-risk breast cancer	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	ectonucleoside triphosphate diphosphohydrolase 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008115	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Whole-brain volume	whole-brain volume	http://www.ebi.ac.uk/efo/EFO_0005089	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Whole-brain volume (Alzheimer's disease interaction)	whole-brain volume	http://www.ebi.ac.uk/efo/EFO_0005089	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	dynein light chain roadblock-type 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008114	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	endothelial cell-selective adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008120	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrocardiographic conduction measures	P wave duration	http://www.ebi.ac.uk/efo/EFO_0005094	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
P wave duration	P wave duration	http://www.ebi.ac.uk/efo/EFO_0005094	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Electrocardiographic conduction measures	PR segment	http://www.ebi.ac.uk/efo/EFO_0005095	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
PR segment	PR segment	http://www.ebi.ac.uk/efo/EFO_0005095	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Eotaxin levels	eotaxin measurement	http://www.ebi.ac.uk/efo/EFO_0008122	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	endothelin-converting enzyme 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008121	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Basophil count	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Blood cell traits (multivariate analysis)	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Sum basophil neutrophil counts	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Sum eosinophil basophil counts	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
White blood cell count	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
White blood cell count (basophil)	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
White blood cell types	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Blood cell traits (multivariate analysis)	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Monocyte count	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count (monocyte)	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell types	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Entorhinal cortical volume	entorhinal cortical volume	http://www.ebi.ac.uk/efo/EFO_0005092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Entorhinal cortical volume (Alzheimer's disease interaction)	entorhinal cortical volume	http://www.ebi.ac.uk/efo/EFO_0005092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cardiometabolic traits	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hip circumference	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hip circumference (psychosocial stress interaction)	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity-related traits	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Crohn's disease-related phenotypes	erythema nodosum	http://purl.obolibrary.org/obo/HP_0012219	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Erythema nodosum in inflammatory bowel disease	erythema nodosum	http://purl.obolibrary.org/obo/HP_0012219	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Metastasis at diagnosis in osteosarcoma	osteosarcoma	http://www.ebi.ac.uk/efo/EFO_0000637	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Osteosarcoma	osteosarcoma	http://www.ebi.ac.uk/efo/EFO_0000637	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Overall survival in osteosarcoma	osteosarcoma	http://www.ebi.ac.uk/efo/EFO_0000637	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma (survival)	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Overall survival in osteosarcoma	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postoperative survival time in hepatocellular carcinoma	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in TP53 positive breast cancer	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in breast cancer (TP53 expression interaction)	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colon cancer	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in microsatellite instability low/stable colorectal cancer	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in pancreatic cancer	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in rectal cancer	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Presence of epithelioid cells in uveal melanoma	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma (TNM stage 1 or 2)	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma (TNM stage 3 or 4)	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma with any chromosomal aberration	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveal melanoma with chromosome 3 loss	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL24 measurement	http://www.ebi.ac.uk/efo/EFO_0009418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (maternal genetic effect)	CCL24 measurement	http://www.ebi.ac.uk/efo/EFO_0009418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CX3CL1 measurement	http://www.ebi.ac.uk/efo/EFO_0009419	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	tyrosine measurement	http://www.ebi.ac.uk/efo/EFO_0005058	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	tyrosine measurement	http://www.ebi.ac.uk/efo/EFO_0005058	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	tyrosine measurement	http://www.ebi.ac.uk/efo/EFO_0005058	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tyrosine levels	tyrosine measurement	http://www.ebi.ac.uk/efo/EFO_0005058	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL21 measurement	http://www.ebi.ac.uk/efo/EFO_0009416	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acylcarnitine levels	acylcarnitine measurement	http://www.ebi.ac.uk/efo/EFO_0005059	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	acylcarnitine measurement	http://www.ebi.ac.uk/efo/EFO_0005059	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL23 measurement	http://www.ebi.ac.uk/efo/EFO_0009417	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL17 measurement	http://www.ebi.ac.uk/efo/EFO_0009414	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL19 measurement	http://www.ebi.ac.uk/efo/EFO_0009415	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	anti-thyroglobulin antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	anti-thyroglobulin antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	anti-thyroglobulin antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma anti-thyroglobulin levels	anti-thyroglobulin antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrocardiographic traits	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (12-leadsum)	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (Cornell)	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS complex (Sokolow-Lyon)	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS duration	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Interleukin-1-alpha levels	interleukin 1 alpha measurement	http://www.ebi.ac.uk/efo/EFO_0009412	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	interleukin 1 alpha measurement	http://www.ebi.ac.uk/efo/EFO_0009412	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Electrocardiographic conduction measures	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Electrocardiographic traits	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS duration	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS duration in Tripanosoma cruzi seropositivity	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
QRS interval (sulfonylurea treatment interaction)	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Neonatal cytokine/chemokine levels (fetal genetic effect)	CCL15 measurement	http://www.ebi.ac.uk/efo/EFO_0009413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aging traits	age at death	http://www.ebi.ac.uk/efo/EFO_0005056	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	carbamazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009894	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Carbamazepine-induced hyponatremia in epilepsy	carbamazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009894	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	carbamazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009894	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Uterine fibroid number (single vs multiple)	uterine fibroid measurement	http://www.ebi.ac.uk/efo/EFO_0009410	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Uterine fibroid size (maximum dimension)	uterine fibroid measurement	http://www.ebi.ac.uk/efo/EFO_0009410	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Uterine fibroid size (maximum volume)	uterine fibroid measurement	http://www.ebi.ac.uk/efo/EFO_0009410	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	oxcarbazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009895	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Oxcarbazepine-induced hyponatremia in epilepsy	oxcarbazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009895	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	oxcarbazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009895	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Protein quantitative trait loci	myoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0005057	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CXCL12 measurement	http://www.ebi.ac.uk/efo/EFO_0009420	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile myoclonic epilepsy	Juvenile myoclonic epilepsy	http://www.orpha.net/ORDO/Orphanet_307	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Menstruation quality of life impact (bowel movement)	abnormal peristalsis	http://purl.obolibrary.org/obo/HP_0030914	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Narcolepsy	narcolepsy with cataplexy	http://www.ebi.ac.uk/efo/EFO_0000614	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Narcolepsy (age of onset)	narcolepsy with cataplexy	http://www.ebi.ac.uk/efo/EFO_0000614	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Narcolepsy (onset before 2009 H1N1 influenza pandemic)	narcolepsy with cataplexy	http://www.ebi.ac.uk/efo/EFO_0000614	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Narcolepsy with cataplexy	narcolepsy with cataplexy	http://www.ebi.ac.uk/efo/EFO_0000614	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Birth weight or myocardial infarction (pleiotropy)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Incident myocardial infarction	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction (early onset)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in coronary artery disease	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (ACE inhibitor interaction)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (beta blocker interaction)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (calcium channel blocker interaction)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (diuretic interaction)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in placebo-treated cardiovascular disease (time to event)	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Perioperative myocardial infarction in coronary artery bypass surgery	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adventurousness	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Automobile speeding propensity	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
General risk tolerance	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
General risk tolerance (MTAG)	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Risk-taking tendency (4-domain principal component model)	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Self-reported risk-taking behaviour	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sperm motility	sperm motility measurement	http://www.ebi.ac.uk/efo/EFO_0008578	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CXCL6 measurement	http://www.ebi.ac.uk/efo/EFO_0009423	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	CXCL13 measurement	http://www.ebi.ac.uk/efo/EFO_0009421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (maternal genetic effect)	CXCL5 measurement	http://www.ebi.ac.uk/efo/EFO_0009422	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thrombin-activatable fibrinolysis inhibitor activation peptide	thrombin activatable fibrinolysis inhibitor activation peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008582	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	contactin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008100	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Taxane-induced peripheral neuropathy in breast cancer	response to taxane	http://www.ebi.ac.uk/efo/EFO_0008580	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bleeding gums	gingival bleeding	http://purl.obolibrary.org/obo/HP_0000225	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Severe gingival inflammation	gingival bleeding	http://purl.obolibrary.org/obo/HP_0000225	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Idiopathic osteonecrosis of the femoral head	idiopathic osteonecrosis of the femoral head	http://www.ebi.ac.uk/efo/EFO_1001930	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Oropharynx cancer	oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_1001931	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Inflammatory skin disease	inflammatory skin disease	http://www.ebi.ac.uk/efo/EFO_1000636	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Acute respiratory distress syndrome	acute respiratory distress syndrome	http://www.ebi.ac.uk/efo/EFO_1000637	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Preeclampsia	preeclampsia	http://www.ebi.ac.uk/efo/EFO_0000668	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood protein levels	hemopexin measurement	http://www.ebi.ac.uk/efo/EFO_0008149	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	growth-regulated alpha protein measurement	http://www.ebi.ac.uk/efo/EFO_0008146	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Growth-regulated protein alpha levels	growth-regulated alpha protein measurement	http://www.ebi.ac.uk/efo/EFO_0008146	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DHEAS levels in polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Follicule stimulating hormone levels in polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Luteinizing hormone levels in polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sex hormone-binding globulin levels in polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Testosterone levels in polycystic ovary syndrome	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	granzyme A measurement	http://www.ebi.ac.uk/efo/EFO_0008145	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	hemojuvelin measurement	http://www.ebi.ac.uk/efo/EFO_0008148	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cannabis use disorder	substance abuse	http://purl.obolibrary.org/obo/MONDO_0002491	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cannabis use disorder vs schizophrenia	substance abuse	http://purl.obolibrary.org/obo/MONDO_0002491	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	hepatocyte growth factor receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008153	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	hepatocyte growth factor activator measurement	http://www.ebi.ac.uk/efo/EFO_0008152	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	histidine-rich glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008155	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	hepatocyte growth factor-like protein measurement	http://www.ebi.ac.uk/efo/EFO_0008154	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	hepatitis A virus cellular receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008151	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Approach coping (positive reappraisal/problem solving)	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disengagement	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emotional coping (emotional expression/emotional support seeking)	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emotional expression	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emotional support seeking	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Positive reappraisal	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Problem solving	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	heparin cofactor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008150	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Marginal zone lymphoma	marginal zone B-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_1000630	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Marginal zone lymphoma or multiple sclerosis	marginal zone B-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_1000630	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Marginal zone lymphoma or rheumatoid arthritis	marginal zone B-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_1000630	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Marginal zone lymphoma or systemic lupus erythematosus	marginal zone B-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_1000630	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Crohn's disease and psoriasis	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Cutaneous psoriasis	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Inflammatory skin disease	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Multiple traits (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Psoriasis	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Psoriatic arthritis vs Cutaneous psoriasis	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Bipolar disorder and schizophrenia	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Depression (age of onset)	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Eating disorders	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Personality disorders	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychiatric disorder	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychosis	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, bipolar disorder and depression (combined)	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Suicide risk	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	inorganic pyrophosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0008157	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	human Chorionic Gonadotropin measurement	http://www.ebi.ac.uk/efo/EFO_0008156	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	inosine-5-monophosphate dehydrogenase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008159	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	inosine-5-monophosphate dehydrogenase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008158	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	intercellular adhesion molecule 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008164	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	intercellular adhesion molecule 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008163	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Virologic severity in Herpes simplex virus type 2 infection	HSV2 virologic severity measurement	http://www.ebi.ac.uk/efo/EFO_0009010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interferon gamma levels	interferon gamma measurement	http://www.ebi.ac.uk/efo/EFO_0008165	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	interferon gamma measurement	http://www.ebi.ac.uk/efo/EFO_0008165	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rubella-specific interferon-gamma secretion	interferon gamma measurement	http://www.ebi.ac.uk/efo/EFO_0008165	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	insulin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008160	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	integrin alpha-I: beta-1 complex measurement	http://www.ebi.ac.uk/efo/EFO_0008162	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	insulin-like growth factor-binding protein 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008161	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glaucoma (primary angle closure)	primary angle closure glaucoma	http://www.ebi.ac.uk/efo/EFO_1001506	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Asparaginase-induced acute pancreatitis	http://www.ebi.ac.uk/efo/EFO_1001507	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Asparaginase-induced acute pancreatitis	http://www.ebi.ac.uk/efo/EFO_1001507	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Papillary thyroid cancer	papillary thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0000641	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	fetuin-B measurement	http://www.ebi.ac.uk/efo/EFO_0008128	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Fc receptor-like protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008127	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol use disorder	alcohol use disorder measurement	http://www.ebi.ac.uk/efo/EFO_0009458	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol use disorder (consumption score)	alcohol use disorder measurement	http://www.ebi.ac.uk/efo/EFO_0009458	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol use disorder (total score)	alcohol use disorder measurement	http://www.ebi.ac.uk/efo/EFO_0009458	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epigenetic age acceleration in alcohol use disorder	alcohol use disorder measurement	http://www.ebi.ac.uk/efo/EFO_0009458	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009459	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Joint damage progression in ACPA-positive rheumatoid arthritis	ACPA-positive rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009459	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Blood protein levels	fibroblast growth factor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008129	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	ephrin type-B receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008124	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	ephrin type-A receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008123	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	extracellular matrix protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008126	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	estrogen receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008125	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	fibronectin fragment 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008131	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fibroblast growth factor basic levels	fibroblast growth factor basic measurement	http://www.ebi.ac.uk/efo/EFO_0008130	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	fibronectin measurement	http://www.ebi.ac.uk/efo/EFO_0008133	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	fibronectin fragment 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008132	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009460	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Joint damage progression in ACPA-negative rheumatoid arthritis	ACPA-negative rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009460	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Breast cancer (estrogen-receptor negative)	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (survival)	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer specific mortality in estrogen receptor negative breast cancer	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in breast cancer (estrogen-receptor negative)	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Recalcitrant atopic dermatitis	recalcitrant atopic dermatitis	http://www.ebi.ac.uk/efo/EFO_1000651	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic periodontitis	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic periodontitis (generalised)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic periodontitis (localised)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic periodontitis (severe)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Chronic periodontitis (slight)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontal disease-related phenotype (Socransky)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontal microbiota	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis (CDC/AAP)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis (DPAL)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis (Mean PAL)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis (PAL4Q3)	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Periodontitis or loose teeth	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Anthracycline-induced cardiotoxicity in childhood cancer	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cardiomyopathy in childhood cancer survivors	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Obesity in adult survivors of childhood cancer exposed to cranial radiation	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Obesity in adult survivors of childhood cancer not exposed to cranial radiation	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Creutzfeldt-Jakob disease (sporadic)	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Alzheimer's disease or small vessel stroke	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ischemic stroke (small-vessel)	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Multiple traits (pleiotropy)	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Small vessel stroke	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Rectal cancer	rectum cancer	http://www.ebi.ac.uk/efo/EFO_1000657	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in rectal cancer	rectum cancer	http://www.ebi.ac.uk/efo/EFO_1000657	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Developmental dysplasia of the hip	developmental dysplasia of the hip	http://www.ebi.ac.uk/efo/EFO_1000648	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Breast cancer (estrogen-receptor positive)	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (survival)	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer specific mortality in estrogen receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Plasma androstenedione levels in resected early stage-receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Plasma estrone levels in resected estrogen-receptor positive breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in breast cancer (estrogen-receptor positive)	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in endocrine treated breast cancer (estrogen-receptor positive)	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Anti-thyroid drug induced agranulocytosis	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antithyroid drug-induced agranulocytosis	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Clozapine-induced agranulocytosis	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Non-chemotherapy drug induced agranulocytosis	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sulfasalazine-induced agranulocytosis	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thionamide-induced agranulocytosis in Graves' disease	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	glypican-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008139	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	GDNF family receptor alpha-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008138	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	ficolin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008135	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	response to anti-vascular endothelial growth factor drug	http://www.ebi.ac.uk/efo/EFO_0009467	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	ficolin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008134	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	galectin-3 measurement	http://www.ebi.ac.uk/efo/EFO_0008137	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	galactoside 34-L-fucosyltransferase measurement	http://www.ebi.ac.uk/efo/EFO_0008136	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sarcoidosis (Lofgren's syndrome)	Löfgren’s syndrome	http://www.ebi.ac.uk/efo/EFO_0009466	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	granulocyte colony-stimulating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008142	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Granulocyte-colony stimulating factor levels	granulocyte colony-stimulating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008142	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	granulins measurement	http://www.ebi.ac.uk/efo/EFO_0008141	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	granulysin measurement	http://www.ebi.ac.uk/efo/EFO_0008144	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	gp41 C34 peptide, HIV measurement	http://www.ebi.ac.uk/efo/EFO_0008140	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Guillain-Barré syndrome	Guillain-Barre syndrome	http://www.ebi.ac.uk/efo/EFO_0007292	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Ischemic stroke (cardioembolic)	cardioembolic stroke	http://www.ebi.ac.uk/efo/EFO_1001976	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Multiple traits (pleiotropy)	cardioembolic stroke	http://www.ebi.ac.uk/efo/EFO_1001976	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Malignant mesothelioma	mesothelioma	http://www.ebi.ac.uk/efo/EFO_0000588	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Biliary atresia	biliary atresia	http://www.orpha.net/ORDO/Orphanet_30391	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Blood protein levels	carboxypeptidase B2 measurement	http://www.ebi.ac.uk/efo/EFO_0008069	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thrombin-activatable fibrinolysis inhibitor levels	carboxypeptidase B2 measurement	http://www.ebi.ac.uk/efo/EFO_0008069	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	carbonic anhydrase 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008068	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subiculum volume	subiculum volume	http://www.ebi.ac.uk/efo/EFO_0009399	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subiculum volume (corrected for total hippocampal volume)	subiculum volume	http://www.ebi.ac.uk/efo/EFO_0009399	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	CD109 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008076	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cation-independent mannose-6-phosphate receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008075	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	CD27 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008078	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	CD209 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008077	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cathepsin B measurement	http://www.ebi.ac.uk/efo/EFO_0008072	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	catalase measurement	http://www.ebi.ac.uk/efo/EFO_0008071	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cathepsin Z measurement	http://www.ebi.ac.uk/efo/EFO_0008074	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cathepsin S measurement	http://www.ebi.ac.uk/efo/EFO_0008073	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	caspase-3 measurement	http://www.ebi.ac.uk/efo/EFO_0008070	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breslow thickness in cutaneous melanoma	Breslow thickness	http://www.ebi.ac.uk/efo/EFO_0004955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gaucher disease severity	Gaucher disease	http://www.orpha.net/ORDO/Orphanet_355	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Metastasis at diagnosis in osteosarcoma	date of diagnosis	http://www.ebi.ac.uk/efo/EFO_0004953	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer-free interval (treatment with aromatase inhibitor)	disease recurrence	http://www.ebi.ac.uk/efo/EFO_0004952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Relapse in multiple sclerosis	disease recurrence	http://www.ebi.ac.uk/efo/EFO_0004952	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to drug	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Body mass index and cholesterol (psychopharmacological treatment)	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Drug-induced torsades de pointes	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Epilepsy (remission after treatment)	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Non-chemotherapy drug induced agranulocytosis	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to amphetamines	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to antiplatelet therapy	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Response to tocilizumab in rheumatoid arthritis	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Treatment response for severe sepsis	response to drug	http://purl.obolibrary.org/obo/GO_0042493	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood protein levels	cell adhesion molecule-related/down-regulated by oncogenes measurement	http://www.ebi.ac.uk/efo/EFO_0008079	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	coagulation factor V measurement	http://www.ebi.ac.uk/efo/EFO_0008087	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma factor V levels in venous thrombosis	coagulation factor V measurement	http://www.ebi.ac.uk/efo/EFO_0008087	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma factor V levels in venous thrombosis (conditioned on rs6027)	coagulation factor V measurement	http://www.ebi.ac.uk/efo/EFO_0008087	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	CMRF35-like molecule 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008086	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement C1q subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008089	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	collectin-11 measurement	http://www.ebi.ac.uk/efo/EFO_0008088	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
CTACK levels	chemokine (C-C motif) ligand 27 measurement	http://www.ebi.ac.uk/efo/EFO_0008082	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Ck-beta-8-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008085	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	chitotriosidase-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008084	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	cGMP-specific 3’,5’-cyclic phosphodiesterase measurement	http://www.ebi.ac.uk/efo/EFO_0008081	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hirschsprung disease	Hirschsprung disease	http://www.orpha.net/ORDO/Orphanet_388	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progression-free survival response to gemcitabine in breast cancer	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 19 measurement	http://www.ebi.ac.uk/efo/EFO_0008047	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 18 measurement	http://www.ebi.ac.uk/efo/EFO_0008046	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 23 measurement	http://www.ebi.ac.uk/efo/EFO_0008049	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 21 measurement	http://www.ebi.ac.uk/efo/EFO_0008048	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008054	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monocyte chemoattractant protein-3 levels	C-C motif chemokine 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008054	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008053	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-X-C motif chemokine 10 measurement	http://www.ebi.ac.uk/efo/EFO_0008056	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interferon gamma-induced protein 10 levels	C-X-C motif chemokine 10 measurement	http://www.ebi.ac.uk/efo/EFO_0008056	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008055	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 25 measurement	http://www.ebi.ac.uk/efo/EFO_0008050	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Musician's dystonia	limb dystonia	http://www.orpha.net/ORDO/Orphanet_93957	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obesity without metabolic disease	metabolically healthy obesity	http://www.ebi.ac.uk/efo/EFO_0009382	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Blood protein levels	C-C motif chemokine 3-like 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008052	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008051	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Circulating fibroblast growth factor 23 levels	fibroblast growth factor 23 measurement	http://www.ebi.ac.uk/efo/EFO_0009381	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Permanent tooth development	tooth eruption	http://purl.obolibrary.org/obo/GO_0044691	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Primary tooth development (time to first tooth eruption)	tooth eruption	http://purl.obolibrary.org/obo/GO_0044691	Biological process	http://purl.obolibrary.org/obo/GO_0008150
B cell non-Hodgkin lymphoma	lymphoma	http://www.ebi.ac.uk/efo/EFO_0000574	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lymphoma	lymphoma	http://www.ebi.ac.uk/efo/EFO_0000574	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Liver disease in chronic hepatitis B virus infection	liver disease	http://www.ebi.ac.uk/efo/EFO_0001421	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver disease severity in Alagille syndrome	liver disease	http://www.ebi.ac.uk/efo/EFO_0001421	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Thiopurine-induced liver dysfunction in inflammatory bowel disease	liver disease	http://www.ebi.ac.uk/efo/EFO_0001421	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis C induced liver fibrosis	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-alcoholic fatty liver disease histology (AST)	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-alcoholic fatty liver disease histology (lobular)	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-alcoholic fatty liver disease histology (other)	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pediatric non-alcoholic fatty liver disease activity score	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Ischemic heart disease in rheumatoid arthritis	ischemic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0001425	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood protein levels	C-X-C motif chemokine 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008058	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-X-C motif chemokine 11 measurement	http://www.ebi.ac.uk/efo/EFO_0008057	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	C-X-C motif chemokine 11 measurement	http://www.ebi.ac.uk/efo/EFO_0008057	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sum basophil neutrophil counts	sum of basophil and neutrophil counts	http://www.ebi.ac.uk/efo/EFO_0009388	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Adenocarcinoma	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Adenocarcinoma in never smokers	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
EGFR mutation-positive lung adenocarcinoma	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Familial lung adenocarcinoma	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung adenocarcinoma	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung adenocarcinoma (clinical stage)	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Smoking interaction in lung adenocarcinoma (1df test)	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	C-X-C motif chemokine 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008059	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sum eosinophil basophil counts	sum of eosinophil and basophil counts	http://www.ebi.ac.uk/efo/EFO_0009389	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	calpastatin measurement	http://www.ebi.ac.uk/efo/EFO_0008065	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dentate gyrus molecular layer volume	hippocampus molecular layer volume	http://www.ebi.ac.uk/efo/EFO_0009397	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	hippocampus molecular layer volume	http://www.ebi.ac.uk/efo/EFO_0009397	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	calpain I measurement	http://www.ebi.ac.uk/efo/EFO_0008064	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal tail volume	hippocampal tail volume	http://www.ebi.ac.uk/efo/EFO_0009398	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal tail volume (corrected for total hippocampal volume)	hippocampal tail volume	http://www.ebi.ac.uk/efo/EFO_0009398	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	carbonic anhydrase 13 measurement	http://www.ebi.ac.uk/efo/EFO_0008067	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA3 volume	hippocampal CA3 volume	http://www.ebi.ac.uk/efo/EFO_0009395	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA3 volume (corrected for total hippocampal volume)	hippocampal CA3 volume	http://www.ebi.ac.uk/efo/EFO_0009395	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	carbohydrate sulfotransferase 15 measurement	http://www.ebi.ac.uk/efo/EFO_0008066	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA4 volume	hippocampal CA4 volume	http://www.ebi.ac.uk/efo/EFO_0009396	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA4 volume (corrected for total hippocampal volume)	hippocampal CA4 volume	http://www.ebi.ac.uk/efo/EFO_0009396	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	calcineurin measurement	http://www.ebi.ac.uk/efo/EFO_0008061	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (pressure in breast)	breast pressure measurement	http://www.ebi.ac.uk/efo/EFO_0009393	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Blood protein levels	cadherin-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008060	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA1 volume	hippocampal CA1 volume	http://www.ebi.ac.uk/efo/EFO_0009394	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	hippocampal CA1 volume	http://www.ebi.ac.uk/efo/EFO_0009394	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	calcium/calmodulin-dependent protein kinase type 1D measurement	http://www.ebi.ac.uk/efo/EFO_0008063	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Spontaneous preterm birth with premature rupture of membranes	preterm premature rupture of the membranes	http://purl.obolibrary.org/obo/MONDO_0012511	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	calcium/calmodulin-dependent protein kinase type 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008062	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Decline in glucose metabolism in posterior cingulate cortex	glucose metabolism decline measurement	http://www.ebi.ac.uk/efo/EFO_0009392	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sum neutrophil eosinophil counts	sum of neutrophil and eosinophil counts	http://www.ebi.ac.uk/efo/EFO_0009390	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hepcidin levels	serum hepcidin measurement	http://www.ebi.ac.uk/efo/EFO_0004504	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic and hematological traits	hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hematology traits	hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hemostatic factors and hematological phenotypes	hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adiponectin levels	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adiponectin levels in pregnancy	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance	HOMA-IR	http://www.ebi.ac.uk/efo/EFO_0004501	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance (dietary factor interaction)	HOMA-IR	http://www.ebi.ac.uk/efo/EFO_0004501	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance adjusted for BMI	HOMA-IR	http://www.ebi.ac.uk/efo/EFO_0004501	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	HOMA-IR	http://www.ebi.ac.uk/efo/EFO_0004501	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Platelet count and reactivity phenotypes	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Platelet reactivity	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Platelet reactivity measurement (collagen-ADP)	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Platelet reactivity measurement (collagen-epinephrine)	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Platelet thrombus formation	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to clopidogrel therapy	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to clopidogrel therapy in coronary heart disease	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Spine bone size	spine bone size	http://www.ebi.ac.uk/efo/EFO_0004508	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
D-dimer levels	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Monocyte early outgrowth colony forming units	monocyte early outgrowth colony forming unit	http://www.ebi.ac.uk/efo/EFO_0004506	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Leukocyte telomere length	telomere length	http://www.ebi.ac.uk/efo/EFO_0004505	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Telomere length	telomere length	http://www.ebi.ac.uk/efo/EFO_0004505	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Appendicular lean mass	appendicular lean mass	http://www.ebi.ac.uk/efo/EFO_0004980	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement C4 measurement	http://www.ebi.ac.uk/efo/EFO_0004984	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Complement C3 and C4 levels	complement C4 measurement	http://www.ebi.ac.uk/efo/EFO_0004984	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Complement C3 and C4 levels	complement C3 measurement	http://www.ebi.ac.uk/efo/EFO_0004983	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic venous disease	Varicose veins	http://purl.obolibrary.org/obo/HP_0002619	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Varicose veins	Varicose veins	http://purl.obolibrary.org/obo/HP_0002619	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Foot deformity in Charcot-Marie-Tooth disease 1A	abnormality of the foot	http://purl.obolibrary.org/obo/HP_0001760	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Accommodative esotropia	accommodative esotropia	http://purl.obolibrary.org/obo/HP_0020046	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood cell traits (multivariate analysis)	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood protein levels	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Clinical laboratory measurements	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Deoxygenated hemoglobin levels	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological and biochemical traits	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin concentration	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin levels	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemostatic factors and hematological phenotypes	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular hemoglobin	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular hemoglobin concentration	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Oxygenated hemoglobin levels	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Protein quantitative trait loci	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Comprehensive strength and appendicular lean mass	muscle measurement	http://www.ebi.ac.uk/efo/EFO_0004515	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
N-glycan levels	N-glycan measurement	http://www.ebi.ac.uk/efo/EFO_0004999	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone properties (heel)	bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0004514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone ultrasound measurement (broadband ultrasound attenuation)	bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0004514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone ultrasound measurement (velocity of sound)	bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0004514	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	carbohydrate measurement	http://www.ebi.ac.uk/efo/EFO_0004998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease and sarcoidosis (combined)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sarcoidosis	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sarcoidosis (Lofgren's syndrome)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sarcoidosis (non-Lofgren's syndrome)	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
High serum lipase activity	serum lipase activity measurement	http://www.ebi.ac.uk/efo/EFO_0005849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum lipase activity	serum lipase activity measurement	http://www.ebi.ac.uk/efo/EFO_0005849	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 2 diabetes and end-stage kidney disease	type 2 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004997	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	type 2 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004997	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes nephropathy	type 2 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004997	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes nephropathy including microalbuminuria	type 2 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004997	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Bone mineral density (wrist)	bone measurement	http://www.ebi.ac.uk/efo/EFO_0004512	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Kidney disease (early and late stages) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Kidney disease (early stage) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Kidney disease (late stage) in type 1 diabetes	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes nephropathy	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	cortisol measurement	http://www.ebi.ac.uk/efo/EFO_0005843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cortisol levels (plasma)	cortisol measurement	http://www.ebi.ac.uk/efo/EFO_0005843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cortisol levels (saliva)	cortisol measurement	http://www.ebi.ac.uk/efo/EFO_0005843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	cortisol measurement	http://www.ebi.ac.uk/efo/EFO_0005843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Soluble levels of adhesion molecules	soluble p-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004519	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Acute kidney injury in coronary artery bypass surgery (creatinine rise)	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic kidney disease	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic kidney disease and serum creatinine levels	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Creatinine levels	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Creatinine levels in ischemic stroke	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate (creatinine)	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in diabetics (creatinine)	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate in non diabetics (creatinine)	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hematological and biochemical traits	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak creatinine levels in vancomycin therapy	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum creatinine levels	serum creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food antigen IgG levels	response to dietary antigen	http://www.ebi.ac.uk/efo/EFO_0005844	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Arterial stiffness	arterial stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0004517	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Arterial stiffness (pulse-wave velocity)	arterial stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0004517	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Arterial stiffness index	arterial stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0004517	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
HbA2 levels	hemoglobin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0005845	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin A2 levels in sickle cell anemia	hemoglobin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0005845	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin levels	hemoglobin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0005845	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fracture-related traits	bone fracture related measurement	http://www.ebi.ac.uk/efo/EFO_0004516	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	cryoglobulinemia	http://www.ebi.ac.uk/efo/EFO_0005846	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Myasthenia gravis	myasthenia gravis	http://www.ebi.ac.uk/efo/EFO_0004991	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bitter taste perception	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bitter taste perception (multivariate analysis)	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Bitter taste response	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Breast cancer and/or colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (SNP x SNP interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (alcohol consumption interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (aspirin and/or NSAID use interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (calcium intake interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (diet interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (environment interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (menopausal hormone therapy interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (oestrogen hormone therapy interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer (smoking interaction)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer or advanced adenoma	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal carcinoma in primary sclerosing cholangitis	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal or endometrial cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Mucinous adenocarcinoma in colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Severe skin toxicity response to cetuximab in colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in colorectal cancer (distant metastatic)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in colorectal cancer (non-distant metastatic)	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in microsatellite instability low/stable colorectal cancer	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Body mass (lean)	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fat-free mass	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lean body mass	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lean mass index	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
TB-LM or TBLH-BMD (pleiotropy)	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck bone geometry	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck length	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck section modulus	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Femoral neck-shaft angle	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Narrowest width of the femoral neck	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disc degeneration (lumbar)	lumbar disc degeneration	http://www.ebi.ac.uk/efo/EFO_0004994	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lumbar spondylosis (Kellgren-Lawrence grade)	lumbar disc degeneration	http://www.ebi.ac.uk/efo/EFO_0004994	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lumbar spondylosis (disc space narrowing)	lumbar disc degeneration	http://www.ebi.ac.uk/efo/EFO_0004994	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lumbar spondylosis (presence and severity of osteophytes)	lumbar disc degeneration	http://www.ebi.ac.uk/efo/EFO_0004994	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HPV seropositivity	hpv seropositivity	http://www.ebi.ac.uk/efo/EFO_0004510	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgM levels	serum IgM measurement	http://www.ebi.ac.uk/efo/EFO_0004993	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	serum IgM measurement	http://www.ebi.ac.uk/efo/EFO_0004993	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Otitis media	otitis media	http://www.ebi.ac.uk/efo/EFO_0004992	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Otitis media (chronic)	otitis media	http://www.ebi.ac.uk/efo/EFO_0004992	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Otitis media (chronic/recurrent)	otitis media	http://www.ebi.ac.uk/efo/EFO_0004992	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Otitis media (recurrent)	otitis media	http://www.ebi.ac.uk/efo/EFO_0004992	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Common traits (Other)	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Salty taste perception in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sour taste perception in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sweet taste perception in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Umami taste perception in obesity with metabolic syndrome	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood protein levels	complement factor H-related protein 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008098	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement factor H measurement	http://www.ebi.ac.uk/efo/EFO_0008097	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cisplatin-induced hearing loss in brain tumor patients	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cisplatin-induced ototoxicity	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to platinum-based chemotherapy (cisplatin)	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Serum platinum levels after completion of cisplatin chemotherapy	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tinnitus in cisplatin-treated testicular cancer	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood protein levels	complement factor I measurement	http://www.ebi.ac.uk/efo/EFO_0008099	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement component C8 measurement	http://www.ebi.ac.uk/efo/EFO_0008094	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement component C7 measurement	http://www.ebi.ac.uk/efo/EFO_0008093	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement factor B measurement	http://www.ebi.ac.uk/efo/EFO_0008096	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement decay-accelerating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008095	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement C1r subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008090	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement C4b measurement	http://www.ebi.ac.uk/efo/EFO_0008092	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	complement C1s subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008091	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute anterior uveitis (with or without ankylosing spondylitis)	anterior uveitis	http://www.ebi.ac.uk/efo/EFO_1000811	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Acute anterior uveitis in ankylosing spondylitis	anterior uveitis	http://www.ebi.ac.uk/efo/EFO_1000811	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	alcoholic liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_1000802	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Chronic alcoholic pancreatitis or alcohol-related cirrhosis	alcoholic liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_1000802	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cirrhosis (alcohol related)	alcoholic liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_1000802	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Comprehensive strength and appendicular lean mass	comprehensive strength index	http://www.ebi.ac.uk/efo/EFO_0004979	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Orofacial clefts	orofacial clefting syndrome	http://www.orpha.net/ORDO/Orphanet_139039	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Orofacial clefts (cleft lip vs. cleft lip and palate)	orofacial clefting syndrome	http://www.orpha.net/ORDO/Orphanet_139039	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Orofacial clefts (maternal alcohol consumption interaction)	orofacial clefting syndrome	http://www.orpha.net/ORDO/Orphanet_139039	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Hemostatic factors and hematological phenotypes	platelet aggregation	http://purl.obolibrary.org/obo/GO_0070527	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Platelet aggregation	platelet aggregation	http://purl.obolibrary.org/obo/GO_0070527	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Chronic fatigue syndrome	chronic fatigue syndrome	http://www.ebi.ac.uk/efo/EFO_0004540	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Familial hepatitis B virus-related hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatitis B virus-related hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatocellular carcinoma in hepatitis B infection	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatocellular carcinoma in hepatitis C infection	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatocellular carcinoma in primary sclerosing cholangitis	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Postoperative survival time in hepatocellular carcinoma	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pre-treatment pain in head and neck squamous cell carcinoma	head and neck squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000181	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_0000183	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hodgkin's lymphoma	hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_0000183	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Birth weight or hemoglobin A1C levels (pleiotropy)	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in HbA1c levels in response to metformin treatment in type 2 diabetes	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diabetes related insulin traits	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycated hemoglobin levels	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycated hemoglobin levels in type 1 diabetes	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic control in type 1 diabetes (HbA1c)	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hemoglobin A1c levels	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to metformin in type 2 diabetes (HbA1c reduction)	a1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nasal polyps	Nasal cavity polyp	http://www.ebi.ac.uk/efo/EFO_1000391	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	non-alcoholic steatohepatitis	http://www.ebi.ac.uk/efo/EFO_1001249	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Pediatric nonalcoholic steatohepatitis	non-alcoholic steatohepatitis	http://www.ebi.ac.uk/efo/EFO_1001249	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Multiple traits (pleiotropy)	psychosis	http://www.ebi.ac.uk/efo/EFO_0005407	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Psychosis (atypical)	psychosis	http://www.ebi.ac.uk/efo/EFO_0005407	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to haloperidol in psychosis	psychosis	http://www.ebi.ac.uk/efo/EFO_0005407	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Metabolite levels (Pyroglutamine)	pyroglutamine measurement	http://www.ebi.ac.uk/efo/EFO_0005408	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits in newborns	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body fat mass	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fat body mass	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fat mass index	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Trunk fat mass	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antibody status in Tripanosoma cruzi seropositivity	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein-Barr virus immune response (EBNA-1)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	response to dietary potassium supplementation	http://www.ebi.ac.uk/efo/EFO_0005403	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood pressure measurement (cold pressor test)	response to cold pressor test	http://www.ebi.ac.uk/efo/EFO_0005404	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood pressure (response to antihypertensive medication)	response to antihypertensive drug	http://www.ebi.ac.uk/efo/EFO_0005405	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	response to antihypertensive drug	http://www.ebi.ac.uk/efo/EFO_0005405	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Colorectal adenoma (advanced)	colorectal adenoma	http://www.ebi.ac.uk/efo/EFO_0005406	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Colorectal cancer or advanced adenoma	colorectal adenoma	http://www.ebi.ac.uk/efo/EFO_0005406	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Adverse response to chemotherapy in breast cancer (alopecia)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Amygdala reactivity	amygdala reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004550	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Functional MRI	amygdala reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004550	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure measurement (high sodium and potassium intervention)	response to high sodium diet	http://www.ebi.ac.uk/efo/EFO_0005401	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood pressure measurement (high sodium intervention)	response to high sodium diet	http://www.ebi.ac.uk/efo/EFO_0005401	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Metabolic syndrome	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Metabolic syndrome (bivariate traits)	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Metabolic syndrome (multivariate analysis)	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Serum bilirubin levels in metabolic syndrome	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Serum bilirubin levels x sex interaction in metabolic syndrome	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Waist Circumference - Triglycerides (WC-TG)	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Blood pressure measurement (low sodium intervention)	response to low sodium diet	http://www.ebi.ac.uk/efo/EFO_0005402	Biological process	http://purl.obolibrary.org/obo/GO_0008150
&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004555	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004555	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004555	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0000196	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Prostate cancer mortality	metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0000196	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Uveitis (juvenile idiopathic arthritis-associated)	uveitis	http://www.ebi.ac.uk/efo/EFO_1001231	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Uveitis in juvenile idiopathic arthritis	uveitis	http://www.ebi.ac.uk/efo/EFO_1001231	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Glucosuria	glycosuria	http://purl.obolibrary.org/obo/HP_0003076	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Glucosuria (mild)	glycosuria	http://purl.obolibrary.org/obo/HP_0003076	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Glucosuria (moderate to severe)	glycosuria	http://purl.obolibrary.org/obo/HP_0003076	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood cell traits (multivariate analysis)	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cardiometabolic and hematological traits	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological parameters	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular volume	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Allergic rhinitis	allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0005854	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Allergic rhinitis in asthma	allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0005854	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Allergic rhinitis in non-asthmatics	allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0005854	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Allergic rhinitis x sex interaction	allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0005854	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Femoral neck bone mineral density or plasma lipids (pleiotropy)	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lipid metabolism phenotypes	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lipid traits	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (lipid measures)	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Polyunsaturated fatty acid levels	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood cell traits (multivariate analysis)	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular hemoglobin concentration in sickle cell disease	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Other erythrocyte phenotypes	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Blood cell traits (multivariate analysis)	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cardiometabolic and hematological traits	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Clinical laboratory measurements	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematological parameters	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemostatic factors and hematological phenotypes	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean corpuscular hemoglobin	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Red blood cell traits	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Emphysema distribution in smoking	emphysema pattern measurement	http://www.ebi.ac.uk/efo/EFO_0005850	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Local histogram emphysema pattern	emphysema pattern measurement	http://www.ebi.ac.uk/efo/EFO_0005850	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Height adjusted BMI	height-adjusted body mass index	http://www.ebi.ac.uk/efo/EFO_0005851	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Heschl's gyrus morphology	Heschl's gyrus morphology measurement	http://www.ebi.ac.uk/efo/EFO_0005852	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pneumoconiosis in silica exposure	response to silica exposure	http://www.ebi.ac.uk/efo/EFO_0005853	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Soluble levels of adhesion molecules	adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0004522	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Obesity-related traits	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Soluble ICAM-1	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Soluble levels of adhesion molecules	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Aortic coarctation	aortic coarctation	http://www.ebi.ac.uk/efo/EFO_1001267	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Neonatal lupus	neonatal systemic lupus erthematosus	http://www.ebi.ac.uk/efo/EFO_0004537	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Esophageal cancer and gastric cancer	gastric carcinoma	http://www.ebi.ac.uk/efo/EFO_0000178	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Gastric cancer	gastric carcinoma	http://www.ebi.ac.uk/efo/EFO_0000178	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	gastric carcinoma	http://www.ebi.ac.uk/efo/EFO_0000178	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-cardia gastric cancer	gastric carcinoma	http://www.ebi.ac.uk/efo/EFO_0000178	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Serum total protein level	total blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0004536	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Biochemical measures	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hematological and biochemical traits	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-albumin protein levels	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum albumin level	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Creatine kinase in statin users	creatine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0004534	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Creatine kinase levels	creatine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0004534	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hematological and biochemical traits	creatine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0004534	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood protein levels	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Clinical laboratory measurements	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Hematological and biochemical traits	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels (alkaline phosphatase)	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Protein quantitative trait loci	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Select biomarker traits	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Serum alkaline phosphatase levels	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Cardiovascular disease risk factors	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Gamma glutamyl transferase levels	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Gamma glutamyl transferase levels in excessive alcohol consumption	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Gamma glutamyl transferase levels in low alcohol consumption	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Gamma glutamyl transpeptidase	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Hematological and biochemical traits	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Liver enzyme levels (gamma-glutamyl transferase)	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Protein quantitative trait loci	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Ewing sarcoma	ewing sarcoma	http://www.ebi.ac.uk/efo/EFO_0000174	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood metabolite levels	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum urate levels in chronic kidney disease	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urate levels	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urate levels (BMI interaction)	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urate levels in lean individuals	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urate levels in obese individuals	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urate levels in overweight individuals	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related disease endophenotypes	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Age-related diseases, mortality and associated endophenotypes	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Biochemical measures	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Birth weight or triglycerides levels (pleiotropy)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
C-reactive protein levels or triglyceride levels (pleiotropy)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cardiometabolic traits	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cardiovascular disease risk factors	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cardiovascular risk factors	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cardiovascular risk factors (age interaction)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cholesterol and Triglycerides	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Coronary artery disease and triglyceride levels (multivariate analysis)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
HDL Cholesterol - Triglycerides (HDLC-TG)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
HDL cholesterol and triglyceride levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
HDL cholesterol and triglyceride levels (pleiotropy)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Hypertriglyceridemia	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Lipid traits	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Lipid traits (pleiotropy) (HIPO component 1)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Lipid traits (pleiotropy) (HIPO component 2)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Metabolic traits	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Multiple sclerosis and triglyceride levels (pleiotropy)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Obesity-related traits	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Quantitative traits	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Response to fenofibrate (triglyceride levels)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Thiazide-induced adverse metabolic effects in hypertensive patients	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Total triglycerides levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triacylglyceride levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triacylglycerol 56:2 levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triacylglycerol 56:6 levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels (parental genotype effect)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in IDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in chylomicrons and largest VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in current drinkers	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in current smokers	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in ever smokers	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in large VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in medium VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in never smokers	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in non smokers	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in response to fenofibrate	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in small HDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in small VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in very large HDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in very large VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in very small VLDL	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglycerides	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglycerides x physical activity interaction (1df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglycerides x physical activity interaction (2df test)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglycerides-Blood Pressure (TG-BP)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Waist Circumference - Triglycerides (WC-TG)	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Waist circumference and related phenotypes	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Rotator cuff tears	rotator cuff tear	http://www.ebi.ac.uk/efo/EFO_1001250	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cardia gastric cancer	gastric cardia carcinoma	http://www.ebi.ac.uk/efo/EFO_1001252	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Antiepileptic drug-induced maculopapular exanthema	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Carbamazepine-induced maculopapular exanthema	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Epilepsy and lamotrigine-induced maculopapular eruptions	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Lamotrigine-induced maculopapular exanthema	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nevirapine-induced hypersensitivity in HIV (rash)	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Phenytoin-induced maculopapular exanthema	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Carotid atherosclerosis in HIV infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Fat distribution (HIV)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HDL Cholesterol in HIV-infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HIV-1 control	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HIV-1 progression	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HIV-1 replication	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HIV-1 susceptibility	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
HIV-1 viral setpoint	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Liver fibrosis severity in HIV/hepatitis C co-infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Neurocognitive impairment in HIV-1 infection (continuous)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Neurocognitive impairment in HIV-1 infection (dichotomous)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Neutrophil count in HIV-infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pre-treatment viral load in HIV-1 infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to stavudine in HIV (lipoatrophy)	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Setpoint viral load in HIV-1 infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Total bilirubin levels in HIV-1 infection	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Noise-induced hearing loss	noise-induced hearing loss	http://www.ebi.ac.uk/efo/EFO_1001254	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asthma treatment response	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Glucocorticoid-induced osteonecrosis	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Glucocorticoid-induced osteonecrosis (age 10 years and older)	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Glucocorticoid-induced osteonecrosis (time dependent analysis)	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Glucocorticoid-induced osteonecrosis (time independent analysis)	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Depressive symptom (suicidal ideation) (binary trait)	suicide ideation measurement	http://www.ebi.ac.uk/efo/EFO_0007619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (suicidal ideation) (ordinal trait)	suicide ideation measurement	http://www.ebi.ac.uk/efo/EFO_0007619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicide ideation score in major depressive disorder	suicide ideation measurement	http://www.ebi.ac.uk/efo/EFO_0007619	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (0.25 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (0.5 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (1 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (2 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (4 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (8 kHz)	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits	brachial circumference	http://www.ebi.ac.uk/efo/EFO_0004589	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Brachial circumference	brachial circumference	http://www.ebi.ac.uk/efo/EFO_0004589	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Platelet thrombus formation	thrombus formation measurement	http://www.ebi.ac.uk/efo/EFO_0007615	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Asthma exacerbations	asthma exacerbation measurement	http://www.ebi.ac.uk/efo/EFO_0007614	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma exacerbations in inhaled corticosteroid treatment	asthma exacerbation measurement	http://www.ebi.ac.uk/efo/EFO_0007614	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (high tone)	pure tone hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (low tone)	pure tone hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (medium tone)	pure tone hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007617	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (0.25 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (0.5 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (1 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (2 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (4 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (8 kHz)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (high tone)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (low tone)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hearing function (medium tone)	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Behavioural disinhibition (generation interaction)	non-substance related disinhibited behaviour	http://www.ebi.ac.uk/efo/EFO_0005432	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Non-substance related behavioral disinhibition	non-substance related disinhibited behaviour	http://www.ebi.ac.uk/efo/EFO_0005432	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood cell traits (multivariate analysis)	mean platelet volume	http://www.ebi.ac.uk/efo/EFO_0004584	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Mean platelet volume	mean platelet volume	http://www.ebi.ac.uk/efo/EFO_0004584	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cancer	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Epithelial ovarian cancer	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Invasive epithelial ovarian cancer	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Ovarian cancer	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Ovarian cancer in BRCA1 mutation carriers	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Ovarian cancer in BRCA2 mutation carriers	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to carboplatin in ovarian cancer (MTT IC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to paclitaxel in ovarian cancer (MTT IC50)	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Alzheimer's disease with memory domain impairment	memory impairment	http://www.ebi.ac.uk/efo/EFO_0001072	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Memory dysfunction in frontotemporal lobe dementia	memory impairment	http://www.ebi.ac.uk/efo/EFO_0001072	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Liver enzyme levels	liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in endocrine treated breast cancer (estrogen-receptor positive)	response to endocrine therapy	http://www.ebi.ac.uk/efo/EFO_0007613	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adiposity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Bilirubin levels in extreme obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Hepatic lipid content in extreme obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Homeostasis model assessment of insulin resistance in obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Hyperglycemia in obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Hyperinsulinemia in obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity (early onset extreme)	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity (extreme)	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity (extreme) (SNP x SNP interaction)	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity and osteoporosis	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity in adult survivors of childhood cancer exposed to cranial radiation	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity in adult survivors of childhood cancer not exposed to cranial radiation	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity-related traits	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Osteoporosis or obesity (pleiotropy)	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (young onset) and obesity	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes or obesity or coronary artery disease (pleiotropy)	obesity	http://www.ebi.ac.uk/efo/EFO_0001073	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Interleukin-18 levels	interleukin 18 measurement	http://www.ebi.ac.uk/efo/EFO_0004581	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin 18 measurement	http://www.ebi.ac.uk/efo/EFO_0004581	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Response to montelukast in asthma (change in FEV1)	response to Montelukast	http://www.ebi.ac.uk/efo/EFO_0007612	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blood cell traits (multivariate analysis)	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hematology traits	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Lymphocyte counts	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count (lymphocyte)	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell types	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Behavioural disinhibition (generation interaction)	nicotine use	http://www.ebi.ac.uk/efo/EFO_0005430	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Nicotine use	nicotine use	http://www.ebi.ac.uk/efo/EFO_0005430	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Behavioural disinhibition (generation interaction)	illegal drug consumption	http://www.ebi.ac.uk/efo/EFO_0005431	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Illicit drug use	illegal drug consumption	http://www.ebi.ac.uk/efo/EFO_0005431	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Naphthyl-keratin adduct levels	naphthyl-keratin adduct measurement	http://www.ebi.ac.uk/efo/EFO_0004585	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Candidemia	candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma (childhood onset)	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Atopic march	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Childhood onset asthma (traffic air pollution exposure interaction)	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Self-reported childhood asthma in adult smokers	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Huntington's disease (age at onset)	Huntington disease	http://www.orpha.net/ORDO/Orphanet_399	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Huntington's disease progression	Huntington disease	http://www.orpha.net/ORDO/Orphanet_399	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hemoglobin A1c levels	hemoglobin A1 measurement	http://www.ebi.ac.uk/efo/EFO_0007629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin levels	hemoglobin A1 measurement	http://www.ebi.ac.uk/efo/EFO_0007629	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Emphysema annual change measurement in smokers (adjusted lung density)	emphysema imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emphysema annual change measurement in smokers (percent low attenuation area)	emphysema imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Emphysema imaging phenotypes	emphysema imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007626	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteolysis in total hip arthroplasty	total hip arthroplasty	http://www.ebi.ac.uk/efo/EFO_0009806	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Osteolysis in total hip arthroplasty (time to prosthesis revision)	total hip arthroplasty	http://www.ebi.ac.uk/efo/EFO_0009806	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Percentage gas trapping	gas trapping measurement	http://www.ebi.ac.uk/efo/EFO_0007628	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Airway imaging phenotypes	airway imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	airway imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	airway imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	airway imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007627	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Advanced glycation end-product levels	sRAGE measurement	http://www.ebi.ac.uk/efo/EFO_0007622	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV (mother-to-child transmission)	hiv mother to child transmission	http://www.ebi.ac.uk/efo/EFO_0004595	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Pediatric bone mineral content (femoral neck)	bone mineral content measurement	http://www.ebi.ac.uk/efo/EFO_0007621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral content (hip)	bone mineral content measurement	http://www.ebi.ac.uk/efo/EFO_0007621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral content (radius)	bone mineral content measurement	http://www.ebi.ac.uk/efo/EFO_0007621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric bone mineral content (spine)	bone mineral content measurement	http://www.ebi.ac.uk/efo/EFO_0007621	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diabetes (gestational)	gestational diabetes	http://www.ebi.ac.uk/efo/EFO_0004593	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Suicide	suicide	http://www.ebi.ac.uk/efo/EFO_0007624	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Suicide behavior	suicide behaviour	http://www.ebi.ac.uk/efo/EFO_0007623	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Acute graft versus host disease	acute graft vs. host disease	http://www.ebi.ac.uk/efo/EFO_0004599	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Acute graft versus host disease in bone marrow transplantation (donor effect)	acute graft vs. host disease	http://www.ebi.ac.uk/efo/EFO_0004599	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Acute graft versus host disease in bone marrow transplantation (recipient effect)	acute graft vs. host disease	http://www.ebi.ac.uk/efo/EFO_0004599	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	acute graft vs. host disease	http://www.ebi.ac.uk/efo/EFO_0004599	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Lumbar spine bone mineral density (integral)	volumetric bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lumbar spine bone mineral density (trabecular)	volumetric bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007620	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cataracts in type 2 diabetes	diabetes mellitus type 2 associated cataract	http://www.ebi.ac.uk/efo/EFO_0004596	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Asymmetrical dimethylarginine levels	serum dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum dimethylarginine levels (asymmetric/symetric ratio)	serum dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Symmetrical dimethylarginine levels	serum dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
5-HTT brain serotonin transporter levels	brain serotonin transporter measurement	http://www.ebi.ac.uk/efo/EFO_0004569	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Paclitaxel-induced neuropathy	brain serotonin transporter measurement	http://www.ebi.ac.uk/efo/EFO_0004569	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Contrast sensitivity	contrast sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0005419	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-albumin protein levels	serum non-albumin protein measurement	http://www.ebi.ac.uk/efo/EFO_0004568	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antipsychotic drug-induced weight gain	antipsychotic drug related weight gain	http://www.ebi.ac.uk/efo/EFO_0004567	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antipsychotic drug-induced weight gain (time interaction)	antipsychotic drug related weight gain	http://www.ebi.ac.uk/efo/EFO_0004567	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antipsychotic drug-induced weight gain in schizophrenia	antipsychotic drug related weight gain	http://www.ebi.ac.uk/efo/EFO_0004567	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cataracts in type 2 diabetes	cataract	http://www.ebi.ac.uk/efo/EFO_0001059	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Airway hyperresponsiveness	airway hyperresponsiveness	http://www.ebi.ac.uk/efo/EFO_0005414	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	serum alpha-1-antitrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0005415	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum alpha1-antitrypsin levels	serum alpha-1-antitrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0005415	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bronchiolitis	Bronchiolitis	http://purl.obolibrary.org/obo/HP_0011950	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Serum protein levels (sST2)	serum ST2 measurement	http://www.ebi.ac.uk/efo/EFO_0005416	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Response to mTOR inhibitor (everolimus)	response to mTOR inhibitor	http://www.ebi.ac.uk/efo/EFO_0005417	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to mTOR inhibitor (rapamycin)	response to mTOR inhibitor	http://www.ebi.ac.uk/efo/EFO_0005417	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cryptorchidism	cryptorchidism	http://www.ebi.ac.uk/efo/EFO_0004562	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Tooth agenesis	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (mandibular second premolars)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (mandibular third molar)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (maxillary lateral incisors)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (maxillary second premolars)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (maxillary third molar)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Tooth agenesis (third molar)	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Anti-saccade error rate in psychotic disorders	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Initial pursuit acceleration in psychotic disorders	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Pursuit maintenance gain in psychotic disorders	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Schizophrenia, schizoaffective disorder or bipolar disorder	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
antipsychotic drug dosage in schizophrenia or schizoaffective disorder	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Ossification of the posterior longitudinal ligament of the spine	ossification of the posterior longitudinal ligament of the spine	http://www.ebi.ac.uk/efo/EFO_0005895	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	functional impairment measurement	http://www.ebi.ac.uk/efo/EFO_0005412	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone erosion in rheumatoid arthritis	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint damage in rheumatoid arthritis	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint damage progression in ACPA-negative rheumatoid arthritis	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint damage progression in ACPA-positive rheumatoid arthritis	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Joint destruction and growth retardation	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite risk score for predicting weight gain	body weight gain	http://www.ebi.ac.uk/efo/EFO_0004566	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Osteoarthritis biomarkers	osteoarthritis biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005890	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food antigen IgG levels	serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0004565	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG levels	serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0004565	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin measurement (zinc sulfate turbidity test)	serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0004565	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Leprosy	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Celiac disease	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Celiac disease and Rheumatoid arthritis	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Crohn's disease and celiac disease	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Borderline personality disorder features	borderline personality disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005429	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
IgE levels	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgE levels in asthmatics	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgE levels in asthmatics (D.f. specific)	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgE levels in asthmatics (D.p. specific)	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum IgE levels	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Folate pathway vitamin levels	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Homocysteine level response to multivitamin in cerebral infarction	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Homocysteine levels	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Obesity-related traits	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Plasma homocysteine levels	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Plasma homocysteine levels (post-methionine load test)	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
vWF levels in ischaemic stroke and hyperhomocysteinaemia	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Alzheimer's disease with language domain impairment	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Language impairment in frontotemporal lobe dementia	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parent of origin effect on language impairment (maternal)	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Parent of origin effect on language impairment (paternal)	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability and language impairment	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Autism spectrum disorder-related traits	autism spectrum disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005426	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Autistic traits score (Social and Communication Disorders Checklist)	autism spectrum disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005426	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social autistic-like traits	autism spectrum disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005426	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social communication problems	social communication impairment	http://www.ebi.ac.uk/efo/EFO_0005427	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chemerin levels	chemerin measurement	http://www.ebi.ac.uk/efo/EFO_0004573	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Circulating chemerin levels	chemerin measurement	http://www.ebi.ac.uk/efo/EFO_0004573	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Homoarginine levels	serum homoarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Atrioventricular septal defects in Down syndrome	Down syndrome	http://www.ebi.ac.uk/efo/EFO_0001064	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
C4b binding protein levels	C4BP measurement	http://www.ebi.ac.uk/efo/EFO_0004572	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Skin youthfulness	skin aging	http://www.ebi.ac.uk/efo/EFO_0005422	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Adolescent idiopathic scoliosis	adolescent idiopathic scoliosis	http://www.ebi.ac.uk/efo/EFO_0005423	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Adolescent idiopathic scoliosis (severe)	adolescent idiopathic scoliosis	http://www.ebi.ac.uk/efo/EFO_0005423	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Curve progression in adolescent idiopathic scoliosis	adolescent idiopathic scoliosis	http://www.ebi.ac.uk/efo/EFO_0005423	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Butyrylcholinesterase levels	butyrylcholinesterase measurement	http://www.ebi.ac.uk/efo/EFO_0004571	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Cardiovascular disease risk factors	butyrylcholinesterase measurement	http://www.ebi.ac.uk/efo/EFO_0004571	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Cervical cancer	cervical carcinoma	http://www.ebi.ac.uk/efo/EFO_0001061	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to platinum-based neoadjuvant chemotherapy in cervical cancer	cervical carcinoma	http://www.ebi.ac.uk/efo/EFO_0001061	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Bilirubin levels	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bilirubin levels in extreme obesity	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bilirubin levels in tenofovir-treated HIV infection	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholelithiasis-related traits in sickle cell anemia	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinical laboratory measurements	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Liver disease biomarker	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Select biomarker traits	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum bilirubin levels in metabolic syndrome	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum bilirubin levels x sex interaction in metabolic syndrome	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total bilirubin levels	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total bilirubin levels in HIV-1 infection	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Handedness in dyslexia	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability and language impairment	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability or specific language impairment (pleiotropy)	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Relative hand skill in reading disability	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Primary tooth development (number of teeth)	odontogenesis	http://purl.obolibrary.org/obo/GO_0042476	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Primary tooth development (time to first tooth eruption)	odontogenesis	http://purl.obolibrary.org/obo/GO_0042476	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Schizophrenia (cytomegalovirus infection interaction)	cytomegalovirus infection	http://www.ebi.ac.uk/efo/EFO_0001062	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Brain development	infant head circumference	http://www.ebi.ac.uk/efo/EFO_0004577	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Head circumference (infant)	infant head circumference	http://www.ebi.ac.uk/efo/EFO_0004577	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
F-cell distribution	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
F-cell distribution in sickle cell anaemia	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fetal hemoglobin levels	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Fetal hemoglobin levels in sickle cell anemia	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hemoglobin levels	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
High fetal hemoglobin in sickle cell disease	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Malaria	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Severe malaria	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Severe malaria (adjusted for sickle cell variant rs334)	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Blood protein levels	e-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004575	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
E-selectin levels	e-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004575	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Soluble E-selectin levels	e-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004575	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Deep ovarian and/or rectovaginal disease with dense adhesions	endometriosis	http://www.ebi.ac.uk/efo/EFO_0001065	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Endometriosis	endometriosis	http://www.ebi.ac.uk/efo/EFO_0001065	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Endometriosis or endometrial cancer (pleiotropy)	endometriosis	http://www.ebi.ac.uk/efo/EFO_0001065	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Ovarian disease with few adhesions	endometriosis	http://www.ebi.ac.uk/efo/EFO_0001065	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Age-related disease endophenotypes	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Age-related diseases, mortality and associated endophenotypes	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Biochemical measures	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Birth weight or total cholesterol levels (pleiotropy)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Body mass index and cholesterol (psychopharmacological treatment)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
C-reactive protein levels or total cholesterol levels (pleiotropy)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cardiometabolic traits	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cholesterol, total	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Cognitive impairment and total cholesterol levels (pleiotropy)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Coronary artery disease and total cholesterol levels (multivariate analysis)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
LDL cholesterol	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 1)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Lipid traits (pleiotropy) (HIPO component 2)	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Obesity-related traits	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Quantitative traits	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Serum total cholesterol levels	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Total cholesterol levels	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Gray matter volume (schizophrenia interaction)	grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0005420	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Collagenous colitis	collagenous colitis	http://www.ebi.ac.uk/efo/EFO_1001293	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Microscopic colitis	microscopic colitis	http://www.ebi.ac.uk/efo/EFO_1001295	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Microscopic colitis in proton-pump inhibitor treatment	microscopic colitis	http://www.ebi.ac.uk/efo/EFO_1001295	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Body mass index (change over time) in lung cancer	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cancer (pleiotropy)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Familial lung cancer	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung Cancer (DNA repair capacity)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer (SNP x SNP interaction)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer (asbestos exposure interaction)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer (household air pollution interaction)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer (smoking interaction)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer and family history of lung cancer	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer in ever smokers	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer in never smokers	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Lung cancer x radon exposure interaction (1df)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Schizophrenia or lung cancer (pleiotropy)	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Peak expiratory flow	peak expiratory flow	http://www.ebi.ac.uk/efo/EFO_0009718	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vestibular neuritis	vestibular neuronitis	http://www.ebi.ac.uk/efo/EFO_0007537	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Primary vesicoureteric reflux	vesicoureteral reflux	http://www.ebi.ac.uk/efo/EFO_0007536	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Menstruation quality of life impact (stiff neck)	Stiff neck	http://purl.obolibrary.org/obo/HP_0025258	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Mesial temporal lobe epilepsy with hippocampal sclerosis	Mesial temporal lobe epilepsy with hippocampal sclerosis	http://www.orpha.net/ORDO/Orphanet_99701	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	autoimmune pancreatitis type 1	http://www.ebi.ac.uk/efo/EFO_1000780	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Acute mountain sickness	altitude sickness	http://www.ebi.ac.uk/efo/EFO_1000782	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Decreased sensory function in Charcot-Marie-Tooth disease type 1A	sensory impairment	http://purl.obolibrary.org/obo/HP_0003474	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hip osteoarthritis or femoral neck bone mineral density	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Hip osteoarthritis or lumbar spine bone mineral density	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis (hip)	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip (hospital diagnosed)	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip (with total joint replacement)	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee (hospital diagnosed)	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteoarthritis of the hip or knee (with total joint replacement)	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
3-month functional outcome in ischaemic stroke (modified Rankin score)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
C-reactive protein levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Creatinine levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Fibrinogen levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke (cardioembolic)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke (large artery atherosclerosis)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke (non-cardioembolic)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke (small artery occlusion)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Ischemic stroke (undetermined subtype)	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Leukocyte count in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Prothrombin fragments F1+2 levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombin-antithrombin complex levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombomodulin levels in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombosis	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
White matter hyperintensities in ischemic stroke	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
vWF levels in ischaemic stroke and hyperhomocysteinaemia	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Balance difficulty in Charcot-Marie-Tooth disease type 1A	gait imbalance	http://purl.obolibrary.org/obo/HP_0002141	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lower body strength	lower body strength measurement	http://www.ebi.ac.uk/efo/EFO_0007999	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eosinophil percentage of granulocytes	eosinophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007996	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Basophil percentage of granulocytes	basophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007995	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cerebrospinal AB1-42 levels in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid p-tau levels in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebrospinal fluid t-tau levels in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive impairment test score	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hippocampal volume in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (delayed recall) in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (immediate recall) in mild cognitive impairment	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurocognitive impairment in HIV-1 infection (continuous)	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurocognitive impairment in HIV-1 infection (dichotomous)	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Granulocyte percentage of myeloid white cells	granulocyte percentage of myeloid white cells	http://www.ebi.ac.uk/efo/EFO_0007997	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Basophil percentage of white cells	basophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007992	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Eosinophil percentage of white cells	eosinophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007991	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Neutrophil percentage of granulocytes	neutrophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007994	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Lymphocyte percentage of white cells	lymphocyte percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007993	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Cognitive decline	cognitive decline	http://purl.obolibrary.org/obo/HP_0001268	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive decline (age-related)	cognitive decline	http://purl.obolibrary.org/obo/HP_0001268	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Latent autoimmune diabetes	latent autoimmune diabetes in adults	http://www.ebi.ac.uk/efo/EFO_0009706	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Latent autoimmune diabetes vs. type 1 diabetes	latent autoimmune diabetes in adults	http://www.ebi.ac.uk/efo/EFO_0009706	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Latent autoimmune diabetes vs. type 2 diabetes	latent autoimmune diabetes in adults	http://www.ebi.ac.uk/efo/EFO_0009706	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Nonunion in individuals with fractures	fractures, ununited	http://www.ebi.ac.uk/efo/EFO_0009707	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Radiation-induced brain injury in nasopharyngeal carcinoma	radiation-induced brain injury	http://www.ebi.ac.uk/efo/EFO_0009704	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-steroidal anti-inflammatory drug-induced enteropathy	small intestine enteropathy	http://www.ebi.ac.uk/efo/EFO_0009705	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Intra-individual response time variability (response selection)	intra-individual reaction time variability measurement	http://www.ebi.ac.uk/efo/EFO_0009702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intra-individual response time variability (selective attention)	intra-individual reaction time variability measurement	http://www.ebi.ac.uk/efo/EFO_0009702	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Red blood cell folate levels	red blood cell folate measurement	http://www.ebi.ac.uk/efo/EFO_0009703	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Perceptual rivalry (Necker cube stimulus)	visual perception measurement	http://www.ebi.ac.uk/efo/EFO_0009700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Perceptual rivalry (binocular rivalry task)	visual perception measurement	http://www.ebi.ac.uk/efo/EFO_0009700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Perceptual rivalry (voluntary modulation strength)	visual perception measurement	http://www.ebi.ac.uk/efo/EFO_0009700	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
visceral adipose tissue/total adipose tissue ratio	visceral:total adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0009701	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Juvenile absence epilepsy	Juvenile absence epilepsy	http://www.orpha.net/ORDO/Orphanet_1941	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Giant cell arteritis	temporal arteritis	http://www.ebi.ac.uk/efo/EFO_1001209	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
IgG disialylation phenotypes (multivariate analysis)	IgG disialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008429	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG sialylation phenotypes (multivariate analysis)	IgG sialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008428	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma-chronic obstructive  pulmonary disease overlap syndrome	Chronic Obstructive Asthma	http://www.ebi.ac.uk/efo/EFO_0009759	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Chronic Obstructive Asthma	http://www.ebi.ac.uk/efo/EFO_0009759	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Copper levels	blood copper measurement	http://www.ebi.ac.uk/efo/EFO_0007578	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG galactosylation phenotypes (multivariate analysis)	IgG galactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008425	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cobalt levels	blood cobalt measurement	http://www.ebi.ac.uk/efo/EFO_0007577	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG digalactosylation phenotypes (multivariate analysis)	IgG digalactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008424	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG fucosylation phenotypes (multivariate analysis)	IgG fucosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008427	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromium levels	blood chromium measurement	http://www.ebi.ac.uk/efo/EFO_0007579	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	IgG bisecting N-acetyl glucosamine measurement	http://www.ebi.ac.uk/efo/EFO_0008426	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brunt grade in nonalcoholic fatty liver disease	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brunt stage in nonalcoholic fatty liver disease	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepatocyte fat droplet content in nonalcoholic fatty liver disease	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-alcoholic fatty liver disease activity score	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric non-alcoholic fatty liver disease activity score	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	parietal cortex measurement	http://www.ebi.ac.uk/efo/EFO_0008420	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	parietal cortex measurement	http://www.ebi.ac.uk/efo/EFO_0008420	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cadmium levels	blood cadmium measurement	http://www.ebi.ac.uk/efo/EFO_0007576	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
IgG monogalactosylation phenotypes (multivariate analysis)	IgG monogalactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008423	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Normal facial asymmetry (angle of deformation score)	facial asymmetry measurement	http://www.ebi.ac.uk/efo/EFO_0009751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Normal facial asymmetry (angle of surface orientation score)	facial asymmetry measurement	http://www.ebi.ac.uk/efo/EFO_0009751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Normal facial asymmetry (deformation magnitude)	facial asymmetry measurement	http://www.ebi.ac.uk/efo/EFO_0009751	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aluminium levels	blood aluminium measurement	http://www.ebi.ac.uk/efo/EFO_0007575	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease with visuospatial domain impairment	visuospatial impairment	http://www.ebi.ac.uk/efo/EFO_0009752	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Thiopurine-induced infection in inflammatory bowel disease	susceptibility to infectious disease measurement	http://www.ebi.ac.uk/efo/EFO_0008422	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Manganese levels	blood manganese measurement	http://www.ebi.ac.uk/efo/EFO_0007581	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mercury levels	blood mercury measurement	http://www.ebi.ac.uk/efo/EFO_0007580	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteolysis in total hip arthroplasty	periprosthetic osteolysis	http://www.ebi.ac.uk/efo/EFO_0009761	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Osteolysis in total hip arthroplasty (time to prosthesis revision)	periprosthetic osteolysis	http://www.ebi.ac.uk/efo/EFO_0009761	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
IgG monosialylation phenotypes (multivariate analysis)	IgG monosialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008430	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nickel levels	blood nickel measurement	http://www.ebi.ac.uk/efo/EFO_0007583	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Molybdenum levels	blood molybdenum measurement	http://www.ebi.ac.uk/efo/EFO_0007582	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spontaneous dizygotic twinning	positive regulation of ovulation	http://purl.obolibrary.org/obo/GO_0060279	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Menstruation quality of life impact (loss of concentration)	decreased attention	http://purl.obolibrary.org/obo/NCIT_C117245	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cardiometabolic traits	glutamine measurement	http://www.ebi.ac.uk/efo/EFO_0009768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	glutamine measurement	http://www.ebi.ac.uk/efo/EFO_0009768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	glutamine measurement	http://www.ebi.ac.uk/efo/EFO_0009768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	glutamine measurement	http://www.ebi.ac.uk/efo/EFO_0009768	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Late gestational weight gain (fetal effect)	late gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Late gestational weight gain (maternal effect)	late gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008436	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at loss of ambulation in Duchenne muscular dystrophy	Duchenne muscular dystrophy	http://www.orpha.net/ORDO/Orphanet_98896	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cardiometabolic traits	histidine measurement	http://www.ebi.ac.uk/efo/EFO_0009769	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	histidine measurement	http://www.ebi.ac.uk/efo/EFO_0009769	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	histidine measurement	http://www.ebi.ac.uk/efo/EFO_0009769	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational weight gain (fetal effect)	gestational weight gain measurement	http://www.ebi.ac.uk/efo/EFO_0008435	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational weight gain (maternal effect)	gestational weight gain measurement	http://www.ebi.ac.uk/efo/EFO_0008435	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting growth hormone levels	growth hormone measurement	http://www.ebi.ac.uk/efo/EFO_0008438	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	asparagine measurement	http://www.ebi.ac.uk/efo/EFO_0009766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	asparagine measurement	http://www.ebi.ac.uk/efo/EFO_0009766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free asparagine levels	asparagine measurement	http://www.ebi.ac.uk/efo/EFO_0009766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycine levels	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early gestation weight gain (maternal effect)	early gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early gestational weight gain (fetal effect)	early gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008437	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or cannabis use	Cannabis use	http://www.ebi.ac.uk/efo/EFO_0007585	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cannabis use	Cannabis use	http://www.ebi.ac.uk/efo/EFO_0007585	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cannabis use (age at onset)	Cannabis use	http://www.ebi.ac.uk/efo/EFO_0007585	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cannabis-related aggression	Cannabis use	http://www.ebi.ac.uk/efo/EFO_0007585	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Eye color	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye color (brightness)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye color (hue)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Eye color (saturation)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iris color (L* coordinate)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iris color (a* coordinate)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iris color (b* coordinate)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iris heterochromicity	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin, hair and eye pigmentation (multivariate analysis)	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	lipoprotein-associated phospholipase A(2) change measurement	http://www.ebi.ac.uk/efo/EFO_0008432	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	lipoprotein-associated phospholipase A(2) change measurement	http://www.ebi.ac.uk/efo/EFO_0008432	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cardiometabolic traits	alanine measurement	http://www.ebi.ac.uk/efo/EFO_0009765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	alanine measurement	http://www.ebi.ac.uk/efo/EFO_0009765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	alanine measurement	http://www.ebi.ac.uk/efo/EFO_0009765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	alanine measurement	http://www.ebi.ac.uk/efo/EFO_0009765	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (maximal voluntary ventilation)	maximal voluntary ventilation	http://www.ebi.ac.uk/efo/EFO_0008431	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Zinc levels	blood zinc measurement	http://www.ebi.ac.uk/efo/EFO_0007584	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Healthspan	healthspan	http://www.ebi.ac.uk/efo/EFO_0009762	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Initial pursuit acceleration	initial pursuit acceleration	http://www.ebi.ac.uk/efo/EFO_0008434	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Initial pursuit acceleration in psychotic disorders	initial pursuit acceleration	http://www.ebi.ac.uk/efo/EFO_0008434	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cannabis use (initiation)	Cannabis use initiation	http://www.ebi.ac.uk/efo/EFO_0007586	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Pursuit maintenance gain	pursuit maintenance gain measurement	http://www.ebi.ac.uk/efo/EFO_0008433	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pursuit maintenance gain in psychotic disorders	pursuit maintenance gain measurement	http://www.ebi.ac.uk/efo/EFO_0008433	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	methionine measurement	http://www.ebi.ac.uk/efo/EFO_0009771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	methionine measurement	http://www.ebi.ac.uk/efo/EFO_0009771	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to bleomycin (chromatid breaks)	response to bleomycin	http://www.ebi.ac.uk/efo/EFO_0007592	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bone mineral accretion in asthma (oral corticosteroid dose interaction)	bone mineral accretion measurement	http://www.ebi.ac.uk/efo/EFO_0007591	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	leucine measurement	http://www.ebi.ac.uk/efo/EFO_0009770	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	leucine measurement	http://www.ebi.ac.uk/efo/EFO_0009770	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	leucine measurement	http://www.ebi.ac.uk/efo/EFO_0009770	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to bleomycin (chromatid breaks)	chromatid break measurement	http://www.ebi.ac.uk/efo/EFO_0007593	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	susceptibility to Mycobacterium tuberculosis infection measurement	http://www.ebi.ac.uk/efo/EFO_0008407	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tuberculosis	susceptibility to Mycobacterium tuberculosis infection measurement	http://www.ebi.ac.uk/efo/EFO_0008407	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plantar warts	susceptibility to plantar warts measurement	http://www.ebi.ac.uk/efo/EFO_0008406	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Scarlet fever	susceptibility to scarlet fever measurement	http://www.ebi.ac.uk/efo/EFO_0008409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Strep throat	susceptibility to strep throat measurement	http://www.ebi.ac.uk/efo/EFO_0008408	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mononucleosis	susceptibility to mononucleosis measurement	http://www.ebi.ac.uk/efo/EFO_0008403	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cold sores	susceptibility to cold sores measurement	http://www.ebi.ac.uk/efo/EFO_0008402	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepatitis B	susceptibility to hepatitis B infection measurement	http://www.ebi.ac.uk/efo/EFO_0008405	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mumps	susceptibility to mumps measurement	http://www.ebi.ac.uk/efo/EFO_0008404	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Shingles	susceptibility to shingles measurement	http://www.ebi.ac.uk/efo/EFO_0008401	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chickenpox	susceptibility to chickenpox measurement	http://www.ebi.ac.uk/efo/EFO_0008400	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rubella	susceptibility to rubella infection measurement	http://www.ebi.ac.uk/efo/EFO_0008418	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Number of common colds	susceptibility to common cold measurement	http://www.ebi.ac.uk/efo/EFO_0008417	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ketamine in bipolar disorder or major depression (antidepressant effects)	response to ketamine	http://www.ebi.ac.uk/efo/EFO_0009748	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to ketamine in bipolar disorder or major depression (dissociation effects)	response to ketamine	http://www.ebi.ac.uk/efo/EFO_0009748	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Age at first sexual intercourse	age at first sexual intercourse measurement	http://www.ebi.ac.uk/efo/EFO_0009749	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic sinus infection	susceptibility to chronic sinus infection measurement	http://www.ebi.ac.uk/efo/EFO_0008419	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Measles	susceptibility to measles measurement	http://www.ebi.ac.uk/efo/EFO_0008414	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary tract infection frequency	susceptibility to urinary tract infection measurement	http://www.ebi.ac.uk/efo/EFO_0008413	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatic fever	susceptibility to rheumatic fever measurement	http://www.ebi.ac.uk/efo/EFO_0008416	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepatitis A	susceptibility to hepatitis A infection measurement	http://www.ebi.ac.uk/efo/EFO_0008415	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pneumonia	susceptibility to pneumonia measurement	http://www.ebi.ac.uk/efo/EFO_0008410	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Yeast infection	susceptibility to vaginal yeast infection measurement	http://www.ebi.ac.uk/efo/EFO_0008412	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bacterial meningitis	susceptibility to bacterial meningitis measurement	http://www.ebi.ac.uk/efo/EFO_0008411	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ketamine in bipolar disorder or major depression (dissociation effects)	dissociation measurement	http://www.ebi.ac.uk/efo/EFO_0009750	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DNA methylation (parent-of-origin)	DNA methylation	http://purl.obolibrary.org/obo/GO_0006306	Biological process	http://purl.obolibrary.org/obo/GO_0008150
DNA methylation (variation)	DNA methylation	http://purl.obolibrary.org/obo/GO_0006306	Biological process	http://purl.obolibrary.org/obo/GO_0008150
DNA methylation variation (age effect)	DNA methylation	http://purl.obolibrary.org/obo/GO_0006306	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Gastric adenocarcinoma (histologically verified)	gastric adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000503	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Follicular thyroid cancer	follicular thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0000501	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	http://www.ebi.ac.uk/efo/EFO_0008469	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Midregional pro atrial natriuretic peptide levels	midregional pro atrial natriuretic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008468	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
GLP-1 levels in response to oral glucose tolerance test (120 minutes)	glucagon-like peptide-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GLP-1 levels in response to oral glucose tolerance test (fasting)	glucagon-like peptide-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung disease severity in cystic fibrosis	lung disease associated with cystic fibrosis	http://www.ebi.ac.uk/efo/EFO_0009797	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
GIP levels in response to oral glucose tolerance test (120 minutes)	glucose-dependent insulinotropic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
GIP levels in response to oral glucose tolerance test (fasting)	glucose-dependent insulinotropic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Inhibitory control	behavioural inhibitory control measurement	http://www.ebi.ac.uk/efo/EFO_0008467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum urea levels	serum urea measurement	http://www.ebi.ac.uk/efo/EFO_0009795	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urea levels	serum urea measurement	http://www.ebi.ac.uk/efo/EFO_0009795	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Matrix metalloproteinase-8 levels	Matrix Metalloproteinase 8 Measurement	http://www.ebi.ac.uk/efo/EFO_0008466	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Response to long-term oxygen therapy in chronic obstructive pulmonary disease	response to supplemental oxygen	http://www.ebi.ac.uk/efo/EFO_0009796	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diabetic macular edema in type 2 diabetes	diabetic macular edema	http://www.ebi.ac.uk/efo/EFO_0009321	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	spine bone mineral density change measurement	http://www.ebi.ac.uk/efo/EFO_0008474	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Area under the curve of insulin levels	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corrected insulin response	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corrected insulin response adjusted for insulin sensitivity index	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels adjusted for BMI	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ratio of the area under the curve for insulin and the area under the curve for glucose	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Two-hour insulin response	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure (dietary potassium intake interaction)	dietary potassium intake measurement	http://www.ebi.ac.uk/efo/EFO_0008470	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure (dietary potassium intake interaction)	dietary potassium intake measurement	http://www.ebi.ac.uk/efo/EFO_0008470	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulse pressure (dietary potassium intake interaction)	dietary potassium intake measurement	http://www.ebi.ac.uk/efo/EFO_0008470	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure (dietary potassium intake interaction)	dietary potassium intake measurement	http://www.ebi.ac.uk/efo/EFO_0008470	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Appendicitis	appendicitis	http://www.ebi.ac.uk/efo/EFO_0007149	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Cerebral cortical growth	cerebral cortex growth measurement	http://www.ebi.ac.uk/efo/EFO_0009328	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebellum growth	cerebellum growth measurement	http://www.ebi.ac.uk/efo/EFO_0009327	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Delayed reward discounting	delayed reward discounting measurement	http://www.ebi.ac.uk/efo/EFO_0008476	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
End stage renal disease in APOL1 risk genotype-negative individuals	APOL1 risk genotype carrier status	http://www.ebi.ac.uk/efo/EFO_0009324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
End stage renal disease in APOL1 risk genotype-positive individuals	APOL1 risk genotype carrier status	http://www.ebi.ac.uk/efo/EFO_0009324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
End stage renal disease x APOL1 genotype interaction	APOL1 risk genotype carrier status	http://www.ebi.ac.uk/efo/EFO_0009324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	APOL1 risk genotype carrier status	http://www.ebi.ac.uk/efo/EFO_0009324	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Basal ganglia growth	basal ganglia growth measurement	http://www.ebi.ac.uk/efo/EFO_0009325	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diarrhoea-associated Entamoeba histolytica infection	amebiasis	http://www.ebi.ac.uk/efo/EFO_0007144	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Emotional lability in attention deficit hyperactivity disorder	mood instability measurement	http://www.ebi.ac.uk/efo/EFO_0008475	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Experiencing mood swings	mood instability measurement	http://www.ebi.ac.uk/efo/EFO_0008475	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mood instability	mood instability measurement	http://www.ebi.ac.uk/efo/EFO_0008475	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proliferative diabetic retinopathy	proliferative diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0009322	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Proliferative diabetic retinopathy (vs NPDR and no DR)	proliferative diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0009322	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Proliferative diabetic retinopathy (vs no DR)	proliferative diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0009322	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Proliferative diabetic retinopathy in type 2 diabetes	proliferative diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0009322	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Cerebrospinal fluid α-synuclein levels	alpha synuclein measurement	http://www.ebi.ac.uk/efo/EFO_0009323	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amygdala volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Caudate volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Hippocampal volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Lateral ventricle volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Nucleus accumbens volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Pallidum volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Post traumatic stress disorder symptom count in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Post-traumatic stress disorder symptoms in trauma-exposed soldiers	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Problematic alcohol use in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Putamen volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Thalamus volume in trauma-exposed individuals	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Erosive tooth wear (severe vs non-severe)	erosive tooth wear measurement	http://www.ebi.ac.uk/efo/EFO_0009331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Erosive tooth wear (severe vs none or mild)	erosive tooth wear measurement	http://www.ebi.ac.uk/efo/EFO_0009331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive flexibility	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Executive function in ADHD	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
executive function (trail making test B)	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
executive function (trail making test B) (age interaction)	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
perceptual and visual search speed and executive function (trail making test BA)	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
perceptual and visual search speed and executive function (trail making test BA) (age interaction)	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Birth weight or insulin secretion (pleiotropy)	insulin secretion rate measurement	http://www.ebi.ac.uk/efo/EFO_0008001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin secretion rate	insulin secretion rate measurement	http://www.ebi.ac.uk/efo/EFO_0008001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
insulin secretion rate (BMI adjusted)	insulin secretion rate measurement	http://www.ebi.ac.uk/efo/EFO_0008001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced hyponatremia in epilepsy	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced liver injury	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced maculopapular exanthema	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced reaction with eosinophilia and systemic symptoms	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carbamazepine-induced serious cutaneous adverse reaction	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Chlamydia trachomatis seropositivity	Chlamydia trachomatis seropositivity	http://www.ebi.ac.uk/efo/EFO_0009330	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak insulin response	peak insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak insulin response (BMI and insulin secretion adjusted)	peak insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peak insulin response (insulin secretion adjusted)	peak insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glioblastoma	glioblastoma multiforme	http://www.ebi.ac.uk/efo/EFO_0000519	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glioblastoma (age-stratified)	glioblastoma multiforme	http://www.ebi.ac.uk/efo/EFO_0000519	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Age-related macular degeneration	glaucoma	http://www.ebi.ac.uk/efo/EFO_0000516	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Glaucoma	glaucoma	http://www.ebi.ac.uk/efo/EFO_0000516	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Glaucoma (primary angle closure)	glaucoma	http://www.ebi.ac.uk/efo/EFO_0000516	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Multiple traits (pleiotropy)	glaucoma	http://www.ebi.ac.uk/efo/EFO_0000516	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tinnitus in cisplatin-treated testicular cancer	tinnitus	http://purl.obolibrary.org/obo/HP_0000360	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sasang constitutional medicine type (So-Eum)	Sasang constitutional medicine type	http://www.ebi.ac.uk/efo/EFO_0007119	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sasang constitutional medicine type (So-Yang)	Sasang constitutional medicine type	http://www.ebi.ac.uk/efo/EFO_0007119	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sasang constitutional medicine type (Tae-Eum)	Sasang constitutional medicine type	http://www.ebi.ac.uk/efo/EFO_0007119	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sasang constitutional medicine type (Tae-Yang)	Sasang constitutional medicine type	http://www.ebi.ac.uk/efo/EFO_0007119	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Behavioural changes in frontotemporal lobe dementia	behavior	http://purl.obolibrary.org/obo/GO_0007610	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Hyperactive-impulsive symptoms	behavior	http://purl.obolibrary.org/obo/GO_0007610	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Inattentive symptoms	behavior	http://purl.obolibrary.org/obo/GO_0007610	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Neutrophil-to-lymphocyte ratio	neutrophil-to-lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0008447	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Triiodothyronine/thyroxine ratio	tri-iodothyronine/thyroxine ratio measurement	http://www.ebi.ac.uk/efo/EFO_0009779	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Platelet-to-lymphocyte ratio	platelet-to-lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0008446	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Plasma free amino acid levels (adjusted for one other PFAA)	citrulline measurement	http://www.ebi.ac.uk/efo/EFO_0009777	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sitting height ratio	sitting height ratio	http://www.ebi.ac.uk/efo/EFO_0007118	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Urinary magnesium-to-creatinine ratio	magnesium:creatinine ratio measurement	http://www.ebi.ac.uk/efo/EFO_0008449	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery intima media thickness	carotid artery intima media thickness	http://www.ebi.ac.uk/efo/EFO_0007117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery intima media thickness (sex interaction)	carotid artery intima media thickness	http://www.ebi.ac.uk/efo/EFO_0007117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid intima media thickness	carotid artery intima media thickness	http://www.ebi.ac.uk/efo/EFO_0007117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid intima media thickness in rheumatoid arthritis	carotid artery intima media thickness	http://www.ebi.ac.uk/efo/EFO_0007117	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	threonine measurement	http://www.ebi.ac.uk/efo/EFO_0009775	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	threonine measurement	http://www.ebi.ac.uk/efo/EFO_0009775	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	threonine measurement	http://www.ebi.ac.uk/efo/EFO_0009775	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	ornithine measurement	http://www.ebi.ac.uk/efo/EFO_0009776	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits in newborns	sum of skinfolds	http://www.ebi.ac.uk/efo/EFO_0006266	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	proline measurement	http://www.ebi.ac.uk/efo/EFO_0009773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	proline measurement	http://www.ebi.ac.uk/efo/EFO_0009773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	proline measurement	http://www.ebi.ac.uk/efo/EFO_0009773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free proline levels	proline measurement	http://www.ebi.ac.uk/efo/EFO_0009773	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels	serine measurement	http://www.ebi.ac.uk/efo/EFO_0009774	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for one other PFAA)	serine measurement	http://www.ebi.ac.uk/efo/EFO_0009774	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma free amino acid levels (adjusted for twenty other PFAAs)	serine measurement	http://www.ebi.ac.uk/efo/EFO_0009774	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fractional excretion of magnesium	fractional excretion of magnesium measurement	http://www.ebi.ac.uk/efo/EFO_0008450	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid plaque	carotid atherosclerosis	http://www.ebi.ac.uk/efo/EFO_0009783	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Carotid plaques in rheumatoid arthritis	carotid atherosclerosis	http://www.ebi.ac.uk/efo/EFO_0009783	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Breast cancer (HER2 negative)	HER2 negative breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0009780	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Mid-arm muscle circumference	mid-arm muscle circumference measurement	http://www.ebi.ac.uk/efo/EFO_0008452	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sasang constitutional medicine type (So-Yang)	So-Yang	http://www.ebi.ac.uk/efo/EFO_0007121	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Activities of daily living score	activities of daily living score measurement	http://www.ebi.ac.uk/efo/EFO_0008451	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer (progesterone-receptor negative)	progesterone-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0009781	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Breast cancer (progesterone-receptor positive)	progesterone-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0009781	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Sasang constitutional medicine type (Tae-Yang)	Tae-Yang	http://www.ebi.ac.uk/efo/EFO_0007120	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	neutropenia	http://purl.obolibrary.org/obo/MONDO_0001475	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Lichen planus in hepatitis C	lichen planus	http://www.ebi.ac.uk/efo/EFO_1000726	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	response to long-chain n-3 PUFA dietary supplementation	http://www.ebi.ac.uk/efo/EFO_0009308	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Atazanavir levels	atazanavir measurement	http://www.ebi.ac.uk/efo/EFO_0009306	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tacrolimus trough concentration in kidney transplant patients	tacrolimus measurement	http://www.ebi.ac.uk/efo/EFO_0008458	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cannabis dependence symptom count	cannabis dependence measurement	http://www.ebi.ac.uk/efo/EFO_0008457	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Percent glycated albumin	percent glycated albumin	http://www.ebi.ac.uk/efo/EFO_0009304	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	response to mepolizumab	http://www.ebi.ac.uk/efo/EFO_0008459	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	response to mepolizumab	http://www.ebi.ac.uk/efo/EFO_0008459	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to mepolizumab in severe asthma	response to mepolizumab	http://www.ebi.ac.uk/efo/EFO_0008459	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Total glycated albumin levels	total glycated albumin	http://www.ebi.ac.uk/efo/EFO_0009305	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sasang constitutional medicine type (So-Eum)	So-Eum	http://www.ebi.ac.uk/efo/EFO_0007123	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Short physical performance battery score	short physical performance battery score measurement	http://www.ebi.ac.uk/efo/EFO_0008454	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Calf circumference	calf circumference measurement	http://www.ebi.ac.uk/efo/EFO_0008453	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fructosamine levels	fructosamine measurement	http://www.ebi.ac.uk/efo/EFO_0009303	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sasang constitutional medicine type (Tae-Eum)	Tae-Eum	http://www.ebi.ac.uk/efo/EFO_0007122	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	lachrymal gland lesion	http://www.ebi.ac.uk/efo/EFO_0007125	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)	sleep apnea measurement during non-REM sleep	http://www.ebi.ac.uk/efo/EFO_0008456	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinical remission in asthma	remission	http://www.ebi.ac.uk/efo/EFO_0009785	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Complete remission in asthma	remission	http://www.ebi.ac.uk/efo/EFO_0009785	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hepatitis C (spontaneous viral clearance)	remission	http://www.ebi.ac.uk/efo/EFO_0009785	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	salivary gland lesion	http://www.ebi.ac.uk/efo/EFO_0007124	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Obstructive sleep apnea during REM sleep (apnea hypopnea index)	sleep apnea measurement during REM sleep	http://www.ebi.ac.uk/efo/EFO_0008455	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	isoleucine measurement	http://www.ebi.ac.uk/efo/EFO_0009793	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cellular nuclear factor (erythroid-derived 2)-like 2 levels	NRF2 measurement	http://www.ebi.ac.uk/efo/EFO_0009794	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colonoscopy-negative controls vs population controls	colorectal health	http://www.ebi.ac.uk/efo/EFO_0008460	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Fatty acid desaturase activity (adipose tissue)	fatty acid desaturase enzyme activity measurement	http://www.ebi.ac.uk/efo/EFO_0009791	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fatty acid desaturase activity (serum)	fatty acid desaturase enzyme activity measurement	http://www.ebi.ac.uk/efo/EFO_0009791	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucagon levels in response to oral glucose tolerance test (120 minutes)	glucagon measurement	http://www.ebi.ac.uk/efo/EFO_0008463	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucagon levels in response to oral glucose tolerance test (fasting)	glucagon measurement	http://www.ebi.ac.uk/efo/EFO_0008463	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alloimmunization response to pregnancy	pregnancy induced alloimmunization	http://www.ebi.ac.uk/efo/EFO_0008462	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alloimmunization response to pregnancy (HLA class I and II)	pregnancy induced alloimmunization	http://www.ebi.ac.uk/efo/EFO_0008462	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alloimmunization response to pregnancy (HLA class I)	pregnancy induced alloimmunization	http://www.ebi.ac.uk/efo/EFO_0008462	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Alloimmunization response to pregnancy (HLA class II)	pregnancy induced alloimmunization	http://www.ebi.ac.uk/efo/EFO_0008462	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cardiometabolic traits	valine measurement	http://www.ebi.ac.uk/efo/EFO_0009792	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	asparaginase activity measurement	http://www.ebi.ac.uk/efo/EFO_0009790	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	apolipoprotein E measurement	http://www.ebi.ac.uk/efo/EFO_0008029	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	apolipoprotein E isoform E2 measurement	http://www.ebi.ac.uk/efo/EFO_0008028	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-hepatitis B virus core antigen (HBc) IgG levels	Anti-hepatitis B virus core antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009359	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-rubella virus IgG levels	Anti-rubella virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009357	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	angiotensinogen measurement	http://www.ebi.ac.uk/efo/EFO_0008025	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-hepatitis B virus surface antigen (HBs) IgG levels	Anti-hepatitis B virus surface antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009358	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to hepatitis B vaccine	Anti-hepatitis B virus surface antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009358	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	angiostatin measurement	http://www.ebi.ac.uk/efo/EFO_0008024	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Celiac disease or Rheumatoid arthritis	immune system disease	http://www.ebi.ac.uk/efo/EFO_0000540	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Myasthenia gravis	immune system disease	http://www.ebi.ac.uk/efo/EFO_0000540	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Anti-measles virus IgG levels	Anti-measles virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009355	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	annexin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0008027	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-mumps virus IgG levels	Anti-mumps virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009356	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	annexin A1 measurement	http://www.ebi.ac.uk/efo/EFO_0008026	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	basal cell adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008032	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-allergic rhinitis	non-allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0009364	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Blood protein levels	aspartate aminotransferase, cytoplasmic measurement	http://www.ebi.ac.uk/efo/EFO_0008031	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heavy vaginal discharge	vaginal discharge	http://www.ebi.ac.uk/efo/EFO_0009365	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Vaginal discharge (metrorrhagia)	vaginal discharge	http://www.ebi.ac.uk/efo/EFO_0009365	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	beta-endorphin measurement	http://www.ebi.ac.uk/efo/EFO_0008034	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nicotine withdrawal	nicotine withdrawal measurement	http://www.ebi.ac.uk/efo/EFO_0009362	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	rectal bleeding	http://purl.obolibrary.org/obo/HP_0002573	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	beta-Ala-His dipeptidase measurement	http://www.ebi.ac.uk/efo/EFO_0008033	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic central serous retinopathy	chronic central serous retinopathy	http://www.ebi.ac.uk/efo/EFO_0009363	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Upper eyelid sagging severity	eyelid sagging measurement	http://www.ebi.ac.uk/efo/EFO_0009360	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mucinous adenocarcinoma in colorectal cancer	colorectal mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0009361	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood protein levels	arylsulfatase B measurement	http://www.ebi.ac.uk/efo/EFO_0008030	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Androgen levels	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hormone measurements	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Testosterone levels	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Testosterone levels in polycystic ovary syndrome	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Androgen levels	dihydrotestosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004909	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coronary heart disease in familial hypercholesterolemia	familial hypercholesterolemia	http://www.ebi.ac.uk/efo/EFO_0004911	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
CYP3A4 enzyme activity	CYP3A4 activity	http://www.ebi.ac.uk/efo/EFO_0004910	Liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
Irritable bowel syndrome	irritable bowel syndrome	http://www.ebi.ac.uk/efo/EFO_0000555	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hearing function	sensory perception of sound	http://purl.obolibrary.org/obo/GO_0007605	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Lobular breast cancer (menopausal hormone therapy interaction)	invasive lobular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000553	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pemphigus	pemphigus	http://www.ebi.ac.uk/efo/EFO_1000749	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vaspin levels	vaspin measurement	http://www.ebi.ac.uk/efo/EFO_0004915	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neural processing (facial expression)	facial neural processing	http://www.ebi.ac.uk/efo/EFO_0004914	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lentiform nucleus volume	lentiform nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0004913	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Suicidal ideation	lentiform nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0004913	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dermatomyositis or juvenile dermatomyositis	juvenile dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0000557	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
IgA levels	serum IgA measurement	http://www.ebi.ac.uk/efo/EFO_0004912	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum IgA levels	serum IgA measurement	http://www.ebi.ac.uk/efo/EFO_0004912	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anthropometric traits	BMI-adjusted hip circumference	http://www.ebi.ac.uk/efo/EFO_0008039	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Hip circumference adjusted for BMI	BMI-adjusted hip circumference	http://www.ebi.ac.uk/efo/EFO_0008039	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Primary spontaneous pneumothorax	spontaneous pneumothorax	http://purl.obolibrary.org/obo/HP_0002108	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cardiometabolic traits	BMI-adjusted fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0008036	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood glucose adjusted for BMI	BMI-adjusted fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0008036	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma factor VII activating protease levels	factor VII activating protease measurement	http://www.ebi.ac.uk/efo/EFO_0009368	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diffusing capacity of carbon monoxide	diffusing capacity of the lung for carbon monoxide	http://www.ebi.ac.uk/efo/EFO_0009369	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diffusing capacity of the lung for carbon monoxide traits	diffusing capacity of the lung for carbon monoxide	http://www.ebi.ac.uk/efo/EFO_0009369	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
beta-nerve growth factor levels	beta-nerve growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0008035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heavy vaginal discharge	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (acne)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (aggressiveness)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (bowel movement)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (depression)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (dysmenorrhea)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (edema)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (fever)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (headache)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (increased appetite)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (joint pain)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (loss of concentration)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (nervousness)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (pressure in breast)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (sleepiness)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (stiff neck)	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pain medicine use during menstruation	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip bone size adjusted for BMI	BMI-adjusted hip bone size	http://www.ebi.ac.uk/efo/EFO_0008038	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Brain glucose metabolism (fluorodeoxyglucose uptake)	glucose metabolism measurement	http://www.ebi.ac.uk/efo/EFO_0009367	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood insulin adjusted for BMI	BMI-adjusted fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0008037	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 15 measurement	http://www.ebi.ac.uk/efo/EFO_0008043	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 14 measurement	http://www.ebi.ac.uk/efo/EFO_0008042	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	C-C motif chemokine 17 measurement	http://www.ebi.ac.uk/efo/EFO_0008045	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (edema)	edema	http://www.ebi.ac.uk/efo/EFO_0009373	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	C-C motif chemokine 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008044	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Energy intake	energy intake measurement	http://www.ebi.ac.uk/efo/EFO_0009374	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cannabis dependence	cannabis dependence	http://www.ebi.ac.uk/efo/EFO_0007191	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cannabis use disorder	cannabis dependence	http://www.ebi.ac.uk/efo/EFO_0007191	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cannabis use disorder vs schizophrenia	cannabis dependence	http://www.ebi.ac.uk/efo/EFO_0007191	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketogenic dietary therapies in epilepsy	response to ketogenic diet	http://www.ebi.ac.uk/efo/EFO_0009372	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Blood protein levels	C-C motif chemokine 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008041	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	breast cancer anti-estrogen resistance protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung cancer x radon exposure interaction (1df)	radon exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009370	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer age at diagnosis	age at diagnosis	http://www.ebi.ac.uk/efo/EFO_0004918	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	age at diagnosis	http://www.ebi.ac.uk/efo/EFO_0004918	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson's disease (age at diagnosis)	age at diagnosis	http://www.ebi.ac.uk/efo/EFO_0004918	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Common traits (Other)	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Odorant perception	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Odorant perception (&beta;-damascenone)	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Odorant perception (&beta;-ionone)	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Odorant perception (isobutyraldehyde)	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sense of smell	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Anti-herpes simplex virus 2 IgG seropositivity	Herpes simplex virus 2 seropositivity	http://www.ebi.ac.uk/efo/EFO_0009339	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure (age interaction)	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x age interaction	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x sex x age interaction	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x sex x age interaction (4df test)	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiovascular risk factors (age interaction)	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuroticism (age interaction)	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x age interaction	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x sex x age interaction	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin aging (microtopography measurement)	skin aging measurement	http://www.ebi.ac.uk/efo/EFO_0008006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
1,5-anhydroglucitol levels	1,5 anhydroglucitol measurement	http://www.ebi.ac.uk/efo/EFO_0008009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity	Epstein-Barr virus early antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009338	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Benign prostatic hyperplasia and lower urinary tract symptoms	lower urinary tract symptom	http://www.ebi.ac.uk/efo/EFO_0008008	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	lower urinary tract symptom	http://www.ebi.ac.uk/efo/EFO_0008008	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Benign prostatic hyperplasia and/or lower urinary tract symptoms	lower urinary tract symptom	http://www.ebi.ac.uk/efo/EFO_0008008	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Urinary symptoms in response to radiotherapy in prostate cancer	lower urinary tract symptom	http://www.ebi.ac.uk/efo/EFO_0008008	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antipsychotic drug-induced QTc interval change in schizophrenia	heart rate variability measurement	http://www.ebi.ac.uk/efo/EFO_0008003	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate variability traits (RMSSD)	heart rate variability measurement	http://www.ebi.ac.uk/efo/EFO_0008003	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate variability traits (SDNN)	heart rate variability measurement	http://www.ebi.ac.uk/efo/EFO_0008003	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Heart rate variability traits (pvRSA/HF)	heart rate variability measurement	http://www.ebi.ac.uk/efo/EFO_0008003	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Lateral ventricle volume in trauma-exposed individuals	lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0008487	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lateral ventricular volume in normal aging	lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0008487	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter growth	white matter growth measurement	http://www.ebi.ac.uk/efo/EFO_0009335	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Accelerometer-based physical activity measurement (average acceleration)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (joint analysis main effects and physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (recreational physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index in physically active individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index in physically inactive individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DIastolic blood pressure x physical activity interaction (2df)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x physical activity interaction (1df)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance in higher physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance in lower physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of insulin resistance x physical activity interaction	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in higher physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in lower physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia x physical activity interaction	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in higher physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in lower physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia x physical activity interaction	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Moderate to vigorous physical activity levels	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Physical activity (moderate intensity activity duration)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Physical activity (overall physical activity time)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Physical activity (walking duration)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sedentary behaviour duration	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Strenuous sports or other exercises	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity interaction (1df)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x physical activity interaction (2df)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vigorous physical activity	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference adjusted for BMI (physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference adjusted for BMI in active individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference adjusted for BMI in inactive individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference adjusted for body mass index	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip circumference ratio (recreational physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI (physical activity interaction)	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI in active individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI in inactive individuals	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for body mass index	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Male sexual orientation	male homosexuality	http://www.ebi.ac.uk/efo/EFO_0008486	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Velopharyngeal dysfunction	velopharyngeal dysfunction	http://www.ebi.ac.uk/efo/EFO_0009336	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Amblyopia	amblyopia (disease)	http://purl.obolibrary.org/obo/MONDO_0001020	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Energy expenditure	energy expenditure measurement	http://www.ebi.ac.uk/efo/EFO_0008005	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Energy expenditure (24h)	energy expenditure measurement	http://www.ebi.ac.uk/efo/EFO_0008005	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resting metabolic rate	resting metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0008004	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Right lateral prefrontal cortical growth	prefrontal cortex growth measurement	http://www.ebi.ac.uk/efo/EFO_0009334	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-measles virus IgG seropositivity	Measles virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009342	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-mumps virus IgG seropositivity	Mumps virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-varicella zoster virus IgG seropositivity	Varicella zoster virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Abelson tyrosine-protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008012	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early-onset Parkinson's disease	Young adult-onset Parkinsonism	http://www.orpha.net/ORDO/Orphanet_2828	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
ADAMTS13 levels	a disintegrin and metalloproteinase with thrombospondin motifs 13	http://www.ebi.ac.uk/efo/EFO_0008011	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	a disintegrin and metalloproteinase with thrombospondin motifs 13	http://www.ebi.ac.uk/efo/EFO_0008011	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Helicobacter pylori IgG seropositivity	Helicobacter pylori seropositivity	http://www.ebi.ac.uk/efo/EFO_0009341	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood pressure response to hydrochlorothiazide in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood pressure traits (multi-trait analysis)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiovascular disease in hypertension (ACE inhibitor interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiovascular disease in hypertension (beta blocker interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiovascular disease in hypertension (calcium channel blocker interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cardiovascular disease in hypertension (diuretic interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Change in glucose in response to thiazide diuretic treatment in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diastolic blood pressure night-to-day ratio in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diastolic blood pressure response to hydrochlorothiazide in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Hypertension (SNP x SNP interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Hypertension risk in short sleep duration	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Medication adherence in chronic diseases	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (ACE inhibitor interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (beta blocker interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (calcium channel blocker interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Myocardial infarction in hypertension (diuretic interaction)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to angiotensin II receptor blocker therapy	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to beta blocker use in hypertension (diastolic blood pressure)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Response to beta blocker use in hypertension (systolic blood pressure)	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Systolic blood pressure night-to-day ratio in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Systolic blood pressure response to hydrochlorothiazide in hypertension	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood protein levels	alpha-1-antichymotrypsin complex measurement	http://www.ebi.ac.uk/efo/EFO_0008018	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	alcohol dehydrogenase [NADP+] measurement	http://www.ebi.ac.uk/efo/EFO_0008017	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Epstein-Barr virus early antigen (EA) IgG levels	Anti-Epstein-Barr virus early antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009348	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chronic back pain	back pain	http://purl.obolibrary.org/obo/HP_0003418	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anti-herpes simplex virus 1 IgG levels	Anti-herpes simplex virus 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009349	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	alpha-1-antichymotrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0008019	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-hepatitis B virus core antigen (HBc) IgG seropositivity	Hepatitis B virus core antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009346	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008014	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-cytomegalovirus IgG levels	Anti-cytomegalovirus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009347	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	acid sphingomyelinase-like phosphodiesterase 3a measurement	http://www.ebi.ac.uk/efo/EFO_0008013	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-rubella virus IgG seropositivity	Rubella virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009344	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	Agouti-related protein measurement	http://www.ebi.ac.uk/efo/EFO_0008016	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Viral basal core promoter double mutation in hepatitis B virus surface antigen (HBsAg) seropositivity	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	afamin measurement	http://www.ebi.ac.uk/efo/EFO_0008015	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Toxoplasma gondii IgG levels	Anti-Toxoplasma gondii IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009353	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	alpha-2-macroglobulin receptor-associated protein measurement	http://www.ebi.ac.uk/efo/EFO_0008021	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-influenza A virus IgG levels	Anti-influenza A virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	alpha-2-HS-glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008020	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-varicella zoster virus IgG levels	Anti-varicella zoster virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009351	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	angiopoietin-1 receptor, soluble measurement	http://www.ebi.ac.uk/efo/EFO_0008023	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	angiogenin measurement	http://www.ebi.ac.uk/efo/EFO_0008022	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-herpes simplex virus 2 IgG levels	Anti-herpes simplex virus 2 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009350	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hypertrophic cardiomyopathy	hypertrophic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000538	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Seborrheic dermatitis	seborrheic dermatitis	http://www.ebi.ac.uk/efo/EFO_1000764	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Emphysema-related traits	emphysema	http://www.ebi.ac.uk/efo/EFO_0000464	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Pulmonary emphysema	emphysema	http://www.ebi.ac.uk/efo/EFO_0000464	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sex ratio	sex ratio	http://www.ebi.ac.uk/efo/EFO_0004820	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex ratio at birth	sex ratio	http://www.ebi.ac.uk/efo/EFO_0004820	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Economic and political preferences	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Economic and political preferences (environmentalism)	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Economic and political preferences (fairness)	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Economic and political preferences (feminism/equality)	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Economic and political preferences (immigration/crime)	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Economic and political preferences (time)	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Political ideology	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antineutrophil cytoplasmic antibody-associated vasculitis	anti-neutrophil antibody associated vasculitis	http://www.ebi.ac.uk/efo/EFO_0004826	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	anti-neutrophil antibody associated vasculitis	http://www.ebi.ac.uk/efo/EFO_0004826	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3	anti-neutrophil antibody associated vasculitis	http://www.ebi.ac.uk/efo/EFO_0004826	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Temperament	temperament and character inventory	http://www.ebi.ac.uk/efo/EFO_0004825	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Posterior cortical atrophy and Alzheimer's disease	posterior cortical atrophy	http://www.orpha.net/ORDO/Orphanet_54247	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Cephalic index	cranial vault morphology measurement	http://www.ebi.ac.uk/efo/EFO_0009278	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Maximum cranial length	cranial vault morphology measurement	http://www.ebi.ac.uk/efo/EFO_0009278	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Maximum cranial width	cranial vault morphology measurement	http://www.ebi.ac.uk/efo/EFO_0009278	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bilirubin levels in tenofovir-treated HIV infection	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tenofovir clearance in HIV infection	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Interventricular septum thickness	interventricular septum thickness	http://www.ebi.ac.uk/efo/EFO_0009287	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Posterior wall thickness	posterior wall thickness	http://www.ebi.ac.uk/efo/EFO_0009288	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Fractional shortening	fractional shortening	http://www.ebi.ac.uk/efo/EFO_0009285	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Relative wall thickness	heart relative wall thickness	http://www.ebi.ac.uk/efo/EFO_0009286	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Potassium levels	potassium measurement	http://www.ebi.ac.uk/efo/EFO_0009283	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary potassium excretion	potassium measurement	http://www.ebi.ac.uk/efo/EFO_0009283	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chloride levels	chloride measurement	http://www.ebi.ac.uk/efo/EFO_0009284	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sub-foveal choroidal thickness	choroidal thickness measurement	http://www.ebi.ac.uk/efo/EFO_0009281	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x sodium interaction (1df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x sodium interaction (2df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x sodium interaction (1df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x sodium interaction (2df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulse pressure x sodium interaction (1df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulse pressure x sodium interaction (2df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sodium levels	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sodium levels in epilepsy	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x sodium interaction (1df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x sodium interaction (2df test)	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary sodium excretion	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	response to irinotecan	http://www.ebi.ac.uk/efo/EFO_0004829	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to irinotecan in non-small-cell lung cancer	response to irinotecan	http://www.ebi.ac.uk/efo/EFO_0004829	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Maternal genotype effects in autism spectrum disorder families	genetic variation	http://www.ebi.ac.uk/efo/EFO_0004828	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate cancer (SNP x SNP interaction)	genetic variation	http://www.ebi.ac.uk/efo/EFO_0004828	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Barrett's esophagus  or Esophageal adenocarcinoma	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal adenocarcinoma	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal adenocarcinoma x BMI interaction	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Esophageal adenocarcinoma x smoking interaction	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Blood cell traits (multivariate analysis)	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Neutrophil count	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Neutrophil count in HIV-infection	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Neutrophil level response to clozapine in treatment-resistant schizophrenia	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Sum basophil neutrophil counts	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Sum neutrophil eosinophil counts	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count (neutrophil)	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell types	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Optic disc area	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic disc parameters	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic nerve measurement (cup area)	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic nerve measurement (cup-to-disc ratio)	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic nerve measurement (disc area)	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Optic nerve measurement (rim area)	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vertical cup-disc ratio	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
RR interval (heart rate)	RR interval	http://www.ebi.ac.uk/efo/EFO_0004831	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval	http://www.ebi.ac.uk/efo/EFO_0004831	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Calcium levels	calcium measurement	http://www.ebi.ac.uk/efo/EFO_0004838	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinical laboratory measurements	calcium measurement	http://www.ebi.ac.uk/efo/EFO_0004838	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	caudate nucleus volume	http://www.ebi.ac.uk/efo/EFO_0004830	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate volume in trauma-exposed individuals	caudate nucleus volume	http://www.ebi.ac.uk/efo/EFO_0004830	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcortical brain region volumes	caudate nucleus volume	http://www.ebi.ac.uk/efo/EFO_0004830	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Carbamazepine-induced hyponatremia in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Epilepsy (remission after treatment)	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Epilepsy and lamotrigine-induced maculopapular eruptions	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Generalized epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Oxcarbazepine-induced hyponatremia in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ketogenic dietary therapies in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Sodium levels in epilepsy	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Left ventricular mass	left ventricular mass	http://www.ebi.ac.uk/efo/EFO_0009289	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Left ventricular mass index	left ventricular mass index	http://www.ebi.ac.uk/efo/EFO_0009290	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
E/A ratio	E/A ratio	http://www.ebi.ac.uk/efo/EFO_0009291	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
CD4:CD8 lymphocyte ratio	CD4:CD8 lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0004839	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Electroencephalographic traits in alcoholism	frontal theta oscillation measurement	http://www.ebi.ac.uk/efo/EFO_0004800	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Burning and freckling	sunburn	http://www.ebi.ac.uk/efo/EFO_0003958	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Sunburns	sunburn	http://www.ebi.ac.uk/efo/EFO_0003958	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Formal thought disorder in schizophrenia	formal thought disorder	http://www.ebi.ac.uk/efo/EFO_0004805	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Male fertility	birth rate	http://www.ebi.ac.uk/efo/EFO_0004804	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Allergic rhinitis	seasonal allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0003956	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Asthma and hay fever	seasonal allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0003956	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
IgE grass sensitization	seasonal allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0003956	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pollinosis	seasonal allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0003956	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Male fertility	male fertility	http://www.ebi.ac.uk/efo/EFO_0004803	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Male fertility	family size	http://www.ebi.ac.uk/efo/EFO_0004802	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Excessive sweating	Hyperhidrosis	http://purl.obolibrary.org/obo/HP_0000975	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Severity of nausea and vomiting of pregnancy	nausea and vomiting of pregnancy severity measurement	http://www.ebi.ac.uk/efo/EFO_0009265	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)	uveal melanoma disease severity	http://www.ebi.ac.uk/efo/EFO_0010244	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Refractory celiac disease type II	refractory celiac disease	http://www.ebi.ac.uk/efo/EFO_0009266	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Nicotine withdrawal symptom count	nicotine withdrawal symptom count	http://www.ebi.ac.uk/efo/EFO_0009263	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum oxytocin levels	oxytocin measurement	http://www.ebi.ac.uk/efo/EFO_0010245	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Smoking behaviour (maximum cigarettes in a 24 hour period)	maximum cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0009264	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to aripiprazole in schizophrenia	response to aripiprazole	http://www.ebi.ac.uk/efo/EFO_0009261	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Fagerstrӧm test for nicotine dependence	nicotine dependence symptom count	http://www.ebi.ac.uk/efo/EFO_0009262	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nicotine dependence and major depression (severity of comorbidity)	nicotine dependence symptom count	http://www.ebi.ac.uk/efo/EFO_0009262	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nicotine dependence symptom count	nicotine dependence symptom count	http://www.ebi.ac.uk/efo/EFO_0009262	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-melanoma skin cancer	non-melanoma skin carcinoma	http://www.ebi.ac.uk/efo/EFO_0009260	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Protein quantitative trait loci	fructose-bisphosphate aldolase measurement	http://www.ebi.ac.uk/efo/EFO_0004809	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lactate dehydrogenase levels	l lactate dehydrogenase measurement	http://www.ebi.ac.uk/efo/EFO_0004808	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Protein quantitative trait loci	l lactate dehydrogenase measurement	http://www.ebi.ac.uk/efo/EFO_0004808	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Hypertension risk in short sleep duration	short sleep	http://www.ebi.ac.uk/efo/EFO_0004807	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peripartum cardiomyopathy	peripartum cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0002628	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Cleft lip	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft lip with or without cleft palate	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with cleft palate	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with or without cleft palate	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Orofacial clefts	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Orofacial clefts (cleft lip vs. cleft lip and palate)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Orofacial clefts (maternal alcohol consumption interaction)	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lung cancer (asbestos exposure interaction)	asbestos exposure measurement	http://www.ebi.ac.uk/efo/EFO_0004806	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
High IL-1beta levels in gingival crevicular fluid	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Inflammatory biomarkers	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Interleukin-1-beta levels	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Chronic obstructive pulmonary disease-related biomarkers	interleukin-8 measurement	http://www.ebi.ac.uk/efo/EFO_0004811	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Interleukin-8 levels	interleukin-8 measurement	http://www.ebi.ac.uk/efo/EFO_0004811	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin-8 measurement	http://www.ebi.ac.uk/efo/EFO_0004811	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Burning and freckling	freckles	http://www.ebi.ac.uk/efo/EFO_0003963	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Freckles	freckles	http://www.ebi.ac.uk/efo/EFO_0003963	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Freckling	freckles	http://www.ebi.ac.uk/efo/EFO_0003963	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Skin pigmentation traits	freckles	http://www.ebi.ac.uk/efo/EFO_0003963	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Chronic obstructive pulmonary disease-related biomarkers	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cytokine and corticosteroid-stimulated IL-6 production	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cytokine-stimulated IL-6 production	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Inflammatory biomarkers	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Interleukin-6 (red blood cell fatty acid level interaction)	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Interleukin-6 levels	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Obesity-related traits	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Rubella-specific interleukin-6 secretion	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	alpha macroglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0004815	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	interleukin-6 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004814	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	alpha globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004813	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Breast cancer (menopausal hormone therapy interaction)	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Colorectal cancer (menopausal hormone therapy interaction)	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Colorectal cancer (oestrogen hormone therapy interaction)	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Lobular breast cancer (menopausal hormone therapy interaction)	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Delirium	delirium	http://www.ebi.ac.uk/efo/EFO_0009267	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Alzheimer's disease or family history of Alzheimer's disease	family history of Alzheimer’s disease	http://www.ebi.ac.uk/efo/EFO_0009268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Family history of Alzheimer's disease	family history of Alzheimer’s disease	http://www.ebi.ac.uk/efo/EFO_0009268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Maternal history of Alzheimer's disease	family history of Alzheimer’s disease	http://www.ebi.ac.uk/efo/EFO_0009268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Paternal history of Alzheimer's disease	family history of Alzheimer’s disease	http://www.ebi.ac.uk/efo/EFO_0009268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ventricular ectopy	ventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009276	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ventricular ectopy or supraventricular ectopy (pleiotropy)	ventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009276	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Supraventricular ectopy	supraventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009277	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Ventricular ectopy or supraventricular ectopy (pleiotropy)	supraventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009277	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels	Epstein Barr viral capsid antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009274	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Viral capsid antigen IgG levels	Epstein Barr viral capsid antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009274	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ventricular ectopy or supraventricular ectopy (pleiotropy)	premature cardiac contractions	http://www.ebi.ac.uk/efo/EFO_0009275	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity	Epstein Barr viral capsid antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Viral capsid antigen IgG seropositivity	Epstein Barr viral capsid antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein-Barr virus immune response (multivariate analysis)	anti-Epstein Barr virus antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009273	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heel bone mineral density	heel bone mineral density	http://www.ebi.ac.uk/efo/EFO_0009270	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Heel bone mineral density (MTAG)	heel bone mineral density	http://www.ebi.ac.uk/efo/EFO_0009270	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity	Epstein Barr virus nuclear antigen-1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0009271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Epstein Barr virus nuclear antigen 1 IgG seropositivity	Epstein Barr virus nuclear antigen-1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0009271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	resistin measurement	http://www.ebi.ac.uk/efo/EFO_0004819	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resistin levels	resistin measurement	http://www.ebi.ac.uk/efo/EFO_0004819	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	transforming growth factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0004818	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	transforming growth factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0004818	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Amyotrophic lateral sclerosis (SNP x SNP interaction)	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Amyotrophic lateral sclerosis (sporadic)	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Moderate functional decline in sporadic amyotrophic lateral sclerosis	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Rapid functional decline in sporadic amyotrophic lateral sclerosis	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Survival in sporadic amyotrophic lateral sclerosis	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Vitamin E levels	vitamin E measurement	http://www.ebi.ac.uk/efo/EFO_0004867	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gastric parietal cell autoantibody levels in type 1 diabetes	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glutamate decarboxylase autoantibody levels in type 1 diabetes	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes autoantibodies	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obstetric antiphospholipid syndrome	antiphospholipid syndrome	http://www.ebi.ac.uk/efo/EFO_0002689	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Post-traumatic stress disorder	post-traumatic stress disorder	http://www.ebi.ac.uk/efo/EFO_0001358	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Post-traumatic stress disorder (asjusted for relatedness)	post-traumatic stress disorder	http://www.ebi.ac.uk/efo/EFO_0001358	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Post-traumatic stress disorder or brain volume (pleiotropy)	post-traumatic stress disorder	http://www.ebi.ac.uk/efo/EFO_0001358	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Atopy	atopy	http://www.ebi.ac.uk/efo/EFO_0002686	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Methotrexate clearance (acute lymphoblastic leukemia)	response to methotrexate	http://purl.obolibrary.org/obo/GO_0031427	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Methotrexate-induced interstitial lung disease in rheumatoid arthritis	response to methotrexate	http://purl.obolibrary.org/obo/GO_0031427	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to methotrexate in juvenile idiopathic arthritis	response to methotrexate	http://purl.obolibrary.org/obo/GO_0031427	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to methotrexate in rheumatoid arthritis	response to methotrexate	http://purl.obolibrary.org/obo/GO_0031427	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Thyroid volume	thyroid volume	http://www.ebi.ac.uk/efo/EFO_0004865	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal sinus fat	renal sinus adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004864	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
C-peptide levels in type I diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Coronary artery disease in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic nephropathy in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
End-stage renal disease in Type 1 diabetics	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
End-stage renal disease or diabetic nephropathy in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Erectile dysfunction in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Fasting C-peptide levels in type I diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Foot ulcer and neuropathy in diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Foot ulcer in diabetes and neuropathy	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Fulminant type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Gastric parietal cell autoantibody levels in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glutamate decarboxylase autoantibody levels in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glycated hemoglobin levels in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Latent autoimmune diabetes vs. type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Pediatric autoimmune diseases	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Random C-peptide levels in type I diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Skin fluorescence in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Stimulated C-peptide levels in type I diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Thyroid peroxidase autoantibody levels in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes and autoimmune thyroid diseases	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes autoantibodies	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 1 diabetes in high risk HLA genotype individuals (time to event)	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Urinary albumin excretion rate in type 1 diabetes	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
YKL-40 levels	YKL40 measurement	http://www.ebi.ac.uk/efo/EFO_0004869	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Volumetric brain MRI	volumetric brain MRI	http://www.ebi.ac.uk/efo/EFO_0004868	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Recombination measurement (females)	recombination rate	http://www.ebi.ac.uk/efo/EFO_0004863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Recombination measurement (males)	recombination rate	http://www.ebi.ac.uk/efo/EFO_0004863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Recombination rate (females)	recombination rate	http://www.ebi.ac.uk/efo/EFO_0004863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Recombination rate (males)	recombination rate	http://www.ebi.ac.uk/efo/EFO_0004863	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phytosterol levels	phytosterol measurement	http://www.ebi.ac.uk/efo/EFO_0004862	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phosphorus levels	phosphorus measurement	http://www.ebi.ac.uk/efo/EFO_0004861	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thyrotoxic hypokalemic periodic paralysis	thyrotoxic periodic paralysis	http://www.orpha.net/ORDO/Orphanet_79102	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Thyrotoxic hypokalemic periodic paralysis and Graves disease	thyrotoxic periodic paralysis	http://www.orpha.net/ORDO/Orphanet_79102	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Thyrotoxic hypokalemic periodic paralysis in Graves disease	thyrotoxic periodic paralysis	http://www.orpha.net/ORDO/Orphanet_79102	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Carotid atherosclerosis in HIV infection	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Carotid intima media thickness	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Common carotid intima-media thickness	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Common carotid intima-media thickness in HIV infection	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Common carotid intima-media thickness in HIV negative individuals	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Subclinical atherosclerosis traits (other)	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hypospadias	familial hypospadias	http://www.orpha.net/ORDO/Orphanet_440	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Joint mobility (Beighton score)	joint hypermobility measurement	http://www.ebi.ac.uk/efo/EFO_0007905	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Childhood ear infection	susceptibility to childhood ear infection measurement	http://www.ebi.ac.uk/efo/EFO_0007904	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Myringotomy	susceptibility to childhood ear infection measurement	http://www.ebi.ac.uk/efo/EFO_0007904	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Methadone dose in opioid dependence	methadone dose measurement	http://www.ebi.ac.uk/efo/EFO_0007907	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Highest math class taken	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Highest math class taken (MTAG)	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Mathematical ability	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Mathematical ability in children with dyslexia	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Multiple traits (pleiotropy)	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Reading or mathematical ability	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Self-reported math ability	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Self-reported math ability (MTAG)	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Monobrow	synophrys measurement	http://www.ebi.ac.uk/efo/EFO_0007906	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepcidin/ferritin ratio	hepcidin:ferritin ratio	http://www.ebi.ac.uk/efo/EFO_0007901	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Retinol levels	retinol measurement	http://www.ebi.ac.uk/efo/EFO_0007900	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary electrolytes (magnesium/calcium ratio)	magnesium:calcium ratio	http://www.ebi.ac.uk/efo/EFO_0007903	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hepcidin/transferrin saturation ratio	hepcidin:transferrin saturation ratio	http://www.ebi.ac.uk/efo/EFO_0007902	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Advanced glycation end-product levels	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Alzheimer's disease or cardiovascular risk factors (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Alzheimer's disease or type 2 diabetes (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Birth weight or type 2 diabetes (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Cardiovascular heart disease in diabetics	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Cataracts in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Change in HbA1c levels in response to metformin treatment in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease and diabetic kidney disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Cystic fibrosis-related diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic macular edema in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic maculopathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic maculopathy with decreased visual acuity in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic peripheral neuropathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic retinopathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Early diabetic kidney disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
End-stage renal disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Foot ulcer and neuropathy in diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Foot ulcer in diabetes and neuropathy	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glomerular filtration rate in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glycemic traits	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Late diabetic kidney disease in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Latent autoimmune diabetes vs. type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Metabolic syndrome	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Multiple sclerosis and type 2 diabetes (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Neuropathic pain in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Plasma haptoglobin levels in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Prevalent type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Proliferative diabetic retinopathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Response to metformin in type 2 diabetes (HbA1c reduction)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Schizophrenia and type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Schizophrenia vs schizophrenia and type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Schizophrenia vs type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Severe diabetic retinopathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Sight-threatening diabetic retinopathy in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (SNP x SNP interaction, 1df)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (SNP x SNP interaction, 2df)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (adjusted for BMI)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (age of onset)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (dietary heme iron intake interaction)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes (young onset) and obesity	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes and 6 quantitative traits	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes or coronary artery disease (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes or obesity or coronary artery disease (pleiotropy)	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes vs schizophrenia and type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Urinary haptoglobin levels in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Yu-Zhi constitution type in type 2 diabetes	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Obesity-related traits	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep (time to least active 5 hours)	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep (time to midpoint)	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (variability)	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep-related phenotypes	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Time to most active 10 hours	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulmonary arterial hypertension	pulmonary arterial hypertension	http://www.ebi.ac.uk/efo/EFO_0001361	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Pulmonary arterial hypertension (without BMPR2 mutations)	pulmonary arterial hypertension	http://www.ebi.ac.uk/efo/EFO_0001361	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Death	dead	http://purl.obolibrary.org/obo/PATO_0001422	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Childhood onset systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic lymphocytic leukemia or systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Diffuse large B-cell lymphoma or systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Follicular lymphoma or systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Interferon alpha levels in systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Lupus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Lupus nephritis in systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Marginal zone lymphoma or systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to belimumab (SLE response index) in systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Serologic markers in systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic lupus erythematosus	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic lupus erythematosus and Systemic sclerosis	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic lupus erythematosus or rheumatoid arthritis	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Brain activation in response to working memory task	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Language performance in older adults (adjusted for episodic memory)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (delayed recall)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (delayed recall) in Alzheimer's disease dementia	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (delayed recall) in mild cognitive impairment	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (delayed recall) in normal cognition	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (immediate recall)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (immediate recall) in Alzheimer's disease dementia	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (immediate recall) in mild cognitive impairment	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Logical memory (immediate recall) in normal cognition	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Memory performance	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Short-term memory (digit-span task)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Short-term memory (shared component of digit-span and visuospatial tasks)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Short-term memory (visuospatial task)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal declarative memory	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (delayed recall change)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (delayed recall level)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (immediate recall change)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (immediate recall level)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (residualized delayed recall change)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Verbal memory performance (residualized delayed recall level)	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Advanced age-related macular degeneration	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (SNP x mitochondrial C16069T interaction)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (SNP x mitochondrial T5004C interaction)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (extreme sampling)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (smoking status interaction)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related macular degeneration (wet)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Disease progression in age-related macular degeneration	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Geographic atrophy lesion growth rate in age-related macular degeneration	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neovascular age-related macular degeneration	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ranibizumab in age-related macular degeneration (dry maculae)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to ranibizumab in age-related macular degeneration (visual acuity)	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Immune reponse to smallpox (secreted IFN-alpha)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune reponse to smallpox (secreted IL-10)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune reponse to smallpox (secreted IL-12p40)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune reponse to smallpox (secreted IL-1beta)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune reponse to smallpox (secreted IL-2)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune reponse to smallpox (secreted TNF-alpha)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immune response to smallpox vaccine (IL-6)	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lipopolysaccharide induced cytokine levels	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Inflammatory biomarkers in Kawasaki disease	inflammatory biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Esotropia	esotropia	http://purl.obolibrary.org/obo/HP_0000565	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Circulating chromogranin peptide levels	CHGA cleavage product measurement	http://www.ebi.ac.uk/efo/EFO_0007909	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Childhood onset asthma (traffic air pollution exposure interaction)	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peripheral arterial disease (traffic-related air pollution interaction)	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sepsis in extremely premature infants	Neonatal sepsis	http://purl.obolibrary.org/obo/HP_0040187	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Magnesium levels	magnesium measurement	http://www.ebi.ac.uk/efo/EFO_0004845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum magnesium levels	magnesium measurement	http://www.ebi.ac.uk/efo/EFO_0004845	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip bone size	hip bone size	http://www.ebi.ac.uk/efo/EFO_0004844	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Folate pathway vitamin levels	vitamin B measurement	http://www.ebi.ac.uk/efo/EFO_0004843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin B levels in ischemic stroke	vitamin B measurement	http://www.ebi.ac.uk/efo/EFO_0004843	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood cell traits (multivariate analysis)	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Eosinophil counts	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Sum eosinophil basophil counts	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Sum neutrophil eosinophil counts	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell count (eosinophil)	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
White blood cell types	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Age of smoking initiation	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related cataracts (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer disease and age of onset	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Amyotrophic lateral sclerosis (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma (time to onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma onset (childhood vs adult)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bipolar disorder (age of onset and psychotic symptoms)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cannabis use (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Childhood onset systemic lupus erythematosus	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depression (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Frontotemporal dementia (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Frontotemporal dementia with GRN mutation (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glioblastoma (age-stratified)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Huntington's disease (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Multiple sclerosis (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Myopia (age of diagnosis)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Narcolepsy (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson's disease (age of onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson's disease (familial, age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson's disease (non-familial, age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson's disease in GBA mutation carriers (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia (age at onset)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia (age at onset) (sex interaction)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spherical equivalent or myopia (age of diagnosis)	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Tuberculosis	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	serotonin measurement	http://www.ebi.ac.uk/efo/EFO_0004846	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Digit length ratio	digit length ratio	http://www.ebi.ac.uk/efo/EFO_0004841	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Digit length ratio (left hand)	digit length ratio	http://www.ebi.ac.uk/efo/EFO_0004841	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Digit length ratio (right hand)	digit length ratio	http://www.ebi.ac.uk/efo/EFO_0004841	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Cortical thickness	cortical thickness	http://www.ebi.ac.uk/efo/EFO_0004840	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Entorhinal cortical thickness	cortical thickness	http://www.ebi.ac.uk/efo/EFO_0004840	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Entorhinal cortical thickness (Alzheimer's disease interaction)	cortical thickness	http://www.ebi.ac.uk/efo/EFO_0004840	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Refractive error	Abnormality of refraction	http://purl.obolibrary.org/obo/HP_0000539	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Breast cancer (survival)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Liver transplant-free survival in primary sclerosing cholangitis (time to event)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-small cell lung cancer (recurrence rate)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in breast cancer (estrogen-receptor positive)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in endocrine treated breast cancer (estrogen-receptor positive)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Leisure-time exercise behaviour	exercise	http://www.ebi.ac.uk/efo/EFO_0000483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Leisure-time exercise behaviour (age-stratified)	exercise	http://www.ebi.ac.uk/efo/EFO_0000483	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Subclinical atherosclerosis traits (other)	abdominal aortic artery calcification	http://www.ebi.ac.uk/efo/EFO_0004859	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Retinol levels	vitamin A measurement	http://www.ebi.ac.uk/efo/EFO_0004857	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperopia	hypermetropia	http://purl.obolibrary.org/obo/HP_0000540	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Heparin-induced thrombocytopenia	thrombocytopenia	http://purl.obolibrary.org/obo/HP_0001873	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thrombocytopenia in coronary artery bypass surgery	thrombocytopenia	http://purl.obolibrary.org/obo/HP_0001873	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Myopia	Myopia	http://purl.obolibrary.org/obo/HP_0000545	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Myopia (age of diagnosis)	Myopia	http://purl.obolibrary.org/obo/HP_0000545	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Spherical equivalent or myopia (age of diagnosis)	Myopia	http://purl.obolibrary.org/obo/HP_0000545	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Opioid sensitivity	response to opiate	http://purl.obolibrary.org/obo/GO_0014072	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	coronary atheroscleroris measurement	http://www.ebi.ac.uk/efo/EFO_0007938	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0007937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neurological blood protein biomarker levels	blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0007937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0007937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum total protein level	blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0007937	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cough	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dyspnea	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phlegm	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0007934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0007934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Creatinine clearance	creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0007934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0007934	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forearm bone mineral density	radius bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric areal bone mineral density (radius)	radius bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ulna and radius bone mineral density	radius bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007933	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer EORTC risk category	disease prognosis measurement	http://www.ebi.ac.uk/efo/EFO_0007936	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Poor prognosis in Crohn's disease	disease prognosis measurement	http://www.ebi.ac.uk/efo/EFO_0007936	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary uric acid to urinary creatinine ratio	urinary uric acid to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007935	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol to HDL cholesterol ratio	LDL cholesterol:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007930	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Multiple keratinocyte cancers	multiple keratinocyte carcinoma susceptibility measurement	http://www.ebi.ac.uk/efo/EFO_0007932	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
NHDL cholesterol to HDL cholesterol ratio	non-HDL cholesterol:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007931	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Atrioventricular septal defects in Down syndrome	Atrioventricular canal defect	http://purl.obolibrary.org/obo/HP_0006695	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
CSF tryptophan concentration in tuberculous meningitis	meningeal tuberculosis	http://www.ebi.ac.uk/efo/EFO_1000039	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Acute-on-chronic liver failure in hepatitis B	acute-on-chronic liver failure	http://www.ebi.ac.uk/efo/EFO_0007949	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
HIV-associated neurocognitive disorder	HIV-associated neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007948	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007948	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007948	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007948	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sepsis from pneumonia (survival)	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Agoraphobic traits	agoraphobia symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007945	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin fluorescence	skin fluorescence measurement	http://www.ebi.ac.uk/efo/EFO_0005766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin fluorescence in type 1 diabetes	skin fluorescence measurement	http://www.ebi.ac.uk/efo/EFO_0005766	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	allergen exposure measurement	http://www.ebi.ac.uk/efo/EFO_0007944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	allergen exposure measurement	http://www.ebi.ac.uk/efo/EFO_0007944	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatoid factor	rheumatoid factor measurement	http://www.ebi.ac.uk/efo/EFO_0005767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rheumatoid factor seropositivity in rheumatoid arthritis	rheumatoid factor measurement	http://www.ebi.ac.uk/efo/EFO_0005767	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to rate control therapy in atrial fibrillation	response to rate control therapy	http://www.ebi.ac.uk/efo/EFO_0005768	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Serum galactose-deficient IgA1 levels	serum galactose-deficient IgA1 measurement	http://www.ebi.ac.uk/efo/EFO_0007947	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Essential tremor	essential tremor	http://www.ebi.ac.uk/efo/EFO_0003108	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Self-reported tiredness	tiredness measurement	http://www.ebi.ac.uk/efo/EFO_0007946	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neuropathic pain in head and neck cancer	neuropathic pain	http://www.ebi.ac.uk/efo/EFO_0005762	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Neuropathic pain in type 2 diabetes	neuropathic pain	http://www.ebi.ac.uk/efo/EFO_0005762	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	neuropathic pain	http://www.ebi.ac.uk/efo/EFO_0005762	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	LDH-related sciatica symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007941	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood pressure (age interaction)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood pressure traits (multi-trait analysis)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Cardiometabolic traits	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure (alcohol consumption interaction)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure (dietary potassium intake interaction)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure (long-term average)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure in young-onset hypertension	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure x alcohol consumption interaction (2df test)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure x sodium interaction (1df test)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Pulse pressure x sodium interaction (2df test)	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Chronic venous disease	chronic venous insufficiency	http://www.ebi.ac.uk/efo/EFO_0007940	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to platinum-based neoadjuvant chemotherapy in cervical cancer	response to platinum-based neoadjuvant chemotherapy	http://www.ebi.ac.uk/efo/EFO_0007943	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Osteoarthritis (with total hip replacement)	hip osteoarthritis symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007942	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Elevated serum carcinoembryonic antigen levels	serum carcinoembryonic antigen measurement	http://www.ebi.ac.uk/efo/EFO_0005760	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bortezomib-induced peripheral neuropathy in multiple myeloma	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Diabetic peripheral neuropathy in type 2 diabetes	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Neuropathy in taxane-treated breast cancer	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Paclitaxel-induced neuropathy	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Taxane-induced peripheral neuropathy in breast cancer	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Lupus nephritis in systemic lupus erythematosus	lupus nephritis	http://www.ebi.ac.uk/efo/EFO_0005761	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	lupus nephritis	http://www.ebi.ac.uk/efo/EFO_0005761	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Chronic rhinosinusitis	chronic rhinosinusitis	http://www.ebi.ac.uk/efo/EFO_1000024	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Postoperative ventricular dysfunction	postoperative ventricular dysfunction	http://www.ebi.ac.uk/efo/EFO_0004889	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
QT interval (drug interaction)	response to tricyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007916	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
QT interval (tricyclic/tetracyclic antidepressant use interaction)	response to tricyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007916	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
RR interval (tricyclic/tetracyclic antidepressant use interaction)	response to tricyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007916	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Agreeableness	agreeableness measurement	http://www.ebi.ac.uk/efo/EFO_0007915	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Postoperative nausea and vomiting	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Alzheimer's disease with multiple cognitive domain impairments	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive decline rate in late mild cognitive impairment	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive impairment	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive impairment (brain beta-amyloid deposition interaction)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive impairment and C-reactive protein levels (pleiotropy)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive impairment and LDL levels (pleiotropy)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive impairment and total cholesterol levels (pleiotropy)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Rate of cognitive decline in mild cognitive impairment (time interaction)	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Drug-induced liver injury (anti-tuberculosis drugs)	response to anti-tuberculosis drug	http://www.ebi.ac.uk/efo/EFO_0007918	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Liver injury in anti-tuberculosis drug treatment	response to anti-tuberculosis drug	http://www.ebi.ac.uk/efo/EFO_0007918	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Maximal oxygen uptake response	maximal oxygen uptake measurement	http://www.ebi.ac.uk/efo/EFO_0004887	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	maximal oxygen uptake measurement	http://www.ebi.ac.uk/efo/EFO_0004887	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0004886	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain structure	intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0004886	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Intracranial volume	intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0004886	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcortical brain region volumes	intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0004886	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Bortezomib-induced peripheral neuropathy in multiple myeloma	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Clostridium difficile infection in multiple myeloma	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma (IgH translocation)	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma (hyperdiploidy)	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma (survival)	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Multiple myeloma and monoclonal gammopathy	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
QT interval (tricyclic/tetracyclic antidepressant use interaction)	response to tetracyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007917	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
RR interval (tricyclic/tetracyclic antidepressant use interaction)	response to tetracyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007917	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Conscientiousness	conscientiousness measurement	http://www.ebi.ac.uk/efo/EFO_0007912	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to SSRI in MDD or conscientiouness	conscientiousness measurement	http://www.ebi.ac.uk/efo/EFO_0007912	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Excitement-seeking behaviour	personality trait measurement	http://www.ebi.ac.uk/efo/EFO_0007911	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Openness	openness measurement	http://www.ebi.ac.uk/efo/EFO_0007914	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Remission after SSRI treatment in MDD or openness	openness measurement	http://www.ebi.ac.uk/efo/EFO_0007914	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to SSRI in MDD or openness	openness measurement	http://www.ebi.ac.uk/efo/EFO_0007914	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Extraversion	extraversion measurement	http://www.ebi.ac.uk/efo/EFO_0007913	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asparaginase hypersensitivity in acute lymphoblastic leukemia	asparaginase hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0004881	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	asparaginase hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0004881	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	asparaginase hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0004881	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anthropometric traits in newborns	neonate	http://www.ebi.ac.uk/efo/EFO_0001372	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Arsenic metabolism	urinary arsenic measurement	http://www.ebi.ac.uk/efo/EFO_0004880	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Circulating chromogranin peptide levels	CHGB cleavage product measurement	http://www.ebi.ac.uk/efo/EFO_0007910	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early cardiac repolarization	early cardiac repolarization measurement	http://www.ebi.ac.uk/efo/EFO_0004885	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Breast size	breast size	http://www.ebi.ac.uk/efo/EFO_0004884	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Response to clopidogrel therapy	response to clopidogrel	http://purl.obolibrary.org/obo/GO_1903493	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to clopidogrel therapy in coronary heart disease	response to clopidogrel	http://purl.obolibrary.org/obo/GO_1903493	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to simvastatin treatment (PCSK9 protein level change)	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Simvastatin-induced myopathy	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cervical artery dissection	cervical artery dissection	http://www.ebi.ac.uk/efo/EFO_1000059	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Drug-induced liver injury (diclofenac)	response to diclofenac	http://www.ebi.ac.uk/efo/EFO_0007919	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (CGI-S score)	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paliperidone in schizophrenia (Multivariate)	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paliperidone in schizophrenia (PANSS score)	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paliperidone in schizophrenia (negative Marder score)	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to paliperidone in schizophrenia (positive Marder score)	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride to HDL cholesterol ratio	triglyceride:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007929	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
Age-related disease endophenotypes	ventricular rate measurement	http://www.ebi.ac.uk/efo/EFO_0007928	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Age-related diseases, mortality and associated endophenotypes	ventricular rate measurement	http://www.ebi.ac.uk/efo/EFO_0007928	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Drug-induced liver injury (terbinafine)	response to terbinafine	http://www.ebi.ac.uk/efo/EFO_0007923	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
JT interval (sulfonylurea treatment interaction)	response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007922	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
QRS interval (sulfonylurea treatment interaction)	response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007922	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
QT interval (drug interaction)	response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007922	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
QT interval (sulfonylurea treatment interaction)	response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007922	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (CGI-S score)	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (Multivariate)	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (PANSS score)	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (negative Marder score)	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to paliperidone in schizophrenia (positive Marder score)	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Tonsillectomy	tonsillectomy risk measurement	http://www.ebi.ac.uk/efo/EFO_0007924	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pubertal anthropometrics	puberty	http://www.ebi.ac.uk/efo/EFO_0001382	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Sasang constitutional medicine type	sasang constitutional medicine	http://www.ebi.ac.uk/efo/EFO_0004892	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Drug-induced liver injury (nitrofurantoin)	response to nitrofurantoin	http://www.ebi.ac.uk/efo/EFO_0007921	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Drug-induced liver injury (fluoroquinolones)	response to fluoroquinolones	http://www.ebi.ac.uk/efo/EFO_0007920	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tourette syndrome	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tourette syndrome or brain region volumes (pleiotropy)	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Tourette's syndrome or obsessive-compulsive disorder	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Testicular dysgenesis syndrome	testicular dysgenesis syndrome	http://www.ebi.ac.uk/efo/EFO_0004893	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Ovarian clear cell cancer	ovarian clear cell adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_1000042	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Ischemic heart disease	myocardial ischemia	http://www.ebi.ac.uk/efo/EFO_1001375	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Pancreatic neuroendocrine tumor	pancreatic neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_1000045	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Glycemic traits (pleiotropy)	HOMA-B	http://www.ebi.ac.uk/efo/EFO_0004469	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of beta-cell function	HOMA-B	http://www.ebi.ac.uk/efo/EFO_0004469	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Homeostasis model assessment of beta-cell function (dietary factor interaction)	HOMA-B	http://www.ebi.ac.uk/efo/EFO_0004469	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related disease endophenotypes	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases, mortality and associated endophenotypes	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood glucose levels	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood sugar levels	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Change in glucose in response to thiazide diuretic treatment in hypertension	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clinical laboratory measurements	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolic traits	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 2 diabetes and 6 quantitative traits	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Red blood cell density in sickle cell anemia	red blood cell density measurement	http://www.ebi.ac.uk/efo/EFO_0007978	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Nervonic acid (24:1n-9) levels	nervonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007977	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Axial length	axial length measurement	http://www.ebi.ac.uk/efo/EFO_0005318	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Axial length or spherical error (univariate decomposition analysis)	axial length measurement	http://www.ebi.ac.uk/efo/EFO_0005318	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	childhood trauma measurement	http://www.ebi.ac.uk/efo/EFO_0007979	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Angiotensin-converting enzyme activity	angiotensin converting enzyme activity measurement	http://www.ebi.ac.uk/efo/EFO_0004463	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vaccenic acid (18:1n-7) levels	vaccenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007974	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Electrocardiographic conduction measures	PR interval	http://www.ebi.ac.uk/efo/EFO_0004462	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Electrocardiographic traits	PR interval	http://www.ebi.ac.uk/efo/EFO_0004462	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
PR interval	PR interval	http://www.ebi.ac.uk/efo/EFO_0004462	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
PR interval in Tripanosoma cruzi seropositivity	PR interval	http://www.ebi.ac.uk/efo/EFO_0004462	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Palmitoleic acid (16:1n-7) levels	palmitoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007973	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Erucic acid (22:1n-9) levels	erucic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007976	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Iron levels	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (ferritin levels)	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (iron levels)	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (transferrin levels)	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (transferrin saturation)	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gondoic acid (20:1n-9) levels	gondoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007975	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Iron status biomarkers	soluble transferrin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004460	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	soluble transferrin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004460	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood proinsulin levels	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Incremental insulin	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (120 minutes)	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (30 minutes)	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin levels in response to oral glucose tolerance test (fasting)	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin-related traits	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolic traits	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proinsulin levels	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proinsulin levels (early-phase conversion)	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Proinsulin levels (late-phase conversion)	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 2 diabetes and 6 quantitative traits	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrone levels	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma estrone levels in resected estrogen-receptor positive breast cancer	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease or fasting insulin levels (pleiotropy)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Birth weight or fasting insulin levels (pleiotropy)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diabetes related insulin traits	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood insulin	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood insulin (BMI interaction)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood insulin adjusted for BMI	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting insulin (dietary factor interaction)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (multi-trait analysis)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (pleiotropy)	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in higher physical activity	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in less-fat diet	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in lower physical activity	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in more-fat diet	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in non-obese individuals	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia in obesity	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia x BMI interaction	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia x physical activity interaction	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperinsulinemia x saturated fatty acids interaction	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin-related traits	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alzheimer's disease or fasting glucose levels (pleiotropy)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Birth weight or fasting glucose levels (pleiotropy)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Elevated fasting plasma glucose	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood glucose	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood glucose (BMI interaction)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting blood glucose adjusted for BMI	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting plasma glucose	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting plasma glucose (childhood)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (multi-trait analysis)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (pleiotropy)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glycemic traits (pregnancy)	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in higher physical activity	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in less-fat diet	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in lower physical activity	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in more-fat diet	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in non-obese individuals	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia in obesity	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia x BMI interaction	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia x physical activity interaction	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperglycemia x saturated fatty acids interaction	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thiazide-induced adverse metabolic effects in hypertensive patients	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Androstenedione levels	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma androstenedione levels in resected early stage-receptor positive breast cancer	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain structure	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain structure (hippocampal volume)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate nucleus volume	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cortical brain region measurements (area, volume and thickness)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Differential aging (cerebellum)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Differential aging (frontal cortex)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Differential aging in older adults (cerebellum)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Differential aging in older adults (frontal cortex)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Differential aging in younger adults (frontal cortex)	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
White matter hyperintensity burden	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Modic changes	Modic type vertebral endplate changes	http://purl.obolibrary.org/obo/HP_0030775	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Facial wrinkles	facial wrinkling	http://purl.obolibrary.org/obo/HP_0009762	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to stavudine in HIV (lipoatrophy)	lipoatrophy	http://purl.obolibrary.org/obo/HP_0100578	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Monocyte percentage of white cells	monocyte percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007989	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Myeloid white cell count	myeloid white cell count	http://www.ebi.ac.uk/efo/EFO_0007988	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Callous-unemotional behaviour	callous-unemotional behaviour	http://www.ebi.ac.uk/efo/EFO_0005322	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Plateletcrit	platelet crit	http://www.ebi.ac.uk/efo/EFO_0007985	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Eczema	Eczema	http://purl.obolibrary.org/obo/HP_0000964	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Platelet distribution width	platelet component distribution width	http://www.ebi.ac.uk/efo/EFO_0007984	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Postoperative complication after cardiac surgery	post-operative sign or symptom	http://www.ebi.ac.uk/efo/EFO_0005323	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Granulocyte count	granulocyte count	http://www.ebi.ac.uk/efo/EFO_0007987	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Sensory disturbances after bilateral sagittal split ramus osteotomy	Post-operative sensory disturbance	http://www.ebi.ac.uk/efo/EFO_0005324	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Angioedema in response to angiotensin-converting enzyme inhibitor	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Angiotensin-converting enzyme inhibitor intolerance	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cardiovascular disease in hypertension (ACE inhibitor interaction)	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cough in response to angiotensin-converting enzyme inhibitor drugs	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in hypertension (ACE inhibitor interaction)	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Birth weight or insulin sensitivity index (pleiotropy)	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corrected insulin response adjusted for insulin sensitivity index	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diabetes related insulin traits	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glucose homeostasis traits	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insulin sensitivity index	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Modified Stumvoll Insulin Sensitivity Index	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High light scatter reticulocyte count	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
High light scatter reticulocyte percentage of red cells	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Immature fraction of reticulocytes	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Reticulocyte count	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Reticulocyte fraction of red cells	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Change in glucose in response to thiazide diuretic treatment in hypertension	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
QT interval (drug interaction)	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cerebral blood flow	cerebral blood flow measurement	http://www.ebi.ac.uk/efo/EFO_0007980	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Allergic dermatitis (nickel)	contact dermatitis due to nickel	http://www.ebi.ac.uk/efo/EFO_0005320	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	asymptomatic neurocognitive impairment	http://www.ebi.ac.uk/efo/EFO_0007983	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	asymptomatic neurocognitive impairment	http://www.ebi.ac.uk/efo/EFO_0007983	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age-related diseases and mortality	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related diseases, mortality and associated endophenotypes	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Heart failure	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Heart rate in heart failure with reduced ejection fraction	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Mortality in heart failure	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	mild neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007982	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated neurocognitive disorder (mild neurocognitive disorder)	mild neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007982	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Molar-incisor hypomineralization	molar-incisor hypomineralization	http://www.ebi.ac.uk/efo/EFO_0005321	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Neutrophil percentage of white cells	neutrophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007990	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Breast milk fatty acid composition (infant genotype effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Early gestational weight gain (fetal effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gestational weight gain (fetal effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Late gestational weight gain (fetal effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PBDEs (fetal genetic effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PCBs (fetal genetic effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (fetal genetic effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Monocyte-lymphocyte ratio	monocyte:lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0007956	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial morphology (factor 5, width of mouth relative to central midface)	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mouth morphology (partial least square model)	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mouth morphology (principal component model)	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Urinary 1,3-butadiene metabolite levels in smokers	urinary 1,3-butadiene measurement	http://www.ebi.ac.uk/efo/EFO_0007957	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiovascular disease risk factors	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ferritin levels	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Iron status biomarkers (ferritin levels)	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Protein quantitative trait loci	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
C-reactive protein	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein (red blood cell fatty acid level interaction)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein and white blood cell count	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels in ischemic stroke	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels or total cholesterol levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
C-reactive protein levels or triglyceride levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cardiometabolic traits	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cardiovascular disease risk factors	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Chronic obstructive pulmonary disease-related biomarkers	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Cognitive impairment and C-reactive protein levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Inflammatory biomarkers	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Inflammatory biomarkers in Kawasaki disease	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Multiple sclerosis and C-reactive protein levels (pleiotropy)	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Obesity-related traits	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Protein quantitative trait loci	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Quantitative traits	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Select biomarker traits	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	Inflammatory measurement	http://www.ebi.ac.uk/efo/EFO_0004872
Blood osmolality (transformed sodium)	blood osmolality measurement	http://www.ebi.ac.uk/efo/EFO_0007967	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Clopidogrel active metabolite levels	clopidogrel metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007966	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	cognitive inhibition measurement	http://www.ebi.ac.uk/efo/EFO_0007969	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Drug-induced torsades de pointes	torsades de pointes	http://www.ebi.ac.uk/efo/EFO_0005307	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Tissue factor pathway inhibitor levels	tissue factor pathway inhibitor measurement	http://www.ebi.ac.uk/efo/EFO_0007968	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute lymphoblastic leukemia (B-cell precursor)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Acute lymphoblastic leukemia in childhood (B cell precursor)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia (abnormal cytogenetics)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia (hyperdiploid negative)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia (normal cytogenetics)	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia in adulthood	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B cell acute lymphoblastic leukaemia in young adulthood	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Paneth cell defects in Crohn's disease	abnormal paneth cell measurement	http://www.ebi.ac.uk/efo/EFO_0007963	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Word reading	word reading	http://www.ebi.ac.uk/efo/EFO_0005300	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Latent naming speed	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Phoneme awareness	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid alternating stimulus test for letters/numbers	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid automised naming and rapid alternating stimulus test performance	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid automised naming of digits	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid automised naming of letters	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid automised naming of objects	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Rapid automised naming of pictures	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Reading and spelling	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Word spelling	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Midgestational circulating levels of PBDEs	polybrominated diphenyl ether measurement	http://www.ebi.ac.uk/efo/EFO_0007962	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PBDEs (fetal genetic effect)	polybrominated diphenyl ether measurement	http://www.ebi.ac.uk/efo/EFO_0007962	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	response to combination chemotherapy	http://www.ebi.ac.uk/efo/EFO_0007965	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	response to combination chemotherapy	http://www.ebi.ac.uk/efo/EFO_0007965	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Follicular lymphoma	neoplasm of mature b-cells	http://www.ebi.ac.uk/efo/EFO_0000096	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Primary central nervous system lymphoma	central nervous system non-hodgkin lymphoma	http://purl.obolibrary.org/obo/MONDO_0044887	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Chronic lymphocytic leukemia	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Chronic lymphocytic leukemia or multiple sclerosis	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Chronic lymphocytic leukemia or rheumatoid arthritis	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Chronic lymphocytic leukemia or systemic lupus erythematosus	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Midgestational circulating levels of PBDEs	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PBDEs (fetal genetic effect)	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PCBs	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PCBs (fetal genetic effect)	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of organochlorine pesticides	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (fetal genetic effect)	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational cytokine/chemokine levels (maternal genetic effect)	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adult hearing aid use	age-related hearing impairment	http://www.ebi.ac.uk/efo/EFO_0005782	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Adult hearing difficulty	age-related hearing impairment	http://www.ebi.ac.uk/efo/EFO_0005782	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related hearing impairment	age-related hearing impairment	http://www.ebi.ac.uk/efo/EFO_0005782	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Age-related hearing impairment (SNP x SNP interaction)	age-related hearing impairment	http://www.ebi.ac.uk/efo/EFO_0005782	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Midgestational circulating levels of PBDEs	polybrominated biphenyl measurement	http://www.ebi.ac.uk/efo/EFO_0007961	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PBDEs (fetal genetic effect)	polybrominated biphenyl measurement	http://www.ebi.ac.uk/efo/EFO_0007961	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of organochlorine pesticides	organochlorine pesticide measurement	http://www.ebi.ac.uk/efo/EFO_0007960	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	organochlorine pesticide measurement	http://www.ebi.ac.uk/efo/EFO_0007960	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aortic-valve calcification	aortic valve calcification	http://www.ebi.ac.uk/efo/EFO_0005239	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Calcific aortic valve stenosis	aortic valve calcification	http://www.ebi.ac.uk/efo/EFO_0005239	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Carotenoid levels (cryptoxanthin)	cryptoxanthin measurement	http://www.ebi.ac.uk/efo/EFO_0007897	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotenoid levels (zeaxanthin)	zeaxanthin measurement	http://www.ebi.ac.uk/efo/EFO_0007896	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High fetal hemoglobin in sickle cell disease	Sickle cell disease and related diseases	http://www.orpha.net/ORDO/Orphanet_275752	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Vitamin E levels (gamma-tocopherol)	gamma-tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0007899	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vitamin E levels (alpha-tocopherol)	alpha-tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0007898	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anxiety	anxiety	http://www.ebi.ac.uk/efo/EFO_0005230	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anxiety and major depressive disorder	anxiety	http://www.ebi.ac.uk/efo/EFO_0005230	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anxiety in major depressive disorder	anxiety	http://www.ebi.ac.uk/efo/EFO_0005230	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Worry	anxiety	http://www.ebi.ac.uk/efo/EFO_0005230	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Carotenoid levels (alpha-carotene)	alpha-carotene measurement	http://www.ebi.ac.uk/efo/EFO_0007893	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft rejection in renal transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft rejection in renal transplantation (donor-recipient interaction)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Acute graft versus host disease in bone marrow transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Estimated glomerular filtration rate change in renal transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Graft survival time in renal transplantation (donor effect)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Graft survival time in renal transplantation (donor-recipient interaction)	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotenoid levels (lutein)	lutein measurement	http://www.ebi.ac.uk/efo/EFO_0007895	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotenoid levels (beta-carotene)	beta-carotene measurement	http://www.ebi.ac.uk/efo/EFO_0007894	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Abnormality of the urinary system	http://purl.obolibrary.org/obo/HP_0000079	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Rhegmatogenous retinal detachment	rhegmatogenous retinal detachment	http://www.ebi.ac.uk/efo/EFO_0005240	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Non-small cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-small cell lung cancer (recurrence rate)	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-small cell lung cancer (survival)	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Non-small cell lung cancer in heavy smokers	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Platinum-induced hepatotoxicity in non-small cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Platinum-induced myelosuppression in non-small cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to irinotecan in non-small-cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to platinum-based chemotherapy in non-small-cell lung cancer	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Smoking interaction in non-small cell lung cancer (1df test)	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Squamous cell carcinoma	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Right-sided colonic diverticulosis	colonic diverticula	http://purl.obolibrary.org/obo/HP_0002253	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
3-month functional outcome in ischaemic stroke (modified Rankin score)	stroke outcome severity measurement	http://www.ebi.ac.uk/efo/EFO_0009603	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	stroke outcome severity measurement	http://www.ebi.ac.uk/efo/EFO_0009603	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	stroke outcome severity measurement	http://www.ebi.ac.uk/efo/EFO_0009603	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Weight loss (gastric bypass surgery)	body weight loss	http://www.ebi.ac.uk/efo/EFO_0005245	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hypersomnia (HLA-DQB1*06:02 negative)	hypersomnia	http://www.ebi.ac.uk/efo/EFO_0005246	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Hypersomnia during a major depressive episode in bipolar disorder	hypersomnia	http://www.ebi.ac.uk/efo/EFO_0005246	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Anti-Helicobacter pylori IgG levels	anti-Helicobacter pylori serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0005247	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Helicobacter pylori serologic status	anti-Helicobacter pylori serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0005247	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Polymyositis	polymyositis	http://www.ebi.ac.uk/efo/EFO_0003063	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Self-employment	employment status	http://www.ebi.ac.uk/efo/EFO_0005241	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis (methamphetamine induced)	methamphetamine-induced psychosis	http://www.ebi.ac.uk/efo/EFO_0005242	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Circulating myeloperoxidase levels (plasma)	myeloperoxidase measurement	http://www.ebi.ac.uk/efo/EFO_0005243	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Circulating myeloperoxidase levels (serum)	myeloperoxidase measurement	http://www.ebi.ac.uk/efo/EFO_0005243	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Weight loss (gastric bypass surgery)	gastric bypass	http://www.ebi.ac.uk/efo/EFO_0005244	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Job-related exhaustion	occupation-related stress disorder	http://www.ebi.ac.uk/efo/EFO_0005250	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Disorders of lipid metabolism	Abnormality of lipid metabolism	http://purl.obolibrary.org/obo/HP_0003119	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Placental abruption	Abruptio Placentae	http://www.ebi.ac.uk/efo/EFO_1001754	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Petaloid toenail	petaloid toenail	http://www.ebi.ac.uk/efo/EFO_0007879	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Alanine aminotransferase levels in excessive alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alanine aminotransferase levels in low alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption (drinkers vs non-drinkers)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption (drinks per week)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption (drinks per week) (MTAG)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption (heavy vs. light/non-drinkers)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption (max-drinks)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption in current drinkers	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol consumption over the past year	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol dependence (giving up activities)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alcohol use disorder (consumption score)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aspartate aminotransferase levels in excessive alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aspartate aminotransferase levels in low alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood pressure x alcohol consumption interaction	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (alcohol intake interaction)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (alcohol consumption interaction)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (environment interaction)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gamma glutamyl transferase levels in excessive alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gamma glutamyl transferase levels in low alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip bone mineral density and alcohol drinking	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Maximum habitual alcohol consumption	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Orofacial clefts (maternal alcohol consumption interaction)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Spine bone mineral density and alcohol drinking	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip circumference ratio (alcohol intake interaction)	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Whole body bone mineral density and alcohol drinking	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bacteremia	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Multiple traits (pleiotropy)	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Daytime sleepiness	excessive daytime sleepiness measurement	http://www.ebi.ac.uk/efo/EFO_0007875	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Excessive daytime sleepiness	excessive daytime sleepiness measurement	http://www.ebi.ac.uk/efo/EFO_0007875	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep traits (multi-trait analysis)	excessive daytime sleepiness measurement	http://www.ebi.ac.uk/efo/EFO_0007875	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Central corneal thickness	central corneal thickness	http://www.ebi.ac.uk/efo/EFO_0005213	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (processing speed)	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive performance (processing speed) in major depressive disorder	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive performance (processing speed) x major depressive disorder status interaction	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cognitive performance (processing speed) x major depressive disorder type interaction	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Information processing speed	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
perceptual and visual search speed (trail making test A)	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
perceptual and visual search speed (trail making test A) (age interaction)	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
perceptual and visual search speed and executive function (trail making test BA)	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
perceptual and visual search speed and executive function (trail making test BA) (age interaction)	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Gut microbiota (alpha diversity)	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiota (bacterial taxa)	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiota (beta diversity)	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiota (functional units)	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Gut microbiota relative abundance (bacterial taxa)	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive decline	psychomotor performance	http://www.ebi.ac.uk/efo/EFO_0004362	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Number of sexual partners	risky sexual behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007877	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Risky sexual behaviors (alcohol dependence interaction)	risky sexual behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007877	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Risky sexual behaviors in alcohol dependence	risky sexual behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007877	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insomnia	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insomnia (caffeine-induced)	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insomnia symptoms (never/rarely vs. sometimes/usually)	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Insomnia symptoms (never/rarely vs. usually)	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep traits (multi-trait analysis)	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-response to citalopram or escitalopram and depression	response to escitalopram	http://www.ebi.ac.uk/efo/EFO_0007871	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to citalopram or escitalopram and depression	response to escitalopram	http://www.ebi.ac.uk/efo/EFO_0007871	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to citalopram or escitalopram in depression	response to escitalopram	http://www.ebi.ac.uk/efo/EFO_0007871	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Aspirin exacerbated respiratory disease in asthmatics	aspirin induced asthma	http://purl.obolibrary.org/obo/HP_0012042	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Aspirin intolerance in asthmatics	aspirin induced asthma	http://purl.obolibrary.org/obo/HP_0012042	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Brain connectivity	brain connectivity measurement	http://www.ebi.ac.uk/efo/EFO_0005210	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hip minimal joint space width	cartilage thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007873	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aspirin hydrolysis (plasma)	aspirin hydrolysis measurement	http://www.ebi.ac.uk/efo/EFO_0005211	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Personality dimensions	personality trait	http://www.ebi.ac.uk/efo/EFO_0004365	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Personality traits in bipolar disorder	personality trait	http://www.ebi.ac.uk/efo/EFO_0004365	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Temperament (bipolar disorder)	personality trait	http://www.ebi.ac.uk/efo/EFO_0004365	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Response to dendritic cell-based immunotherapy in HIV infection	response to dendritic cell-based immunotherapy	http://www.ebi.ac.uk/efo/EFO_0007880	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Dysmenorrheic pain	dysmenorrheic pain measurement	http://www.ebi.ac.uk/efo/EFO_0007889	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dysmenorrheic pain severity	dysmenorrheic pain measurement	http://www.ebi.ac.uk/efo/EFO_0007889	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Menstruation quality of life impact (dysmenorrhea)	dysmenorrheic pain measurement	http://www.ebi.ac.uk/efo/EFO_0007889	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Multiple traits (pleiotropy)	reading	http://www.ebi.ac.uk/efo/EFO_0005229	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Reading ability (multivariate)	reading	http://www.ebi.ac.uk/efo/EFO_0005229	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Reading or mathematical ability	reading	http://www.ebi.ac.uk/efo/EFO_0005229	Biological process	http://purl.obolibrary.org/obo/GO_0008150
DDT metabolite (p,p'-DDE levels)	DDT metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007886	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
JT interval (sulfonylurea treatment interaction)	JT interval	http://www.ebi.ac.uk/efo/EFO_0007885	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Age at voice drop	age at voice drop	http://www.ebi.ac.uk/efo/EFO_0007888	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Photic sneeze reflex	autosomal dominant compelling helio-ophthalmic outburst syndrome	http://www.ebi.ac.uk/efo/EFO_0007887	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Bronchial neuroendocrine tumor	pulmonary neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_0005220	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Hepatitis C (spontaneous viral clearance)	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatitis C induced liver fibrosis	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Hepatocellular carcinoma in hepatitis C infection	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Lichen planus in hepatitis C	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver fibrosis severity in HIV/hepatitis C co-infection	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Pre-treatment viral load in hepatitis C virus genotype 3	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to interferon treatment in hepatitis C virus genotype 3	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0003047	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Job-related exhaustion in shift workers	job-related exhaustion measurement	http://www.ebi.ac.uk/efo/EFO_0007881	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cholangiocarcinoma in primary sclerosing cholangitis	cholangiocarcinoma	http://www.ebi.ac.uk/efo/EFO_0005221	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	cholangiocarcinoma	http://www.ebi.ac.uk/efo/EFO_0005221	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Gut microbiota (bacterial taxa)	taxonomic microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007883	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Trans-epidermal water loss	skin barrier function measurement	http://www.ebi.ac.uk/efo/EFO_0007891	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pericardial adipose tissue adjusted for height and weight	pericardial adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0007890	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pericardial fat	pericardial adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0007890	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Liver fibrosis in non-alcoholic fatty acid liver disease	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Liver fibrosis severity in HIV/hepatitis C co-infection	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Tumor necrosis factor beta levels	tumor necrosis factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008308	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	tuberculin skin test reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0008307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	tuberculin skin test reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0008307	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	tumor necrosis factor receptor superfamily member 19L measurement	http://www.ebi.ac.uk/efo/EFO_0008309	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	trefoil factor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008304	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Full scale intelligence quotient (cesarean section interaction)	cesarean section	http://www.ebi.ac.uk/efo/EFO_0009636	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Performance intelligence quotient (cesarean section interaction)	cesarean section	http://www.ebi.ac.uk/efo/EFO_0009636	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Verbal intelligence quotient (cesarean section interaction)	cesarean section	http://www.ebi.ac.uk/efo/EFO_0009636	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
NT-proBNP levels in acute coronary syndrome	cardiovascular disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005278	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Subclinical atherosclerosis traits (other)	cardiovascular disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005278	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Blood protein levels	transmembrane glycoprotein NMB measurement	http://www.ebi.ac.uk/efo/EFO_0008303	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Temporomandibular joint disorder	temporomandibular joint disorder	http://www.ebi.ac.uk/efo/EFO_0005279	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	tryptase beta-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008306	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	trypsin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008305	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Frontotemporal lobar degeneration	pick disease	http://www.ebi.ac.uk/efo/EFO_0003096	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Sleep time	sleep time	http://www.ebi.ac.uk/efo/EFO_0005274	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
TRAIL levels	TNF-related apoptosis-inducing ligand measurement	http://www.ebi.ac.uk/efo/EFO_0008300	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels (Dihydroxy docosatrienoic acid)	dihydroxy docosatrienoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005275	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	transforming growth factor-beta-induced protein ig-h3 measurement	http://www.ebi.ac.uk/efo/EFO_0008302	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metabolite levels  (X-11787)	Hydroxy-leucine measurement	http://www.ebi.ac.uk/efo/EFO_0005276	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	toll-like receptor 4:Lymphocyte antigen 96 complex measurement	http://www.ebi.ac.uk/efo/EFO_0008301	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Night sleep phenotypes	sleep latency	http://www.ebi.ac.uk/efo/EFO_0005280	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep latency	sleep latency	http://www.ebi.ac.uk/efo/EFO_0005280	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vaginal discharge (metrorrhagia)	metrorrhagia	http://purl.obolibrary.org/obo/HP_0100608	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Sporadic pituitary adenoma	pituitary gland adenoma	http://www.ebi.ac.uk/efo/EFO_1000478	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Sick sinus syndrome	familial sick sinus syndrome	http://www.orpha.net/ORDO/Orphanet_166282	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Blood protein levels	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008319	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	vitamin K-dependent protein C measurement	http://www.ebi.ac.uk/efo/EFO_0008318	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	vascular endothelial growth factor receptor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008315	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	vascular endothelial growth factor receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008314	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cardiometabolic traits	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cholesterol ester levels in large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cholesterol ester levels in medium VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Chylomicron and largest VLDL particle concentration	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Free cholesterol levels in large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Free cholesterol levels in medium VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Free cholesterol levels in small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Medium VLDL particle concentration	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in chylomicrons and largest VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in medium VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in very large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Phospholipid levels in very small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Small VLDL particle concentration	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Total cholesterol levels in large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Total cholesterol levels in medium VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Total cholesterol levels in small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in chylomicrons and largest VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in medium VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in very large VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Triglyceride levels in very small VLDL	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Very large VLDL particle concentration	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Very low density lipoprotein cholesterol levels	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Very small VLDL particle concentration	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Vaso-occlusive pain in sickle-cell anemia	vaso-occlusive pain measurement	http://www.ebi.ac.uk/efo/EFO_0008316	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	tumor necrosis factor-inducible gene 6 protein measurement	http://www.ebi.ac.uk/efo/EFO_0008311	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	tumor necrosis factor receptor superfamily member EDAR measurement	http://www.ebi.ac.uk/efo/EFO_0008310	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	UMP-CMP kinase measurement	http://www.ebi.ac.uk/efo/EFO_0008313	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood protein levels	tyrosine-protein kinase receptor Tie-1, soluble measurement	http://www.ebi.ac.uk/efo/EFO_0008312	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Migraine with aura	migraine with aura	http://www.ebi.ac.uk/efo/EFO_0005295	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adverse response to chemotherapy (congestive heart failure) in breast cancer	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Anthracycline-induced cardiotoxicity in childhood cancer	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Left ventricular function change in anthracycline treatment	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Orthostatic hypotension	orthostatic hypotension	http://www.ebi.ac.uk/efo/EFO_0005252	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	response to antimicrotubule agent	http://www.ebi.ac.uk/efo/EFO_0005260	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	response to antimicrotubule agent	http://www.ebi.ac.uk/efo/EFO_0005260	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Mitral annular calcification	mitral annular calcification	http://www.ebi.ac.uk/efo/EFO_0005262	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (heart involvement)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (liver involvement)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Alcoholic hepatitis	Hepatitis, Alcoholic	http://www.ebi.ac.uk/efo/EFO_1001345	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Proteinuria	proteinuria	http://purl.obolibrary.org/obo/HP_0000093	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Proteinuria (mild)	proteinuria	http://purl.obolibrary.org/obo/HP_0000093	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Proteinuria (moderate to severe)	proteinuria	http://purl.obolibrary.org/obo/HP_0000093	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Proteinuria and chronic kidney disease	proteinuria	http://purl.obolibrary.org/obo/HP_0000093	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Proteinuria in chronic kidney disease	proteinuria	http://purl.obolibrary.org/obo/HP_0000093	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Fragile X syndrome	fragile X syndrome	http://www.orpha.net/ORDO/Orphanet_908	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Blood trace element (Cu levels)	serum copper measurement	http://www.ebi.ac.uk/efo/EFO_0005267	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Blood trace element (Zn levels)	serum zinc measurement	http://www.ebi.ac.uk/efo/EFO_0005268	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Congenital heart malformation	congenital heart malformation	http://www.ebi.ac.uk/efo/EFO_0005269	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Nephropathy	kidney disease	http://www.ebi.ac.uk/efo/EFO_0003086	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood trace element (Se levels)	serum selenium measurement	http://www.ebi.ac.uk/efo/EFO_0005266	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum selenium levels	serum selenium measurement	http://www.ebi.ac.uk/efo/EFO_0005266	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Borderline personality disorder	borderline personality disorder	http://purl.obolibrary.org/obo/HP_0012076	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Night sleep phenotypes	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (long sleep)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (oversleepers vs undersleepers)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (oversleepers)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (short sleep)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep duration (undersleepers)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep traits (multi-trait analysis)	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Night sleep phenotypes	sleep quality	http://www.ebi.ac.uk/efo/EFO_0005272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep (number of episodes)	sleep quality	http://www.ebi.ac.uk/efo/EFO_0005272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep efficiency	sleep quality	http://www.ebi.ac.uk/efo/EFO_0005272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep quality	sleep quality	http://www.ebi.ac.uk/efo/EFO_0005272	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sleep depth	sleep depth	http://www.ebi.ac.uk/efo/EFO_0005273	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Alanine aminotransferase levels in non-alcoholic fatty liver disease	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Aspartate aminotransferase levels in non-alcoholic fatty liver disease	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver fibrosis in non-alcoholic fatty acid liver disease	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Non-alcoholic fatty liver disease histology (AST)	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Non-alcoholic fatty liver disease histology (lobular)	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Non-alcoholic fatty liver disease histology (other)	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Nonalcoholic fatty liver disease	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Nonalcoholic fatty liver disease (SNP x SNP interaction)	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Pediatric non-alcoholic fatty liver disease activity score	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Plantar fascial disorders	Plantar Fibromatosis	http://www.ebi.ac.uk/efo/EFO_1000481	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Peanut allergy	peanut allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007017	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peanut allergy (maternal genetic effects)	peanut allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007017	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Peanut allergy (parent-of-origin effect)	peanut allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007017	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	response to ranibizumab	http://www.ebi.ac.uk/efo/EFO_0008348	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to ranibizumab in age-related macular degeneration (dry maculae)	response to ranibizumab	http://www.ebi.ac.uk/efo/EFO_0008348	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to ranibizumab in age-related macular degeneration (exudative)	response to ranibizumab	http://www.ebi.ac.uk/efo/EFO_0008348	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to ranibizumab in age-related macular degeneration (visual acuity)	response to ranibizumab	http://www.ebi.ac.uk/efo/EFO_0008348	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	response to trastuzumab	http://www.ebi.ac.uk/efo/EFO_0008347	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	response to trastuzumab	http://www.ebi.ac.uk/efo/EFO_0008347	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Food allergy	food allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007016	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food allergy (maternal genetic effects)	food allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007016	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Food allergy (parent-of-origin effect)	food allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007016	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cow's milk allergy	milk allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007019	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Milk allergy	milk allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007019	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Milk allergy (maternal genetic effects)	milk allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007019	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Milk allergy (parent-of-origin effect)	milk allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007019	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Egg allergy	egg allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007018	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Egg allergy (maternal genetic effects)	egg allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007018	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Egg allergy (parent-of-origin effect)	egg allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007018	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hen's egg allergy	egg allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007018	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thiazide-induced hyponatremia	thiazide-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0008349	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Colorectal cancer (aspirin and/or NSAID use interaction)	aspirin use measurement	http://www.ebi.ac.uk/efo/EFO_0007013	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Medication use (salicylic acid and derivatives)	aspirin use measurement	http://www.ebi.ac.uk/efo/EFO_0007013	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Major coronary event in placebo-treated cardiovascular disease (time to event)	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Myocardial infarction in placebo-treated cardiovascular disease (time to event)	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Placebo response in major depressive disorder (% change in symptom score)	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Placebo response in major depressive disorder (remitter/non-remitter status)	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Placebo response in major depressive disorder (responder/non-responder status)	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Aggressive periodontitis (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Allergic rhinitis x sex interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Attention deficit hyperactivity disorder (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x sex interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x sex x age interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Body mass index x sex x age interaction (4df test)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Carotid artery intima media thickness (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obsessive-compulsive disorder x sex interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Renal cell carcinoma x sex interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum bilirubin levels x sex interaction in metabolic syndrome	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Subcutaneous adipose tissue (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue adjusted for BMI (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist circumference (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio (sex interaction)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x sex interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x sex x age interaction	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (aspirin and/or NSAID use interaction)	NSAID use measurement	http://www.ebi.ac.uk/efo/EFO_0007012	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
3-hydroxy-1-methylpropylmercapturic acid levels in smokers	3-hydroxy-1-methylpropylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007015	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	family history of upper gastrointestinal cancer	http://www.ebi.ac.uk/efo/EFO_0008346	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007014	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Duloxetine response in major depressive disorder (% change in symptom score)	response to duloxetine	http://www.ebi.ac.uk/efo/EFO_0008345	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Duloxetine response in major depressive disorder (remitter/non-remitter status)	response to duloxetine	http://www.ebi.ac.uk/efo/EFO_0008345	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Duloxetine response in major depressive disorder (responder/non-responder status)	response to duloxetine	http://www.ebi.ac.uk/efo/EFO_0008345	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX measurement	http://www.ebi.ac.uk/efo/EFO_0007020	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-6 (red blood cell fatty acid level interaction)	alpha-linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008350	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Cellular adhesion molecule (red blood cell fatty acid level interaction)	cellular adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008353	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Parkinson disease and lewy body pathology	Lewy body measurement	http://www.ebi.ac.uk/efo/EFO_0007021	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Infective endocarditis in Staphylococcus aureus infection	bacterial endocarditis	http://www.ebi.ac.uk/efo/EFO_1000830	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Gastric atrophy	atrophic gastritis	http://www.ebi.ac.uk/efo/EFO_1000826	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Severe gastric atrophy	atrophic gastritis	http://www.ebi.ac.uk/efo/EFO_1000826	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Fractures (vertebral)	spinal fracture	http://www.ebi.ac.uk/efo/EFO_0003902	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
C-reactive protein (red blood cell fatty acid level interaction)	eicosadienoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008359	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	dorsolateral prefrontal cortex functional measurement	http://www.ebi.ac.uk/efo/EFO_0008358	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 2 diabetes (dietary heme iron intake interaction)	dietary heme iron intake measurement	http://www.ebi.ac.uk/efo/EFO_0008355	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive function	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (MTAG)	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (language ability)	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (language ability) x major depressive disorder status interaction	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (processing speed)	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (processing speed) in major depressive disorder	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (processing speed) x major depressive disorder status interaction	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive performance (processing speed) x major depressive disorder type interaction	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia or general cognitive function (pleiotropy)	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Asthma or atopy (farm exposure interaction)	farm exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008362	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
beta-lactam allergy measurement	beta-lactam allergy measurement	http://www.ebi.ac.uk/efo/EFO_0009694	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cleft plate (environmental tobacco smoke interaction)	environmental tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008361	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	environmental tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008361	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Common traits (Other)	astigmatism	http://purl.obolibrary.org/obo/HP_0000483	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Corneal astigmatism	astigmatism	http://purl.obolibrary.org/obo/HP_0000483	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Refractive astigmatism	astigmatism	http://purl.obolibrary.org/obo/HP_0000483	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Household income	household income	http://www.ebi.ac.uk/efo/EFO_0009695	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Behavioural disinhibition (generation interaction)	generational effect measurement	http://www.ebi.ac.uk/efo/EFO_0008364	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	thiopurine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009693	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	thiopurine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009693	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	thiopurine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009693	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	thiopurine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009693	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	environmental exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008360	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	environmental exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008360	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	environmental exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008360	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Thrombosis	deep vein thrombosis	http://www.ebi.ac.uk/efo/EFO_0003907	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Facial emotion recognition	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial emotion recognition (angry faces)	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial emotion recognition (fearful faces)	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial emotion recognition (happy faces)	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Facial emotion recognition (sad faces)	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to drug	adverse effect	http://www.ebi.ac.uk/efo/EFO_0009658	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to radiotherapy in prostate cancer (overall toxicity)	adverse effect	http://www.ebi.ac.uk/efo/EFO_0009658	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Blood protein levels	a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008326	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Chronotype	chronotype measurement	http://www.ebi.ac.uk/efo/EFO_0008328	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ease of getting up in the morning	chronotype measurement	http://www.ebi.ac.uk/efo/EFO_0008328	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Morning person	chronotype measurement	http://www.ebi.ac.uk/efo/EFO_0008328	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Morningness	chronotype measurement	http://www.ebi.ac.uk/efo/EFO_0008328	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Migraine without aura	migraine without aura	http://www.ebi.ac.uk/efo/EFO_0005296	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	decreased susceptibility to bacterial infection	http://www.ebi.ac.uk/efo/EFO_0008322	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	decreased susceptibility to bacterial infection	http://www.ebi.ac.uk/efo/EFO_0008322	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blood protein levels	WNT1-inducible-signaling pathway protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008321	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Wegener's granulomatosis	Granulomatosis with Polyangiitis	http://www.ebi.ac.uk/efo/EFO_0005297	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Allergic sensitization	allergic sensitization measurement	http://www.ebi.ac.uk/efo/EFO_0005298	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sulfasalazine-induced agranulocytosis	response to sulfasalazine	http://www.ebi.ac.uk/efo/EFO_0008324	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Non-word reading	non-word reading	http://www.ebi.ac.uk/efo/EFO_0005299	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Non-word repetition	non-word reading	http://www.ebi.ac.uk/efo/EFO_0005299	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Interleukin-2 levels	interleukin 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Neonatal cytokine/chemokine levels (fetal genetic effect)	interleukin 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008331	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Prostate cancer aggressiveness	Gleason score measurement	http://www.ebi.ac.uk/efo/EFO_0007000	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fear of pain	fear of pain measurement	http://www.ebi.ac.uk/efo/EFO_0008330	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	response to topoisomerase inhibitor	http://purl.obolibrary.org/obo/GO_0072758	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Severity of facial solar lentigines	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin pigmentation	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin pigmentation (conditioned on rs1426654 and rs35397)	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin reflectance (Melanin index)	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Skin, hair and eye pigmentation (multivariate analysis)	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depression	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depression in response to interferon-based therapy in chronic hepatitis C	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (appetite changes) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (appetite changes) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (concentration problems) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (concentration problems) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (depressed mood) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (depressed mood) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (fatigue) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (fatigue) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (low self-esteem) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (low self-esteem) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (psychomotor changes) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (psychomotor changes) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (sleep problems) (binary trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom (sleep problems) (ordinal trait)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom improvement	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptom measurement or major depressive disorder	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (MTAG)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (SSRI exposure interaction)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (binary sum-score)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (stressful life events interaction)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (sum-score)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms measurement (lack of negative affect domain)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms measurement (lack of positive affect domain)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms measurement (somatic complaints domain)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x dependent stressful life events interaction (1df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x dependent stressful life events interaction (2df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x independent stressful life events interaction (1df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x independent stressful life events interaction (2df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x stressful life events interaction (1df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms x stressful life events interaction (2df test)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Nicotine dependence and major depression (severity of comorbidity)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychological distress	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ketamine in bipolar disorder or major depression (antidepressant effects)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social science traits (pleiotropy) (HIPO component 1)	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (hypomanic personality scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (perceptual aberration scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (revised physical anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (revised social anhedonia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Psychosis proneness (schizoidia scale)	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Age at loss of ambulation in Duchenne muscular dystrophy	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cerebral microbleed progression	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease (indolent vs progressive)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease (time to first abdominal surgery)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Crohn's disease (time to progression)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Curve progression in adolescent idiopathic scoliosis	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disease progression in age-related macular degeneration	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disease progression to choroidal neovascularization form in age-related macular degeneration	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disease progression to geographic atrophy form in age-related macular degeneration	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Huntington's disease progression	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer tumour size	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Osteolysis in total hip arthroplasty (time to prosthesis revision)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Rate of cognitive decline in mild cognitive impairment (time interaction)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Severe progression in rheumatoid arthritis	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	free androgen index	http://www.ebi.ac.uk/efo/EFO_0007005	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fear of medical pain (dental)	fear of medical pain measurement	http://www.ebi.ac.uk/efo/EFO_0008339	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fear of severe pain	fear of severe pain measurement	http://www.ebi.ac.uk/efo/EFO_0008338	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	ticagrelor measurement	http://www.ebi.ac.uk/efo/EFO_0007007	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Luteinizing hormone levels in polycystic ovary syndrome	luteinizing hormone measurement	http://www.ebi.ac.uk/efo/EFO_0007002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	luteinizing hormone measurement	http://www.ebi.ac.uk/efo/EFO_0007002	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	T wave amplitude	http://www.ebi.ac.uk/efo/EFO_0008333	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	T wave amplitude	http://www.ebi.ac.uk/efo/EFO_0008333	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	T wave amplitude	http://www.ebi.ac.uk/efo/EFO_0008333	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	T wave amplitude	http://www.ebi.ac.uk/efo/EFO_0008333	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
DHEAS levels	dehydroepiandrosterone sulphate measurement	http://www.ebi.ac.uk/efo/EFO_0007001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
DHEAS levels in polycystic ovary syndrome	dehydroepiandrosterone sulphate measurement	http://www.ebi.ac.uk/efo/EFO_0007001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Dehydroepiandrosterone sulphate levels	dehydroepiandrosterone sulphate measurement	http://www.ebi.ac.uk/efo/EFO_0007001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	dehydroepiandrosterone sulphate measurement	http://www.ebi.ac.uk/efo/EFO_0007001	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Interleukin-2 receptor antagonist levels	interleukin 2 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0008332	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Progesterone levels	progesterone  measurement	http://www.ebi.ac.uk/efo/EFO_0007004	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sex hormone levels	progesterone  measurement	http://www.ebi.ac.uk/efo/EFO_0007004	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	ventricular repolarisation duration measurement	http://www.ebi.ac.uk/efo/EFO_0008335	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	ventricular repolarisation duration measurement	http://www.ebi.ac.uk/efo/EFO_0008335	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	ventricular repolarisation duration measurement	http://www.ebi.ac.uk/efo/EFO_0008335	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	ventricular repolarisation duration measurement	http://www.ebi.ac.uk/efo/EFO_0008335	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	TpTe measurement	http://www.ebi.ac.uk/efo/EFO_0008334	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	TpTe measurement	http://www.ebi.ac.uk/efo/EFO_0008334	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	TpTe measurement	http://www.ebi.ac.uk/efo/EFO_0008334	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	TpTe measurement	http://www.ebi.ac.uk/efo/EFO_0008334	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Fear of minor pain	fear of minor pain measurement	http://www.ebi.ac.uk/efo/EFO_0008340	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	response to ximelagatran	http://purl.obolibrary.org/obo/GO_0036288	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	parental emotion expression measurmement	http://www.ebi.ac.uk/efo/EFO_0008342	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Conduct disorder (maternal expressed emotions interaction)	parental emotion expression measurmement	http://www.ebi.ac.uk/efo/EFO_0008342	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (SSRI exposure interaction)	SSRI use measurement	http://www.ebi.ac.uk/efo/EFO_0007011	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Colorectal cancer (aspirin and/or NSAID use interaction)	drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Depressive symptoms (SSRI exposure interaction)	drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Drug experimentation measurement	drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pain medicine use during menstruation	drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007010	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Snoring	snoring measurement	http://www.ebi.ac.uk/efo/EFO_0008341	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Corneal structure	keratoconus	http://www.orpha.net/ORDO/Orphanet_156071	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Lumbar spinal stenosis	spinal stenosis	http://www.ebi.ac.uk/efo/EFO_0007490	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Response to iloperidone treatment (PANSS-T score)	response to iloperidone	http://purl.obolibrary.org/obo/GO_0036287	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to iloperidone treatment (QT prolongation)	response to iloperidone	http://purl.obolibrary.org/obo/GO_0036287	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Bone fracture in osteoporosis	bone fracture	http://www.ebi.ac.uk/efo/EFO_0003931	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Fractures	bone fracture	http://www.ebi.ac.uk/efo/EFO_0003931	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Nonunion in individuals with fractures	bone fracture	http://www.ebi.ac.uk/efo/EFO_0003931	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Phosphatidylethanolamine-ether levels	phosphatidylethanolamine ether measurement	http://www.ebi.ac.uk/efo/EFO_0010229	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	gamma wave measurement	http://www.ebi.ac.uk/efo/EFO_0008388	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate activity during disappointment	caudate nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0008387	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate activity during reward	caudate nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0008387	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen activity during reward	putamen measurement	http://www.ebi.ac.uk/efo/EFO_0008389	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Putamen actvity during disappointment	putamen measurement	http://www.ebi.ac.uk/efo/EFO_0008389	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to carbamazepine	response to anticonvulsant	http://purl.obolibrary.org/obo/GO_0036277	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to lamotrigine and phenytoin	response to anticonvulsant	http://purl.obolibrary.org/obo/GO_0036277	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Antiepileptic drug-induced maculopapular exanthema	response to anticonvulsant	http://purl.obolibrary.org/obo/GO_0036277	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	response to anticonvulsant	http://purl.obolibrary.org/obo/GO_0036277	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Major coronary event in darapladib-treated cardiovascular disease (time to event)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Odor events in darapladib-treated cardiovascular disease (time to event)	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Systemising	systemising measurement	http://www.ebi.ac.uk/efo/EFO_0010221	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Ceramide levels	ceramide measurement	http://www.ebi.ac.uk/efo/EFO_0010222	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Classic bladder exstrophy	bladder exstrophy	http://www.orpha.net/ORDO/Orphanet_93930	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Cytokine and corticosteroid-stimulated IL-6 production	response to cytokine	http://purl.obolibrary.org/obo/GO_0034097	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cytokine-stimulated IL-6 production	response to cytokine	http://purl.obolibrary.org/obo/GO_0034097	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Schizophrenia or verbal-numerical reasoning (pleiotropy)	verbal-numerical reasoning measurement	http://www.ebi.ac.uk/efo/EFO_0008394	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Caudate activity during disappointment	response to disappointment	http://www.ebi.ac.uk/efo/EFO_0008397	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Putamen actvity during disappointment	response to disappointment	http://www.ebi.ac.uk/efo/EFO_0008397	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diacylglyceride levels	diglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0010223	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Caudate activity during reward	response to reward	http://www.ebi.ac.uk/efo/EFO_0008396	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Putamen activity during reward	response to reward	http://www.ebi.ac.uk/efo/EFO_0008396	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Lysophosphatidylcholine levels	lysophosphatidylcholine measurement	http://www.ebi.ac.uk/efo/EFO_0010224	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Lysophosphatidylethanolamine levels	lysophosphatidylethanolamine measurement	http://www.ebi.ac.uk/efo/EFO_0010225	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Protein quantitative trait loci	erythropoetin measurement	http://www.ebi.ac.uk/efo/EFO_0008391	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Serum erythropoietin levels	erythropoetin measurement	http://www.ebi.ac.uk/efo/EFO_0008391	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phosphatidylcholine levels	phosphatidylcholine measurement	http://www.ebi.ac.uk/efo/EFO_0010226	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Prothrombin time	prothrombin time measurement	http://www.ebi.ac.uk/efo/EFO_0008390	Hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
Phosphatidylcholine-ether levels	phosphatidylcholine ether measurement	http://www.ebi.ac.uk/efo/EFO_0010227	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Reaction time	reaction time measurement	http://www.ebi.ac.uk/efo/EFO_0008393	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia or reaction time (pleiotropy)	reaction time measurement	http://www.ebi.ac.uk/efo/EFO_0008393	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Phosphatidylethanolamine levels	phosphatidylethanolamine measurement	http://www.ebi.ac.uk/efo/EFO_0010228	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Protein quantitative trait loci	triiodothyronine measurement	http://www.ebi.ac.uk/efo/EFO_0008392	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triiodothyronine levels	triiodothyronine measurement	http://www.ebi.ac.uk/efo/EFO_0008392	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Triiodothyronine levels and thyroxine levels	triiodothyronine measurement	http://www.ebi.ac.uk/efo/EFO_0008392	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
HIV-associated dementia	aids dementia	http://www.ebi.ac.uk/efo/EFO_0002608	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Arthritis (juvenile idiopathic)	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Pediatric autoimmune diseases	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Response to methotrexate in juvenile idiopathic arthritis	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Uveitis (juvenile idiopathic arthritis-associated)	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
Uveitis in juvenile idiopathic arthritis	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609	Immune system disorder	http://www.ebi.ac.uk/efo/EFO_0000540
BMI x dairy intake interaction (1df interaction test)	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Confectionary intake	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Dietary macronutrient intake	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Fat intake	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Obesity-related traits	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cardiovascular disease in hypertension (diuretic interaction)	response to diuretic	http://purl.obolibrary.org/obo/GO_0036270	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Myocardial infarction in hypertension (diuretic interaction)	response to diuretic	http://purl.obolibrary.org/obo/GO_0036270	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to diuretic therapy	response to diuretic	http://purl.obolibrary.org/obo/GO_0036270	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to diuretic therapy in hypertension	response to diuretic	http://purl.obolibrary.org/obo/GO_0036270	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	response to methylphenidate	http://purl.obolibrary.org/obo/GO_0036271	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	response to methylphenidate	http://purl.obolibrary.org/obo/GO_0036271	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Progression-free survival response to gemcitabine in breast cancer	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to cytidine analogues (gemcitabine)	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to gemcitabine in pancreatic cancer	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Cerivastatin-induced rhabdomyolysis	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Coronary heart disease event reduction (statin therapy interaction)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Coronary heart disease events during statin therapy	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Creatine kinase in statin users	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Drug-induced liver injury (statins)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to statin therapy	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to statin therapy (LDL cholesterol subfractions)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to statins (HDL cholesterol change)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to statins (LDL cholesterol change)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Statin-induced myopathy	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Statin-induced myopathy (severe)	response to statin	http://purl.obolibrary.org/obo/GO_0036273	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Lapatinib-induced hepatotoxicity	response to lapatinib	http://purl.obolibrary.org/obo/GO_0036274	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Lapatinib-induced hepatotoxicity in breast cancer	response to lapatinib	http://purl.obolibrary.org/obo/GO_0036274	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	response to 5' fluorouracil	http://purl.obolibrary.org/obo/GO_0036275	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	response to 5' fluorouracil	http://purl.obolibrary.org/obo/GO_0036275	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	response to 5' fluorouracil	http://purl.obolibrary.org/obo/GO_0036275	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Fluorouracil treatment response in colorectal cancer	response to 5' fluorouracil	http://purl.obolibrary.org/obo/GO_0036275	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
17-hydroxyprogesterone (17-OHP) levels	17-hydroxyprogesterone measurement	http://www.ebi.ac.uk/efo/EFO_0010220	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antidepressant treatment resistance (> 2 drugs prescribed)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Antidepressant treatment resistance (number of drugs prescribed)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Depressive symptom improvement	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Non-response to antidepressants and depression	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Remission after antidepressant treatment in major depression	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to anti-depressant treatment in major depressive disorder	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressant treatment	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressant treatment (citalopram)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressants	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressants (symptom improvement)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressants (symptom remission)	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressants and depression	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to antidepressants in depression	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to citalopram treatment	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Treatment resistant depression	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Body mass index (physical activity interaction)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HDL cholesterol x physical activity interaction (1df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
HDL cholesterol x physical activity interaction (2df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL cholesterol x physical activity interaction (1df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
LDL cholesterol x physical activity interaction (2df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Obesity-related traits	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Triglycerides x physical activity interaction (1df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Triglycerides x physical activity interaction (2df test)	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Cocaine dependence	cocaine dependence	http://www.ebi.ac.uk/efo/EFO_0002610	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Common traits (Other)	personality	http://www.ebi.ac.uk/efo/EFO_0003947	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Childhood insulin resistance	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Diabetes related insulin traits	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in higher physical activity	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in less-fat diet	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in lower physical activity	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in more-fat diet	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in non-obese individuals	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance in obesity	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance x BMI interaction	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance x physical activity interaction	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Insulin resistance/response	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Insulin-related traits	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Total mean fractional anisotropy measurement in first episode schizophrenia	mean fractional anisotropy measurement	http://www.ebi.ac.uk/efo/EFO_0008399	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
T wave morphology restitution during exercise	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
T wave morphology restitution during exercise (MTAG)	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
T wave morphology restitution during recovery from exercise	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
T wave morphology restitution during recovery from exercise (MTAG)	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Hormone measurements	osteocalcin measurement	http://www.ebi.ac.uk/efo/EFO_0010232	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Chromosomal aberration frequency (total) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High chromosomal aberration frequency (total) in genotoxic compound exposure	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Viral basal core promoter double mutation in hepatitis B virus surface antigen (HBsAg) seropositivity	viral subtype carrier status	http://www.ebi.ac.uk/efo/EFO_0010234	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Microscopic colitis in proton-pump inhibitor treatment	response to proton-pump inhibitor	http://www.ebi.ac.uk/efo/EFO_0010235	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Blue vs. brown eyes	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blue vs. green eyes	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Eye color	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Eye color traits	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iris color	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iris color (L* coordinate)	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iris color (a* coordinate)	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iris color (b* coordinate)	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Iris heterochromicity	eye color	http://www.ebi.ac.uk/efo/EFO_0003949	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Barrett's esophagus x gastroesophageal reflux disease interaction	gastroesophageal reflux disease	http://www.ebi.ac.uk/efo/EFO_0003948	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	gastroesophageal reflux disease	http://www.ebi.ac.uk/efo/EFO_0003948	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Gastroesophageal reflux disease	gastroesophageal reflux disease	http://www.ebi.ac.uk/efo/EFO_0003948	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pancreatic cancer	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Pancreatic ductal adenocarcinoma	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Response to gemcitabine in pancreatic cancer	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Survival in pancreatic cancer	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Phosphatidylinositol levels	phosphatidylinositol measurement	http://www.ebi.ac.uk/efo/EFO_0010230	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Sterol levels	sterol measurement	http://www.ebi.ac.uk/efo/EFO_0010231	Lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004529
Age-related diseases and mortality	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Age-related diseases, mortality and associated endophenotypes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease and diabetic kidney disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Coronary artery disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetes (incident)	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetes mellitus	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Early diabetic kidney disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
End-stage renal disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Estimated glomerular filtration rate in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glomerular filtration rate in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Glomerular filtration rate in diabetics (creatinine)	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Late diabetic kidney disease in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Medication adherence in chronic diseases	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Urinary albumin-to-creatinine ratio in diabetes	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease and diabetic kidney disease in diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Chronic kidney disease and diabetic kidney disease in type 2 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in type 2 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Diabetic nephropathy in type 1 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Early diabetic kidney disease in diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Early diabetic kidney disease in type 2 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
End-stage renal disease or diabetic nephropathy in type 1 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Late diabetic kidney disease in diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Late diabetic kidney disease in type 2 diabetes	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Type 2 diabetes nephropathy	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401	Metabolic disorder	http://www.ebi.ac.uk/efo/EFO_0000589
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	response to docetaxel	http://purl.obolibrary.org/obo/GO_1902519	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	response to docetaxel	http://purl.obolibrary.org/obo/GO_1902519	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	response to docetaxel	http://purl.obolibrary.org/obo/GO_1902519	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Neuropathy in taxane-treated breast cancer	response to docetaxel	http://purl.obolibrary.org/obo/GO_1902519	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Carotid intima media thickness	atherosclerosis	http://www.ebi.ac.uk/efo/EFO_0003914	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Diffuse cutaneous systemic sclerosis	diffuse scleroderma	http://www.ebi.ac.uk/efo/EFO_0000404	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	response to cyclophosphamide	http://purl.obolibrary.org/obo/GO_1902518	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	response to cyclophosphamide	http://purl.obolibrary.org/obo/GO_1902518	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	response to cyclophosphamide	http://purl.obolibrary.org/obo/GO_1902518	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	response to cyclophosphamide	http://purl.obolibrary.org/obo/GO_1902518	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	digestive system disease	http://www.ebi.ac.uk/efo/EFO_0000405	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Thiopurine-induced digestive symptoms in inflammatory bowel disease	digestive system disease	http://www.ebi.ac.uk/efo/EFO_0000405	Other disease	http://www.ebi.ac.uk/efo/EFO_0000408
Ankle-brachial index	ankle brachial index	http://www.ebi.ac.uk/efo/EFO_0003912	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Minimum ankle–brachial index	ankle brachial index	http://www.ebi.ac.uk/efo/EFO_0003912	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Subclinical atherosclerosis traits (other)	ankle brachial index	http://www.ebi.ac.uk/efo/EFO_0003912	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Diffuse large B cell lymphoma	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Diffuse large B-cell lymphoma or multiple sclerosis	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Diffuse large B-cell lymphoma or rheumatoid arthritis	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Diffuse large B-cell lymphoma or systemic lupus erythematosus	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Large B-cell lymphoma	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Antibody level in response to infection	human herpesvirus 8 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007039	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Anti-influenza A virus IgG seropositivity	Influenza A seropositivity	http://www.ebi.ac.uk/efo/EFO_0007038	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antibody level in response to infection	Influenza A seropositivity	http://www.ebi.ac.uk/efo/EFO_0007038	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain volume in infants (intracranial brain volume)	infant intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0008369	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Hyperopia	hyperopia	http://purl.obolibrary.org/obo/MONDO_0004891	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Antibody level in response to infection	Chlamydia pneumoniae seropositivity	http://www.ebi.ac.uk/efo/EFO_0007035	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting glucose in pregnancy (gestational week 14-16)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Fasting glucose in pregnancy (gestational week 30-32)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
General glucose level in pregnancy (gestational week 14-16)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
General glucose level in pregnancy (gestational week 30-32)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Timing of glucose curve peak in pregnancy (gestational week 14-16)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Timing of glucose curve peak in pregnancy (gestational week 30-32)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Two-hour glucose in pregnancy (gestational week 14-16)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Two-hour glucose in pregnancy (gestational week 30-32)	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antibody level in response to infection	seropositivity measurement	http://www.ebi.ac.uk/efo/EFO_0007034	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	foot muscle strength measurement	http://www.ebi.ac.uk/efo/EFO_0009699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	foot muscle strength measurement	http://www.ebi.ac.uk/efo/EFO_0009699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	foot muscle strength measurement	http://www.ebi.ac.uk/efo/EFO_0009699	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	heart amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008365	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Immunoglobulin light chain (AL) amyloidosis (heart involvement)	heart amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008365	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Anti-cytomegalovirus IgG seropositivity	cytomegalovirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007037	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antibody level in response to infection	cytomegalovirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007037	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bipolar disorder (inflammation and infection response interaction)	cytomegalovirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007037	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia (inflammation and infection response interaction)	cytomegalovirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007037	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain volume in infants (grey matter)	infant grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0008368	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Social deprivation	social deprivation	http://www.ebi.ac.uk/efo/EFO_0009696	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Antibody level in response to infection	herpes virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007036	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain volume in infants (cerebrospinal fluid)	infant cerebrospinal fluid volume measurement	http://www.ebi.ac.uk/efo/EFO_0008367	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PCBs	polychlorinated biphenyls measurement	http://www.ebi.ac.uk/efo/EFO_0007042	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Midgestational circulating levels of PCBs (fetal genetic effect)	polychlorinated biphenyls measurement	http://www.ebi.ac.uk/efo/EFO_0007042	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Polychlorinated biphenyl levels	polychlorinated biphenyls measurement	http://www.ebi.ac.uk/efo/EFO_0007042	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Laterality in neovascular age-related macular degeneration	laterality measurement	http://www.ebi.ac.uk/efo/EFO_0008372	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obese vs. thin	obese body mass index status	http://www.ebi.ac.uk/efo/EFO_0007041	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Obesity (extreme)	obese body mass index status	http://www.ebi.ac.uk/efo/EFO_0007041	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Urate levels in obese individuals	obese body mass index status	http://www.ebi.ac.uk/efo/EFO_0007041	Body measurement	http://www.ebi.ac.uk/efo/EFO_0004324
Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0007044	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Macular thickness	macula measurement	http://www.ebi.ac.uk/efo/EFO_0008375	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ranibizumab in age-related macular degeneration (dry maculae)	macula measurement	http://www.ebi.ac.uk/efo/EFO_0008375	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Glomerular filtration rate change in heart transplantation	response to transplant	http://www.ebi.ac.uk/efo/EFO_0007043	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Immunoglobulin light chain (AL) amyloidosis (liver involvement)	liver amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008374	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density x blood lead interaction in current smokers (1df test)	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density x blood lead interaction in current smokers (2df test)	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lead levels	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lead levels in blood	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mental development (prenatal lead exposure interaction)	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Motor development (prenatal lead exposure interaction)	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	kidney amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008371	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	kidney amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008371	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain volume in infants (white matter)	infant white matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0008370	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Urinary retention	http://purl.obolibrary.org/obo/HP_0000016	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Obstructive sleep apnea	obstructive sleep apnea	http://www.ebi.ac.uk/efo/EFO_0003918	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obstructive sleep apnea (average oxygen saturation during sleep)	obstructive sleep apnea	http://www.ebi.ac.uk/efo/EFO_0003918	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obstructive sleep apnea trait (apnea hypopnea index)	obstructive sleep apnea	http://www.ebi.ac.uk/efo/EFO_0003918	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Obstructive sleep apnea trait (average respiratory event duration)	obstructive sleep apnea	http://www.ebi.ac.uk/efo/EFO_0003918	Neurological disorder	http://www.ebi.ac.uk/efo/EFO_0000618
Bronchopulmonary dysplasia in preterm infants	premature birth	http://www.ebi.ac.uk/efo/EFO_0003917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Preterm birth (maternal effect)	premature birth	http://www.ebi.ac.uk/efo/EFO_0003917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	premature birth	http://www.ebi.ac.uk/efo/EFO_0003917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Surgical necrotising enterocolitis in extremely premature birth	premature birth	http://www.ebi.ac.uk/efo/EFO_0003917	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Disease-free survival in breast cancer	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Morbidity-free survival	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in colon cancer	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in microsatellite instability low/stable colorectal cancer	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in rectal cancer	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Type 1 diabetes in high risk HLA genotype individuals (time to event)	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Idiopathic dilated cardiomyopathy	dilated cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000407	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Age-related nuclear cataracts	age-related nuclear cataract	http://purl.obolibrary.org/obo/HP_0011142	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Cognitive function	cognition	http://www.ebi.ac.uk/efo/EFO_0003925	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Residual cognition	cognition	http://www.ebi.ac.uk/efo/EFO_0003925	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Black vs. blond hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Black vs. non-black hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Black vs. red hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blond vs non-blond hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blond vs. brown hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Blond vs. brown/black hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Brown vs. black hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Brown vs. non-brown hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Light vs. dark hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Red vs non-red hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Red vs. brown/black hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Red vs. non-red hair color	hair color	http://www.ebi.ac.uk/efo/EFO_0003924	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Biomedical quantitative traits	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (hip)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (paediatric, lower limb)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (paediatric, skull)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (paediatric, total body less head)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (paediatric, upper limb)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (sex interaction)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density (spine)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density x blood lead interaction in current smokers (1df test)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone mineral density x blood lead interaction in current smokers (2df test)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bone properties (heel)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
High bone mineral density	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Lumbar spine bone mineral density	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Obesity-related traits	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric areal bone mineral density (concordant skeletal phenotype)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
TB-LM or TBLH-BMD (pleiotropy)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (MTAG)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (age 0-15)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (age 15-30)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (age 30-45)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (age 45-60)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Total body bone mineral density (age over 60)	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Whole body bone mineral density and alcohol drinking	bone density	http://www.ebi.ac.uk/efo/EFO_0003923	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Aldosterone levels	aldosterone measurement	http://www.ebi.ac.uk/efo/EFO_0010219	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	response to epirubicin	http://purl.obolibrary.org/obo/GO_1902522	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	response to epirubicin	http://purl.obolibrary.org/obo/GO_1902522	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	response to doxorubicin	http://purl.obolibrary.org/obo/GO_1902520	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	response to doxorubicin	http://purl.obolibrary.org/obo/GO_1902520	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
Executive function	executive function	http://www.ebi.ac.uk/efo/EFO_0007046	Biological process	http://purl.obolibrary.org/obo/GO_0008150
Itch intensity from mosquito bite	mosquito bite reaction itch intensity measurement	http://www.ebi.ac.uk/efo/EFO_0008377	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Itch intensity from mosquito bite adjusted by bite size	mosquito bite reaction itch intensity measurement	http://www.ebi.ac.uk/efo/EFO_0008377	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	response to etoposide	http://purl.obolibrary.org/obo/GO_1902521	Response to drug	http://purl.obolibrary.org/obo/GO_0042493
P wave terminal force	P wave terminal force measurement	http://www.ebi.ac.uk/efo/EFO_0008379	Cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
Age-related cataracts	age-related cataract	http://purl.obolibrary.org/obo/HP_0011141	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Age-related cataracts (age at onset)	age-related cataract	http://purl.obolibrary.org/obo/HP_0011141	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anti-Toxoplasma gondii IgG seropositivity	Toxoplasma gondii seropositivity	http://www.ebi.ac.uk/efo/EFO_0007047	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia (inflammation and infection response interaction)	Toxoplasma gondii seropositivity	http://www.ebi.ac.uk/efo/EFO_0007047	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Itch intensity from mosquito bite adjusted by bite size	mosquito bite reaction size measurement	http://www.ebi.ac.uk/efo/EFO_0008378	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Mosquito bite size	mosquito bite reaction size measurement	http://www.ebi.ac.uk/efo/EFO_0008378	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Platinum-induced myelosuppression in non-small cell lung cancer	myelosuppression	http://www.ebi.ac.uk/efo/EFO_0007053	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Thiopurine-induced myelosuppression in inflammatory bowel disease	myelosuppression	http://www.ebi.ac.uk/efo/EFO_0007053	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	tumor necrosis factor receptor II measurement	http://www.ebi.ac.uk/efo/EFO_0008384	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Adult antisocial behavior	antisocial behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007052	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Antisocial behavior	antisocial behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007052	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	treatment outcome measurement	http://www.ebi.ac.uk/efo/EFO_0008383	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Odor events in darapladib-treated cardiovascular disease (time to event)	body odor measurement	http://www.ebi.ac.uk/efo/EFO_0008386	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Brain arteriovenous malformations (sporadic)	Cerebral arteriovenous malformation	http://www.orpha.net/ORDO/Orphanet_46724	Cancer	http://www.ebi.ac.uk/efo/EFO_0000616
Diabetic maculopathy with decreased visual acuity in type 2 diabetes	visual acuity measurement	http://www.ebi.ac.uk/efo/EFO_0008385	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	visual acuity measurement	http://www.ebi.ac.uk/efo/EFO_0008385	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Response to ranibizumab in age-related macular degeneration (visual acuity)	visual acuity measurement	http://www.ebi.ac.uk/efo/EFO_0008385	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vision loss in proton beam irradiation treatment of choroidal melanoma	visual acuity measurement	http://www.ebi.ac.uk/efo/EFO_0008385	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Inguinal hernia	inguinal hernia	http://purl.obolibrary.org/obo/HP_0000023	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Survival in microsatellite instability low/stable colorectal cancer	microsatellite instability measurement	http://www.ebi.ac.uk/efo/EFO_0007054	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Perceived unattractiveness to mosquitoes	perceived unattractiveness to mosquitos measurement	http://www.ebi.ac.uk/efo/EFO_0008380	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Survival in breast cancer (TP53 expression interaction)	TP53 mutation status	http://www.ebi.ac.uk/efo/EFO_0008382	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Vein graft stenosis in coronary artery bypass grafting	vein graft stenosis	http://www.ebi.ac.uk/efo/EFO_0007051	Other trait	http://www.ebi.ac.uk/efo/EFO_0000001
Anti-herpes simplex virus 1 IgG seropositivity	HSV1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007050	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Bipolar disorder (inflammation and infection response interaction)	HSV1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007050	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Schizophrenia (inflammation and infection response interaction)	HSV1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007050	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Occipital cortical area (total cortical area interaction)	total cortical area measurement	http://www.ebi.ac.uk/efo/EFO_0008381	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Coronary arterial lesions in patients with Kawasaki disease	coronary aneurysm	http://www.ebi.ac.uk/efo/EFO_1000881	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Coronary artery aneurysm in Kawasaki disease	coronary aneurysm	http://www.ebi.ac.uk/efo/EFO_1000881	Cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
Surgical necrotising enterocolitis in extremely premature birth	necrotizing enterocolitis	http://www.ebi.ac.uk/efo/EFO_0003928	Digestive system disorder	http://www.ebi.ac.uk/efo/EFO_0000405
Cognitive performance	neuropsychological test	http://www.ebi.ac.uk/efo/EFO_0003926	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444
Cognitive test performance	neuropsychological test	http://www.ebi.ac.uk/efo/EFO_0003926	Other measurement	http://www.ebi.ac.uk/efo/EFO_0001444